Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81110487-81166221 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 184.7" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 243.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.0" "Group enriched" "Detected in some" 6 "CACO-2: 60.1;SH-SY5Y: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 39: CACO-2 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 3.3 4.2 35.4 3.1 79.2 3.7 2.3 43.4 82.0 2.8 0.0 7.7 30.9 0.9 0.5 1.8 2.8 2.7 3.9 30.6 30.8 1.0 0.9 9.5 0.9 99.2 67.9 0.9 20.6 3.0 17.3 2.0 63.4 5.2 0.5 2.1 5.9 3.3 0.6 4.5 23.7 0.8 38.8 9.7 5.8 0.7 78.4 0.1 2.9 1.0 0.2 2.8 4.2 184.7 0.3 0.5 0.7 4.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 60.1 0.2 0.0 0.3 0.0 0.0 1.2 0.6 0.0 0.0 0.0 2.0 2.2 3.2 2.8 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 0.0 6.6 0.0 0.2 0.7 0.6 0.3 2.1 4.1 0.6 0.0 0.2 4.5 17.1 0.2 0.4 2.3 0.2 1.1 2.2 2.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 0.2 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 35.4 79.2 43.4 82.0 30.6 30.8 99.2 67.9 63.4 38.8 78.4 184.7 6.3 32.1 20.3 17.0 0.3 0.3 1.0 1.9 0.6 43.0 1.3 5.1 2.2 2.8 0.1 0.0 4.2 0.1 0.5 6.8 0.0 0.6 0.0 0.4 0.2 1.8 1.8 0.0 34.6 1.8 0.1 0.5 7.1 0.6 6.3 2.0 1.1 0.1 2.1 21.9 36.0 4.6 0.0 2.8 0.4 0.0 1.5 8.2 5.4 2.8 1.5 9.6 4.1 21.1 243.2 1.1 4.2 2.6 0.1 0.9 34.1 0.9 0.0 4.4 0.0 4.3 0.8 0.4 0.5 0.0 0.3 2.3 1.4 0.4 7.0 0.2 AC010422.5 ENSG00000269590 "Novel protein" 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.2;lymphoid tissue: 1.4;skeletal muscle: 1.3" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Lineage enhanced" "Detected in single" "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "MCF7: 10.8;RT4: 5.5" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Endoplasmic reticulum" "HPA065685: AB_2685531" 0.1 0.8 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 1.4 0.1 0.1 0.5 0.0 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.4 0.0 0.3 0.7 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.6 0.0 0.3 0.7 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.9 0.1 0.0 0.0 0.1 0.3 2.7 0.0 10.8 2.8 0.3 0.7 0.0 0.0 1.0 0.0 0.0 0.9 5.5 1.6 1.3 0.0 1.3 0.3 0.0 1.7 0.5 0.0 3.7 0.1 1.4 1.7 1.7 2.5 1.3 3.4 0.6 1.5 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068533.4 ENSG00000249319 "Novel protein" 7 66087761-66152277 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 10.6" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.24e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" "unprognostic (2.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.74e-1)" "unprognostic (2.32e-1)" "unprognostic (2.50e-3)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" 0.5 0.4 1.0 0.9 1.2 1.8 1.7 1.1 3.4 2.0 0.8 2.8 2.0 1.0 0.9 0.9 1.1 0.8 0.4 1.1 1.5 1.6 4.7 1.2 0.5 1.3 1.3 0.9 0.5 1.8 0.5 0.5 1.3 1.4 1.8 2.7 0.6 1.4 0.4 0.5 1.0 1.2 1.0 0.7 1.6 0.4 1.2 0.9 1.1 1.3 1.0 0.6 0.4 1.1 1.6 0.0 1.6 1.2 3.9 6.0 0.5 2.1 2.7 0.6 1.0 1.0 2.4 2.1 2.4 6.7 4.1 2.2 0.3 1.4 3.0 0.4 1.8 0.7 0.9 0.0 2.2 1.0 2.3 3.4 3.1 3.7 6.0 5.6 1.1 0.5 1.7 0.9 0.3 0.9 1.5 1.2 0.0 7.9 1.9 0.8 1.1 2.2 2.7 1.1 2.2 2.9 1.6 10.6 0.5 4.0 3.4 0.6 3.8 0.8 0.6 1.9 1.7 1.4 2.0 0.6 7.4 3.0 0.3 2.0 0.8 0.4 1.0 0.5 1.2 1.9 0.4 1.0 0.3 1.0 1.1 1.4 1.6 1.7 1.3 0.4 0.9 0.3 1.0 1.2 1.1 3.4 1.1 1.5 1.3 1.3 1.3 1.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC072022.2 ENSG00000285938 "BCL6 antisense 1" 3 187743686-187746028 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "bone marrow: 6.9;brain: 17.6;skeletal muscle: 22.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "neutrophil: 10.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "Daudi: 3.0;U-698: 6.8" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 3.0 1.8 2.2 3.2 1.4 6.9 0.0 3.5 1.9 0.0 0.0 0.1 0.3 0.7 0.0 0.7 0.2 1.6 1.0 1.0 6.1 0.2 0.4 0.5 1.3 17.6 3.8 0.7 1.7 0.1 0.3 5.8 0.2 0.0 0.8 1.2 0.0 22.9 1.8 0.5 0.0 3.7 1.3 0.2 2.2 4.9 0.0 0.4 0.4 0.1 0.4 3.8 0.0 0.5 1.1 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 3.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.1 1.1 0.9 0.0 0.0 0.9 0.2 0.3 0.2 0.9 0.6 6.8 0.4 0.2 0.4 0.0 0.8 0.9 0.1 0.3 0.8 0.2 0.2 0.3 0.2 0.1 0.0 0.1 10.3 0.1 0.2 0.1 0.1 0.1 2.2 1.4 3.5 1.9 1.0 6.1 17.6 3.8 5.8 3.7 4.9 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC090527.2 ENSG00000260170 "Novel protein" 15 45587351-45676314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;THP-1: 1.1" HPA041589 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: THP-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA041589: AB_2677565" "unprognostic (5.93e-2)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.2 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.3 0.2 2.2 1.7 0.9 0.8 0.8 1.0 0.7 0.7 0.3 0.0 1.3 1.6 0.4 6.2 0.0 0.9 0.5 1.2 0.4 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC099489.1 ENSG00000188897 "Novel lipoprotein amino terminal region containing protein" 16 11359845-11527245 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 5.3;Glandular and luminal cells: 2.3;granulocytes: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 12 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "Daudi: 3.1;HDLM-2: 3.4;U-266/70: 1.7" "Not detected" "Not detected" HPA042154 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA042154: AB_2677877" "unprognostic (4.69e-2)" "unprognostic (3.80e-2)" "unprognostic (7.24e-2)" "unprognostic (5.91e-2)" "unprognostic (1.21e-3)" "unprognostic (7.91e-2)" "unprognostic (9.18e-2)" "unprognostic (6.08e-2)" "unprognostic (8.04e-2)" "unprognostic (5.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.04e-1)" "unprognostic (3.72e-6)" "unprognostic (3.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (4.33e-5)" 2.2 0.5 0.7 3.7 0.6 1.5 0.9 0.8 1.7 1.7 0.6 0.8 0.1 0.9 0.3 0.5 3.4 0.5 1.4 0.6 0.4 2.2 2.3 5.2 0.8 0.6 0.5 0.7 0.8 0.5 1.0 0.3 1.0 1.9 0.1 0.2 3.0 0.4 2.4 3.6 1.0 0.1 0.4 18.6 1.2 4.8 0.5 0.2 0.9 0.4 0.3 1.6 1.1 0.9 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.1 1.0 0.3 0.0 0.0 0.2 0.1 1.1 0.0 0.2 0.3 0.2 0.0 0.4 0.4 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.8 1.7 0.6 0.4 0.6 0.5 1.0 0.4 0.5 0.9 0.4 9.6 5.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 1.5 0.0 0.0 1.3 0.0 0.0 0.1 1.0 0.0 0.0 0.5 0.0 1.6 0.9 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.0 2.3 3.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 AC107959.5 ENSG00000284956 "Novel protein" 8 23084403-23115536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 1.6;testis: 1.8" "Cell type enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 7 "neutrophil: 221.6" "Lineage enriched" "Detected in many" 142 "granulocytes: 221.6" "Cell line enhanced" "Detected in many" "AN3-CA: 18.5;HDLM-2: 22.7" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 44: HDLM-2 - Immune response" "Cluster 60: Granulocytes - Receptor signaling" 0.2 1.0 0.6 0.5 0.6 1.2 0.0 0.4 0.7 0.1 1.0 0.1 0.2 0.0 0.1 0.1 0.0 1.6 0.0 0.5 0.6 1.0 0.0 0.1 0.0 0.6 0.5 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.5 0.3 0.1 1.8 0.5 0.0 0.2 0.2 0.1 0.0 0.5 3.4 5.6 1.0 18.5 0.0 3.6 3.7 0.0 0.7 0.4 3.4 0.7 1.3 3.7 5.0 1.6 1.2 0.1 0.8 0.8 2.7 22.7 1.9 0.0 2.4 11.5 2.0 0.6 7.5 2.0 2.6 1.1 0.9 4.5 3.6 0.5 0.9 0.0 0.8 0.3 0.0 1.1 4.2 4.4 0.8 0.1 1.1 0.4 1.0 0.2 0.3 0.1 0.4 2.3 5.7 1.3 2.2 0.4 1.4 5.9 7.8 8.2 0.9 7.7 6.6 0.4 7.5 1.7 5.6 2.4 1.5 31.4 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 221.6 0.2 1.4 0.0 0.0 0.4 0.6 0.6 0.4 0.7 0.5 0.6 0.6 0.5 0.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAP2 "CENTB2, CNT-B2, KIAA0041" ENSG00000114331 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 2" Q15057 3 195274745-195443044 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 215.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034807, HPA034808" Supported Approved Endosomes NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" Endosomes "HPA034807: AB_10669896, HPA034808: AB_10673103" "unprognostic (9.13e-2)" "unprognostic (1.75e-3)" "unprognostic (7.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.90e-2)" "unprognostic (5.64e-2)" "unprognostic (3.08e-3)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (3.77e-2)" "unprognostic (8.54e-2)" 15.9 10.2 10.7 22.2 10.3 39.6 13.5 21.4 14.5 14.3 1.8 17.0 14.0 14.4 10.9 21.7 12.2 14.2 8.3 14.1 6.4 10.3 11.8 15.7 26.9 2.5 4.2 19.0 9.0 13.2 8.5 15.5 6.1 10.7 17.3 29.4 9.5 10.4 5.3 15.5 15.3 14.5 3.3 23.6 14.0 15.1 5.0 21.0 21.7 9.7 27.9 13.5 11.5 7.7 34.6 13.5 21.5 21.1 34.3 41.9 31.6 28.0 37.2 20.5 21.4 18.5 19.8 38.7 65.7 25.8 20.0 21.6 16.5 14.0 29.4 43.4 9.7 38.5 14.2 7.6 33.5 52.5 26.7 32.3 24.0 20.4 46.1 17.6 22.7 21.4 19.1 37.0 30.3 20.3 33.7 19.1 13.0 19.8 18.1 39.7 24.8 27.8 14.1 32.2 23.8 11.5 30.7 27.4 32.9 18.2 51.7 30.6 40.3 25.9 14.7 34.6 32.7 21.8 50.2 84.0 19.1 56.2 27.5 62.8 55.2 55.3 27.5 49.0 21.2 39.3 26.1 21.3 32.9 45.6 22.0 22.4 215.8 17.6 59.0 34.4 26.2 25.4 10.7 10.3 21.4 14.5 14.1 6.4 2.5 4.2 6.1 3.3 5.0 7.7 110.7 44.8 40.9 103.8 103.1 44.5 28.8 45.1 88.2 58.7 43.1 50.3 17.9 22.8 43.4 31.3 77.2 20.2 101.9 75.8 19.6 24.1 11.1 49.7 60.4 74.1 51.6 50.1 141.2 24.3 22.2 62.2 44.4 49.7 39.9 33.5 57.5 32.5 65.4 121.1 143.1 44.4 22.4 115.7 67.5 9.7 46.6 110.8 35.6 143.4 122.3 29.1 68.0 132.7 130.1 31.7 70.7 37.6 67.6 41.5 39.3 28.6 45.1 92.6 59.2 43.8 61.4 39.6 26.7 143.7 51.7 29.0 85.1 43.0 37.6 38.6 ADARB2 "ADAR3, hRED2, RED2" ENSG00000185736 "Adenosine deaminase RNA specific B2 (inactive)" Q9NS39 10 1177313-1737525 "Predicted intracellular proteins" "mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 46.7" "Group enriched" "Detected in many" 4 "Inhibitory neurons: 1726.7;Oligodendrocyte precursor cells: 693.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 4.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.64e-2)" "unprognostic (7.44e-3)" "unprognostic (2.12e-1)" "unprognostic (2.62e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (9.58e-2)" "unprognostic (9.28e-3)" "unprognostic (3.41e-1)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-1)" "unprognostic (3.81e-3)" 0.1 0.2 18.8 0.0 25.9 0.2 0.8 15.6 18.1 0.7 0.2 2.3 0.1 0.2 0.0 0.3 1.1 0.0 0.4 12.9 20.7 0.3 0.1 0.6 0.2 21.7 20.2 0.1 3.5 0.0 0.4 0.1 21.7 0.5 0.0 3.0 4.2 0.8 0.0 0.3 0.8 0.0 16.4 0.1 0.7 2.9 29.7 1.0 0.1 0.1 0.4 0.6 0.5 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 4.7 1.1 0.0 0.0 0.4 0.1 18.8 25.9 15.6 18.1 12.9 20.7 21.7 20.2 21.7 16.4 29.7 46.7 0.3 0.0 0.0 57.8 0.7 0.0 0.1 0.0 4.6 11.1 1.7 0.6 1.9 2.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 40.9 1.6 0.1 0.5 0.0 0.0 9.2 0.0 0.0 0.3 0.5 0.3 0.0 4.8 4.6 0.0 0.2 1.7 1726.7 0.0 0.0 0.0 0.0 133.9 0.3 0.0 3.6 6.5 0.0 30.5 2.1 693.7 254.6 0.0 0.0 0.4 0.0 0.1 0.1 2.9 0.0 1.4 6.6 0.0 0.4 1.2 1.0 3.3 0.0 0.0 0.6 0.2 0.3 0.1 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 225.2;Microglial cells: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.2 18.0 10.7 18.1 11.8 35.0 22.8 8.1 13.0 24.8 51.4 25.9 18.2 25.6 11.8 19.1 21.4 19.6 19.6 10.2 10.0 32.8 24.8 20.7 16.3 16.3 9.8 28.8 28.2 31.8 12.5 26.8 11.8 18.2 22.5 63.6 24.0 22.8 55.6 23.4 19.4 31.9 9.1 19.4 19.0 6.9 14.2 22.8 54.9 41.8 13.4 18.5 19.0 12.0 15.3 13.5 11.3 12.0 18.3 21.6 15.9 15.1 22.2 11.3 16.7 14.7 27.8 17.3 20.2 18.7 14.4 6.8 18.0 22.8 15.7 29.8 7.2 36.0 38.3 12.3 14.1 35.0 27.4 17.7 16.1 19.4 17.0 16.4 42.1 14.1 22.5 47.5 4.8 4.1 31.6 10.1 15.0 25.6 4.8 24.7 6.7 22.2 33.1 14.5 25.6 4.7 23.1 15.0 7.2 23.5 9.0 28.9 21.3 20.9 18.8 12.9 8.5 41.0 24.8 29.6 17.1 39.5 7.7 5.4 7.4 17.6 8.8 5.4 9.8 12.0 11.8 8.9 8.5 14.5 6.0 5.8 28.4 7.7 3.3 20.7 11.3 4.2 10.7 11.8 8.1 13.0 10.2 10.0 16.3 9.8 11.8 9.1 14.2 12.0 88.0 41.7 55.6 125.7 29.3 24.1 20.2 17.8 33.6 41.7 20.6 11.6 119.8 40.0 28.4 92.0 225.2 1.4 29.1 40.7 3.9 11.9 7.2 32.4 39.1 50.2 32.3 54.5 69.2 12.6 4.2 36.3 42.8 46.2 25.2 40.3 65.0 34.2 13.0 18.5 47.5 35.8 16.2 41.7 32.8 9.3 29.2 34.8 23.2 202.4 16.5 21.4 16.5 74.4 84.0 13.1 31.4 28.6 53.9 21.9 29.8 50.3 36.0 147.2 26.3 41.9 31.2 3.8 11.3 45.3 31.7 32.8 26.4 13.3 29.0 15.8 AHSP "EDRF, ERAF" ENSG00000169877 "Alpha hemoglobin stabilizing protein" Q9NZD4 16 31527900-31528803 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 62 "bone marrow: 1669.9" "Cell type enriched" "Detected in some" 296 "Erythroid cells: 8721.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 3.0;K-562: 1.5" "Low region specificity" "Detected in some" HPA040940 Enhanced NA NA 5300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" "HPA040940: AB_10796231" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (8.44e-2)" "unprognostic (3.76e-1)" "unprognostic (1.53e-1)" "unprognostic (3.10e-1)" "unprognostic (2.16e-1)" "unprognostic (3.70e-3)" "unprognostic (2.04e-2)" "unprognostic (9.02e-2)" "unprognostic (3.25e-2)" 1.3 0.1 0.6 0.2 0.6 1669.9 0.4 0.6 2.6 0.4 0.6 0.1 0.0 0.1 0.0 0.2 0.2 0.0 1.5 0.6 0.5 1.9 4.7 4.5 0.2 0.7 0.7 0.2 0.3 0.1 1.4 27.1 0.7 0.1 0.3 0.0 0.5 0.0 0.2 1.4 0.1 0.0 0.6 23.7 0.2 4.1 0.6 2.9 0.7 8.9 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 4.7 0.6 0.6 0.6 2.6 0.6 0.5 0.7 0.7 0.7 0.6 0.6 0.8 0.1 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.6 0.0 8721.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 2.9 4.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 29.4 0.3 2.8 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.0 0.0 2.1 0.0 0.0 0.1 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 11.4 13.3 10.5 12.3 12.4 10.6 12.3 11.4 13.6 11.5 15.1 11.4 9.5 12.4 8.8 10.6 10.4 10.7 7.4 11.3 11.6 13.1 8.1 11.0 16.0 9.9 10.7 13.5 8.4 15.1 7.5 12.2 10.6 10.9 11.6 15.3 9.8 11.7 7.2 9.5 10.1 13.3 10.4 14.9 11.1 14.2 13.8 14.1 15.1 9.4 12.5 11.3 10.2 14.7 18.1 21.3 13.9 9.7 18.0 22.5 25.7 20.6 21.9 22.4 26.7 23.2 10.6 15.4 13.6 16.4 19.4 18.8 18.1 17.2 30.4 12.8 15.4 13.2 20.2 11.4 17.0 9.7 20.7 19.1 21.1 20.5 25.1 25.0 18.3 18.5 8.6 7.5 23.6 13.1 18.1 14.3 9.1 25.1 7.2 11.8 45.5 8.1 18.7 11.3 4.7 14.1 23.6 11.0 19.7 84.8 26.7 10.7 16.1 17.2 14.2 14.8 19.3 9.3 10.7 18.8 22.8 11.5 17.0 4.9 9.7 12.6 8.6 14.4 8.0 8.4 8.4 9.4 8.5 9.2 10.0 8.9 33.8 7.6 13.9 6.3 7.1 4.3 10.5 12.4 11.4 13.6 11.3 11.6 9.9 10.7 10.6 10.4 13.8 14.7 13.4 3.2 12.3 71.2 24.4 7.0 9.7 8.9 10.2 24.6 11.1 9.0 8.4 21.5 11.9 5.5 16.7 14.9 16.8 15.8 1.9 9.9 12.8 11.0 14.8 12.6 7.2 15.2 55.1 7.2 11.1 11.7 14.8 10.8 10.1 18.0 16.8 13.6 16.5 33.7 54.6 9.9 12.2 35.1 10.5 13.9 15.2 21.4 5.4 61.8 32.3 11.7 25.7 51.8 78.5 7.9 15.2 13.9 11.2 15.6 14.6 5.7 15.3 23.2 19.7 10.5 11.2 23.1 23.6 11.0 7.7 14.0 19.0 15.6 11.8 12.1 AKAP8L "HAP95, NAKAP95" ENSG00000011243 "A-kinase anchoring protein 8 like" Q9ULX6 19 15380050-15419141 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042485, HPA042546" Enhanced Supported "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Nuclear speckles" "HPA042485: AB_2678019, HPA042546: AB_2678046" "unprognostic (9.52e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (3.53e-2)" "unprognostic (1.38e-2)" "unprognostic (2.87e-2)" "unprognostic (1.08e-1)" "unprognostic (3.57e-2)" "prognostic favorable (8.04e-4)" "unprognostic (1.01e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.77e-1)" "unprognostic (1.07e-1)" "unprognostic (8.80e-2)" "unprognostic (2.34e-3)" 27.2 32.8 25.1 4.0 25.5 32.3 26.9 26.0 32.2 34.8 21.8 32.7 2.5 23.5 11.9 23.4 31.8 7.5 41.5 24.4 25.3 29.3 28.8 33.5 9.4 24.1 24.4 36.2 22.5 11.1 40.4 9.3 24.7 32.3 5.8 37.4 23.2 6.3 60.5 34.5 24.0 6.4 25.0 31.5 24.7 48.8 25.8 20.6 33.9 24.1 10.8 26.8 28.1 26.1 25.4 25.8 32.3 17.2 32.3 34.0 18.8 21.0 25.1 34.0 30.9 41.5 35.2 23.2 38.8 23.4 31.8 29.9 51.2 28.3 29.8 39.8 44.2 40.3 21.9 34.0 57.3 38.8 26.6 29.6 52.0 27.2 35.3 31.3 25.4 38.0 51.3 41.9 21.3 34.3 39.0 32.6 31.9 32.0 41.9 46.6 22.8 25.2 28.7 8.5 37.2 23.5 26.2 28.3 37.5 42.4 20.8 42.2 30.4 20.5 15.4 34.4 36.7 60.1 48.0 49.5 19.2 39.8 23.5 0.1 1.8 1.7 0.9 0.8 1.8 1.7 0.8 1.0 1.5 2.3 1.3 1.2 3.5 0.5 1.0 1.4 2.8 0.8 25.1 25.5 26.0 32.2 24.4 25.3 24.1 24.4 24.7 25.0 25.8 26.1 34.7 6.4 15.9 55.5 39.1 31.6 48.2 22.6 26.2 60.9 34.6 29.3 7.7 17.2 30.0 35.0 77.2 35.6 47.3 22.5 25.4 32.6 34.6 52.7 33.7 29.8 25.6 114.9 59.1 31.8 28.6 26.0 50.0 42.6 13.9 69.6 17.5 17.0 16.3 79.1 45.1 22.0 26.4 18.6 32.8 9.9 26.4 31.3 26.6 19.7 24.0 42.0 30.9 29.7 38.5 32.5 19.9 29.3 38.2 33.2 13.6 17.3 32.1 83.2 26.3 27.8 45.2 83.3 63.9 26.4 39.2 62.4 44.0 60.2 18.3 40.2 AL049634.2 ENSG00000260861 "Novel protein, SIRPB1-SIRPD readthrough" 20 1540144-1620009 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.7;lymphoid tissue: 2.6;testis: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 78.3;neutrophil: 127.7" "Group enriched" "Detected in many" 7 "granulocytes: 127.7;monocytes: 43.6" "Cell line enhanced" "Detected in some" "HL-60: 3.5;HMC-1: 6.7;NB-4: 2.6;THP-1: 4.0;U-937: 2.1" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" 0.4 0.8 0.1 2.6 0.1 2.7 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.5 0.7 0.8 0.1 0.2 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.6 0.6 0.2 0.8 0.1 3.3 0.5 0.2 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.7 0.0 0.1 0.2 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.0 1.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 2.1 0.1 0.6 35.3 78.3 0.6 27.5 0.3 0.1 0.0 0.4 12.9 0.0 0.1 0.1 127.7 0.2 43.6 10.4 0.2 26.0 0.1 0.1 0.0 0.3 0.1 0.3 0.1 0.2 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121899.2 ENSG00000286022 "Novel protein" 20 2207328-2341059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 3.1;fallopian tube: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.0" HPA004728 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 38: EFO-21 - Unknown function" "HPA004728: AB_1080360" 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.2 0.1 0.1 3.1 3.4 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.7 0.8 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.7 0.8 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL627230.1 ENSG00000275493 9 67725914-67726255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "K-562: 14.5;Karpas-707: 19.6;PC-3: 12.0;SCLC-21H: 17.1" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 2: Karpas-707 - Immune response" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (2.79e-3)" "unprognostic (2.78e-1)" "unprognostic (3.24e-2)" 1.2 0.9 2.9 1.4 2.3 1.3 0.4 9.5 9.3 0.4 1.0 1.1 2.1 1.5 0.0 3.6 2.5 1.9 1.1 10.3 0.3 1.6 0.1 0.8 0.9 0.8 0.3 1.6 4.8 0.2 1.0 0.9 1.1 0.5 1.9 2.2 0.0 0.4 3.7 2.1 0.2 0.2 0.8 1.6 4.1 1.8 0.2 1.3 0.0 0.0 0.9 0.8 2.9 2.3 1.4 5.6 1.6 0.5 0.0 0.8 0.0 0.0 0.9 0.0 2.5 0.7 0.4 0.0 3.9 4.4 6.4 1.6 0.0 1.5 1.1 1.7 10.2 2.4 2.1 0.4 4.2 0.6 6.1 0.0 0.0 1.2 0.6 6.8 14.5 19.6 0.0 0.5 2.9 0.4 0.2 1.8 12.0 0.9 3.8 2.1 2.1 0.3 17.1 4.5 5.0 2.2 1.5 0.5 0.0 0.4 1.7 2.6 6.5 3.7 2.2 0.5 0.1 3.8 1.5 5.8 5.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.9 2.3 9.5 9.3 10.3 0.3 0.8 0.3 0.9 0.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH1A2 RALDH2 ENSG00000128918 "Aldehyde dehydrogenase 1 family member A2" O94788 15 57953424-58497866 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 82.2;fallopian tube: 74.5" "Group enriched" "Detected in many" 4 "Early spermatids: 115.7;Endometrial stromal cells: 142.2;Late spermatids: 48.7;Microglial cells: 42.2;Spermatocytes: 78.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 13.1;hippocampal formation: 8.4" "Immune cell enriched" "Detected in some" 15 "neutrophil: 32.6" "Lineage enriched" "Detected in single" 62 "granulocytes: 32.6" "Group enriched" "Detected in some" 5 "AN3-CA: 402.4;HEK 293: 128.8;JURKAT: 387.2;K-562: 316.2;MOLT-4: 408.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010022 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 36: Stromal cells - Cell proliferation" "HPA010022: AB_1844723" "unprognostic (1.11e-2)" "unprognostic (2.52e-2)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" "unprognostic (1.44e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-4)" "unprognostic (1.08e-1)" "unprognostic (9.03e-3)" "unprognostic (6.92e-3)" "unprognostic (5.48e-2)" "unprognostic (6.19e-2)" "unprognostic (2.57e-3)" "unprognostic (3.18e-2)" "unprognostic (4.95e-2)" "unprognostic (1.99e-2)" "unprognostic (1.80e-3)" 21.3 3.9 1.9 2.9 1.4 4.0 5.9 2.1 13.1 52.3 3.4 1.7 0.7 82.2 7.8 2.4 74.5 24.0 28.4 8.4 0.9 19.5 2.6 7.8 0.6 1.7 1.6 24.0 3.2 29.8 14.6 5.2 1.9 21.0 0.7 6.0 2.0 53.3 10.7 1.7 1.3 31.9 1.8 4.3 0.7 57.6 2.5 2.8 1.4 3.0 0.4 4.0 12.9 1.1 1.2 0.0 0.0 402.4 0.0 0.0 0.1 0.0 5.7 0.6 1.3 0.0 0.3 0.4 3.9 0.0 0.1 1.0 11.8 0.0 0.7 0.0 128.8 0.0 2.7 0.7 0.3 0.0 3.0 2.3 0.0 0.0 0.0 0.0 21.4 387.2 316.2 0.0 0.0 0.0 408.5 0.1 0.7 11.2 19.6 0.0 0.8 0.0 70.7 2.0 0.8 0.1 0.4 0.4 1.9 0.4 0.2 0.1 0.9 0.3 1.0 3.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 2.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.3 0.0 0.0 0.0 1.9 1.4 2.1 13.1 8.4 0.9 1.7 1.6 1.9 1.8 2.5 1.1 13.1 6.4 13.9 0.0 0.0 0.6 1.9 0.2 0.0 1.1 1.1 0.9 2.4 20.0 3.4 7.3 0.0 0.3 0.1 5.2 13.7 11.6 115.7 6.8 142.2 7.6 0.0 0.0 5.8 0.4 0.3 17.6 0.0 3.6 1.3 0.3 10.8 17.4 2.2 0.0 9.6 0.1 0.0 1.6 0.8 48.7 5.3 3.0 1.8 42.2 0.7 10.1 0.0 0.0 1.2 0.7 0.3 5.3 0.0 1.3 0.3 0.3 1.4 0.3 0.0 8.3 3.3 78.9 14.7 0.2 0.4 0.5 1.0 0.1 0.7 1.3 ANGPT1 "Ang1, KIAA0003" ENSG00000154188 "Angiopoietin 1" Q15389 8 107249482-107498055 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 33.5" "Group enriched" "Detected in many" 4 "Astrocytes: 60.4;Fibroblasts: 20.4;Inhibitory neurons: 37.6;Smooth muscle cells: 48.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "neutrophil: 5.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.8" "Cell line enhanced" "Detected in many" "ASC diff: 87.9;HEL: 53.1;HSkMC: 145.5;U-138 MG: 70.5;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017815, HPA018793, HPA018816" Approved "Secreted to blood" NA NA 32000000 110000 "Cluster 1: Neutrophils - Mixed function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821" "unprognostic (7.71e-2)" "unprognostic (2.13e-1)" "unprognostic (6.37e-2)" "unprognostic (4.11e-3)" "unprognostic (7.36e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-3)" "unprognostic (3.29e-2)" "unprognostic (1.07e-2)" "unprognostic (5.54e-2)" "unprognostic (2.62e-1)" "unprognostic (1.44e-1)" "prognostic favorable (4.40e-4)" "unprognostic (4.56e-3)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" 25.1 5.6 3.2 2.6 4.5 0.7 4.6 4.5 2.2 5.8 2.5 3.4 2.3 3.5 4.8 3.5 3.0 13.2 4.8 4.5 6.1 11.1 2.1 21.7 1.4 8.0 3.5 9.5 1.6 1.2 5.8 20.5 4.8 17.7 3.3 0.6 12.0 33.5 23.4 1.2 2.6 3.3 4.8 11.0 4.0 2.3 2.1 2.1 3.5 7.0 1.0 3.9 3.7 11.9 0.0 2.4 9.3 5.3 87.9 30.2 6.6 30.0 25.8 8.1 11.9 6.2 0.1 0.0 0.1 16.0 0.0 0.0 4.2 0.1 10.5 0.0 1.4 53.1 0.6 0.0 24.5 0.7 0.0 145.5 0.0 4.9 0.6 7.5 0.6 0.0 28.2 5.1 10.9 0.0 1.1 7.9 9.6 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.1 4.2 1.1 0.6 0.0 11.6 2.2 0.0 0.3 70.5 0.9 2.5 0.7 0.2 3.2 0.0 9.7 1.1 47.5 0.1 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.0 0.6 3.2 4.5 4.5 2.2 4.5 6.1 8.0 3.5 4.8 4.8 2.1 11.9 9.0 0.0 2.3 60.4 0.0 0.6 10.1 0.4 5.2 0.9 0.5 2.8 3.3 0.0 2.2 7.3 0.0 5.2 0.0 0.0 1.9 0.3 8.1 0.7 9.1 5.6 0.0 10.1 6.5 0.0 7.6 20.4 1.5 1.9 0.0 0.0 3.3 0.1 0.5 0.0 37.6 0.0 2.0 0.3 1.0 2.4 2.5 2.9 0.0 6.5 1.5 0.5 0.0 3.0 0.6 0.0 0.0 3.8 1.1 1.2 0.0 2.8 0.8 0.0 6.6 3.5 48.6 1.6 5.4 4.0 0.1 2.7 0.8 1.7 0.1 1.2 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 15.8 9.3 17.1 20.5 21.4 20.5 13.7 59.9 26.0 11.1 2.2 13.0 12.9 11.8 9.5 14.4 6.2 14.6 11.9 13.9 18.4 13.0 13.8 11.5 22.4 11.2 13.4 14.1 11.9 10.5 5.9 14.1 13.2 12.2 12.0 29.8 12.3 10.6 26.7 20.2 13.4 9.1 10.4 19.9 14.5 27.7 15.8 11.4 16.4 12.3 18.5 13.5 8.0 32.3 10.1 6.7 9.0 6.0 14.2 14.5 7.3 15.3 14.2 5.4 7.4 6.1 7.6 13.9 8.7 10.6 16.4 9.1 6.8 6.0 14.5 14.8 8.1 6.4 4.7 9.0 10.5 15.0 19.7 7.6 13.1 7.7 12.4 12.2 9.2 8.0 14.7 106.4 13.2 5.7 10.1 10.2 3.4 24.7 6.8 9.0 12.6 51.1 7.1 15.8 20.9 7.7 15.0 7.4 11.1 8.0 9.2 12.4 19.9 39.5 18.1 32.1 14.4 30.8 52.0 25.9 19.4 7.9 15.2 102.0 26.4 85.1 42.4 24.1 47.9 63.6 54.9 42.0 19.2 56.2 55.9 43.4 157.3 30.4 37.2 60.6 44.0 18.3 17.1 21.4 59.9 26.0 13.9 18.4 11.2 13.4 13.2 10.4 15.8 32.3 235.1 278.9 261.5 198.5 246.9 108.2 205.9 83.3 116.7 301.0 87.5 108.5 138.6 94.4 137.7 68.0 523.3 46.3 267.2 163.1 19.6 99.7 204.9 144.3 91.9 136.8 92.7 90.7 172.1 83.5 41.1 126.8 64.2 292.9 187.2 76.3 121.7 74.0 67.8 286.0 218.1 90.4 107.8 99.7 126.2 230.9 134.8 149.3 90.7 161.1 178.2 125.5 244.1 184.5 347.4 93.0 147.1 141.4 210.1 196.8 126.1 37.0 88.5 315.4 111.7 173.2 150.0 239.5 152.8 70.9 96.0 78.1 298.3 63.0 71.0 170.7 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 63 "heart muscle: 437.1;skeletal muscle: 981.2;tongue: 823.8" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 218.3" "Cancer enhanced" "Detected in many" "renal cancer: 4.9;testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles NA NA 110000 "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 0.4 0.8 2.5 0.1 2.3 0.0 0.5 2.5 3.7 0.2 2.0 0.3 0.0 0.3 0.3 1.0 0.1 0.3 437.1 2.5 2.7 11.8 0.3 0.8 0.2 2.5 2.4 0.1 0.9 0.0 0.6 0.0 2.5 2.9 0.0 0.3 3.4 0.9 981.2 2.7 0.2 0.2 1.9 0.1 0.2 0.5 2.7 0.0 0.5 823.8 0.1 0.1 0.4 2.5 17.6 5.4 0.0 0.0 0.2 0.0 0.4 0.9 0.0 7.3 4.7 0.3 5.3 0.0 0.6 0.2 0.4 13.0 0.0 4.7 5.0 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.8 2.1 4.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.4 0.8 0.0 0.0 0.0 4.4 0.0 0.4 2.1 0.3 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 2.3 2.5 3.7 2.5 2.7 2.5 2.4 2.5 1.9 2.7 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.7 1.7 1.2 0.0 0.2 0.4 218.3 2.8 0.2 3.7 0.0 0.2 0.0 0.0 31.3 1.2 0.6 0.1 0.3 1.6 0.0 0.0 1.3 0.2 0.4 1.0 0.0 0.1 0.0 0.7 0.4 0.2 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.5 0.4 0.9 0.0 1.9 0.0 0.1 0.0 19.1 0.0 0.1 0.0 13.6 1.1 2.5 3.5 0.6 0.3 0.3 0.2 0.1 0.0 0.5 ANTXRL ENSG00000274209 "ANTXR like" A6NF34 10 46286345-46330207 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 12.7" "Group enriched" "Detected in some" 27 "Early spermatids: 58.5;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 6 "ovarian cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (3.65e-3)" "unprognostic (2.59e-2)" "unprognostic (3.40e-1)" "unprognostic (8.11e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000471.1 ENSG00000286224 "Novel protein" 21 46326288-46326491 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6;skin 1: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;hTERT-HME1: 1.6;TIME: 2.7" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 20: HeLa - Mitochondria" 0.0 0.0 0.2 0.2 0.6 0.9 0.5 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.7 0.0 0.0 0.0 0.9 0.6 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.4 0.5 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.9 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.7 1.4 0.6 0.7 0.6 0.0 0.8 0.1 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 subunit beta 1" Q2VPB7 11 65773898-65780976 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 44.0" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 25.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 8.3 4.8 3.2 6.9 2.6 44.0 6.6 5.8 3.6 5.4 1.3 6.0 5.7 7.1 2.0 10.2 5.2 3.1 5.0 3.6 1.2 5.7 5.8 8.7 4.7 3.9 1.5 2.9 10.3 6.4 3.5 3.8 3.0 5.0 3.0 2.5 7.0 4.5 9.6 9.1 6.8 3.2 1.1 10.0 6.0 2.5 1.8 4.8 4.9 3.4 4.3 6.6 5.1 1.6 12.8 9.8 2.8 14.3 8.6 4.1 16.4 5.3 6.2 6.1 4.7 7.7 6.0 7.8 9.4 6.3 12.4 15.8 8.7 4.3 2.9 12.1 10.1 7.0 12.0 3.8 5.8 9.9 13.3 7.0 10.1 4.0 2.9 6.0 5.2 13.6 15.6 9.7 3.6 9.2 5.5 10.5 4.6 4.4 10.1 17.3 0.5 16.8 5.9 15.8 2.7 5.4 4.1 2.6 26.0 3.7 4.4 14.1 7.6 10.2 8.6 13.6 6.0 10.0 11.2 8.1 7.5 8.5 10.5 1.1 1.7 0.6 0.5 1.0 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 25.0 0.4 1.3 0.3 0.2 0.8 3.2 2.6 5.8 3.6 3.6 1.2 3.9 1.5 3.0 1.1 1.8 1.6 2.0 0.0 8.8 6.2 3.9 2.4 12.3 4.3 7.4 5.0 4.2 2.0 1.6 2.8 3.7 7.3 14.6 7.6 5.9 12.8 1.9 8.9 1.4 6.3 2.9 3.0 3.0 0.0 3.6 13.6 18.2 2.9 6.6 10.7 2.5 5.3 1.4 7.1 14.0 11.8 3.2 3.8 6.1 12.4 2.1 0.7 0.6 11.6 7.2 3.7 17.8 3.0 6.2 1.0 2.2 9.4 6.9 3.8 3.6 5.6 10.1 8.8 2.9 8.0 0.0 3.7 3.0 0.6 4.7 6.0 2.3 34.9 4.3 2.0 4.5 10.0 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645290-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32.0" "Cell type enhanced" "Detected in many" "monocytes: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 71.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 4.5 2.8 2.4 8.9 2.8 32.0 5.0 2.5 2.7 5.5 1.2 8.5 5.1 5.5 3.5 3.2 4.0 7.3 2.6 2.8 1.3 3.7 4.7 6.7 9.4 2.3 1.2 7.7 4.0 2.8 3.1 7.6 2.2 3.9 9.6 5.8 4.6 3.4 3.4 5.7 7.1 5.0 1.9 9.7 6.6 3.1 2.2 7.7 4.7 3.1 8.8 5.8 3.9 4.3 6.8 8.7 30.3 11.6 9.4 18.2 8.3 17.3 12.1 11.7 11.6 6.3 4.8 9.8 4.5 12.7 4.4 11.3 20.2 11.4 13.9 7.3 8.0 18.5 9.6 7.7 3.5 18.6 22.7 7.5 3.5 12.1 5.5 14.1 19.6 7.3 9.1 5.2 18.7 1.8 9.4 19.0 8.1 7.5 5.8 11.9 22.8 3.1 7.1 11.5 4.1 7.4 13.5 5.3 4.6 18.6 9.2 25.7 17.7 7.5 6.6 9.0 5.4 3.5 7.1 11.5 3.3 25.4 11.5 16.8 18.1 17.0 4.0 8.0 3.1 5.5 2.8 2.3 14.3 6.2 2.9 1.9 71.1 2.9 8.5 10.4 2.1 3.9 2.4 2.8 2.5 2.7 2.8 1.3 2.3 1.2 2.2 1.9 2.2 4.3 11.7 12.8 8.2 10.4 13.8 3.8 5.7 8.7 8.6 5.8 6.4 6.5 1.5 1.5 7.8 7.3 14.6 3.8 21.4 22.3 0.0 9.4 0.7 5.9 11.6 11.1 12.0 7.6 12.8 8.0 8.0 9.1 14.8 8.7 6.3 18.6 13.2 6.7 12.3 5.0 13.8 18.9 4.1 34.7 25.3 1.3 5.9 34.1 10.6 30.9 54.6 2.7 20.6 14.1 11.2 19.7 20.3 5.3 8.9 8.7 9.2 2.7 8.9 9.8 0.0 6.9 8.1 6.9 10.0 8.7 3.3 1.9 14.6 4.3 13.3 15.0 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438341-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 145.4" "Cell type enhanced" "Detected in many" "B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 182.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Cluster 1: Neutrophils - Mixed function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 30.7 4.7 7.0 47.8 8.0 45.5 14.5 10.4 7.6 3.5 5.7 6.1 7.1 2.2 1.6 3.4 5.9 11.6 5.7 7.6 10.4 5.0 38.3 15.5 50.0 16.4 12.5 1.5 4.3 1.6 2.8 8.8 18.0 2.6 6.7 0.6 5.1 2.1 1.4 3.4 17.8 7.5 16.0 56.6 9.2 0.8 15.5 145.4 3.5 2.7 44.3 10.5 3.6 27.3 0.1 1.8 0.0 0.0 12.8 21.2 11.3 37.0 7.2 20.8 19.8 0.0 0.0 101.0 0.5 24.9 22.2 0.1 0.0 0.0 28.6 0.0 0.0 73.3 0.2 0.0 0.0 13.9 0.1 30.3 0.0 0.7 0.0 2.6 0.0 40.5 0.1 62.0 0.0 0.0 87.7 19.5 0.1 7.9 0.0 195.4 0.1 72.4 5.8 0.0 0.1 0.0 3.4 0.3 0.1 0.3 0.1 47.6 0.1 0.0 0.5 6.8 0.1 16.8 0.0 204.7 16.9 71.0 0.0 81.5 23.8 58.5 30.2 23.6 24.9 32.6 25.8 25.9 15.4 39.5 29.3 28.8 182.9 19.1 38.9 50.3 27.2 13.4 7.0 8.0 10.4 7.6 7.6 10.4 16.4 12.5 18.0 16.0 15.5 27.3 3.2 0.0 25.3 1.6 88.2 1.1 0.1 0.1 0.6 0.1 1.6 3.2 1.0 8.6 2.6 3.7 0.0 2.2 149.1 0.1 0.0 3.9 0.4 0.7 12.8 4.7 0.0 28.2 1.1 0.0 20.7 15.0 3.6 0.4 23.4 0.1 6.8 28.9 59.9 0.0 2.9 0.2 0.0 117.7 18.4 0.3 0.0 93.4 3.6 381.3 65.2 0.0 134.9 4.0 1.5 0.1 0.1 0.0 41.7 0.1 0.0 5.1 3.7 0.2 0.0 0.9 11.3 0.1 1.1 0.4 0.1 1.4 125.9 0.4 0.1 0.1 APOA2 ENSG00000158874 "Apolipoprotein A2" P02652 1 161222292-161223631 "Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction, Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1388 "liver: 36012.6" "Cell type enriched" "Detected in some" 75 "Hepatocytes: 50065.8" "Cancer enriched" "Detected in many" 329 "liver cancer: 11230.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Hep G2: 16822.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025885, HPA072575" Supported "Secreted to blood" NA NA 115000000000 92000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "CAB025885: , HPA072575: " "unprognostic (2.05e-1)" "unprognostic (4.70e-2)" "unprognostic (1.12e-1)" "unprognostic (2.99e-1)" "unprognostic (9.82e-2)" "unprognostic (1.92e-1)" "unprognostic (3.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (4.40e-3)" "unprognostic (3.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" 3.8 1.1 0.7 0.7 0.6 25.9 1.8 0.5 1.4 0.9 1.0 0.7 0.0 0.7 0.1 1.0 1.9 0.0 2.0 0.6 0.8 9.5 36012.6 2.1 0.3 1.1 0.8 0.7 2.0 0.0 1.2 1.3 1.1 0.6 0.5 0.0 0.6 0.0 0.6 0.9 0.9 0.0 0.8 7.7 1.9 1.2 0.7 0.4 0.8 0.0 0.3 0.4 0.8 1.0 0.0 0.6 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 1814.4 0.0 3.6 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 5.8 10.0 16822.4 0.0 19.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.7 0.7 1.5 0.0 1.1 1.3 14.6 0.3 0.0 11.3 0.8 0.0 7.8 0.0 0.2 5.2 0.1 0.0 4.1 0.0 0.1 0.0 0.0 3.8 0.0 5.2 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 0.6 0.5 1.4 0.6 0.8 1.1 0.8 1.1 0.8 0.7 1.0 0.0 0.0 0.0 0.0 40.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 480.4 0.0 0.0 0.0 0.8 0.0 0.1 1.9 0.0 1.7 0.0 0.0 22.5 0.0 323.6 0.0 0.6 6.4 0.2 0.0 0.0 0.0 0.0 425.9 50065.8 4.7 0.0 0.0 0.2 0.0 665.8 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 9.8 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 5.6 26.0 0.0 0.0 0.0 ARHGAP28 "FLJ10312, KIAA1314" ENSG00000088756 "Rho GTPase activating protein 28" Q9P2N2 18 6729716-6915716 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 25.9;testis: 77.5" "Group enriched" "Detected in many" 14 "Early spermatids: 536.8;Late spermatids: 488.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 4 "neutrophil: 3.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 3.0" "Cell line enhanced" "Detected in many" "AF22: 30.4;CACO-2: 32.8;SuSa: 22.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA030413, HPA030414, HPA030415" Enhanced Supported "Cell Junctions" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Cell Junctions" "HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598" "unprognostic (8.33e-2)" "unprognostic (8.79e-3)" "unprognostic (3.15e-3)" "unprognostic (6.94e-5)" "unprognostic (1.49e-1)" "unprognostic (2.92e-2)" "unprognostic (1.11e-3)" "unprognostic (1.10e-1)" "unprognostic (7.56e-3)" "unprognostic (9.52e-4)" "unprognostic (1.43e-2)" "unprognostic (3.12e-1)" "unprognostic (4.53e-3)" "unprognostic (3.59e-3)" "unprognostic (6.00e-2)" "unprognostic (3.61e-2)" "unprognostic (2.76e-2)" 4.7 1.9 1.1 1.7 1.2 0.8 2.7 1.7 1.6 8.6 0.8 1.9 1.7 2.9 8.7 1.9 3.1 6.6 2.0 1.5 1.6 8.4 0.9 4.6 1.7 0.4 0.2 10.4 3.8 3.0 0.8 25.9 0.5 3.9 2.3 1.4 0.8 2.2 4.9 2.1 1.8 1.4 0.1 12.6 2.1 77.5 1.1 3.8 2.9 1.6 0.9 5.4 3.0 0.8 0.2 0.2 30.4 3.1 6.3 10.5 4.9 2.2 5.1 2.5 5.3 32.8 0.2 0.2 1.0 0.4 1.7 1.4 0.1 0.8 3.7 1.0 1.8 0.1 2.9 0.2 1.1 0.1 0.1 12.6 0.6 2.7 0.2 0.3 7.8 0.5 0.8 2.5 4.1 0.5 0.5 0.3 9.6 0.4 1.4 0.1 2.7 0.2 0.0 2.9 2.9 11.9 0.1 2.8 0.5 22.6 0.2 0.1 1.3 0.5 13.1 10.1 0.4 0.2 0.1 0.1 5.0 0.3 1.1 0.7 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 3.0 0.1 0.0 0.2 0.0 0.0 1.1 1.2 1.7 1.6 1.5 1.6 0.4 0.2 0.5 0.1 1.1 0.8 8.3 0.0 1.9 6.2 0.1 1.9 1.3 0.2 0.0 1.5 0.9 0.5 1.8 0.0 0.7 1.8 20.9 14.9 0.0 0.0 0.0 1.1 536.8 0.5 14.6 7.9 0.0 0.0 7.1 2.7 2.7 16.1 0.0 0.4 0.0 25.8 4.2 0.2 2.1 0.0 34.4 0.1 0.0 0.3 0.4 488.0 18.3 0.5 0.0 12.2 0.0 0.2 0.0 24.6 3.6 0.7 0.0 14.3 0.1 4.7 0.0 3.8 0.0 0.8 0.0 11.0 5.4 14.3 3.7 0.8 1.4 6.6 0.3 23.7 0.0 1.3 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298504-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favorable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favorable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 9.8 6.9 8.6 11.1 9.2 34.7 9.1 14.8 10.0 8.6 8.9 7.7 8.8 9.5 6.8 7.4 6.8 9.0 8.7 8.0 11.7 9.4 18.7 10.3 14.9 7.9 7.7 12.5 7.4 9.8 5.4 9.8 7.6 8.6 8.8 14.0 6.7 7.6 5.4 8.7 9.1 8.2 6.8 14.0 8.9 6.9 12.3 14.5 10.6 6.3 11.2 8.4 7.5 10.7 8.5 7.0 19.2 9.5 9.3 11.2 9.7 9.9 8.4 6.6 10.4 8.3 13.1 20.4 10.3 8.4 6.3 9.6 8.6 4.8 9.6 14.3 5.5 9.2 8.2 8.0 5.6 19.7 12.8 8.4 5.2 6.4 6.6 10.5 10.6 11.6 10.7 16.3 7.1 11.5 14.3 17.7 3.8 8.2 8.7 14.5 16.6 6.1 7.1 14.9 16.5 14.3 16.9 8.4 12.0 9.4 14.3 17.8 15.3 11.2 8.7 9.1 4.6 5.3 4.2 18.3 6.7 12.3 5.8 65.8 19.5 59.1 20.6 20.1 23.3 31.5 25.3 22.1 14.9 42.3 27.0 26.5 109.4 29.1 40.8 19.8 19.8 10.1 8.6 9.2 14.8 10.0 8.0 11.7 7.9 7.7 7.6 6.8 12.3 10.7 57.7 83.3 100.9 68.9 73.5 38.4 21.2 22.1 64.3 111.0 29.5 35.8 55.0 24.3 32.3 27.6 52.1 19.9 74.0 33.0 19.6 23.3 18.2 40.5 37.6 47.1 22.8 45.8 94.2 21.7 21.3 40.1 26.0 52.6 65.2 39.9 37.5 41.9 34.7 112.7 78.6 35.5 20.3 47.7 49.5 8.8 36.4 59.3 26.6 63.7 75.8 63.9 49.4 86.5 91.4 24.9 38.6 36.1 55.1 20.9 43.4 14.9 11.2 64.2 19.7 40.0 43.0 38.6 33.8 55.4 33.4 20.4 77.0 34.1 32.9 17.7 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 486.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 11.3 10.9 9.6 14.1 11.2 33.0 13.5 12.8 13.0 15.0 7.8 10.2 8.1 15.9 14.4 9.8 10.9 13.2 7.4 8.4 9.5 10.6 11.9 12.0 21.0 10.4 10.5 17.2 11.4 13.6 10.9 12.7 10.8 14.3 9.1 14.6 11.5 10.8 9.0 9.0 10.3 10.2 9.9 18.4 13.2 17.1 9.6 21.4 16.9 9.8 17.0 12.9 10.6 13.0 15.8 10.5 18.0 16.5 15.3 15.5 17.5 17.6 15.1 11.3 10.9 12.2 16.9 18.1 19.9 12.0 8.7 13.4 16.4 7.4 17.8 23.5 17.3 14.7 14.7 10.9 11.9 15.8 21.0 10.8 10.4 13.5 12.7 16.1 18.2 11.4 19.3 25.4 11.9 7.5 21.9 15.3 18.9 12.1 8.2 9.4 13.4 15.3 14.1 13.2 15.9 22.4 22.1 20.3 18.3 6.2 19.1 27.4 21.6 14.4 11.5 18.2 17.7 25.1 22.1 18.2 9.8 11.9 19.4 61.7 13.7 41.1 29.9 15.0 27.5 32.2 31.6 26.0 13.8 34.0 31.2 26.7 72.5 33.8 25.6 23.6 28.3 12.6 9.6 11.2 12.8 13.0 8.4 9.5 10.4 10.5 10.8 9.9 9.6 13.0 156.8 102.5 106.8 107.7 150.1 124.3 83.8 61.2 103.0 125.5 86.2 78.5 77.4 47.1 91.7 31.3 120.9 64.0 218.9 47.9 19.6 76.4 334.7 119.3 127.9 128.9 90.1 45.2 157.0 47.9 70.2 101.6 59.1 169.2 110.1 78.0 67.8 27.6 44.4 112.7 158.4 53.2 65.1 61.2 127.6 486.5 101.2 97.3 83.6 107.7 122.8 67.7 204.9 144.8 304.2 68.6 57.3 77.5 104.1 108.7 48.3 20.6 82.3 150.7 46.0 130.2 121.4 236.7 161.9 66.5 106.4 156.7 209.8 84.8 44.7 149.6 ARMH2 C6orf229 ENSG00000260286 "Armadillo like helical domain containing 2" H3BNL8 6 24797335-24798917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 13.4" "Cell type enriched" "Detected in single" 9 "Endometrial ciliated cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 13.4 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.1 0.3 0.1 0.7 0.5 0.3 0.5 0.2 0.7 0.5 0.3 2.5 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASXL2 "ASXH2, FLJ10898, KIAA1685" ENSG00000143970 "ASXL transcriptional regulator 2" Q76L83 2 25733753-25878487 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034646, HPA058040" Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA034646: AB_2674261, HPA058040: AB_2683586" "unprognostic (4.78e-2)" "unprognostic (3.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.88e-2)" "unprognostic (2.98e-2)" "unprognostic (2.80e-1)" "unprognostic (2.68e-3)" "unprognostic (3.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.33e-3)" "unprognostic (1.82e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-1)" "unprognostic (3.75e-2)" 6.8 6.2 3.8 9.5 5.1 8.3 7.2 4.8 3.9 8.2 4.5 9.1 6.4 7.1 5.0 7.7 7.2 6.8 7.1 3.5 7.7 8.7 6.1 6.9 11.1 7.5 5.0 6.6 7.7 14.1 3.5 7.1 7.5 6.3 8.9 8.8 6.6 6.3 8.0 7.6 7.1 8.2 3.6 9.9 7.8 17.7 6.3 13.9 10.5 7.3 10.5 7.5 4.2 6.4 25.1 23.1 11.0 7.8 9.8 13.7 12.9 16.0 19.0 12.4 10.5 19.4 12.6 14.8 9.7 13.9 13.8 14.1 21.1 14.9 16.9 22.5 10.2 32.9 20.1 16.6 8.3 42.2 25.1 6.8 15.2 17.9 15.3 10.4 15.2 8.8 29.0 12.2 12.5 9.2 15.5 9.2 14.4 13.2 9.4 15.4 48.2 11.4 10.7 30.1 11.3 12.5 22.2 13.9 13.5 10.4 8.9 12.3 31.4 16.6 22.0 15.9 22.4 26.8 39.8 41.0 15.5 27.4 13.2 1.7 2.7 4.2 2.7 1.4 2.3 2.2 1.9 1.9 1.5 2.0 2.2 2.5 6.0 1.2 3.3 2.3 2.2 0.8 3.8 5.1 4.8 3.9 3.5 7.7 7.5 5.0 7.5 3.6 6.3 6.4 16.1 25.6 24.1 54.2 25.9 32.4 8.9 15.9 29.0 22.3 19.1 10.8 27.0 14.3 19.1 9.2 25.0 10.2 22.5 20.1 15.6 15.7 48.9 25.8 20.4 22.0 10.3 33.6 62.5 14.4 9.4 17.3 24.5 19.8 23.5 12.6 28.5 12.6 18.2 25.2 47.6 16.8 18.3 25.7 23.6 26.9 19.6 25.2 23.2 68.4 34.4 12.4 12.3 46.3 72.8 18.4 14.2 13.2 29.8 13.4 12.4 14.3 41.3 24.9 39.5 20.6 16.8 34.4 26.6 29.7 41.1 14.6 45.0 17.2 19.7 19.3 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917211 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 16.4 20.1 11.4 6.5 10.9 60.2 16.9 8.6 40.1 19.9 11.4 18.9 7.5 18.2 1.8 15.7 19.2 4.2 18.4 11.5 9.8 22.0 59.2 24.2 6.1 13.9 12.3 24.9 22.7 4.9 21.6 4.9 12.7 21.6 2.6 1.9 15.2 5.7 26.7 34.9 21.4 3.3 9.0 25.7 23.2 15.3 11.4 5.4 19.3 4.4 3.3 17.7 15.6 10.4 13.2 12.6 4.4 12.0 5.7 4.0 12.3 7.1 10.3 9.4 6.8 11.0 9.9 9.3 14.7 6.0 12.0 10.8 4.5 8.3 2.5 9.1 15.7 8.7 19.1 10.0 8.4 6.5 18.2 10.9 7.1 11.8 6.3 5.4 7.9 9.5 16.1 7.3 4.1 21.3 7.8 21.9 5.1 3.5 14.3 8.6 7.1 13.5 5.0 10.9 16.5 6.7 10.6 14.6 13.3 3.3 14.3 8.1 10.1 9.0 8.6 18.3 5.3 14.7 5.5 6.5 13.0 5.2 5.6 3.0 2.0 2.2 2.5 2.1 2.1 0.8 1.7 2.2 1.4 0.9 1.3 2.4 16.9 1.8 1.7 2.4 0.9 1.2 11.4 10.9 8.6 40.1 11.5 9.8 13.9 12.3 12.7 9.0 11.4 10.4 9.8 9.6 16.2 20.2 17.0 28.9 8.7 35.7 16.5 16.6 15.8 10.3 8.1 7.2 17.6 9.2 33.3 12.7 40.1 38.8 1.9 10.2 2.5 12.4 9.2 10.2 35.9 16.2 7.6 10.3 5.3 12.6 16.8 24.4 9.5 15.4 7.9 23.2 10.9 13.5 8.4 17.6 24.4 20.1 19.9 3.6 12.8 24.2 30.2 5.6 11.9 12.3 19.6 6.6 7.1 14.9 21.7 10.1 27.3 12.2 26.8 6.6 13.3 26.0 13.1 11.6 10.6 9.0 6.2 16.3 38.4 66.9 40.2 27.2 19.0 15.9 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274789-193378820 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7" "Group enriched" "Detected in some" 5 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031772, HPA031774" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" Nucleoplasm "HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.0 0.1 2.3 0.0 1.9 0.2 17.3 1.5 2.7 0.0 38.5 0.0 0.0 0.1 0.8 0.7 0.1 0.0 0.2 3.1 1.8 0.2 0.0 0.5 0.1 1.6 2.3 0.2 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.8 11.7 0.0 1.3 3.9 0.0 0.0 0.8 0.0 1.6 0.4 2.4 0.0 1.3 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 2.3 1.9 1.5 2.7 3.1 1.8 1.6 2.3 1.5 0.8 2.4 1.8 0.1 0.0 0.5 37.9 0.0 0.0 0.0 0.3 0.0 0.0 5.8 5.8 0.7 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.9 0.0 0.0 0.0 26.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57906039-57959148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "A549: 1.0;Karpas-707: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: AB_2678361" "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 7.5 4.9 0.6 0.4 0.5 0.1 5.6 0.6 0.9 4.1 0.5 8.1 0.2 3.1 0.0 5.6 3.2 0.0 4.6 1.0 0.3 4.0 5.2 2.6 0.1 0.4 0.2 3.1 5.9 0.0 2.8 0.1 0.4 3.3 0.0 0.5 3.6 0.0 12.4 4.4 4.3 0.0 0.3 3.2 4.2 27.8 0.5 0.0 3.5 0.0 0.1 4.7 4.0 0.3 0.6 1.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.6 2.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.8 0.1 0.0 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.4 0.0 0.0 0.4 0.0 0.6 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.3 0.2 0.2 1.6 0.1 0.1 0.1 0.1 0.0 0.6 0.5 0.6 0.9 1.0 0.3 0.4 0.2 0.4 0.3 0.5 0.3 8.0 0.0 9.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 7.4 12.7 0.0 0.0 1.8 3.7 0.0 14.4 4.2 0.0 17.6 6.1 0.0 5.6 4.9 2.8 0.0 0.0 0.0 10.7 15.2 2.3 0.0 6.0 11.4 6.8 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.9 0.0 0.0 26.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.4 3.0 9.5 0.0 0.0 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 106.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 781.6;Langerhans cells: 435.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 314.6;LHCN-M2: 501.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported Supported "Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 18.5 11.2 33.0 25.6 92.0 106.8 19.6 14.0 59.1 18.8 0.0 33.1 40.8 18.2 12.1 14.7 18.6 25.2 11.0 52.7 4.9 16.4 22.7 21.3 29.2 0.0 14.4 13.1 17.1 21.5 11.0 27.3 0.0 13.9 32.3 71.2 11.5 14.9 24.4 26.0 30.1 19.7 0.0 30.7 29.0 23.0 10.9 18.4 14.4 24.1 28.8 37.0 10.6 34.9 24.0 117.8 45.5 22.1 64.5 102.2 20.9 71.2 232.6 67.5 106.8 47.7 21.6 46.8 4.9 99.3 77.6 21.0 40.3 19.7 187.5 16.2 46.9 16.6 39.8 41.9 209.6 70.7 26.6 85.0 36.9 210.8 314.6 78.9 17.5 17.6 27.9 16.6 501.1 37.6 22.1 30.1 35.6 32.9 55.6 31.1 146.4 19.7 64.4 108.5 42.9 23.4 82.6 22.9 20.2 91.7 33.9 7.8 12.5 181.8 29.4 67.6 78.9 12.7 21.2 49.1 82.6 19.6 41.0 9.4 39.4 22.3 20.9 42.5 26.4 84.5 36.3 26.8 51.3 84.4 13.2 16.8 127.1 27.0 86.1 9.0 53.7 21.8 33.0 92.0 14.0 59.1 52.7 4.9 0.0 14.4 0.0 0.0 10.9 34.9 46.0 44.8 46.0 90.8 226.4 201.6 71.0 29.3 76.2 370.9 30.9 109.7 20.3 45.8 30.0 53.3 154.3 176.8 139.8 181.5 1.9 27.6 2.3 29.3 61.0 63.6 91.6 31.5 781.6 28.5 42.1 91.6 44.9 59.4 31.6 45.5 49.6 39.5 193.5 302.9 279.1 30.7 16.2 116.0 435.1 9.6 29.2 285.4 55.2 126.5 157.1 96.4 50.4 193.5 91.9 25.5 80.6 32.0 133.9 54.7 75.0 22.1 20.6 113.3 32.9 97.0 69.5 44.5 130.7 30.4 204.7 228.8 125.1 76.0 65.9 90.2 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.4;skin 1: 26.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.0 0.0 1.4 2.4 1.4 11.0 2.5 0.5 1.3 6.4 0.5 30.1 27.3 1.0 0.1 4.7 6.8 4.6 0.0 1.3 1.1 1.8 0.1 10.5 0.0 1.0 0.9 0.0 0.7 3.3 1.0 0.9 1.0 12.5 37.4 0.9 19.6 0.2 0.1 26.0 20.3 0.6 0.6 0.4 5.9 0.4 1.1 0.0 8.9 0.0 0.5 4.0 4.6 0.8 6.2 0.4 0.9 0.1 0.0 0.0 6.4 0.2 0.0 0.0 0.0 5.8 5.2 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 44.4 0.1 0.0 0.0 0.2 0.0 19.3 4.9 0.0 0.0 33.0 0.2 0.9 11.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.5 1.3 1.3 1.1 1.0 0.9 1.0 0.6 1.1 0.8 0.0 32.1 56.2 4.2 0.0 0.6 14.3 39.9 0.6 1.3 20.8 3.2 0.8 5.7 50.0 0.0 0.0 2.0 0.1 44.4 0.0 9.0 3.2 26.8 2.5 0.7 34.2 0.0 8.3 2.5 2.4 0.5 22.4 28.0 8.9 0.0 0.0 0.1 0.3 0.0 1.8 82.3 8.2 0.0 1.2 1.9 0.0 0.6 1.8 1.0 0.0 1.9 0.0 58.8 2.4 4.7 29.2 0.0 0.0 13.8 10.2 1.8 78.2 5.2 0.0 0.1 1.8 0.8 1.0 1.5 1.1 24.1 0.9 0.2 77.1 9.9 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ionocytes: 61.1;Microglial cells: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 2: Karpas-707 - Immune response" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA012887: AB_1845205, HPA048107: AB_2680266" "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 3.0 4.3 1.2 3.6 1.7 5.9 6.3 2.3 2.1 3.9 1.6 3.4 3.9 3.6 5.0 4.9 3.5 3.6 2.5 1.3 2.1 4.4 2.3 4.5 4.1 2.1 2.1 3.6 2.4 7.3 2.5 4.0 3.8 5.3 3.4 3.0 5.1 3.4 1.8 11.1 3.4 3.2 1.1 4.7 5.5 1.6 1.6 4.7 4.6 2.9 4.6 3.9 2.8 2.9 3.2 8.3 5.4 5.5 5.0 5.3 0.9 4.8 6.6 2.8 5.7 1.0 3.6 4.7 6.9 4.8 3.3 3.8 7.1 3.9 5.2 7.0 4.8 2.4 7.8 0.8 6.3 4.1 4.1 5.6 1.6 5.9 1.8 6.5 7.3 4.7 19.6 17.4 5.2 2.8 4.6 1.4 1.5 11.2 1.7 3.7 9.0 15.8 4.6 8.8 1.6 20.4 11.9 2.8 6.0 3.3 2.2 1.3 9.4 3.7 3.6 5.2 1.9 5.6 10.7 5.2 6.0 2.5 5.7 7.1 1.5 4.5 1.8 1.5 0.9 1.8 1.2 1.2 1.0 1.4 1.4 2.1 8.1 1.2 1.9 1.0 0.4 1.0 1.2 1.7 2.3 2.1 1.3 2.1 2.1 2.1 3.8 1.1 1.6 2.9 14.3 0.0 8.4 15.7 12.6 7.4 5.1 5.8 13.1 6.4 17.3 10.0 5.1 1.5 8.2 9.2 4.2 2.0 15.0 4.5 1.9 5.6 0.5 5.3 9.2 9.7 4.8 22.5 11.1 13.6 2.2 9.4 20.4 8.8 9.5 6.4 14.6 3.6 14.3 1.7 12.5 4.8 61.1 11.7 6.7 1.1 7.2 12.6 19.6 44.0 5.5 4.4 11.3 37.7 35.0 6.2 4.1 9.8 10.5 4.8 4.1 5.5 10.2 4.1 32.9 10.3 8.7 1.8 5.4 20.5 16.6 2.2 13.8 6.7 5.2 6.6 AVIL "ADVIL, DOC6, FLJ12386, p92" ENSG00000135407 Advillin O75366 12 57797376-57818704 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 9.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.3;Gastric mucus-secreting cells: 23.9" "Cancer enriched" "Detected in all" 5 "glioma: 9.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "Daudi: 4.6;RH-30: 8.5;U-266/84: 3.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA058864 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "HPA058864: AB_2683838" "unprognostic (3.86e-2)" "unprognostic (9.86e-3)" "unprognostic (4.36e-2)" "unprognostic (3.38e-3)" "unprognostic (1.36e-1)" "unprognostic (7.79e-4)" "unprognostic (1.42e-1)" "unprognostic (7.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.02e-2)" "unprognostic (1.04e-2)" "unprognostic (1.07e-2)" "unprognostic (2.57e-4)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (3.29e-1)" "prognostic favorable (2.71e-4)" 1.3 3.5 2.0 1.5 3.6 0.7 1.3 7.6 2.5 1.3 2.6 2.8 3.0 1.0 3.2 0.6 1.3 1.9 1.5 2.2 1.7 1.6 1.7 1.5 0.7 2.2 1.8 1.6 3.8 0.3 1.8 1.4 2.0 1.5 1.6 4.9 1.7 1.2 9.3 5.6 3.4 1.2 1.0 1.3 1.1 0.8 2.3 1.0 2.9 1.5 0.8 1.2 1.0 1.4 0.3 0.4 2.9 2.0 0.7 1.3 0.2 0.2 0.1 0.0 0.2 0.0 1.0 4.6 0.4 0.4 0.0 1.6 0.1 0.0 0.3 0.0 1.4 0.5 1.3 0.9 0.3 1.9 0.0 0.9 0.7 0.1 0.4 0.1 0.4 0.4 0.3 1.9 0.0 0.4 0.0 2.0 0.2 0.0 1.0 0.1 8.5 0.3 0.2 0.9 0.6 0.0 0.4 0.3 1.0 0.6 0.6 0.0 0.2 1.2 0.1 0.9 0.0 0.9 3.5 0.5 0.5 0.3 0.3 0.2 0.8 1.4 0.6 0.4 0.7 0.6 1.1 0.5 0.3 1.1 1.0 0.8 5.0 0.4 0.5 0.8 0.3 0.0 2.0 3.6 7.6 2.5 2.2 1.7 2.2 1.8 2.0 1.0 2.3 1.4 5.3 3.2 7.7 15.0 3.4 2.9 3.7 3.6 4.0 28.3 8.8 7.4 1.2 5.7 4.6 3.7 18.8 1.3 1.3 11.9 0.0 4.7 6.0 6.1 5.4 5.0 7.7 2.7 13.4 6.0 1.0 5.4 23.9 11.1 1.3 2.0 12.8 2.8 2.2 8.4 8.5 3.4 10.2 3.3 3.1 2.8 4.1 2.6 3.6 5.6 3.4 11.3 5.2 5.5 7.0 4.5 3.7 0.7 1.3 4.9 2.9 1.1 3.2 21.6 6.6 8.8 4.1 1.4 2.7 2.5 4.1 2.9 2.7 5.8 4.1 2.7 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "bone marrow: 1578.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in some" 15 "THP-1: 659.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 320000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.8 0.2 0.4 0.0 0.4 1578.1 1.5 0.2 0.9 0.2 0.2 0.2 0.0 0.5 0.0 0.1 1.4 0.0 2.0 0.4 0.3 0.4 2.8 15.9 0.6 0.3 0.3 0.2 0.2 0.0 0.9 0.9 0.4 0.4 0.0 0.0 2.6 0.0 0.5 0.6 0.2 0.0 0.2 33.1 0.2 2.4 0.4 3.1 0.5 0.0 0.0 0.3 0.2 0.3 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 44.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.6 659.5 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.6 0.0 34.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.2 0.9 0.4 0.3 0.3 0.3 0.4 0.2 0.4 0.3 3.5 0.0 0.0 0.0 0.6 0.0 0.1 1.2 0.0 0.0 4.5 4.6 0.7 0.0 0.5 0.0 0.0 0.2 2.8 0.6 0.0 0.1 0.0 8.9 1.2 1.0 0.0 8.8 0.8 0.0 0.3 0.8 0.0 2.3 0.0 0.1 0.0 0.4 3.2 0.0 1.4 0.4 0.0 3.7 0.4 0.7 0.0 3.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.0 4.5 0.0 0.0 5.7 1.2 0.1 6.4 0.9 0.1 0.0 1.0 0.0 0.6 0.0 BAZ1A "ACF1, hACF1, WALp1, WCRF180" ENSG00000198604 "Bromodomain adjacent to zinc finger domain 1A" Q9NRL2 14 34752731-34875647 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.6" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 428.6;Early spermatids: 555.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 29.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002730 Supported NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "HPA002730: AB_1078269" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (2.76e-2)" "unprognostic (1.84e-2)" "unprognostic (4.24e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (4.11e-2)" "unprognostic (3.99e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-3)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.31e-7)" "unprognostic (2.44e-1)" "unprognostic (7.83e-2)" "unprognostic (2.90e-2)" "unprognostic (4.37e-2)" 14.4 6.0 4.7 22.5 5.8 74.6 11.7 4.5 6.4 8.5 5.0 12.5 10.4 7.6 7.3 16.6 8.9 13.5 5.7 4.8 5.6 6.8 11.9 19.3 25.2 6.3 5.6 7.8 7.1 6.2 3.6 12.7 5.9 8.8 12.9 1.7 11.5 5.8 9.7 21.6 12.4 9.0 5.1 20.2 13.1 30.8 6.6 21.7 7.7 6.4 20.7 27.9 11.2 7.0 46.4 24.1 39.7 30.5 16.9 19.6 49.2 36.7 20.0 33.6 33.6 23.9 32.8 92.1 28.0 26.3 18.7 47.0 68.4 23.8 58.2 33.4 29.5 60.0 22.6 66.9 19.9 99.6 69.8 18.2 24.2 36.3 48.1 13.5 49.3 41.2 56.4 23.0 28.5 52.9 95.3 31.3 19.1 36.4 34.1 72.4 40.9 25.7 21.0 44.2 50.4 41.2 49.6 67.4 20.2 13.5 34.5 68.7 44.6 31.0 22.7 33.6 37.2 12.7 13.5 77.1 10.0 45.9 36.0 7.6 5.7 7.7 3.5 6.2 2.5 5.3 3.6 3.9 3.4 4.7 3.6 2.9 29.3 2.7 7.1 4.2 4.2 1.5 4.7 5.8 4.5 6.4 4.8 5.6 6.3 5.6 5.9 5.1 6.6 7.0 68.5 60.9 77.9 24.5 103.5 428.6 237.6 96.9 174.2 2.6 79.7 54.0 14.7 28.6 82.8 16.5 2.1 68.6 135.4 89.2 0.0 86.8 555.2 87.5 72.3 103.8 30.5 85.2 12.2 74.7 118.0 76.1 66.3 112.1 101.6 33.1 27.8 28.6 87.9 0.0 9.4 69.9 77.3 96.7 263.7 373.0 40.4 158.7 72.9 47.8 165.8 2.4 129.8 26.7 35.8 121.7 133.6 13.5 90.5 213.2 51.6 15.3 89.2 2.0 6.6 106.8 76.1 199.9 38.7 141.8 389.6 196.9 152.1 23.8 62.1 372.5 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616569 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 477.3;Oligodendrocytes: 604.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 115.8;neutrophil: 213.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 213.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: AB_2683968" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 20.6 23.8 23.0 18.1 43.7 36.7 22.1 57.4 26.8 23.8 3.6 18.2 17.1 33.6 19.7 22.1 24.4 26.1 18.4 21.8 41.4 17.3 16.8 24.7 14.7 45.3 29.1 42.4 19.3 24.6 17.5 20.5 47.7 18.4 16.4 52.0 23.4 19.8 18.4 17.5 18.5 23.5 26.0 20.9 17.0 26.4 43.7 21.5 25.4 22.3 13.6 20.9 14.7 75.3 7.4 14.7 48.4 29.4 14.2 22.8 8.4 15.3 18.7 8.2 9.6 22.1 19.9 12.4 25.8 15.0 8.4 16.6 19.4 20.7 13.0 4.5 11.1 24.7 26.9 3.1 9.3 16.3 17.0 18.0 22.2 20.6 22.2 30.4 42.5 8.3 25.7 2.3 13.1 9.1 5.6 10.5 16.1 1.5 12.4 13.1 15.7 8.8 16.4 26.2 32.1 27.9 30.3 3.7 18.5 25.0 5.8 46.7 42.6 14.9 30.1 6.5 10.3 9.0 1.0 14.0 14.1 17.5 10.0 115.8 27.4 36.4 10.1 12.0 8.3 6.5 6.1 10.5 17.7 9.6 4.1 6.6 213.2 19.7 11.3 24.5 7.1 6.0 23.0 43.7 57.4 26.8 21.8 41.4 45.3 29.1 47.7 26.0 43.7 75.3 105.3 99.3 148.0 477.3 34.3 32.6 70.1 35.8 66.0 91.8 56.4 38.9 60.8 61.5 71.5 68.0 310.6 18.5 40.1 45.4 9.8 55.5 158.0 69.8 63.9 82.5 99.9 42.1 180.4 38.9 7.2 54.9 59.7 118.9 73.9 71.9 71.0 29.4 25.5 94.2 177.3 52.1 36.7 58.0 37.1 35.4 59.4 76.6 14.2 289.5 81.4 87.3 41.2 300.6 604.3 54.3 55.5 35.0 42.2 50.0 51.7 12.4 73.3 332.3 13.1 74.9 54.1 98.2 20.7 49.6 37.5 26.7 38.9 83.2 48.6 91.6 BCL2L15 "Bfk, C1orf178, FLJ22588" ENSG00000188761 "BCL2 like 15" Q5TBC7 1 113876816-113887581 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2;stomach 1: 18.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 67.6;Exocrine glandular cells: 115.9;Intestinal goblet cells: 39.3;Pancreatic endocrine cells: 74.9;Proximal enterocytes: 133.2;Undifferentiated cells: 54.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 16.9;EFO-21: 5.4;OE19: 15.2;RPTEC TERT1: 5.5" "Region enriched" "Detected in some" 32 "cerebellum: 32.9" "Low region specificity" "Detected in all" "HPA029732, HPA029733" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" "HPA029732: AB_10599615, HPA029733: AB_10600422" "unprognostic (5.96e-2)" "unprognostic (6.41e-3)" "unprognostic (5.82e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.16e-1)" "unprognostic (6.23e-3)" "unprognostic (4.97e-4)" "unprognostic (1.74e-1)" "unprognostic (2.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.49e-1)" "unprognostic (2.42e-7)" "unprognostic (5.20e-2)" "unprognostic (2.24e-2)" "unprognostic (9.04e-3)" "unprognostic (4.27e-2)" 0.2 0.1 1.2 3.1 1.4 13.2 0.5 2.7 1.9 3.9 0.4 32.5 43.2 1.0 5.2 2.2 0.6 8.3 0.2 1.4 1.4 0.7 0.2 0.5 0.2 1.2 1.7 0.1 9.6 0.1 0.1 0.1 1.1 0.3 26.9 1.3 0.3 0.2 0.3 0.2 41.8 0.8 0.8 0.5 18.4 0.8 1.1 1.2 0.1 0.0 0.2 0.5 0.6 1.3 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 2.2 0.3 0.1 0.0 15.2 0.0 0.1 0.3 0.6 5.5 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 1.4 2.7 1.9 1.4 1.4 1.2 1.7 1.1 0.8 1.1 1.3 0.6 0.0 1.3 2.0 0.9 0.4 5.0 3.4 2.2 1.6 0.3 0.3 0.4 4.3 12.2 23.9 6.2 0.1 1.0 67.6 0.0 4.1 1.4 4.3 0.5 1.2 2.4 0.0 2.3 115.9 0.0 1.2 29.6 5.5 0.0 0.4 0.0 0.3 0.8 1.7 1.8 39.3 6.1 0.6 5.0 0.2 0.0 1.6 0.0 0.0 2.5 0.3 0.0 0.5 1.6 74.9 23.3 0.0 1.0 2.7 133.2 0.4 6.3 2.6 0.0 6.6 2.2 0.6 0.6 2.0 1.1 0.1 1.8 0.4 54.9 14.9 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427295-66493529 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.8;Early spermatids: 10.7;Excitatory neurons: 9.9;Extravillous trophoblasts: 10.9;Inhibitory neurons: 7.7;Late spermatids: 13.6;Oligodendrocyte precursor cells: 7.5;Spermatocytes: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 9.2;BEWO: 4.2;RPTEC TERT1: 9.1;U-87 MG: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 0.7 0.3 1.3 0.3 1.2 0.8 0.6 2.4 4.1 0.8 0.0 0.6 0.2 0.8 0.3 0.6 1.1 0.4 0.9 2.4 0.7 0.5 0.7 0.6 0.2 5.1 1.6 0.9 0.5 0.6 0.3 1.5 5.0 0.4 0.2 1.7 0.5 0.1 1.0 0.9 0.4 0.2 0.7 0.4 0.4 1.1 3.0 0.0 0.7 0.1 0.2 0.6 0.6 1.7 0.5 0.8 0.8 9.2 0.1 0.1 4.2 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.3 1.6 0.4 0.1 1.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.4 0.0 0.1 0.3 9.1 0.3 0.0 0.1 0.1 0.1 1.4 0.5 0.1 0.0 0.1 0.2 2.0 0.0 0.3 0.3 0.0 0.0 4.8 0.1 1.0 0.2 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.9 0.0 0.0 1.3 1.2 2.4 4.1 2.4 0.7 5.1 1.6 5.0 0.7 3.0 1.7 0.1 0.0 0.0 2.0 0.0 0.1 0.3 0.2 0.0 0.6 0.2 0.6 1.4 0.0 0.2 0.0 0.0 5.8 0.0 0.1 0.0 0.4 10.7 0.2 0.2 0.4 0.0 0.0 9.9 0.0 10.9 0.4 0.0 0.2 0.0 0.3 0.7 0.0 1.0 0.0 7.7 0.0 0.0 0.8 0.4 13.6 0.3 0.1 3.6 3.7 0.0 0.0 1.0 7.5 2.6 1.7 0.0 2.2 0.0 1.7 0.0 0.1 0.1 1.4 0.0 0.2 0.3 6.6 0.3 0.0 0.1 2.9 0.1 0.5 0.0 0.8 BOD1L1 "BOD1L, FAM44A, FLJ33215, KIAA1327" ENSG00000038219 "Biorientation of chromosomes in cell division 1 like 1" Q8NFC6 4 13568738-13627725 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036943, HPA037362, HPA041290" Approved Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (7.73e-2)" "unprognostic (2.29e-2)" "unprognostic (5.94e-2)" "unprognostic (6.15e-2)" "unprognostic (6.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-2)" "unprognostic (3.19e-1)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.48e-6)" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (6.60e-2)" 15.9 10.6 11.8 17.6 12.8 41.6 16.2 17.5 15.0 14.3 10.1 16.1 10.8 16.6 16.8 12.8 14.8 12.4 11.9 11.2 14.4 13.5 11.1 12.9 21.8 13.5 12.3 23.0 13.7 22.6 9.1 16.6 13.1 12.3 12.5 22.0 14.5 12.7 11.3 17.7 18.8 11.8 10.6 21.9 14.2 16.7 12.9 25.3 13.7 14.1 20.8 12.7 14.0 15.7 17.6 23.2 22.7 16.3 27.0 28.4 17.4 20.0 21.0 16.3 18.1 17.6 18.7 23.6 8.9 22.0 30.2 11.7 18.7 19.9 31.2 16.3 10.7 33.2 31.0 21.6 16.6 50.5 26.4 22.9 22.1 33.7 25.9 22.3 17.0 16.4 23.8 27.4 20.6 10.5 26.2 33.4 29.2 11.3 19.9 19.8 33.6 9.6 30.6 17.5 13.5 24.6 22.0 7.7 18.2 24.3 9.1 19.3 38.9 25.1 13.2 15.6 26.7 32.3 20.3 29.0 24.6 23.4 20.3 2.5 1.1 2.3 1.1 1.1 0.9 1.3 0.7 0.8 0.7 1.5 1.0 0.8 9.2 0.6 0.7 1.9 0.7 0.4 11.8 12.8 17.5 15.0 11.2 14.4 13.5 12.3 13.1 10.6 12.9 15.7 113.2 83.3 95.8 72.1 93.7 26.3 22.6 17.4 33.0 170.8 39.6 67.8 88.5 51.5 49.7 36.8 89.6 16.5 105.8 31.0 3.9 30.2 20.8 135.4 108.7 68.7 34.7 57.4 56.1 25.3 18.6 60.0 29.6 193.7 63.3 110.1 41.0 32.7 21.5 161.5 62.8 29.1 6.1 41.5 29.0 17.6 50.4 70.9 24.9 56.2 64.1 87.6 57.7 57.8 96.5 33.2 23.8 57.9 68.4 24.8 22.4 7.6 40.0 198.3 46.0 103.4 78.8 83.1 32.1 29.7 28.8 18.6 73.5 106.7 24.3 27.4 BTBD19 ENSG00000222009 "BTB domain containing 19" C9JJ37 1 44808482-44815585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;HUVEC TERT2: 5.1;TIME: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042633, HPA076404" Uncertain Uncertain Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA042633: AB_2678091, HPA076404: AB_2686796" "unprognostic (4.69e-2)" "unprognostic (8.74e-3)" "unprognostic (1.82e-3)" "unprognostic (1.20e-4)" "unprognostic (5.32e-2)" "unprognostic (3.80e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.70e-1)" "unprognostic (1.53e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.18e-8)" "unprognostic (2.20e-3)" "unprognostic (2.78e-2)" "unprognostic (8.29e-2)" "unprognostic (1.70e-1)" 2.7 4.3 0.4 1.1 0.4 0.9 1.4 0.5 1.0 3.8 9.0 1.1 0.4 5.4 0.7 0.7 4.0 1.2 2.0 0.5 1.2 1.5 0.8 2.3 0.4 3.2 2.1 4.2 0.6 1.5 5.3 0.8 2.0 1.3 0.4 0.0 0.8 1.2 0.4 0.6 1.1 1.6 1.4 0.9 1.0 0.7 1.7 0.1 3.2 0.4 0.3 1.1 2.1 1.5 0.1 0.9 0.8 0.8 1.7 2.0 0.6 1.7 1.0 0.7 1.6 0.0 0.7 0.0 0.7 2.9 0.4 0.2 0.0 0.8 0.3 0.8 0.1 1.6 0.3 0.9 1.8 0.0 1.2 3.0 0.1 2.9 0.5 5.4 5.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.9 1.0 0.0 0.0 11.9 3.0 2.3 1.4 1.3 0.4 0.1 0.0 1.8 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 1.0 0.5 1.2 3.2 2.1 2.0 1.4 1.7 1.5 5.8 3.2 4.2 0.0 1.4 2.0 1.9 0.8 3.4 0.1 4.2 1.8 1.3 1.5 2.9 1.8 0.0 0.4 1.2 2.6 0.0 0.9 0.6 3.8 6.8 5.2 0.0 0.4 0.6 0.6 0.4 6.2 2.0 7.3 2.5 1.1 6.1 3.3 2.9 0.0 0.3 1.7 0.0 5.9 6.2 0.1 3.1 8.1 3.6 1.9 0.5 1.1 0.0 0.5 0.1 1.0 1.4 1.2 2.3 1.1 2.6 3.3 1.5 0.1 0.0 9.3 4.5 1.0 0.2 2.1 2.3 1.2 2.7 4.1 1.0 1.4 BTNL8 "BTN9.2, FLJ21458" ENSG00000113303 "Butyrophilin like 8" Q6UX41 5 180899077-180950906 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "intestine: 119.0" "Group enriched" "Detected in some" 4 "Distal enterocytes: 79.6;Proximal enterocytes: 178.9" "Group enriched" "Detected in some" 12 "colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 12 "neutrophil: 233.4" "Lineage enriched" "Detected in many" 221 "granulocytes: 233.4" "Group enriched" "Detected in some" 28 "CACO-2: 39.3;OE19: 56.2" HPA039738 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA039738: AB_2676656" "unprognostic (4.31e-1)" "unprognostic (6.85e-6)" "unprognostic (6.99e-2)" "unprognostic (1.48e-1)" "unprognostic (6.33e-2)" "unprognostic (1.91e-1)" "unprognostic (6.27e-3)" "unprognostic (6.07e-2)" "unprognostic (3.08e-3)" "unprognostic (3.28e-1)" "unprognostic (1.67e-1)" "unprognostic (9.02e-2)" "unprognostic (4.96e-3)" "unprognostic (2.93e-1)" "unprognostic (1.42e-1)" "unprognostic (4.43e-1)" "unprognostic (1.17e-2)" 1.6 0.3 0.2 2.1 0.2 7.3 0.5 0.2 0.4 0.0 0.1 26.7 119.0 0.1 0.0 0.2 1.3 6.9 0.3 0.2 0.3 0.6 0.6 2.6 0.3 0.3 0.3 0.1 1.7 0.2 0.2 0.2 0.4 0.1 25.7 0.0 0.1 0.0 0.3 0.0 86.5 0.6 0.2 3.1 7.2 5.5 0.3 0.2 1.1 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 56.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.0 1.6 0.0 0.2 0.4 0.0 0.1 1.0 20.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.4 0.0 0.5 0.0 0.4 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 0.3 0.4 0.2 0.3 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 8.6 0.1 0.0 0.0 0.0 0.0 79.6 0.0 0.2 0.3 0.0 0.0 0.6 3.6 0.0 0.3 2.6 0.0 0.2 12.2 0.0 0.0 0.0 11.7 0.1 0.8 0.0 0.1 29.6 0.0 4.5 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 26.3 0.0 0.0 0.0 178.9 0.1 0.8 0.0 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 15.6 0.1 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 9.1;fallopian tube: 29.9" "Cell type enhanced" "Detected in some" "Early spermatids: 113.0;Endometrial ciliated cells: 63.0;Late spermatids: 25.4;Respiratory ciliated cells: 101.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.6 0.9 1.0 3.2 0.0 0.0 0.5 0.0 0.0 29.9 0.0 0.0 1.5 2.3 0.1 0.0 3.2 0.0 8.4 9.1 0.0 0.0 0.6 0.3 0.0 5.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 2.6 0.6 0.9 1.5 2.3 8.4 9.1 5.9 6.2 2.4 2.7 0.0 0.0 1.5 4.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 11.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 113.0 63.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 25.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.7 0.0 0.0 0.0 0.7 11.4 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 2915.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1" "Cancer enhanced" "Detected in all" "liver cancer: 276.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 18 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2" "Not detected" "Not detected" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 93000000000 14000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 62: Liver - Hemostasis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favorable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 416.4 136.1 26.4 207.7 28.5 1.7 252.5 27.1 43.1 309.2 36.7 192.4 84.6 209.0 147.2 152.9 315.4 543.8 191.5 25.4 34.8 60.2 2915.2 224.9 209.2 44.3 31.7 485.9 62.1 21.8 33.1 52.9 31.2 174.4 215.2 9.7 96.9 139.1 57.0 104.1 154.2 251.8 30.9 168.5 150.1 90.0 30.9 88.1 139.0 154.7 192.5 455.7 189.8 31.3 0.2 18.6 1.2 10.2 769.5 1012.7 4.5 143.3 336.1 74.7 135.7 0.9 2.0 0.5 19.7 179.6 20.2 1.1 0.3 2.1 6.7 0.7 0.7 0.5 5.6 48.2 230.3 1.8 0.9 540.2 2.8 60.2 4.4 94.2 0.1 0.2 0.4 0.1 9.9 0.0 0.4 1.6 10.3 0.0 0.6 0.2 1.1 1.5 3.1 2.5 0.8 0.9 86.6 1.8 2.1 17.4 0.1 0.0 0.5 34.2 2.6 133.8 0.2 0.6 0.5 0.8 73.6 1.2 2.5 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 26.4 28.5 27.1 43.1 25.4 34.8 44.3 31.7 31.2 30.9 30.9 31.3 37.6 16.0 41.0 9.4 5.7 76.2 18.9 22.2 23.9 0.9 4.5 15.4 21.5 171.6 15.5 3.7 0.0 3.7 0.7 0.1 1.9 285.2 6.6 8.7 272.4 30.6 0.0 112.2 2.9 42.9 2.5 687.0 11.2 7.3 5.1 25.7 93.5 2795.1 8.1 5.0 1.7 0.0 2.0 62.8 103.7 29.9 1193.2 6.4 88.9 19.7 1.0 15.2 0.0 1.5 0.6 31.7 0.1 640.1 1.8 9.7 0.0 7.1 4.6 1.1 138.1 34.9 127.6 6.3 5.3 6.3 53.8 2.6 12.8 30.7 0.2 5.2 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268596-49277232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 40.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 40.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043328 Approved "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favorable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.20e-4)" "prognostic favorable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favorable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favorable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favorable (1.62e-5)" 6.5 10.5 3.0 4.5 3.6 8.5 5.5 4.4 5.5 6.1 7.0 7.6 3.1 5.6 4.5 6.9 7.9 4.8 6.5 3.5 4.0 5.7 5.6 7.3 4.9 3.8 3.4 11.3 3.2 3.1 7.8 2.7 4.2 7.5 2.6 9.0 4.2 2.1 3.9 5.7 5.5 2.7 2.2 11.7 4.0 17.3 5.0 4.2 6.0 3.6 3.4 6.4 6.1 4.4 4.3 2.5 5.9 7.4 4.7 4.0 3.3 2.5 4.2 2.2 3.2 3.6 3.2 8.5 3.8 3.9 4.6 3.3 2.9 2.8 2.4 7.5 3.4 5.6 5.8 4.0 1.4 8.0 10.0 3.3 8.1 3.2 6.0 3.8 2.5 4.9 6.5 6.3 1.8 2.7 5.9 5.8 4.2 3.6 3.6 4.4 3.1 4.5 3.6 9.8 4.5 6.1 6.8 5.2 9.1 4.3 2.6 8.8 3.1 3.0 7.3 5.2 4.7 5.5 10.2 7.1 2.2 7.4 4.2 1.0 5.1 5.3 1.2 1.7 1.0 1.9 1.1 1.2 0.6 1.2 0.8 1.0 40.0 0.3 1.7 2.5 1.4 1.3 3.0 3.6 4.4 5.5 3.5 4.0 3.8 3.4 4.2 2.2 5.0 4.4 8.6 9.6 16.1 4.6 4.4 6.8 3.5 7.9 1.8 12.6 5.7 6.0 9.1 7.2 10.3 11.0 22.9 7.0 7.8 7.6 0.0 4.9 12.4 6.6 9.2 8.1 5.4 7.0 7.3 3.9 4.3 7.3 5.6 10.1 2.5 8.5 9.7 6.3 9.8 5.0 6.1 9.8 2.0 18.0 7.1 17.3 8.7 11.3 8.8 9.4 14.2 7.3 9.2 4.5 7.0 6.0 3.8 8.6 4.6 7.0 4.9 5.2 11.1 13.7 0.0 14.9 6.4 51.8 6.8 4.2 8.7 4.1 6.9 12.1 7.4 2.7 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453925-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 8.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.6" "Group enriched" "Detected in some" 5 "OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 3.4 0.3 2.7 3.0 2.9 3.8 3.8 5.3 4.3 10.2 5.9 25.5 17.7 6.7 0.2 2.1 2.8 9.2 0.4 3.5 4.2 12.4 36.0 3.7 0.5 4.9 4.9 0.2 24.9 16.0 1.2 7.6 4.2 1.7 23.7 4.6 28.2 6.8 0.2 1.6 19.6 4.0 4.5 0.3 20.7 1.4 4.9 0.2 1.5 0.4 4.3 8.8 2.9 4.1 0.1 0.2 3.2 0.3 0.0 0.0 4.2 0.7 0.0 0.0 0.0 12.6 5.2 0.1 3.0 0.0 0.1 0.4 0.2 0.8 0.1 0.0 0.4 0.0 8.3 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 14.3 0.2 0.2 0.5 64.6 1.7 0.1 7.8 0.2 12.7 81.0 0.9 0.3 0.5 32.6 1.0 4.0 113.1 0.7 0.6 0.4 4.5 0.2 1.6 0.2 0.1 0.5 0.0 6.9 5.6 0.9 1.4 2.1 0.6 0.2 0.4 0.2 0.3 0.4 0.2 0.5 0.5 0.8 8.6 0.8 0.1 1.6 0.7 0.3 2.7 2.9 5.3 4.3 3.5 4.2 4.9 4.9 4.2 4.5 4.9 4.1 0.3 0.0 12.6 45.4 0.7 0.3 7.8 4.9 0.0 0.6 7.1 3.9 0.2 27.1 10.1 11.0 0.0 6.7 0.2 61.3 11.7 25.2 1.2 9.5 0.4 0.9 9.6 0.0 2.3 51.8 4.7 0.3 33.6 5.5 0.0 0.0 0.0 13.1 0.7 0.0 2.4 28.0 4.1 0.0 0.3 2.4 0.0 0.2 3.6 22.5 0.6 5.3 0.0 46.8 1.8 53.6 67.2 0.0 0.0 7.8 52.3 9.2 12.3 1.0 0.0 0.2 0.9 0.3 0.2 0.5 0.0 47.5 0.4 0.1 31.8 19.1 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.3;fallopian tube: 13.6;retina: 15.1;testis: 13.3" "Cell type enhanced" "Detected in many" "Early spermatids: 191.3;Endometrial ciliated cells: 50.0;Excitatory neurons: 36.6;Respiratory ciliated cells: 106.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.4;hTERT-RPE1: 4.9;U-87 MG: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.5 0.3 3.2 0.2 4.4 0.3 2.1 3.8 2.9 1.0 24.3 0.3 0.1 1.2 3.8 0.3 13.6 0.9 0.9 3.3 3.6 2.7 0.4 2.0 0.1 7.2 8.2 0.7 0.7 0.6 2.9 0.2 5.5 0.6 0.2 15.1 0.5 0.6 0.1 1.0 0.2 0.3 7.1 0.2 0.3 13.3 3.9 0.2 4.6 0.1 0.2 0.3 0.3 3.9 2.4 0.0 0.2 1.2 0.4 2.3 0.7 0.0 0.1 0.2 0.3 0.3 1.4 0.1 0.4 0.1 0.2 0.2 0.3 0.4 0.5 0.5 0.4 0.0 0.1 0.3 0.5 0.0 0.1 0.5 0.5 0.5 0.2 4.9 0.0 0.5 0.3 0.1 1.8 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.2 0.7 0.0 1.3 0.6 0.4 0.0 1.5 0.5 0.1 0.4 0.7 0.4 0.1 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.2 0.0 0.0 3.2 4.4 3.8 2.9 3.3 3.6 7.2 8.2 5.5 7.1 3.9 3.9 0.6 3.2 1.5 21.5 2.0 0.6 0.9 8.7 4.6 0.9 2.2 3.9 0.6 1.5 13.2 3.7 10.4 0.1 0.4 0.4 1.9 2.8 191.3 50.0 1.5 1.3 0.0 0.0 36.6 0.6 1.5 2.4 6.6 3.4 0.0 0.3 1.1 0.1 0.2 1.7 26.3 0.0 2.0 0.6 0.4 20.9 0.6 0.7 1.8 4.7 0.1 3.6 0.0 18.6 13.4 1.0 0.0 0.7 9.6 0.6 0.0 3.7 106.6 14.8 0.0 3.0 3.1 12.6 5.0 2.6 0.6 0.3 1.5 0.5 0.0 0.3 CALR3 "CRT2, CT93, FLJ25355, MGC26577" ENSG00000269058 "Calreticulin 3" Q96L12 19 16479061-16496167 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" Chaperone "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "testis: 64.9" "Group enriched" "Detected in some" 7 "Early spermatids: 51.0;Late spermatids: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025749, HPA043355, HPA048460" Enhanced "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" "CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403" "unprognostic (1.19e-1)" "unprognostic (3.84e-1)" "unprognostic (7.17e-2)" "unprognostic (4.34e-1)" "unprognostic (2.32e-1)" "unprognostic (2.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (1.18e-2)" "unprognostic (6.69e-7)" "unprognostic (1.60e-1)" "unprognostic (2.78e-1)" "unprognostic (6.28e-3)" "unprognostic (6.34e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" P49913 3 48223347-48225491 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 2914.5" "Cell type enhanced" "Detected in some" "Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 84.4;neutrophil: 335.4" "Lineage enriched" "Detected in many" 12 "granulocytes: 335.4" "Cell line enhanced" "Detected in some" "Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5" "Not detected" "Not detected" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 28000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.8 0.1 0.1 1.6 0.1 2914.5 0.5 0.1 0.5 0.6 0.1 0.3 0.0 0.6 339.9 0.4 0.1 0.3 1.4 0.1 0.1 0.4 3.9 7.4 6.8 0.2 0.1 0.2 0.1 0.1 0.5 2.4 0.2 0.5 0.1 0.0 15.2 0.6 0.2 3.7 1.7 0.1 0.1 23.2 0.4 1.9 0.1 10.7 5.7 0.2 2.9 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 19.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 1.0 1.4 0.1 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 77.5 0.0 3.4 0.1 37.9 5.5 84.4 0.0 9.8 0.0 2.3 0.0 0.0 7.7 2.4 0.0 0.0 335.4 2.6 28.1 4.7 0.0 86.9 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.9 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.3 0.9 0.3 0.2 0.0 2.1 0.0 0.2 0.0 6.9 0.5 1.4 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 1.3 1.1 17.4 0.9 3.6 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.8 9.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 5.0 7.2 0.0 0.0 0.0 1.0 0.0 0.4 0.6 CAPN15 SOLH ENSG00000103326 "Calpain 15" O75808 16 527712-554636 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 4.7;neutrophil: 16.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011960 Uncertain Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA011960: AB_10610556" "unprognostic (4.11e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-3)" "unprognostic (8.31e-3)" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.86e-1)" "unprognostic (4.02e-2)" "unprognostic (2.53e-3)" "unprognostic (2.54e-3)" "unprognostic (5.91e-2)" "unprognostic (1.83e-1)" "unprognostic (9.23e-3)" 13.0 12.0 3.6 7.2 2.5 8.1 10.8 11.6 6.2 12.2 0.2 20.2 16.3 13.4 0.4 18.5 13.2 1.6 11.2 3.2 0.2 18.4 17.2 15.3 5.1 4.1 1.0 13.2 24.8 2.2 15.2 2.6 1.4 12.3 2.3 1.1 12.6 2.8 14.9 22.3 22.7 1.2 0.2 21.2 16.5 18.7 2.1 2.8 11.7 0.9 2.5 12.5 12.8 0.8 16.8 21.5 3.0 9.3 1.7 3.4 46.2 17.5 4.6 4.9 3.3 28.2 12.1 24.0 16.3 3.2 5.0 21.9 2.0 6.9 1.8 25.2 37.1 20.2 25.7 17.6 7.3 23.8 27.3 3.9 4.0 4.9 2.2 2.9 5.3 14.7 37.6 7.1 1.6 25.9 27.1 26.0 26.7 8.6 20.2 46.5 8.7 24.2 3.3 11.0 19.6 17.8 11.7 16.2 10.2 1.8 13.3 24.7 26.2 15.3 21.4 15.7 22.0 18.2 11.0 21.3 6.7 13.8 9.7 4.7 1.3 0.8 0.3 0.8 0.1 0.4 0.1 0.4 0.3 2.3 0.1 0.2 16.2 1.1 1.3 0.5 0.2 0.3 3.6 2.5 11.6 6.2 3.2 0.2 4.1 1.0 1.4 0.2 2.1 0.8 7.6 3.2 8.4 10.1 5.9 8.9 5.7 6.2 3.4 12.1 7.6 6.6 3.1 8.6 5.6 7.3 16.7 3.7 22.3 54.3 1.9 6.2 16.5 6.1 8.9 8.7 4.2 1.7 10.6 15.7 4.4 6.9 20.4 13.3 7.0 10.8 8.9 16.5 6.8 20.2 11.3 26.9 8.2 12.0 6.8 6.2 7.5 8.2 1.8 7.5 6.5 9.1 23.7 10.6 7.8 14.3 37.1 4.5 5.8 13.4 33.1 5.7 4.6 11.2 0.0 10.2 5.2 5.3 7.4 5.8 8.0 2.5 9.2 9.6 25.9 11.6 CAPN3 "CANP3, LGMD2, LGMD2A, nCL-1, p94" ENSG00000092529 "Calpain 3" P20807 15 42359498-42412949 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 279.2;skeletal muscle: 905.9;tongue: 377.4" "Group enriched" "Detected in many" 5 "Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2" "Cancer enriched" "Detected in some" 10 "melanoma: 9.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 27 "SK-MEL-30: 238.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040052 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA040052: AB_2676821" "unprognostic (1.06e-2)" "unprognostic (1.31e-1)" "unprognostic (4.00e-2)" "unprognostic (8.71e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-2)" "unprognostic (2.11e-4)" "unprognostic (3.12e-3)" "unprognostic (2.82e-1)" "unprognostic (2.47e-1)" "unprognostic (2.37e-3)" "unprognostic (3.26e-2)" "unprognostic (3.91e-4)" "unprognostic (5.56e-3)" "unprognostic (2.43e-1)" "unprognostic (8.93e-3)" "unprognostic (1.38e-1)" 13.5 8.8 136.1 4.0 206.6 47.6 14.1 194.2 243.3 18.8 113.0 13.3 3.1 11.2 163.7 14.5 13.7 4.5 16.1 142.9 159.9 93.6 36.9 21.5 7.0 212.0 194.9 15.7 8.7 2.4 11.3 3.0 212.1 16.0 5.3 7.5 18.6 5.2 905.9 54.9 14.0 4.7 155.2 19.1 8.9 30.8 187.8 3.4 10.7 377.4 5.1 11.7 15.5 279.2 0.5 0.3 0.6 1.1 8.8 6.1 0.6 2.6 1.9 0.5 0.8 1.2 0.5 0.2 0.9 1.6 0.4 3.7 0.4 3.5 0.3 0.9 0.8 0.8 0.8 4.1 0.6 1.0 1.5 4.7 3.7 0.8 0.7 1.5 0.1 0.7 0.2 1.8 0.7 0.1 0.2 1.2 0.4 0.2 0.9 1.1 0.4 1.9 1.9 1.3 0.4 0.1 0.2 0.5 238.0 1.0 0.0 5.4 0.9 0.3 0.4 2.6 0.7 1.5 2.1 0.2 0.4 2.4 1.8 0.5 1.0 0.1 0.7 0.2 0.8 0.3 0.1 0.3 0.5 0.5 0.1 0.9 0.9 0.6 0.1 0.5 0.4 0.6 136.1 206.6 194.2 243.3 142.9 159.9 212.0 194.9 212.1 155.2 187.8 279.2 0.5 12.8 34.5 16.0 2.9 20.1 0.8 2.2 3.4 2.2 0.4 0.3 0.4 1.5 4.4 1.8 2.1 0.7 1.4 2.0 1.9 0.1 512.5 0.5 0.6 2.2 0.0 0.0 4.0 0.0 0.6 1.6 3.6 0.7 1.3 0.4 2.2 8.7 32.7 0.0 5.2 1.8 2.0 4.4 11.6 183.6 5.3 2.9 482.0 13.1 2.5 3.7 2.1 4.5 220.2 0.0 5.4 3.4 0.6 0.9 2.4 59.5 2.6 3.9 0.0 13.8 1.6 15.9 4.7 1.6 8.5 3.3 1.8 1.2 2.3 0.8 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206298-119313926 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Approved Cytosol NA NA 67000 "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 6.8 4.0 5.6 9.5 5.7 8.5 5.6 5.3 6.5 5.0 0.2 6.2 3.9 6.5 3.4 5.6 5.6 3.9 4.1 5.3 8.1 4.4 2.7 7.9 10.7 5.8 6.3 3.7 3.8 6.1 2.9 6.4 6.5 4.0 5.0 8.3 3.6 4.6 2.5 5.2 6.6 7.4 5.2 9.9 5.2 18.2 7.9 22.5 4.1 3.2 11.2 5.8 4.9 6.0 10.7 7.6 26.6 16.7 7.8 9.2 16.0 11.2 11.4 10.8 10.2 16.7 12.6 25.1 10.0 14.0 21.7 15.2 18.4 9.4 22.7 14.8 4.7 26.4 6.2 5.1 9.5 30.3 27.9 8.1 10.1 26.7 28.4 11.1 26.3 23.7 21.7 9.9 19.1 11.3 16.2 17.0 14.0 9.2 8.8 17.5 13.5 4.6 9.3 8.2 3.7 11.3 20.9 8.8 7.3 18.1 9.4 24.8 22.8 16.0 11.5 11.6 14.7 3.3 5.3 19.9 6.7 25.4 11.9 0.8 2.4 2.0 0.9 2.8 0.8 1.5 1.1 0.9 2.6 1.2 1.2 1.3 8.6 0.4 2.5 1.4 1.0 0.9 5.6 5.7 5.3 6.5 5.3 8.1 5.8 6.3 6.5 5.2 7.9 6.0 23.2 9.6 8.3 23.5 23.2 18.0 5.9 7.5 19.4 14.0 13.6 11.7 8.8 5.7 6.0 11.0 45.9 6.3 24.0 7.6 1.9 6.1 28.2 9.9 19.6 23.2 8.4 5.7 38.5 6.7 10.5 9.4 9.2 16.8 3.8 20.8 20.0 3.1 16.0 13.5 39.1 4.9 2.0 59.1 43.2 42.0 7.8 41.2 16.0 45.0 46.8 13.2 22.6 26.2 19.6 10.6 11.6 12.8 19.7 8.0 5.1 5.4 4.8 33.3 26.3 11.6 22.7 38.0 36.2 18.5 21.9 7.0 24.9 10.6 5.1 10.9 CBX1 "CBX, HP1-BETA, HP1Hs-beta, M31, MOD1" ENSG00000108468 "Chromobox 1" P83916 17 48070052-48101478 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 350.8;Spermatogonia: 304.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012265 Supported Supported "Nucleoplasm,Nuclear bodies" NA NA 120000 "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "CAB012265: AB_297216" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (2.02e-1)" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (2.70e-4)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" "unprognostic (6.55e-2)" "unprognostic (2.78e-1)" "unprognostic (2.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.48e-3)" "unprognostic (3.82e-1)" "unprognostic (3.65e-1)" "unprognostic (6.73e-2)" 30.9 31.4 60.3 35.5 59.9 16.5 37.2 61.6 73.2 53.6 54.5 40.7 19.0 66.5 47.9 36.8 40.2 27.9 32.1 59.8 63.9 37.9 21.6 26.9 35.0 63.2 59.7 77.5 22.3 43.8 34.8 34.7 64.0 38.0 33.1 59.5 29.7 47.1 68.4 28.8 24.0 55.6 64.9 33.7 26.6 69.1 60.3 73.6 39.5 46.0 46.9 36.4 37.9 67.3 217.3 121.1 392.4 185.6 78.0 69.3 217.7 197.0 95.1 188.0 200.6 319.2 84.5 148.4 204.5 155.6 144.8 85.3 146.3 124.6 329.2 273.8 118.1 119.8 121.1 119.3 47.5 115.5 71.9 49.8 68.4 140.3 178.3 144.7 157.1 176.6 152.0 67.2 153.8 135.7 325.9 79.8 150.6 118.8 156.9 241.8 322.7 95.8 110.3 121.7 138.5 345.6 135.0 44.6 75.5 281.8 211.0 82.5 110.7 260.2 238.9 112.0 201.1 94.0 227.9 140.4 71.4 50.4 119.0 5.1 12.2 16.0 12.4 12.7 10.0 16.1 11.2 10.4 9.9 15.7 11.5 9.7 33.6 9.5 9.3 10.6 12.4 5.9 60.3 59.9 61.6 73.2 59.8 63.9 63.2 59.7 64.0 64.9 60.3 67.3 32.9 67.3 27.6 7.8 31.4 43.6 30.5 46.1 36.5 46.9 48.0 54.7 70.9 18.6 33.6 42.3 20.9 66.4 27.5 19.2 35.2 68.7 26.8 40.8 78.9 40.2 40.3 34.3 13.0 29.7 86.6 61.5 10.2 39.6 39.9 65.3 30.0 15.6 69.6 50.5 15.5 27.3 42.7 33.5 24.5 59.5 80.2 26.7 40.9 7.5 47.7 106.6 42.2 12.5 13.7 34.7 12.9 91.7 20.0 51.1 9.6 30.9 32.2 36.3 39.5 33.3 71.8 350.8 304.0 26.7 36.2 27.8 25.6 35.8 28.6 20.1 CCDC157 ENSG00000187860 "Coiled-coil domain containing 157" Q569K6 22 30356635-30378658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.6" "Cell type enhanced" "Detected in many" "Early spermatids: 118.0;Late spermatids: 142.4;Respiratory ciliated cells: 44.9;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042943 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA042943: AB_10794767" "unprognostic (3.69e-3)" "unprognostic (1.72e-4)" "unprognostic (4.35e-2)" "unprognostic (1.24e-2)" "unprognostic (3.61e-1)" "unprognostic (7.74e-3)" "unprognostic (8.72e-4)" "unprognostic (1.35e-2)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.89e-4)" "unprognostic (2.33e-2)" "unprognostic (2.60e-2)" "unprognostic (4.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.42e-1)" "unprognostic (3.45e-2)" 0.7 1.4 3.9 0.9 3.5 1.8 1.2 2.9 3.8 1.5 7.3 0.9 0.9 1.0 1.8 1.1 7.4 1.2 0.7 3.8 4.1 3.0 0.9 2.2 1.1 4.3 5.9 1.2 1.9 2.2 5.0 0.5 3.3 1.7 0.4 1.9 1.5 0.9 0.6 1.0 1.2 0.4 3.6 1.6 1.1 27.6 5.0 0.8 3.6 0.5 0.7 0.9 1.0 2.7 1.8 2.0 1.8 3.4 1.0 0.6 2.2 0.9 1.1 1.7 1.7 2.6 1.3 1.6 1.1 0.9 2.6 1.9 1.0 1.2 0.9 1.1 4.3 0.9 2.0 1.4 1.1 1.7 1.4 0.6 0.8 3.1 0.5 1.1 1.0 2.3 1.5 1.4 1.4 1.6 2.2 1.8 2.4 1.2 1.0 1.9 1.0 1.4 4.2 1.8 6.1 4.0 2.8 1.1 1.2 1.3 3.3 0.8 1.8 1.8 2.2 1.1 0.8 1.2 0.7 1.2 2.7 1.0 1.4 0.8 0.6 0.8 0.7 0.4 0.8 0.4 0.7 0.8 0.3 0.5 0.4 0.6 2.5 0.7 0.6 0.9 0.7 0.5 3.9 3.5 2.9 3.8 3.8 4.1 4.3 5.9 3.3 3.6 5.0 2.7 2.6 3.2 3.3 2.0 2.6 1.3 2.4 4.2 0.6 6.2 6.6 5.2 0.9 4.3 7.3 9.2 12.5 2.5 7.0 3.0 0.0 5.5 118.0 31.3 3.3 2.8 1.2 0.4 4.2 2.3 2.3 2.6 2.0 5.0 2.5 3.8 5.7 0.9 2.0 6.7 3.1 1.5 8.2 3.8 3.9 142.4 3.7 3.4 0.0 1.0 2.2 4.4 4.1 1.0 0.6 3.0 3.2 2.6 6.6 1.4 1.7 6.9 44.9 28.3 0.0 6.7 3.8 59.3 16.5 1.5 1.7 3.4 4.8 4.5 1.8 1.9 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410329-46413564 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 36.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 33: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 4.1 16.3 4.1 2.7 3.8 0.7 8.8 3.9 2.6 13.9 7.5 3.3 0.9 13.9 10.5 1.3 22.9 4.2 24.7 3.6 3.9 11.2 0.7 4.4 0.9 5.2 7.4 36.8 13.6 9.1 12.9 6.7 5.3 6.4 1.2 1.3 10.8 7.5 2.1 3.1 2.2 6.5 4.8 2.3 2.2 5.9 4.2 5.6 9.0 2.4 0.8 7.5 7.3 4.4 1.9 0.1 18.5 22.2 4.8 6.0 8.9 9.6 0.0 2.1 0.9 0.1 0.1 0.2 12.5 7.6 0.4 0.2 0.1 15.0 1.0 0.0 9.4 0.0 0.2 1.0 16.0 0.1 0.1 19.6 0.0 5.2 15.2 0.3 0.1 0.1 20.3 0.0 6.8 0.0 0.0 1.3 13.3 0.0 0.0 0.7 24.8 0.0 16.1 0.1 2.9 0.1 0.1 0.1 0.1 14.2 0.1 4.7 1.7 1.2 4.9 0.2 0.4 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.1 3.8 3.9 2.6 3.6 3.9 5.2 7.4 5.3 4.8 4.2 4.4 0.7 0.0 1.1 1.3 0.0 0.9 6.5 1.5 0.0 0.4 1.8 19.3 27.0 7.2 4.0 11.0 0.0 7.5 0.1 0.0 39.2 14.8 0.4 15.0 13.9 1.2 0.0 0.0 0.0 1.1 10.0 17.3 0.0 3.9 1.3 25.7 1.1 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.9 2.9 70.8 0.6 1.8 1.0 0.0 14.6 0.0 1.5 0.1 3.6 0.0 57.9 0.0 3.7 0.0 1.2 2.4 0.5 13.1 12.3 8.3 0.4 5.5 0.0 0.1 2.1 0.2 32.7 0.0 0.8 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 52.1 25.2 12.4 11.6 12.9 56.6 27.3 14.2 21.2 21.9 12.6 22.5 13.5 19.4 5.7 22.1 30.5 13.5 23.1 13.0 13.2 31.8 45.3 30.2 14.1 15.1 12.8 31.2 33.5 8.3 21.8 10.3 13.1 23.8 6.6 5.3 18.7 6.2 21.3 25.3 29.7 9.1 11.9 35.6 29.1 9.1 13.0 20.0 23.7 10.3 9.8 19.4 22.9 14.7 19.2 11.4 16.8 11.6 16.1 10.9 16.0 12.0 14.4 13.9 13.0 19.7 14.8 20.3 10.0 8.9 9.7 14.7 12.4 14.6 12.8 18.2 14.1 12.6 12.2 17.2 13.2 8.8 7.7 13.3 25.1 13.2 17.7 13.9 11.1 11.4 8.7 12.7 10.2 13.8 17.8 16.7 13.9 14.7 12.5 16.2 13.6 31.7 8.9 11.4 8.9 16.5 9.1 8.4 26.1 12.5 8.7 26.1 9.1 12.8 7.1 13.8 15.9 25.3 21.5 26.7 12.8 13.1 12.6 5.9 10.3 16.0 13.5 8.4 14.1 13.4 12.5 14.0 13.1 15.2 17.1 14.2 28.6 17.4 11.3 14.0 15.4 8.2 12.4 12.9 14.2 21.2 13.0 13.2 15.1 12.8 13.1 11.9 13.0 14.7 367.4 218.0 392.4 33.0 222.5 268.0 499.2 203.8 310.7 73.7 279.3 247.0 54.3 177.3 259.0 68.0 133.5 139.2 253.6 389.6 23.5 189.4 41.0 379.7 426.5 287.1 247.7 86.5 30.6 127.8 152.9 302.7 268.1 761.2 222.2 281.6 167.8 90.4 164.6 40.4 32.3 294.6 154.6 241.5 251.4 20.9 128.0 292.5 140.5 42.2 160.1 69.5 122.6 35.7 66.3 143.2 378.2 75.2 258.5 408.2 415.6 21.2 188.9 183.3 131.5 460.0 276.4 46.5 25.0 252.6 276.9 209.1 282.8 182.6 244.1 503.2 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20589086-20618903 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 193.5;esophagus: 87.1;liver: 86.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 1234.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 1234.7" "Cell line enhanced" "Detected in many" "A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 7.1 3.0 8.0 9.6 8.1 193.5 3.7 8.3 10.6 19.7 7.4 23.7 6.4 5.3 5.5 87.1 6.4 4.3 6.7 7.9 8.3 14.0 86.7 7.1 1.5 9.0 8.2 1.5 0.8 3.2 1.2 10.8 9.5 4.3 27.8 0.5 15.0 3.1 1.7 17.1 16.3 11.3 8.3 23.4 2.1 1.0 8.9 2.0 4.5 6.4 4.4 5.5 38.5 8.7 200.3 21.4 0.0 0.0 0.2 5.5 0.0 16.7 4.3 4.1 16.2 1.0 141.9 0.0 8.1 30.8 8.7 63.9 4.5 46.8 10.7 0.1 3.9 0.0 207.1 34.4 1.4 0.0 0.0 8.8 8.9 31.4 0.0 0.5 2.7 0.0 0.0 0.0 1.6 0.2 0.0 1.0 0.1 24.7 107.0 0.0 0.1 3.4 1.5 0.0 0.1 0.0 249.9 0.0 0.3 2.2 0.0 4.3 3.4 0.2 8.3 18.5 1.2 0.0 0.1 0.0 2.4 96.9 0.0 216.2 207.2 471.1 0.5 124.7 0.8 0.1 0.4 0.9 12.7 0.2 0.3 0.4 1234.7 0.4 110.8 3.1 0.7 86.8 8.0 8.1 8.3 10.6 7.9 8.3 9.0 8.2 9.5 8.3 8.9 8.7 9.9 3.2 1.1 0.3 1.2 1.5 0.1 2.4 0.0 0.2 0.2 0.3 2.6 1.5 2.7 5.5 0.0 1.1 0.0 364.9 43.0 7.5 0.8 2.1 2.6 42.7 0.0 6.1 0.2 1.5 6.4 9.1 0.0 20.3 0.0 0.0 47.2 107.8 5.9 0.0 0.3 23.1 85.5 60.7 0.9 1.0 0.3 36.6 0.0 5.6 61.5 0.1 0.0 0.5 0.0 120.2 400.5 0.0 3.0 2.1 137.6 0.6 0.4 0.1 0.0 1.3 1.3 0.0 1.2 6.3 1.1 2.5 1.7 0.0 19.8 0.8 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127162-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 314.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 5 "neutrophil: 16.0" "Lineage enriched" "Detected in single" 17 "granulocytes: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 7500000 "Cluster 1: Neutrophils - Mixed function" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.9 0.2 0.7 28.8 0.5 2.7 0.5 1.1 0.8 0.1 1.9 260.9 314.2 1.3 0.8 1.7 0.3 3.0 0.6 0.5 0.2 0.8 0.3 0.2 1.5 0.3 0.1 0.5 1.7 0.0 0.0 0.2 0.3 1.2 246.7 0.5 0.9 1.6 0.5 0.6 270.6 9.3 0.1 5.5 2.5 0.6 0.2 0.3 0.7 0.1 1.8 0.8 0.1 0.7 0.2 18.5 0.2 0.4 0.0 0.4 1.6 0.2 0.3 0.2 0.3 98.8 3.5 0.3 0.3 0.0 0.1 1.0 0.3 0.3 0.3 0.2 1.1 0.1 0.8 0.6 0.3 0.2 4.3 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.4 1.5 0.1 0.7 0.5 1.3 0.3 430.1 0.5 0.3 0.0 2.8 0.3 0.2 1.3 1.2 0.4 0.4 0.5 0.4 0.7 0.9 0.0 0.6 0.7 1.2 0.5 157.2 0.3 0.2 0.3 0.3 0.6 2.9 0.9 1.4 0.2 0.8 0.1 0.3 0.2 0.1 0.5 0.8 0.2 0.3 16.0 0.7 0.5 0.4 0.2 0.2 0.7 0.5 1.1 0.8 0.5 0.2 0.3 0.1 0.3 0.1 0.2 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 569.4 0.0 0.3 1.0 0.0 0.0 0.0 108.4 0.0 0.5 0.0 0.0 0.1 2.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 183.7 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 408.6 0.0 0.2 0.0 336.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.1 0.0 241.6 0.1 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880597-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;kidney: 5.7" "Group enriched" "Detected in some" 33 "Excitatory neurons: 307.2;Inhibitory neurons: 459.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 6.8;basal ganglia: 4.3;cerebral cortex: 6.4;hippocampal formation: 5.8" "Immune cell enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 4.9" "Cell line enhanced" "Detected in some" "K-562: 7.3;NTERA-2: 10.1;U-698: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.3 0.2 6.8 0.6 4.3 1.9 0.3 0.0 6.4 0.0 0.0 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.1 5.8 0.0 5.7 0.1 0.3 1.0 0.0 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.5 0.6 1.3 0.2 0.1 0.1 1.0 0.8 0.4 0.0 0.4 0.5 2.2 0.0 0.2 1.0 0.1 1.0 0.3 0.0 0.9 1.9 0.7 0.4 0.6 0.2 0.0 1.2 0.0 0.3 0.1 0.2 0.0 0.7 1.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.4 0.6 2.2 0.0 0.0 1.2 0.2 0.3 0.0 0.0 0.0 0.1 0.6 7.3 1.8 0.0 1.3 0.6 0.4 10.1 0.2 0.4 0.2 0.2 0.3 0.3 0.4 2.2 0.2 0.0 0.3 0.3 1.8 0.3 0.7 1.3 0.1 0.7 0.6 0.2 2.0 0.8 4.6 0.6 0.8 0.6 1.2 0.1 0.2 0.1 0.4 0.3 2.3 0.1 0.1 0.1 1.6 0.1 0.3 4.9 0.0 0.7 0.5 0.5 0.6 6.8 4.3 0.0 6.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 459.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 11.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDK11B "CDC2L1, CDK11-p110, CDK11-p46, CDK11-p58" ENSG00000248333 "Cyclin dependent kinase 11B" P21127 1 1635225-1659012 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 174.6;Spermatogonia: 176.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025061, HPA073626" Approved Approved "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (7.52e-3)" "unprognostic (4.85e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (2.18e-1)" "unprognostic (1.14e-2)" "unprognostic (6.04e-2)" "unprognostic (8.45e-2)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (6.52e-3)" 31.8 29.0 20.6 17.6 20.8 43.0 30.0 18.1 20.9 32.4 16.6 46.1 25.6 35.9 5.8 30.3 31.6 9.9 39.6 18.3 20.2 28.2 32.1 41.0 19.5 21.2 19.8 33.4 35.0 8.9 30.5 10.6 20.7 31.7 9.4 9.0 28.4 12.7 85.9 39.3 44.6 10.4 20.4 47.7 34.5 49.8 20.8 13.2 30.8 17.8 10.6 37.9 30.8 21.6 47.2 36.4 21.9 17.4 17.8 12.0 30.6 43.7 18.8 24.0 20.8 41.3 43.7 40.8 43.9 18.7 16.9 35.4 18.6 22.0 18.4 36.3 40.4 43.9 68.9 36.1 24.1 50.4 44.3 16.1 15.8 26.2 19.9 14.1 24.5 42.3 51.9 26.9 14.4 31.0 47.9 42.5 38.9 13.8 43.7 46.9 43.4 33.5 12.7 16.6 28.3 36.4 40.3 36.7 42.3 15.0 25.2 33.4 37.4 29.8 33.0 22.7 43.0 60.5 58.7 85.6 37.4 55.9 23.2 7.2 3.3 5.3 6.1 2.8 2.7 3.3 3.8 3.6 2.8 3.7 4.1 3.1 13.8 4.4 3.2 5.1 3.2 1.6 20.6 20.8 18.1 20.9 18.3 20.2 21.2 19.8 20.7 20.4 20.8 21.6 35.2 19.2 43.1 13.7 42.9 14.4 19.5 10.2 25.6 32.0 22.2 18.3 42.9 30.0 31.7 27.6 20.9 27.7 44.7 86.6 9.8 33.3 39.7 28.1 34.2 32.3 28.8 25.0 14.1 35.2 31.5 25.1 48.9 36.3 55.6 24.1 25.7 38.6 20.5 15.2 12.3 73.8 10.2 30.1 14.5 25.6 28.9 33.9 5.4 15.0 36.3 20.5 76.2 10.1 18.2 37.4 93.3 26.7 54.7 19.6 95.4 19.2 29.4 42.4 52.6 25.9 31.0 174.6 176.5 27.5 17.3 44.6 48.9 16.5 56.9 15.9 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT enhancer binding protein delta" P49716 8 47736913-47738164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 54.9" "Group enriched" "Detected in many" 5 "granulocytes: 54.9;monocytes: 19.9" "Cell line enhanced" "Detected in many" "BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067581 Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 251.6 72.0 33.4 62.1 35.2 34.3 168.0 37.2 42.0 99.7 43.9 143.5 26.7 82.8 2.7 85.4 192.0 14.7 136.9 35.8 63.6 106.9 207.8 157.5 8.7 81.5 49.3 265.3 81.9 7.6 117.4 50.0 49.5 151.1 12.1 16.9 89.3 19.4 133.0 106.9 79.6 21.6 46.5 109.7 116.3 14.3 47.4 18.5 103.5 21.6 6.6 168.1 139.9 44.6 9.5 7.4 0.3 0.1 41.5 43.2 51.9 24.1 18.7 6.8 14.4 14.8 14.8 0.1 17.3 6.6 5.8 9.9 1.7 12.9 2.1 0.1 3.9 0.5 6.0 6.3 66.8 4.1 0.0 66.7 33.7 1.6 16.0 4.3 1.4 0.4 4.1 7.3 2.5 2.9 0.1 148.7 2.8 6.2 2.5 0.1 5.1 0.5 20.6 7.8 2.8 1.0 58.7 7.7 6.3 2.6 6.4 33.5 6.2 1.5 3.9 15.6 1.5 0.1 0.1 0.1 7.9 0.1 0.3 2.3 19.9 10.6 2.1 8.4 6.2 0.1 0.3 1.2 7.4 0.6 0.0 0.0 54.9 3.7 3.2 0.2 0.3 2.8 33.4 35.2 37.2 42.0 35.8 63.6 81.5 49.3 49.5 46.5 47.4 44.6 1541.7 102.5 196.3 31.3 14.9 663.5 1435.6 98.7 2487.0 6.0 551.3 617.1 79.2 185.8 76.5 224.3 6.2 189.8 152.8 59.2 217.2 50.7 3.5 287.0 418.9 547.9 23.4 30.3 12.5 77.2 457.9 1377.3 387.3 621.0 5.1 96.4 269.5 157.7 220.3 1.7 2.5 44.3 42.7 520.1 502.0 21.5 435.5 912.6 268.6 29.0 163.5 321.9 150.4 6.0 0.5 53.2 58.4 144.8 34.9 1668.5 127.1 353.4 54.9 17.3 466.8 1386.3 1290.5 3.7 13.9 940.2 817.5 351.9 122.7 85.9 73.2 814.5 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661682-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 6.6 5.8 7.5 6.3 8.1 16.0 8.3 14.4 10.5 7.6 5.0 8.7 6.2 7.0 7.4 5.8 6.8 5.2 5.3 7.3 6.9 6.2 5.0 6.0 11.1 6.3 5.9 8.3 6.6 4.7 8.4 6.3 6.6 8.3 6.8 14.7 5.5 5.2 5.3 8.9 7.5 5.5 4.9 9.4 6.2 12.0 7.6 10.3 8.7 5.8 7.4 7.7 6.6 10.2 10.5 9.4 23.9 20.4 10.8 10.4 11.6 13.2 9.7 12.2 14.2 17.3 19.2 3.1 19.1 8.3 16.9 18.7 11.8 9.5 12.4 15.0 9.4 19.0 28.2 8.6 6.5 17.1 17.4 7.7 5.6 11.6 10.0 11.5 10.4 16.9 21.6 19.4 15.8 8.8 8.9 28.1 7.5 19.6 9.7 17.7 22.6 12.6 10.1 17.9 13.9 12.9 20.9 13.8 3.7 14.8 22.8 9.4 9.6 11.3 14.8 20.9 10.1 6.9 16.7 20.2 6.7 19.7 15.9 3.3 1.7 3.6 1.5 0.9 1.2 3.2 1.3 1.0 0.8 3.5 1.6 1.4 5.2 1.6 1.3 1.7 1.1 0.4 7.5 8.1 14.4 10.5 7.3 6.9 6.3 5.9 6.6 4.9 7.6 10.2 10.9 9.6 14.3 24.2 14.0 0.0 3.3 0.0 5.2 30.5 7.0 8.9 9.4 5.7 5.6 5.5 27.1 12.8 8.6 2.5 3.9 7.8 78.7 12.4 15.0 9.6 3.6 25.7 41.2 7.8 10.3 8.8 11.2 10.2 16.4 48.8 6.8 4.2 8.0 18.5 40.8 5.5 0.0 7.9 0.0 21.4 12.8 7.7 0.0 15.0 10.3 10.3 10.3 23.6 33.5 5.3 4.1 14.3 12.2 5.6 5.8 4.0 5.1 38.1 6.6 9.4 8.7 48.8 18.6 7.5 0.0 6.6 9.8 15.8 5.8 2.8 CEP43 "FGFR1OP, FOP" ENSG00000213066 "Centrosomal protein 43" O95684 6 166999317-167094789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071876 Approved Supported Centrosome NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Centrosome "HPA071876: AB_2686467" "unprognostic (9.14e-2)" "unprognostic (2.24e-1)" "unprognostic (3.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (9.59e-2)" "unprognostic (1.00e-1)" "unprognostic (6.95e-2)" "unprognostic (8.83e-2)" "unprognostic (1.08e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 6.9 14.8 8.8 12.6 8.3 16.7 14.3 8.3 10.0 13.5 9.2 12.4 15.9 14.9 16.9 9.0 27.0 11.2 8.9 8.1 8.3 17.4 36.3 7.3 14.8 8.7 11.4 13.0 11.3 10.5 14.1 8.4 9.4 9.4 16.9 25.4 8.8 9.1 8.5 11.6 15.8 10.4 7.7 11.1 11.3 58.4 8.4 15.7 15.5 10.4 17.7 9.2 9.3 9.4 26.1 14.3 35.3 24.2 20.3 15.1 42.7 33.0 21.9 26.4 25.3 53.1 21.6 31.0 18.3 20.2 70.3 24.0 31.4 23.3 49.3 19.5 27.0 21.4 26.7 58.2 10.8 38.4 21.6 8.4 16.8 54.2 25.2 16.4 18.5 34.5 70.9 25.8 34.2 24.0 31.1 55.8 30.2 50.0 10.9 35.3 23.9 25.7 27.8 13.8 26.2 26.2 26.9 28.6 11.7 24.6 23.5 46.7 12.2 26.1 43.7 31.6 42.1 21.8 32.3 31.4 29.4 35.4 32.7 0.4 6.5 23.5 5.1 6.1 7.6 12.1 5.8 4.8 10.7 8.4 3.4 5.5 38.8 6.3 6.7 16.4 11.7 4.9 8.8 8.3 8.3 10.0 8.1 8.3 8.7 11.4 9.4 7.7 8.4 9.4 3.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 14.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 16.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.0 0.0 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353833-104455102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.4;testis: 13.4" "Group enriched" "Detected in some" 4 "Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;U-2 OS: 6.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.9" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.4 0.6 1.0 0.5 1.3 0.4 0.4 0.4 0.7 2.2 2.4 0.5 0.1 1.8 0.2 0.2 8.4 0.2 2.5 0.8 1.2 0.7 0.1 1.3 0.3 2.9 3.7 0.5 0.3 0.7 1.5 0.4 2.2 0.5 0.0 0.6 0.2 0.4 1.3 0.3 0.2 0.6 2.0 0.3 0.3 13.4 1.0 0.1 0.8 0.8 0.4 0.3 0.6 1.1 0.1 0.0 0.7 0.1 0.1 0.3 0.1 1.0 3.1 0.6 1.6 0.0 0.0 2.4 0.2 0.4 1.7 0.2 0.0 0.2 1.8 0.3 0.1 0.5 0.9 0.0 0.3 0.3 0.4 0.3 1.3 0.5 1.6 1.3 1.0 0.1 0.7 0.7 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.5 0.7 0.1 0.4 2.0 0.6 6.5 0.3 1.8 0.2 0.0 0.1 0.7 0.8 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.4 0.7 0.8 1.2 2.9 3.7 2.2 2.0 1.0 1.1 0.4 0.0 0.5 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 10.0 0.0 9.3 0.0 0.0 0.1 0.1 0.0 0.0 0.6 73.3 25.1 0.3 0.4 0.0 0.0 4.0 0.2 0.4 0.7 0.0 0.4 0.0 0.3 1.8 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.0 58.9 0.6 0.2 0.0 1.9 0.1 0.7 1.0 1.0 0.0 0.3 0.0 1.2 0.0 0.2 0.0 0.0 56.9 0.3 0.0 0.8 1.0 34.4 4.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 CFAP92 "FAP92, FLJ43738, KIAA1257" ENSG00000114656 "Cilia and flagella associated protein 92 (putative)" Q9ULG3 3 128909866-129002690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 22.1" "Group enriched" "Detected in some" 4 "Adipocytes: 1.3;Cardiomyocytes: 1.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "neutrophil: 34.0" "Lineage enriched" "Detected in single" 48 "granulocytes: 34.0" "Cell line enhanced" "Detected in many" "AF22: 7.6;HL-60: 13.5;THP-1: 9.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042811, HPA048445" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 43: THP-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042811: AB_2678180, HPA048445: AB_2680397" "unprognostic (4.17e-2)" "unprognostic (5.16e-2)" "unprognostic (2.46e-1)" "unprognostic (2.67e-1)" "unprognostic (9.41e-3)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (4.22e-2)" "unprognostic (6.48e-3)" "unprognostic (7.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.88e-2)" "unprognostic (1.42e-2)" "unprognostic (3.38e-1)" "unprognostic (4.69e-2)" "unprognostic (2.52e-1)" "unprognostic (5.50e-2)" 0.4 0.6 3.1 1.0 2.1 2.1 0.8 3.9 2.2 0.4 4.4 0.7 0.8 0.7 0.5 1.1 3.3 1.4 0.6 3.7 2.5 0.5 0.2 1.1 1.0 3.1 4.7 1.2 0.9 1.7 1.8 1.1 3.2 1.0 0.8 2.7 0.7 0.3 0.7 4.3 0.9 0.2 1.4 1.0 1.1 22.1 3.3 4.2 0.8 0.5 0.3 0.4 0.1 1.3 1.0 1.4 7.6 1.6 0.1 0.2 2.4 0.3 0.3 0.1 0.0 1.2 1.0 1.5 0.3 0.0 0.7 1.1 2.3 0.1 0.0 0.6 1.1 3.3 1.9 1.0 0.0 13.5 0.7 0.0 1.4 0.0 0.1 0.5 0.1 2.9 0.9 1.7 0.2 1.5 1.3 2.5 1.4 2.6 1.4 1.1 0.8 0.9 0.0 1.5 1.5 0.7 0.4 0.5 0.6 1.0 2.6 9.2 0.4 0.8 1.2 0.8 0.5 2.2 2.0 2.5 0.6 5.0 0.6 0.8 0.7 2.9 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.5 34.0 0.3 0.3 0.3 0.2 0.2 3.1 2.1 3.9 2.2 3.7 2.5 3.1 4.7 3.2 1.4 3.3 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93027996 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 13.9 12.3 22.7 20.7 25.5 73.5 20.4 42.0 32.7 15.7 32.0 15.2 14.8 19.4 29.1 14.6 16.2 15.6 12.0 21.3 24.7 16.9 15.4 21.6 26.4 29.0 23.3 26.1 19.6 18.2 16.6 20.5 24.5 20.4 14.8 30.8 21.2 13.4 17.4 18.8 18.7 13.3 22.1 23.3 17.7 20.8 25.9 27.0 26.3 14.7 25.4 13.7 16.1 27.6 21.3 11.6 30.6 13.6 17.9 45.3 23.0 19.4 20.0 13.0 16.1 14.5 27.4 5.2 16.1 17.3 22.1 31.1 17.6 19.5 18.0 0.1 10.6 25.3 26.1 12.9 24.6 27.1 19.0 28.7 23.0 15.5 31.1 26.8 22.4 36.7 26.8 57.1 19.9 13.1 14.2 14.0 19.5 10.5 12.6 19.9 27.6 28.4 13.3 28.5 16.8 18.1 34.2 12.3 25.9 30.6 14.1 22.6 36.2 10.7 13.9 9.3 12.8 53.4 23.2 21.6 15.9 15.9 9.4 35.9 10.8 27.7 22.1 6.6 21.8 48.7 21.5 20.5 7.4 39.6 30.1 22.1 53.7 20.6 13.4 27.9 24.9 10.9 22.7 25.5 42.0 32.7 21.3 24.7 29.0 23.3 24.5 22.1 25.9 27.6 59.3 70.5 176.3 182.2 137.8 164.3 112.3 102.3 153.7 71.4 62.6 46.5 42.3 37.1 137.3 46.0 91.8 30.7 116.3 59.6 3.9 36.1 56.5 96.9 61.7 58.6 59.3 65.4 161.5 38.3 28.5 64.5 96.4 189.8 99.3 70.7 25.0 34.9 24.8 57.2 146.2 54.9 91.6 55.1 297.4 39.2 34.8 89.5 96.0 119.9 50.7 34.2 48.4 140.8 155.9 64.2 61.6 37.6 133.0 110.0 39.9 11.5 93.9 82.2 32.9 52.7 64.4 15.3 14.7 125.2 180.7 60.5 153.2 42.9 51.5 143.6 CHIT1 "CHI3, CHIT" ENSG00000133063 "Chitinase 1" Q13231 1 203212827-203273641 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 49.8;lung: 36.4;lymphoid tissue: 21.7" "Cell type enriched" "Detected in some" 10 "Hofbauer cells: 40.6" "Cancer enhanced" "Detected in many" "testis cancer: 31.9" "Region enriched" "Detected in some" 6 "cerebral cortex: 12.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010575, HPA074844" Enhanced "Secreted to blood" NA NA 26400000 57000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Macrophages - Innate immune response" "HPA010575: AB_1078512, HPA074844: " "unprognostic (5.80e-3)" "prognostic favorable (2.02e-4)" "unprognostic (2.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.87e-2)" "unprognostic (2.28e-2)" "unprognostic (7.55e-2)" "unprognostic (6.36e-3)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" 13.6 0.3 0.2 0.4 0.2 49.8 8.3 0.0 12.4 8.1 0.0 1.2 0.0 3.6 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.1 0.7 36.4 21.7 0.4 0.2 0.5 2.1 0.0 0.0 0.7 1.3 1.0 1.0 0.0 0.4 0.0 0.2 0.4 0.8 0.0 0.4 5.7 0.5 0.0 0.3 3.4 1.3 0.0 1.1 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.0 12.4 0.2 0.0 0.4 0.2 1.3 0.4 0.3 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968497-34067458 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.8" "Cell type enriched" "Detected in some" 9 "Oligodendrocytes: 178.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9" "Region enhanced" "Detected in many" "hypothalamus: 13.2" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.1 0.1 2.4 0.3 5.8 0.4 0.3 4.2 4.8 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.0 1.8 8.4 0.2 0.6 0.1 0.3 9.5 8.3 0.1 0.3 0.0 0.2 1.5 9.0 0.1 0.0 1.3 0.1 0.0 0.2 0.4 0.5 0.0 3.1 0.2 0.1 1.5 18.8 0.0 0.6 0.0 0.0 0.0 0.1 13.8 0.1 0.1 0.5 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.6 0.2 0.2 0.0 0.4 10.4 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.5 1.0 0.0 0.1 0.2 1.9 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.1 0.1 1.0 0.1 0.1 0.2 0.2 0.1 0.7 0.2 0.3 0.0 0.2 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 2.4 5.8 4.2 4.8 1.8 8.4 9.5 8.3 9.0 3.1 18.8 13.8 0.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 0.0 5.9 0.2 0.1 0.0 0.0 0.0 8.7 0.0 18.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 12.6 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.8 0.1 0.2 1.0 2.5 178.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.8 0.0 0.2 0.0 0.0 CHURC1 "C14orf52, FLJ33064, My015" ENSG00000258289 "Churchill domain containing 1" Q8WUH1 14 64914361-64944591 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040072 Approved Approved Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Cytosol "HPA040072: AB_10963788" "unprognostic (2.94e-1)" "unprognostic (2.42e-1)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.80e-1)" "unprognostic (2.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.64e-2)" "unprognostic (4.64e-1)" "unprognostic (6.78e-3)" "unprognostic (2.12e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-2)" "unprognostic (6.67e-2)" "unprognostic (3.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" 47.8 42.0 29.9 39.1 34.8 43.8 37.4 34.5 41.2 41.2 27.2 43.8 30.9 40.0 32.6 34.3 34.2 32.5 58.8 29.8 33.7 34.7 52.4 29.3 43.8 38.8 33.3 43.9 30.2 46.1 25.2 34.5 38.6 32.4 36.4 35.7 26.5 37.7 82.9 30.1 33.9 45.8 34.7 42.2 33.7 25.4 34.3 61.2 32.9 53.0 43.3 38.3 30.5 40.3 119.6 61.8 58.8 43.7 70.1 75.6 68.9 85.3 74.3 47.4 53.9 34.1 75.1 69.9 57.7 73.7 75.2 84.9 51.7 69.2 51.8 79.7 25.3 67.9 47.7 79.3 66.1 37.7 64.9 89.9 50.5 43.0 81.4 79.7 51.6 107.2 30.6 60.5 58.1 97.6 72.7 61.6 31.4 140.9 101.1 63.4 63.2 42.6 64.5 83.8 30.0 36.7 57.6 59.8 81.0 53.7 101.8 78.4 64.8 41.3 87.8 45.0 56.0 49.5 46.8 162.0 43.0 44.6 51.8 201.6 131.9 145.4 111.5 137.6 128.2 161.8 167.5 134.1 107.4 135.9 166.3 139.8 292.8 122.4 138.3 154.7 238.5 143.5 29.9 34.8 34.5 41.2 29.8 33.7 38.8 33.3 38.6 34.7 34.3 40.3 154.6 102.5 89.0 0.0 128.2 58.5 73.8 176.8 130.3 73.8 85.0 98.7 53.4 94.4 98.2 99.3 43.8 90.4 97.9 89.3 131.0 160.7 82.0 130.8 87.3 109.9 89.8 91.5 0.0 222.7 89.7 100.9 75.4 80.8 95.6 69.6 127.5 190.4 89.3 53.8 0.0 100.3 107.8 172.6 69.6 27.1 104.1 130.5 83.6 0.0 214.3 155.2 132.8 0.0 0.0 216.8 118.9 121.5 79.7 70.5 124.6 211.0 145.1 87.2 131.5 100.6 135.7 131.1 81.1 158.3 65.9 89.8 137.0 205.8 121.1 72.2 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540905 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 75.7;lymphoid tissue: 52.3" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5" "Cancer enhanced" "Detected in many" "testis cancer: 6.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 128.8;neutrophil: 448.8" "Group enriched" "Detected in many" 17 "granulocytes: 448.8;monocytes: 128.8" "Group enriched" "Detected in some" 4 "NB-4: 4.3;RPTEC TERT1: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 41: Macrophages - Immune response" Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 13.3 5.4 2.3 37.5 2.1 75.7 4.5 1.8 4.4 5.8 2.2 2.2 0.4 2.3 0.4 3.2 5.5 11.8 2.5 2.3 2.9 3.6 6.6 22.4 7.6 1.3 1.3 1.7 6.2 1.7 1.9 2.1 1.2 2.3 1.0 1.3 1.4 1.2 0.7 0.9 3.1 5.7 0.7 52.3 2.5 1.1 2.0 2.2 10.5 5.0 2.3 9.6 1.7 2.9 0.1 0.4 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.1 0.1 2.0 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.1 0.0 1.5 0.0 0.5 0.2 0.2 0.2 0.2 0.0 0.1 0.0 4.3 0.3 0.0 0.0 0.0 0.2 0.1 12.4 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.4 1.0 0.5 0.1 1.0 0.1 0.2 0.1 0.1 1.3 0.4 0.1 0.2 128.8 0.5 0.1 18.1 0.3 0.1 0.1 0.1 16.9 0.1 0.0 0.1 448.8 0.0 0.7 0.7 0.0 30.3 2.3 2.1 1.8 4.4 2.3 2.9 1.3 1.3 1.2 0.7 2.0 2.9 6.2 0.0 4.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 5.7 1.8 1.8 0.0 0.0 0.3 0.0 0.0 9.0 0.3 2.1 4.4 3.5 0.0 0.0 0.0 0.0 0.1 1.4 0.0 31.9 0.0 0.0 7.1 2.1 5.6 0.0 0.0 0.0 0.0 158.0 9.0 2.9 0.9 115.2 0.0 0.0 109.5 0.0 4.1 0.0 0.0 0.4 0.0 0.4 1.3 0.0 0.0 0.2 0.7 0.0 13.1 0.2 0.4 0.2 0.5 0.1 0.0 0.1 1.1 0.0 0.0 0.1 CMTM2 "CKLFSF2, FLJ25732, MGC39436" ENSG00000140932 "CKLF like MARVEL transmembrane domain containing 2" Q8TAZ6 16 66579448-66588275 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 429 "testis: 648.9" "Group enriched" "Detected in some" 73 "Early spermatids: 3619.3;Late spermatids: 3073.4;Spermatocytes: 1347.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 20 "REH: 32.1" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 36: Testis - Spermatogenesis" "Cluster 14: REH - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (2.81e-1)" "unprognostic (3.75e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (8.71e-2)" "unprognostic (3.31e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (1.91e-2)" "unprognostic (3.27e-2)" "unprognostic (1.02e-4)" "unprognostic (1.80e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" 0.2 0.1 0.5 0.4 0.2 1.1 0.5 0.6 0.9 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.5 0.0 0.4 0.3 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.2 0.0 0.7 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.0 1.5 0.2 648.9 0.0 1.1 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.5 0.1 0.1 1.5 0.5 0.1 0.0 0.0 32.1 0.2 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.6 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 21.9 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 5.0 0.0 0.0 0.1 1.5 0.2 0.0 0.3 3619.3 0.1 0.1 2.3 0.0 0.0 1.1 0.2 0.2 1.8 0.0 0.1 18.9 0.1 1.1 0.3 1.4 0.0 0.6 0.0 0.0 0.9 0.3 3073.4 36.4 5.5 0.0 0.0 7.7 0.0 1.0 0.0 0.6 0.8 0.0 30.5 0.0 0.0 0.0 0.4 0.7 0.6 19.7 0.7 0.1 1347.5 20.4 0.0 0.0 0.1 1.7 0.4 0.0 0.0 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798800-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 42.4" "Group enriched" "Detected in many" 5 "Early spermatids: 70.5;Late spermatids: 124.8;Respiratory ciliated cells: 47.0;Spermatocytes: 150.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;ASC diff: 1.6;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA072363 Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Vesicles "HPA072363: " "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.3 0.2 0.9 0.0 0.9 0.1 1.8 1.2 1.9 0.1 0.1 0.8 0.1 0.1 1.4 0.0 0.7 0.0 0.1 0.9 1.0 1.5 0.0 0.5 0.0 1.0 0.9 0.4 1.0 0.3 0.0 0.1 0.9 1.3 1.9 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.1 3.3 42.4 0.8 0.0 0.3 0.6 0.0 0.2 0.0 1.9 2.9 0.3 0.2 0.5 1.6 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.8 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.2 1.9 0.9 1.0 1.0 0.9 0.9 0.8 0.8 1.9 1.2 3.2 4.6 2.3 1.0 0.4 0.5 0.4 0.0 1.7 5.5 2.2 1.1 1.5 2.1 0.0 0.0 0.3 1.2 1.4 5.9 0.2 70.5 5.4 1.7 0.8 0.0 2.7 1.9 0.4 0.4 1.9 4.1 1.6 6.3 0.2 0.4 1.1 0.3 6.7 1.6 5.3 4.1 1.0 0.7 124.8 2.5 1.1 0.0 0.0 0.2 1.0 0.0 2.0 1.1 0.4 0.4 1.2 0.7 5.6 0.9 0.5 47.0 0.7 6.6 1.0 1.7 150.2 17.1 0.0 0.6 0.3 0.9 0.5 2.7 2.3 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein family member 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 26.1;Excitatory neurons: 18.6;Hepatic stellate cells: 30.0;Inhibitory neurons: 103.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 74 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "A549: 18.9;AF22: 22.5;TIME: 14.5;WM-115: 37.9" HPA047731 Uncertain "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.7 0.4 4.8 0.5 7.6 1.2 3.2 0.4 2.7 1.3 2.7 4.0 0.8 0.6 0.5 7.2 2.2 1.2 4.0 5.0 3.3 1.8 0.8 1.1 0.3 0.9 5.4 0.3 0.4 0.1 1.1 1.6 0.9 1.5 1.3 2.7 3.4 1.4 0.4 7.2 1.8 2.3 0.1 2.6 0.6 1.8 1.7 2.5 1.2 0.7 0.6 1.0 2.5 2.8 1.1 18.9 22.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 1.4 4.7 1.9 4.4 0.0 0.0 1.6 0.0 5.2 0.5 0.2 0.3 0.0 0.5 4.1 0.0 1.7 9.4 8.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.9 0.2 5.7 0.0 0.6 5.4 0.4 0.8 2.1 0.7 6.7 0.0 3.7 2.4 0.0 3.2 14.5 0.0 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 4.8 7.6 0.4 2.7 5.0 3.3 0.9 5.4 0.9 0.1 1.7 2.8 8.0 3.2 1.7 26.1 0.0 6.2 4.0 1.8 18.2 1.3 0.9 3.0 3.5 4.3 1.5 1.8 2.1 0.8 0.0 0.1 0.0 0.4 1.9 1.4 0.7 7.5 3.5 0.0 18.6 0.2 2.5 1.2 0.0 0.2 0.0 0.1 30.0 1.3 0.1 0.0 103.1 0.3 0.0 1.6 0.8 0.9 0.3 0.2 0.0 13.1 0.0 10.5 0.0 3.0 13.3 0.7 0.0 0.0 1.2 1.4 0.0 1.9 4.1 0.7 0.0 0.5 0.9 1.7 8.8 10.4 7.7 0.7 0.4 0.0 0.1 2.7 CNTNAP3B ENSG00000154529 "Contactin associated protein family member 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 69.6;Hepatic stellate cells: 91.8;Inhibitory neurons: 161.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 38 "granulocytes: 3.7" "Cell line enhanced" "Detected in many" "A549: 29.9;AF22: 41.8;WM-115: 28.5" HPA047731 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047731: AB_2680137" "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 8.9 1.6 6.1 1.4 10.0 0.3 10.1 2.9 6.3 3.7 6.4 8.6 1.4 2.5 0.7 9.3 5.0 2.5 5.7 7.1 7.4 7.0 2.6 3.4 1.0 4.7 9.0 1.1 1.5 0.4 2.9 3.8 4.4 2.8 2.8 6.3 6.6 2.1 1.6 8.8 3.7 3.2 2.5 3.8 2.1 1.9 5.1 2.4 2.1 1.6 1.1 3.2 4.2 3.4 0.2 29.9 41.8 0.0 1.3 0.5 0.1 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.1 0.6 3.7 2.4 2.3 0.0 0.1 1.3 0.0 5.4 2.6 0.9 1.4 0.0 3.3 3.4 0.4 0.5 10.4 7.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 4.1 1.0 9.0 0.0 0.7 11.9 1.4 0.8 3.0 0.3 1.1 0.0 5.8 1.3 0.0 4.2 7.4 0.2 2.8 0.1 0.8 0.0 0.0 0.0 0.0 1.3 28.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 6.1 10.0 2.9 6.3 7.1 7.4 4.7 9.0 4.4 2.5 5.1 3.4 69.6 0.0 6.3 34.6 0.6 4.2 7.8 2.4 15.4 2.6 3.9 11.8 7.1 4.3 1.2 3.7 0.0 3.1 0.3 0.3 0.0 2.1 2.0 2.8 0.3 35.0 1.8 2.7 34.6 3.3 2.1 6.2 0.0 1.3 1.3 0.4 91.8 7.5 0.1 0.0 161.6 1.6 6.1 3.8 0.8 1.4 0.9 0.5 5.4 33.7 0.0 27.9 0.0 8.0 1.3 2.0 0.0 0.7 0.0 3.2 0.0 9.7 11.1 1.0 0.0 0.7 3.6 0.8 7.0 8.4 5.3 0.7 0.7 0.2 0.1 6.0 CNTNAP3C ENSG00000283378 "Contactin associated protein family member 3C" 9 61330717-61453030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 11.0;brain: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 12 "neutrophil: 30.9" "Lineage enriched" "Detected in single" 182 "granulocytes: 30.9" "Cell line enhanced" "Detected in some" "A549: 27.5;SiHa: 6.1;TIME: 8.7;WM-115: 24.0" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 17: WM-115 - Nervous system development" 0.2 0.0 1.8 0.1 3.2 11.0 0.2 0.2 0.9 0.2 2.6 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.9 2.1 1.3 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.4 0.1 0.0 1.1 0.2 0.2 0.0 0.4 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.3 0.8 1.3 27.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.9 3.0 0.4 2.1 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 1.8 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.6 0.0 0.9 0.0 0.5 3.3 0.0 0.9 0.4 0.8 6.1 0.1 1.7 0.3 0.1 0.1 8.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 24.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 1.8 3.2 0.2 0.9 2.1 1.3 0.0 1.5 0.2 0.0 0.4 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104085880 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 580.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 227.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in many" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 1.5 0.4 0.8 6.6 1.1 12.2 37.3 1.0 1.4 50.1 0.6 37.4 10.7 0.6 6.6 116.6 1.1 0.3 0.5 0.5 0.6 0.3 0.3 0.9 0.1 0.6 0.7 0.2 0.4 0.0 1.2 35.4 0.6 17.9 27.3 0.0 82.2 9.6 0.5 580.3 37.2 1.0 0.5 2.3 19.8 25.4 0.6 42.7 5.1 0.0 19.8 9.9 102.0 0.8 26.3 0.4 1.5 0.2 0.1 0.0 80.6 0.5 0.3 0.1 0.2 0.3 204.3 0.0 5.1 0.3 3.9 463.8 0.7 745.8 0.7 0.0 0.7 0.0 0.3 0.2 0.1 0.0 0.4 0.7 914.1 0.5 783.7 0.2 3.5 0.1 0.1 0.9 0.0 0.0 0.0 0.3 1.7 5.1 2.6 0.0 0.0 0.3 35.9 26.4 0.2 0.3 0.0 0.2 0.9 4.0 0.2 0.0 1.5 0.5 5.0 0.3 5.5 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 1.1 1.0 1.4 0.5 0.6 0.6 0.7 0.6 0.5 0.6 0.8 1.0 0.0 1.1 0.7 0.3 585.7 17.7 136.0 299.9 0.6 1.7 85.5 1.1 0.0 16.5 0.0 0.0 10.2 0.3 211.5 0.0 0.8 14.2 23.7 2.3 3.7 2.4 0.0 0.1 0.9 18.9 2.4 23.0 8.1 0.0 0.1 0.0 0.0 1.3 0.0 0.2 5.7 6.1 0.0 28.9 3.6 0.3 0.7 33.8 0.0 0.0 0.4 0.0 0.0 0.4 78.8 35.7 0.7 1.4 16.6 108.5 0.1 5.9 0.4 0.0 0.4 3.0 22.7 1.5 31.9 139.4 5.6 1.3 0.1 21.6 10.7 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067614-19080095 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 40.4;neutrophil: 126.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 126.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 10.2 13.6 10.7 7.0 11.2 4.8 13.4 10.9 11.6 10.8 12.5 14.1 12.4 15.6 12.3 12.4 15.5 10.7 23.4 11.0 10.8 14.1 12.3 10.0 8.3 10.6 11.3 20.0 10.3 24.4 9.7 10.0 11.1 17.7 13.2 14.0 10.4 14.7 45.8 7.9 11.8 11.6 10.4 10.0 12.8 20.9 11.3 10.3 16.2 44.9 8.4 10.3 8.8 13.1 23.5 24.8 21.1 12.4 11.6 12.2 17.7 13.5 11.0 18.0 18.5 15.9 19.1 17.8 63.9 10.4 19.4 24.5 29.6 16.9 13.0 15.2 29.9 9.5 22.8 49.3 14.4 22.9 20.1 10.3 14.6 16.8 12.2 14.8 14.8 20.9 26.4 16.2 12.9 42.4 24.0 18.4 16.1 9.1 13.1 29.0 23.3 22.8 15.7 15.5 30.4 17.4 12.6 27.4 16.2 10.2 25.2 30.7 16.3 19.0 10.9 14.1 19.7 15.0 26.2 19.7 20.4 13.1 12.5 40.4 11.4 17.8 9.9 10.6 9.4 16.3 8.9 8.7 12.6 15.3 12.2 10.8 126.5 12.9 12.3 15.6 6.2 5.6 10.7 11.2 10.9 11.6 11.0 10.8 10.6 11.3 11.1 10.4 11.3 13.1 13.3 16.0 12.6 6.2 35.5 11.0 26.3 20.9 13.6 31.2 18.3 21.1 21.8 31.5 14.9 16.5 39.6 21.2 28.7 38.1 45.0 25.2 14.8 23.7 16.2 16.1 24.0 4.8 6.0 18.0 17.9 14.9 32.1 23.2 25.4 31.1 20.7 11.1 23.3 20.2 8.8 39.0 30.5 29.4 12.9 8.5 18.6 18.8 10.6 4.7 11.6 39.5 8.2 5.0 9.4 13.2 30.4 13.9 11.6 17.8 71.5 23.7 24.4 53.9 19.7 20.0 20.2 81.3 53.1 12.8 12.4 32.2 23.9 38.2 39.8 24.0 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.3;prostate: 25.3" "Cell type enriched" "Detected in some" 10 "Excitatory neurons: 351.2" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Group enriched" "Detected in many" 4 "basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 0.6 0.5 4.8 0.1 34.3 0.0 0.2 0.0 15.2 0.2 0.0 0.3 0.7 0.2 0.6 0.3 0.4 0.0 0.9 16.8 3.7 1.0 0.1 0.4 0.0 0.0 4.2 0.0 0.2 1.9 3.0 0.0 0.1 25.3 0.2 2.0 0.4 3.7 0.0 0.2 0.5 0.3 0.5 0.8 0.5 1.4 12.1 0.0 0.3 0.1 0.0 0.1 0.4 1.2 0.0 6.2 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 0.4 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.8 0.4 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.8 34.3 0.0 15.2 16.8 3.7 0.0 4.2 0.1 0.5 12.1 1.2 0.9 0.0 0.0 8.8 0.0 0.3 0.4 0.1 0.0 0.8 0.0 0.0 17.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.6 0.1 0.6 4.9 0.0 351.2 0.0 0.0 0.6 3.6 0.6 0.0 0.2 0.0 0.0 0.1 1.7 33.0 0.1 0.0 0.0 0.3 5.6 0.3 1.1 0.0 8.4 0.6 0.3 0.0 8.5 7.1 0.1 0.0 0.0 0.0 17.0 0.0 2.6 0.3 0.6 0.0 0.0 0.4 1.4 1.1 0.3 0.1 0.0 0.0 0.1 0.0 0.9 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880713 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 17.4 10.6 5.8 17.1 5.2 52.9 16.8 25.4 11.5 20.9 3.7 18.8 12.5 26.5 12.4 16.5 22.4 16.6 14.4 5.9 3.1 12.0 14.3 15.9 17.6 8.9 6.8 37.3 29.7 18.5 11.3 16.9 2.9 16.1 14.1 13.8 17.2 16.2 29.6 21.0 16.4 19.6 0.4 21.0 16.3 33.2 7.9 29.1 23.3 28.9 20.7 16.6 16.5 6.4 12.3 31.0 39.3 17.4 23.5 23.1 20.4 17.4 28.9 29.2 28.2 28.2 22.4 33.7 20.1 33.3 18.7 23.2 45.7 14.2 32.9 57.5 18.5 26.6 29.2 17.9 26.0 26.9 36.5 20.7 14.2 32.5 38.9 18.0 22.3 17.0 30.9 44.8 16.0 42.0 17.9 13.0 32.3 11.7 12.7 83.4 31.1 26.1 11.2 16.2 32.6 21.5 29.5 28.7 16.8 25.3 25.6 25.9 34.7 35.5 35.2 18.4 16.0 20.8 24.3 63.7 7.2 15.8 25.6 1.9 1.1 0.9 1.7 1.5 0.8 3.7 0.8 1.3 0.7 2.1 0.8 1.1 6.7 1.4 2.9 1.5 0.8 0.9 5.8 5.2 25.4 11.5 5.9 3.1 8.9 6.8 2.9 0.4 7.9 6.4 48.1 44.8 51.6 91.1 38.3 56.2 31.0 16.0 27.3 34.2 34.4 25.7 41.2 40.0 28.0 11.0 25.0 17.4 50.1 31.2 5.9 20.9 43.0 37.2 56.4 35.7 15.0 33.4 88.7 20.3 11.3 39.5 32.1 63.5 30.4 53.1 32.5 29.5 20.9 28.6 89.8 25.3 18.3 44.0 42.8 80.2 56.5 49.0 17.8 87.1 52.5 34.5 43.3 111.6 101.2 27.5 19.5 51.1 35.6 39.8 25.2 10.9 28.2 17.6 46.0 75.8 44.9 35.1 42.2 34.6 58.8 30.8 44.2 36.2 24.6 44.2 CREBRF "C5orf41, LRF" ENSG00000164463 "CREB3 regulatory factor" Q8IUR6 5 173056352-173139284 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 21.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015329 Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA015329: AB_2669192" "unprognostic (8.00e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (3.14e-2)" "unprognostic (5.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.35e-1)" "unprognostic (6.03e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.17e-2)" "unprognostic (4.69e-2)" "prognostic favorable (3.20e-7)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.52e-1)" "prognostic favorable (9.30e-4)" 12.9 10.8 9.6 10.4 12.6 68.1 11.1 14.6 11.6 12.2 11.6 9.9 8.4 11.6 11.3 8.7 8.7 9.8 11.2 8.1 12.3 14.5 10.8 11.8 13.2 12.0 11.6 19.0 7.9 15.9 5.8 12.7 12.2 10.0 8.5 11.2 8.8 11.6 8.4 12.1 9.5 10.4 11.0 15.2 8.3 13.4 10.7 12.4 23.2 11.9 10.4 10.3 9.3 14.6 1.2 2.8 2.6 4.1 11.7 15.6 6.1 3.7 18.0 3.4 6.5 3.8 6.3 2.3 8.7 3.8 6.3 1.5 1.2 2.9 4.8 8.4 2.5 1.8 1.9 1.2 9.0 1.4 10.0 9.5 7.3 3.7 9.2 8.3 4.2 2.9 1.6 11.7 4.0 2.3 2.2 2.0 0.8 1.9 1.4 2.1 1.8 3.6 4.8 2.5 2.0 3.0 3.7 1.6 13.6 5.5 1.7 2.6 6.9 5.2 1.7 3.5 1.0 13.0 11.7 4.0 3.8 2.5 1.8 5.6 2.7 6.1 3.6 2.4 3.3 2.9 3.6 3.1 1.4 5.6 4.4 3.6 21.8 1.5 3.3 3.1 3.6 1.8 9.6 12.6 14.6 11.6 8.1 12.3 12.0 11.6 12.2 11.0 10.7 14.6 103.6 51.3 48.4 33.6 95.9 79.2 26.0 19.7 105.3 50.1 68.3 48.1 61.4 44.3 25.9 38.6 68.8 11.6 104.1 50.8 15.6 17.4 5.3 68.9 51.1 66.3 76.7 70.7 57.3 15.7 11.1 67.5 21.4 154.0 48.1 75.2 64.6 39.5 20.4 112.7 64.2 30.3 32.6 96.2 57.7 8.4 51.9 76.7 65.8 70.3 81.7 33.1 55.6 40.2 65.3 17.4 31.8 54.9 78.9 67.6 42.4 23.2 34.8 65.0 59.2 89.8 65.6 74.8 48.0 42.7 92.9 37.4 83.5 26.2 20.5 40.9 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819985-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 87.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 87.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 15.6" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 113.4 29.0 3.3 46.6 4.9 8.1 64.2 3.9 4.6 112.9 2.6 88.9 10.8 115.7 20.3 39.9 129.0 104.0 36.6 3.7 5.2 40.9 17.1 92.7 7.3 5.9 5.5 80.7 23.5 2.5 19.3 122.7 5.9 98.9 18.1 2.4 18.1 27.7 15.0 36.7 58.5 95.0 4.4 24.9 65.9 21.5 4.3 8.2 47.9 12.2 3.7 119.9 69.8 5.7 0.9 2.2 0.6 6.0 43.7 16.2 69.2 34.5 30.4 27.2 19.1 4.7 2.9 0.1 3.0 30.5 8.0 1.0 0.1 0.1 27.3 0.0 0.2 0.5 0.9 0.1 161.4 0.0 0.3 68.0 0.1 8.0 0.1 9.0 0.2 0.0 0.3 0.3 3.1 1.4 0.3 1.7 2.0 4.6 2.0 0.1 0.3 0.4 0.2 5.5 6.7 0.5 8.1 3.5 0.7 9.4 13.7 0.9 3.8 0.4 1.8 28.3 1.0 0.4 0.1 5.8 0.2 0.5 4.1 14.8 20.2 0.7 0.0 1.2 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.0 87.2 0.0 0.0 0.1 0.0 4.2 3.3 4.9 3.9 4.6 3.7 5.2 5.9 5.5 5.9 4.4 4.3 5.7 5.9 3.2 2.3 0.7 0.7 46.1 8.6 0.6 9.6 0.5 3.9 7.6 8.6 2.8 1.6 0.0 0.0 7.4 0.8 1.8 0.0 1.4 12.6 7.0 137.3 21.7 3.0 0.0 2.2 0.5 42.4 185.5 27.0 6.3 7.0 11.5 38.6 0.8 4.7 1.7 1.5 4.1 0.0 36.6 39.6 19.6 271.5 14.8 48.0 9.4 41.5 5.1 3.1 54.3 0.6 0.9 0.3 265.9 0.9 17.1 0.2 0.1 0.9 0.7 92.1 146.2 341.2 1.0 1.9 3.7 42.8 9.0 5.4 5.7 2.2 6.5 CSAD "CSD, PCAP" ENSG00000139631 "Cysteine sulfinic acid decarboxylase" Q9Y600 12 53157663-53180925 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 16.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.3" "Cell line enhanced" "Detected in all" "ASC diff: 84.5;T-47d: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039487 Approved "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" "HPA039487: AB_10672776" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (1.57e-1)" "unprognostic (7.99e-2)" "prognostic favorable (6.33e-4)" "prognostic favorable (1.37e-4)" "unprognostic (2.46e-2)" "unprognostic (7.87e-3)" "unprognostic (1.01e-1)" "prognostic favorable (3.39e-4)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.93e-6)" "unprognostic (4.59e-2)" "unprognostic (3.47e-1)" "unprognostic (1.38e-1)" "prognostic favorable (6.81e-6)" 68.0 28.3 24.3 15.9 25.4 39.1 62.4 25.2 25.7 54.9 33.8 34.3 17.3 31.2 52.3 29.3 41.5 19.2 25.2 24.0 24.5 39.2 101.7 30.8 19.1 26.1 23.0 54.0 35.9 14.9 40.9 13.0 24.8 50.3 16.0 16.8 34.7 19.8 19.6 59.6 28.5 19.6 20.2 37.5 31.9 27.7 24.7 14.2 36.0 7.7 14.1 25.8 37.6 36.7 3.7 6.8 16.0 6.8 84.5 34.4 5.7 14.5 3.2 6.0 5.0 4.1 8.8 4.9 10.6 7.7 2.0 12.6 7.1 11.2 3.5 6.6 8.6 7.8 19.4 8.8 7.6 3.3 4.9 42.6 13.8 9.0 11.2 30.8 5.6 10.4 8.4 42.8 5.7 30.8 1.8 9.2 3.1 1.9 6.3 6.6 1.0 11.4 8.0 9.6 8.0 6.3 14.3 19.9 5.7 9.9 52.7 6.5 12.6 17.5 3.4 5.2 4.2 12.2 3.4 2.6 14.7 8.3 7.1 3.7 2.0 2.5 1.3 1.1 0.8 1.1 1.8 0.8 1.0 1.8 2.4 1.4 16.3 1.6 1.3 2.3 3.4 0.5 24.3 25.4 25.2 25.7 24.0 24.5 26.1 23.0 24.8 20.2 24.7 36.7 23.5 3.2 22.0 40.1 15.6 16.6 28.3 18.3 4.0 29.0 27.9 43.4 8.9 20.0 17.4 23.9 16.7 12.2 18.5 19.3 3.9 12.6 0.7 11.6 20.4 22.5 14.4 0.4 47.0 9.1 6.9 23.0 19.4 14.3 9.5 22.0 21.4 38.2 8.4 26.9 51.1 21.3 14.2 11.9 12.8 3.5 27.1 11.1 14.2 30.0 15.6 18.3 20.6 34.2 62.4 10.0 25.5 30.9 6.9 28.8 22.5 5.1 15.4 30.0 39.5 22.5 27.9 48.0 64.4 5.5 18.3 8.9 13.0 17.9 15.4 24.2 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861880-37984469 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 132.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA048325: AB_2680359" "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favorable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 21.1 9.2 19.4 6.3 20.6 10.0 28.1 24.3 23.2 20.3 17.1 33.4 14.3 20.2 14.0 23.8 17.9 29.3 29.4 18.8 17.3 39.7 21.5 27.2 4.1 19.2 17.7 19.6 15.8 12.0 10.7 31.7 16.6 26.5 30.2 3.2 27.1 31.3 21.2 52.9 17.6 23.2 18.1 17.3 31.7 10.6 19.5 7.2 14.0 19.9 5.5 26.4 19.1 17.3 44.5 18.9 7.6 24.0 29.2 41.0 57.2 30.0 37.0 20.1 23.5 27.4 35.3 0.2 17.9 36.9 8.4 36.3 19.2 56.1 16.0 0.1 15.1 27.2 18.8 63.1 26.4 0.0 6.4 21.5 132.3 21.2 25.5 22.4 28.2 12.0 8.9 0.0 33.7 13.7 11.1 0.1 31.5 17.7 2.7 12.3 14.9 0.2 63.3 28.7 6.3 19.9 16.5 28.7 33.5 30.5 28.1 7.3 23.2 14.4 20.4 27.3 19.1 0.6 0.2 0.2 15.8 14.8 27.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.1 19.4 20.6 24.3 23.2 18.8 17.3 19.2 17.7 16.6 18.1 19.5 17.3 26.8 67.3 27.6 170.4 1.2 30.1 17.0 17.7 27.9 10.1 25.7 59.4 42.2 65.8 25.7 23.9 0.0 34.7 1.0 35.6 23.5 14.2 21.5 7.6 17.6 22.4 45.2 7.8 189.3 4.7 9.9 32.4 10.2 27.2 1.3 15.7 22.9 18.1 7.2 10.1 126.3 18.5 2.0 13.3 6.5 51.3 71.7 11.3 8.8 22.5 1.4 9.5 1.0 87.4 48.8 14.2 17.9 98.2 0.4 15.5 9.1 19.7 12.4 1.7 26.3 55.4 40.4 10.0 16.9 17.7 28.7 9.4 2.0 65.8 42.0 14.4 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800441-38825355 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 28.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 13.3 12.6 7.9 9.9 8.9 62.2 12.3 8.5 9.7 11.6 8.8 11.1 10.3 10.3 5.4 12.5 11.9 7.6 9.0 8.2 8.5 11.6 16.2 13.0 12.6 8.7 8.5 11.2 12.6 7.2 11.0 6.7 8.5 11.7 6.1 8.6 10.9 4.5 12.7 17.4 13.1 6.8 8.0 16.8 11.6 18.4 8.5 14.2 11.3 7.1 9.0 10.9 11.5 9.4 11.2 13.1 8.2 14.1 10.9 7.1 8.3 11.5 7.9 12.0 11.0 8.4 11.7 12.7 7.8 9.2 9.2 25.3 8.2 7.7 14.5 12.0 8.7 9.9 14.9 10.4 10.8 25.2 15.6 8.4 12.3 11.8 9.7 12.7 9.8 13.5 15.5 15.0 10.2 6.2 26.4 25.6 8.5 8.2 6.4 20.0 12.1 11.4 12.0 10.7 9.3 8.2 10.7 7.6 13.8 12.2 12.0 19.8 10.2 10.8 9.9 14.3 17.9 11.9 9.3 18.8 11.4 12.1 10.9 18.0 4.1 10.6 4.6 3.9 4.0 4.5 4.3 4.8 3.5 6.0 4.9 3.7 28.7 5.9 8.1 1.7 2.9 3.0 7.9 8.9 8.5 9.7 8.2 8.5 8.7 8.5 8.5 8.0 8.5 9.4 50.7 57.7 69.5 10.4 54.2 63.9 61.2 45.9 39.9 37.2 40.8 31.2 18.3 21.5 46.3 23.9 83.4 35.1 60.6 56.6 29.4 27.5 118.4 63.8 51.7 45.3 41.8 34.5 10.0 23.6 35.2 43.8 52.0 100.2 58.9 23.8 37.9 27.2 28.6 26.9 7.9 51.9 26.4 27.0 37.9 31.9 37.3 38.2 26.6 5.6 38.7 30.1 41.2 5.5 8.1 29.3 70.9 34.6 43.2 51.4 61.5 27.2 41.9 43.4 39.5 57.0 45.7 93.9 33.6 30.5 76.7 79.1 54.6 28.8 32.6 72.4 DDX17 P72 ENSG00000100201 "DEAD-box helicase 17" Q92841 22 38483438-38507660 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024908, HPA063142" Supported Supported "Nuclear speckles" "Intracellular and membrane" NA NA 420000 "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB024908: , HPA063142: AB_2684949" "unprognostic (1.46e-2)" "unprognostic (5.99e-3)" "unprognostic (4.24e-3)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.06e-4)" "unprognostic (1.17e-1)" "unprognostic (5.51e-1)" "unprognostic (2.52e-2)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.76e-1)" "unprognostic (4.31e-2)" "unprognostic (3.19e-3)" 181.2 172.4 142.0 124.3 160.1 74.5 198.5 150.9 178.4 248.7 174.8 233.8 107.8 216.1 255.3 150.4 248.1 121.1 168.7 143.5 152.1 247.2 152.8 202.2 186.4 152.8 149.4 298.8 214.0 144.7 309.9 158.8 155.3 234.4 114.2 342.0 188.4 123.3 184.8 197.0 227.2 119.7 146.8 293.0 192.1 91.1 148.2 215.2 300.0 106.6 158.2 204.4 201.5 196.5 122.0 79.9 237.6 141.8 148.2 166.0 120.7 104.3 85.9 118.3 121.2 89.0 100.5 225.8 65.8 119.5 82.9 133.2 212.5 127.9 145.9 202.5 142.1 140.4 175.8 133.5 153.4 192.9 170.8 122.3 183.7 86.8 142.9 211.7 153.3 109.6 139.7 255.3 116.0 75.6 128.7 164.0 148.0 172.1 51.6 218.0 122.9 137.1 141.2 132.6 134.1 75.3 155.0 125.9 161.2 180.5 110.0 148.4 140.8 125.7 77.6 80.0 79.3 203.7 130.3 183.4 156.7 123.1 154.2 6.7 8.1 9.5 7.6 7.9 8.9 9.0 7.1 7.3 7.0 7.2 5.7 6.8 16.6 5.1 8.7 10.5 9.1 6.0 142.0 160.1 150.9 178.4 143.5 152.1 152.8 149.4 155.3 146.8 148.2 196.5 252.6 214.7 325.5 483.8 241.9 223.6 206.1 129.3 158.2 448.3 300.7 195.3 147.2 180.1 223.5 283.3 352.3 127.6 297.5 172.8 33.2 111.7 44.4 280.0 293.4 250.4 236.1 177.1 198.9 90.2 99.9 207.5 216.1 234.2 200.7 505.3 233.8 205.3 113.9 321.4 242.1 191.6 146.5 200.6 194.8 49.1 323.7 197.7 154.7 253.9 235.1 223.4 304.9 334.3 553.3 104.7 153.1 278.7 213.1 193.5 154.8 89.8 270.8 559.4 289.3 260.5 213.6 136.4 74.2 120.4 279.9 139.4 218.6 293.7 147.0 255.3 DDX58 "DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455302-32526208 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8" "CAB012643, HPA047193, HPA073217" Approved Supported "Plasma membrane,Cytosol" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane, Cytosol" "CAB012643: , HPA047193: AB_2679978, HPA073217: " "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 6.3 4.9 3.5 7.5 2.9 1.3 6.0 3.0 4.3 7.1 3.1 6.3 2.9 5.6 4.7 6.4 4.4 6.0 4.1 2.7 3.6 5.5 6.3 7.1 7.4 5.2 3.7 4.6 5.7 2.5 5.2 5.7 4.0 4.2 5.3 2.3 10.0 3.5 4.8 7.8 7.1 5.7 6.5 9.2 4.8 2.8 3.6 15.6 4.3 1.7 5.2 5.1 5.3 2.9 4.3 2.4 2.5 2.2 7.5 6.4 2.7 2.1 14.6 79.0 76.0 2.4 1.4 0.4 2.7 2.7 22.8 2.8 2.3 1.3 11.4 7.4 0.9 1.1 2.4 3.5 5.0 1.4 4.5 4.9 1.3 6.9 1.3 4.2 14.3 1.5 1.8 1.0 6.6 0.6 3.8 12.4 1.8 0.6 2.0 2.4 3.1 0.0 11.6 0.6 2.0 0.3 1.7 1.7 12.6 1.7 3.5 0.9 13.4 1.5 0.9 1.7 1.1 0.0 0.3 0.9 2.6 3.3 2.1 0.0 0.1 0.3 0.2 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.2 0.2 1.3 0.4 0.2 0.0 0.2 0.0 3.5 2.9 3.0 4.3 2.7 3.6 5.2 3.7 4.0 6.5 3.6 2.9 41.7 22.4 8.8 20.5 13.9 4.2 5.1 7.2 13.6 4.1 5.8 5.1 5.1 5.7 6.7 1.8 2.1 5.6 13.9 13.8 0.0 19.5 2.7 12.9 8.7 23.6 3.0 5.7 10.4 12.2 7.6 13.9 21.9 20.3 5.1 16.8 9.3 6.7 5.6 6.7 13.2 4.6 4.1 7.3 4.6 0.4 6.5 11.6 0.0 39.4 12.3 6.4 21.6 31.2 17.5 16.2 7.7 6.0 9.1 4.9 16.9 7.2 7.3 2.5 6.6 16.8 13.1 0.5 2.3 10.9 5.4 2.5 17.8 10.4 2.6 5.3 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018297 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 64 "bone marrow: 37615.2" "Cell type enhanced" "Detected in some" "B-cells: 17.9;Erythroid cells: 10.1;Hepatocytes: 17.0;Macrophages: 5.7;Plasma cells: 4.0;T-cells: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in many" 19 "neutrophil: 854.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 854.3" "Cell line enriched" "Detected in single" 8 "NB-4: 1.5" HPA052517 Supported "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 8.8 1.2 0.5 1.0 0.3 37615.2 5.0 0.2 1.2 2.0 0.3 1.3 0.0 5.6 0.0 1.0 0.7 0.2 16.1 0.2 0.3 4.4 26.1 180.2 5.3 0.4 0.6 1.3 1.6 0.0 7.6 18.8 0.5 0.8 0.0 0.2 24.2 0.0 5.0 42.1 0.7 0.0 0.5 589.4 1.8 0.6 0.6 147.9 4.5 1.1 1.3 1.1 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 24.4 3.6 44.3 1.2 1.6 2.3 1.0 0.8 1.0 1.1 6.9 0.3 854.3 0.4 2.6 1.4 0.3 6033.6 0.5 0.3 0.2 1.2 0.2 0.3 0.4 0.6 0.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.8 17.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 163.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Collecting duct cells: 29.5;Cytotrophoblasts: 30.9;Endometrial ciliated cells: 29.4;Granulosa cells: 49.8;Hofbauer cells: 31.7;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 200.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 23.9 32.2 38.5 21.4 46.0 21.7 16.7 53.5 49.2 25.0 76.1 33.5 25.1 26.0 17.2 28.4 38.6 22.6 122.3 36.6 39.8 35.6 24.9 25.0 21.6 45.5 51.3 22.9 16.8 47.9 21.5 16.6 42.1 22.8 30.4 8.3 32.2 34.1 143.0 25.6 23.7 32.0 38.0 33.6 38.1 19.0 45.4 27.3 30.1 163.6 19.9 31.9 20.2 45.2 6.2 16.4 8.0 20.1 32.8 30.6 21.0 6.6 17.7 19.3 19.6 10.9 46.7 41.3 46.0 18.8 24.9 18.0 23.0 24.7 7.9 22.8 9.5 27.7 9.1 13.8 47.8 28.5 38.2 47.5 10.5 10.6 4.0 25.3 34.6 22.8 14.0 54.4 18.4 1.4 22.7 27.0 16.4 0.8 1.4 38.2 15.7 30.9 32.7 25.9 22.4 11.2 10.4 17.8 7.3 8.4 32.0 24.5 24.7 5.7 4.8 17.1 5.9 30.9 23.8 14.0 29.6 36.8 3.8 67.5 48.8 30.8 30.1 69.4 30.3 34.0 19.3 24.5 72.9 22.4 15.9 20.0 200.5 21.0 60.7 22.0 45.2 29.0 38.5 46.0 53.5 49.2 36.6 39.8 45.5 51.3 42.1 38.0 45.4 45.2 19.2 28.9 16.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 11.5 13.2 0.0 0.0 5.6 29.5 0.0 30.9 12.5 0.0 21.5 17.6 0.0 29.4 14.8 6.2 0.0 0.0 0.0 5.8 15.8 7.4 0.0 25.0 7.6 49.8 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 2.7 0.0 0.0 17.0 5.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 16.8 8.7 35.6 0.0 0.0 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206407 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.6" "Group enriched" "Detected in many" 4 "Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 65: Brain - Ion transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: AB_2686407" "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 7.8 4.4 17.1 6.6 41.6 1.4 4.8 11.4 21.9 5.0 0.0 3.2 1.5 4.6 2.8 2.5 5.2 5.0 4.9 40.6 17.8 4.5 10.0 17.3 2.7 16.5 18.1 8.4 3.2 3.3 3.2 6.9 15.6 4.0 2.8 10.5 3.3 2.5 6.2 2.5 2.4 7.3 14.9 1.8 2.2 2.1 19.2 1.7 3.5 7.3 2.2 3.7 3.5 26.0 0.1 3.5 8.8 7.8 7.2 10.4 5.3 1.0 9.6 1.7 2.8 0.0 0.2 0.8 7.6 2.3 2.0 0.5 1.5 8.8 6.5 2.9 12.9 0.4 5.8 14.3 5.1 1.1 0.4 4.9 1.0 43.3 20.8 3.0 75.5 3.4 0.1 22.6 3.8 1.0 2.0 0.7 5.1 1.5 15.8 0.8 7.0 3.6 6.0 0.5 1.9 7.5 6.2 4.3 5.8 8.2 0.8 0.4 69.0 6.6 3.4 13.7 3.0 1.2 0.5 0.9 0.7 1.8 16.5 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.1 0.0 0.1 17.1 41.6 11.4 21.9 40.6 17.8 16.5 18.1 15.6 14.9 19.2 26.0 56.4 48.1 6.8 791.0 1.1 5.2 3.3 7.5 8.6 27.4 3.7 6.3 13.1 2.8 16.7 3.7 22.9 0.3 0.1 2.3 0.0 2.1 3.8 1.3 5.5 47.1 10.9 5.3 422.8 0.4 0.2 21.4 0.5 2.2 2.5 5.0 43.9 17.0 14.6 94.2 177.1 0.7 14.2 16.7 21.0 1.5 5.6 27.4 8.8 1568.3 6.1 5.4 0.0 434.3 815.3 1.2 8.0 8.2 0.2 8.2 0.0 1.8 12.2 11.4 13.1 4.2 5.8 0.6 1.9 2.3 2.7 0.0 0.6 26.2 1.5 1.8 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.9;Paneth cells: 99.9;Proximal enterocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 94.2;CACO-2: 107.8;SH-SY5Y: 239.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008348, HPA055849" Supported Approved Cytosol NA No "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA008348: , HPA055849: AB_2682942" "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 10.5 9.2 12.0 9.6 12.2 1.8 8.8 12.2 12.7 20.7 9.0 43.9 46.1 16.9 12.1 32.8 15.2 17.5 14.8 11.1 11.8 42.0 33.7 23.3 4.3 8.3 11.0 19.8 17.6 12.0 19.8 10.9 13.0 18.3 31.3 4.1 12.6 25.8 3.0 43.2 49.9 12.2 7.5 10.5 37.3 7.0 10.8 3.8 10.7 3.9 7.4 16.7 21.6 9.4 10.3 94.2 15.0 26.8 20.6 22.6 16.7 17.7 23.5 12.4 3.8 107.8 53.1 1.1 75.4 37.2 7.3 21.0 9.2 4.9 5.3 2.7 6.9 22.3 28.2 63.2 29.3 0.3 2.3 15.8 14.2 16.4 1.8 27.6 19.0 3.8 7.3 4.3 14.9 9.9 1.1 4.1 9.6 46.1 4.0 8.9 7.8 1.2 64.8 3.9 73.6 239.9 14.5 6.3 4.5 66.0 5.6 4.2 20.5 2.1 15.1 6.1 0.8 2.9 4.1 0.8 6.7 4.7 9.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 12.0 12.2 12.2 12.7 11.1 11.8 8.3 11.0 13.0 7.5 10.8 9.4 8.3 12.8 14.0 0.7 1.4 7.9 7.2 3.6 5.2 15.5 3.7 5.0 2.4 30.0 3.3 14.7 0.0 0.9 1.8 127.9 5.9 15.0 1.2 2.1 5.3 11.3 3.6 1.3 5.0 23.7 7.6 7.9 36.2 2.9 0.0 19.6 6.8 20.4 0.9 8.4 7.1 30.3 2.0 0.8 1.6 2.0 13.4 1.0 3.6 1.0 0.7 2.2 0.0 2.0 0.4 30.8 99.9 12.0 1.4 7.1 96.6 46.9 2.5 0.8 6.6 1.1 6.9 0.2 4.1 11.6 18.0 0.5 2.5 4.8 34.1 6.1 DYNLRB2 "DNCL2B, DNLC2B, ROBLD2" ENSG00000168589 "Dynein light chain roadblock-type 2" Q8TF09 16 80540734-80550811 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 60.8;testis: 227.1" "Cell type enhanced" "Detected in many" "Early spermatids: 2380.9;Late spermatids: 965.0;Respiratory ciliated cells: 523.6;Spermatocytes: 706.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;MCF7: 5.6;RPTEC TERT1: 2.8;SCLC-21H: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.41e-2)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.91e-5)" "unprognostic (2.29e-2)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (1.17e-1)" "unprognostic (1.05e-3)" "unprognostic (1.41e-1)" "unprognostic (8.82e-3)" "unprognostic (1.73e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-4)" "unprognostic (1.55e-4)" 0.9 2.5 6.0 0.5 6.3 0.0 3.3 5.8 7.5 2.4 13.5 0.8 0.4 1.3 17.8 0.9 60.8 1.9 0.7 6.3 6.9 5.7 1.0 6.1 0.4 13.2 13.0 1.3 1.2 4.6 4.3 0.9 10.7 2.2 0.2 4.2 1.1 2.7 0.3 1.9 0.5 0.3 9.8 0.3 0.7 227.1 6.0 0.9 3.3 0.4 0.6 0.9 0.6 9.9 0.1 0.0 0.3 0.0 0.7 0.5 0.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 5.6 0.0 0.0 0.1 0.2 1.1 0.1 0.0 0.0 2.8 0.7 1.7 0.2 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.3 0.2 0.4 0.3 0.0 0.1 0.6 1.3 1.8 0.5 0.0 1.3 1.3 0.2 6.0 6.3 5.8 7.5 6.3 6.9 13.2 13.0 10.7 9.8 6.0 9.9 0.7 3.2 7.4 4.2 0.2 5.1 4.5 25.9 5.2 1.0 9.8 12.6 0.2 2.8 32.0 1.8 0.0 3.0 0.1 0.4 35.2 5.9 2380.9 274.1 2.8 2.0 3.0 0.0 2.5 1.5 0.7 2.7 0.0 5.1 7.6 1.1 1.1 0.8 0.6 0.0 2.3 1.3 30.5 0.8 0.3 965.0 19.6 2.3 0.0 1.0 3.1 23.9 1.0 0.5 1.5 1.2 0.1 15.4 0.5 2.7 0.3 44.7 523.6 2.6 13.1 0.5 7.8 706.2 22.1 0.8 2.8 3.4 0.9 2.9 0.2 3.0 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Spermatocytes: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 3.6 3.3 2.1 8.2 1.9 19.8 7.5 3.4 3.4 8.1 1.4 11.5 9.3 4.4 1.8 8.9 3.3 5.3 3.2 2.4 1.4 4.3 2.6 5.2 10.5 2.1 1.7 1.3 2.9 3.6 1.2 8.8 2.7 3.2 15.8 12.5 5.6 2.6 2.1 7.1 7.6 7.5 0.7 4.3 9.4 15.9 2.3 23.3 3.9 2.7 11.4 6.9 4.2 3.5 192.0 133.6 103.2 54.0 10.6 21.8 51.6 81.5 67.5 121.4 116.9 74.7 196.9 47.2 122.1 48.8 116.0 81.8 84.2 53.1 164.3 67.8 46.6 29.6 70.0 38.5 4.6 46.2 32.8 7.1 9.0 72.2 73.2 34.0 53.0 68.6 31.3 67.2 97.2 67.6 47.5 34.6 84.4 156.7 72.0 33.7 101.1 60.7 92.2 43.7 68.6 44.1 104.5 117.4 42.2 51.5 195.4 34.1 46.5 58.5 55.7 79.6 174.9 32.8 47.2 88.2 51.6 39.7 78.0 6.0 2.0 0.7 1.0 1.7 1.1 1.4 1.4 0.9 1.6 1.3 0.6 0.9 6.3 0.7 0.7 1.6 2.5 0.7 2.1 1.9 3.4 3.4 2.4 1.4 2.1 1.7 2.7 0.7 2.3 3.5 6.7 6.4 3.2 4.2 3.8 19.5 4.9 6.2 9.1 3.4 10.1 6.5 3.6 5.7 5.7 3.7 64.6 12.0 2.9 10.7 0.0 9.5 3.3 20.1 6.6 7.7 4.8 25.2 6.5 9.2 14.9 6.0 17.9 20.5 0.0 17.9 5.3 2.9 7.3 0.0 2.5 13.5 10.2 4.7 6.3 2.8 0.9 5.1 7.2 15.0 2.8 3.1 2.1 3.0 4.9 20.7 3.8 1.5 9.6 12.8 1.5 3.7 11.0 16.3 0.0 2.9 5.2 42.6 30.4 16.9 12.8 3.8 4.1 3.3 13.5 8.8 EFHD2 MGC4342 ENSG00000142634 "EF-hand domain family member D2" Q96C19 1 15409888-15430339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 372.4;NK-cells: 416.1;Pancreatic endocrine cells: 481.2;Urothelial cells: 431.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 133.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 370.3" "Low region specificity" "Detected in all" HPA048961 Enhanced Approved Cytosol No No 220000 "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA048961: AB_2680572" "unprognostic (1.37e-3)" "unprognostic (3.69e-1)" "unprognostic (7.83e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-1)" "unprognostic (3.82e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (5.57e-4)" "unprognostic (9.11e-2)" "unprognostic (9.61e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.31e-9)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "prognostic favorable (2.70e-4)" "prognostic favorable (3.60e-5)" 37.7 78.9 52.5 77.7 56.8 174.3 27.5 31.6 76.9 32.8 20.4 74.3 83.3 33.7 5.9 58.7 29.3 32.9 28.5 75.4 34.9 23.0 33.3 60.0 46.3 100.2 31.4 26.9 75.7 10.7 28.6 21.4 101.7 44.6 29.6 2.7 27.3 19.0 6.4 35.9 96.4 17.3 29.6 140.0 92.0 95.2 36.1 25.2 41.6 4.9 29.5 62.6 40.5 62.9 370.3 91.8 8.8 23.8 14.1 30.0 46.8 46.0 43.4 42.7 40.5 35.5 98.8 79.6 141.6 32.1 54.8 88.1 24.5 80.9 27.0 99.8 47.8 19.1 21.6 57.4 22.5 98.1 160.1 23.9 27.2 87.0 21.9 19.9 55.5 35.5 46.4 37.6 26.6 36.8 50.8 188.6 11.6 50.1 112.9 67.2 82.1 63.4 25.3 76.2 20.1 15.6 40.5 34.3 76.8 6.9 15.1 104.8 105.4 62.5 66.9 196.7 74.8 25.4 63.8 34.9 87.4 193.2 86.8 16.3 33.8 52.5 44.0 34.4 12.7 3.9 9.8 20.9 29.5 4.2 4.6 18.0 133.2 28.5 30.0 10.3 7.6 17.0 52.5 56.8 31.6 76.9 75.4 34.9 100.2 31.4 101.7 29.6 36.1 62.9 54.2 3.2 12.2 5.9 44.1 66.2 123.7 25.2 26.7 1.8 21.3 23.0 7.2 32.9 24.4 22.0 10.4 23.7 372.4 280.0 19.6 69.6 93.6 55.4 28.8 52.6 61.7 28.0 33.9 259.4 222.8 31.1 157.0 69.4 44.5 49.4 23.6 20.9 219.3 0.0 21.9 160.8 24.4 217.1 188.2 221.2 9.9 246.9 23.2 13.1 171.3 4.9 416.1 0.5 3.7 481.2 190.5 6.8 62.9 112.2 305.8 28.1 25.7 5.0 46.0 26.7 28.5 5.4 5.7 48.9 68.5 53.4 120.1 178.3 117.8 431.4 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912883-110013766 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 110.2;pancreas: 89.5;skeletal muscle: 29.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 680000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.0 0.0 1.0 0.1 1.0 0.2 14.7 0.2 0.8 0.0 0.2 0.8 0.0 0.4 2.4 0.7 0.3 1.0 2.8 0.9 2.0 110.2 0.0 0.5 0.0 1.4 0.9 0.0 89.5 0.2 0.4 0.0 1.5 1.4 1.1 13.6 15.7 0.4 29.6 0.7 0.2 0.5 1.2 0.1 0.0 0.1 0.7 0.0 3.0 17.4 0.0 0.4 0.1 1.8 0.2 0.2 1.9 0.0 0.0 0.1 0.0 0.4 1.1 0.5 0.4 0.1 0.0 0.0 6.4 0.6 1.6 0.0 0.3 0.0 0.4 0.0 0.3 0.1 0.6 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.1 0.6 0.1 0.0 0.0 2.3 0.0 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.0 11.6 0.4 1.2 2.8 0.0 0.0 0.9 1.3 0.0 3.6 0.0 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.0 1.0 0.2 0.8 0.9 2.0 1.4 0.9 1.5 1.2 0.7 1.8 0.1 0.0 0.0 3.3 0.0 1.0 0.2 0.1 0.0 1.0 12.9 8.1 8.2 0.0 0.5 0.0 0.0 0.0 0.2 2.0 7.9 0.2 5.6 0.2 0.1 0.6 0.0 0.0 8.5 5.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 11.2 0.1 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.3 26.2 0.0 1.5 0.3 1.0 0.4 0.0 0.0 1.1 0.1 1.2 1.0 1.2 0.0 8.2 0.2 0.5 0.4 0.0 1.4 0.0 0.1 0.1 1.6 0.3 EGR1 "AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225" ENSG00000120738 "Early growth response 1" P18146 5 138465479-138469303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 1113.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 133.1" "Immune cell enhanced" "Detected in some" "neutrophil: 7.1" "Group enriched" "Detected in many" 7 "granulocytes: 7.1;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019427, HPA029937, HPA029938" Supported Enhanced Nucleoplasm No No "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 16: U-266 - Nucleosome" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259" "unprognostic (5.47e-2)" "unprognostic (4.09e-1)" "unprognostic (1.57e-1)" "unprognostic (7.74e-2)" "unprognostic (6.32e-2)" "unprognostic (2.66e-1)" "unprognostic (1.80e-1)" "unprognostic (2.96e-1)" "unprognostic (7.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (3.51e-3)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" 565.5 354.0 7.5 135.4 15.9 176.7 173.9 133.1 70.1 302.5 10.0 246.5 54.8 197.6 13.5 370.9 911.7 345.2 258.8 20.7 30.4 173.2 149.5 173.4 145.2 9.9 13.2 974.6 137.0 93.5 243.3 54.2 12.9 309.7 161.1 56.0 140.9 84.4 66.0 363.1 107.2 474.3 4.4 77.5 254.5 26.9 10.4 301.5 584.4 354.9 19.1 191.4 115.9 19.5 21.8 0.9 45.0 67.6 119.6 192.0 5.1 36.7 22.7 48.4 39.0 26.4 18.9 1.1 5.9 80.2 165.8 10.1 2.6 74.5 22.2 1.1 3.3 3.0 11.5 7.6 15.5 8.0 57.8 15.2 286.6 43.2 9.8 37.6 4.2 53.9 112.5 26.0 14.3 108.2 3.2 34.1 4.1 80.3 0.1 0.8 6.7 4.1 36.8 13.1 56.5 6.4 44.7 120.1 106.6 43.3 1.5 6.6 1.8 17.5 22.6 8.7 14.2 60.1 478.8 8.6 20.3 103.5 5.2 0.0 2.6 0.3 0.1 3.6 0.0 0.7 0.1 0.0 0.7 0.2 0.1 0.1 7.1 0.1 1.2 0.0 0.2 0.5 7.5 15.9 133.1 70.1 20.7 30.4 9.9 13.2 12.9 4.4 10.4 19.5 920.4 275.7 485.6 6.8 116.4 181.8 719.6 207.4 816.1 43.5 550.0 459.0 652.4 420.4 124.0 29.5 64.6 159.5 46.2 645.2 7.9 255.4 1.4 356.0 836.5 383.1 960.5 27.3 20.3 101.7 110.1 989.9 736.0 645.4 354.0 274.8 347.0 183.1 131.4 3.3 2.7 747.6 93.6 218.6 109.7 3.8 164.7 300.7 106.7 20.6 8.6 191.6 0.0 1.5 2.4 135.3 380.8 53.0 67.2 405.1 224.8 5.7 127.4 101.3 223.5 1113.1 613.2 3.2 2.9 644.8 200.3 129.7 83.4 104.9 480.2 145.4 EHMT1 "bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D" ENSG00000181090 "Euchromatic histone lysine methyltransferase 1" Q9H9B1 9 137618992-137870016 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 167.0;Plasma cells: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060022, HPA074729" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nuclear bodies" "HPA060022: AB_2684190, HPA074729: " "unprognostic (1.18e-1)" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.03e-1)" "prognostic favorable (8.91e-4)" "unprognostic (5.87e-2)" "unprognostic (1.74e-2)" "unprognostic (4.18e-3)" "unprognostic (2.34e-1)" "unprognostic (2.26e-2)" "unprognostic (7.55e-3)" "unprognostic (2.01e-2)" "unprognostic (6.58e-3)" "unprognostic (4.24e-1)" "unprognostic (7.12e-3)" "unprognostic (7.75e-2)" 17.7 18.3 11.0 22.3 12.0 30.5 18.2 16.0 12.3 17.0 13.8 19.3 18.8 21.5 9.7 19.1 18.1 14.0 13.5 8.6 8.3 11.0 14.4 15.8 29.6 10.7 10.2 19.9 14.9 13.8 12.9 15.0 11.1 16.2 13.1 13.7 18.4 13.9 31.4 19.3 19.6 15.1 4.4 25.9 18.2 40.5 12.7 22.9 19.6 15.0 21.2 18.3 16.2 19.9 26.7 52.3 57.4 53.2 23.9 24.6 48.1 34.5 21.4 24.7 20.2 34.7 32.5 81.6 32.7 26.0 29.9 56.2 34.8 37.8 19.2 45.3 24.7 34.4 54.2 22.4 20.9 52.9 39.5 22.6 25.9 29.9 28.9 18.1 41.3 30.1 52.6 27.5 17.9 61.9 62.5 26.3 56.0 42.1 34.8 79.3 49.5 47.2 20.7 47.7 50.6 41.1 65.4 45.4 15.3 40.6 51.1 42.0 39.0 28.9 29.5 44.8 33.2 17.2 52.0 67.0 21.3 27.6 32.0 19.5 16.2 21.2 18.0 14.3 11.3 16.4 15.6 15.6 12.9 23.0 14.9 13.5 28.8 17.3 15.6 23.3 14.2 9.7 11.0 12.0 16.0 12.3 8.6 8.3 10.7 10.2 11.1 4.4 12.7 19.9 34.3 19.2 19.2 130.6 64.9 17.5 23.4 26.9 32.5 39.7 30.5 26.7 31.5 25.8 24.7 22.0 52.1 23.8 36.9 24.4 3.9 24.1 86.8 29.3 44.8 29.9 28.1 31.7 74.4 21.0 21.8 27.6 45.3 40.6 18.9 55.8 18.9 41.7 19.7 50.5 76.4 22.2 10.2 25.8 18.1 167.0 35.8 26.9 12.4 71.2 31.2 19.7 51.5 64.3 104.0 25.4 30.3 37.6 170.6 34.9 20.7 14.3 22.6 46.8 13.1 34.7 28.5 80.4 51.9 35.3 20.2 26.5 38.9 81.3 23.8 28.8 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 91 "bone marrow: 3894.9" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 4.0;neutrophil: 12.1" "Group enriched" "Detected in many" 9 "granulocytes: 12.1;monocytes: 4.0" "Cell line enriched" "Detected in some" 91 "THP-1: 3105.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015409, HPA066836, HPA073774" Enhanced "Secreted to blood" NA NA 370000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: " "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 3.4 1.0 0.3 0.0 0.3 3894.9 3.4 0.1 0.7 0.5 0.2 2.0 0.4 1.0 0.0 1.1 1.4 0.1 4.0 0.3 0.2 0.7 3.3 19.4 0.6 0.1 0.2 0.5 0.5 0.0 1.2 0.8 0.1 2.9 0.0 0.0 2.4 0.1 1.5 5.4 1.8 0.1 0.1 42.6 1.4 0.4 0.2 6.3 3.1 0.0 0.0 2.1 1.0 0.2 2.0 0.1 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3105.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.0 34.0 0.0 0.0 4.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 27.2 0.3 0.3 0.1 0.7 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.9 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 0.0 4.2 0.1 0.0 1.3 16.2 0.0 0.1 0.0 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.0 3.4 11.1 0.0 6.2 1.1 7.2 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 0.0 0.0 7.4 0.0 0.7 0.2 0.0 0.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 80.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 42.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 136.3;K-562: 136.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 105.6" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 1100000 "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 11.0 10.2 1.8 21.9 18.3 63.3 14.1 42.2 6.0 14.5 4.9 23.6 17.7 10.2 5.3 16.6 6.3 15.0 9.7 1.2 4.7 12.7 21.7 15.1 37.4 8.2 5.6 16.3 18.8 15.5 4.7 7.2 8.5 15.0 23.1 80.0 19.1 9.1 15.9 15.3 23.3 9.9 3.5 22.9 27.0 10.4 4.7 69.0 15.2 13.8 37.0 15.5 1.9 3.0 27.0 6.9 62.3 29.4 5.2 0.8 19.5 6.9 10.1 8.4 10.5 16.8 31.2 49.1 17.2 9.2 13.5 11.9 78.7 6.6 8.6 86.4 23.8 136.3 19.7 28.6 10.1 45.8 88.2 1.7 18.4 8.2 13.8 19.9 14.1 73.5 136.5 36.2 0.1 8.8 72.3 30.4 62.0 44.1 10.0 110.9 28.2 68.3 7.7 33.3 78.0 60.5 19.7 19.2 43.3 21.7 14.7 18.2 1.2 0.3 13.3 12.9 13.4 52.5 72.4 85.2 12.1 47.8 6.8 33.3 3.2 21.4 12.9 1.1 15.4 17.2 18.3 14.1 4.4 13.6 22.1 12.7 44.2 10.9 1.5 4.4 28.9 15.3 1.8 18.3 42.2 6.0 1.2 4.7 8.2 5.6 8.5 3.5 4.7 3.0 25.3 19.2 71.7 20.2 58.2 10.5 8.6 7.8 15.4 151.6 20.0 12.2 21.5 20.0 16.8 16.5 137.6 2.4 75.3 26.5 17.6 17.1 16.4 11.3 4.1 15.1 41.6 187.1 76.3 18.7 4.2 7.9 29.6 29.1 24.1 24.9 17.5 30.0 7.1 21.9 61.7 29.0 16.2 23.7 9.0 22.7 2.1 32.4 0.0 78.7 29.3 15.7 85.5 7.5 4.8 28.6 20.3 2.2 46.7 12.2 32.8 13.4 15.2 171.4 13.1 2.8 8.5 39.3 55.7 14.9 16.8 4.1 71.6 4.2 33.0 12.6 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990356-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.7" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 22.8 33.0 4.8 8.5 4.5 9.3 15.0 4.1 6.4 10.0 5.1 5.7 3.5 10.0 32.5 15.2 8.0 16.4 6.2 4.7 6.2 4.8 3.2 9.7 5.7 6.2 7.9 7.3 5.3 15.3 8.2 13.4 5.4 7.3 5.7 13.5 12.1 7.5 3.6 12.3 4.5 7.6 4.8 6.9 6.3 8.7 5.9 6.6 7.6 1.8 7.4 6.2 11.5 5.1 3.3 1.0 17.4 27.7 11.3 4.7 12.4 5.7 6.3 2.0 4.6 1.2 20.5 5.5 5.3 2.2 4.0 3.9 2.6 1.5 3.2 4.1 1.5 2.8 1.6 11.5 1.0 6.7 3.7 5.1 1.6 1.8 0.6 10.4 11.6 6.0 12.7 10.3 8.1 8.1 4.9 5.0 5.1 10.8 1.2 11.4 0.7 3.7 3.5 6.8 3.6 16.8 6.2 1.9 0.7 18.9 4.7 16.4 9.2 6.7 1.0 5.1 2.8 3.2 7.8 1.6 5.7 20.8 4.1 0.0 1.0 2.4 0.6 1.8 0.5 0.4 0.1 0.4 0.8 0.5 0.3 0.4 7.0 1.1 0.5 0.4 1.2 0.6 4.8 4.5 4.1 6.4 4.7 6.2 6.2 7.9 5.4 4.8 5.9 5.1 7.1 3.2 13.1 17.9 32.5 4.2 15.6 17.0 7.4 24.8 13.7 10.4 2.1 24.3 25.5 16.5 29.2 16.5 21.6 4.4 9.8 14.4 7.3 6.2 8.6 10.9 13.8 19.4 12.2 17.9 12.7 8.3 12.8 5.9 8.2 20.4 13.6 3.6 9.7 18.5 13.0 9.1 16.2 21.8 16.5 4.8 11.5 19.8 10.6 14.0 16.7 11.3 36.0 24.1 14.0 17.6 7.8 9.8 10.0 12.5 15.4 4.9 14.0 21.4 6.6 7.6 8.7 12.2 11.8 8.6 5.7 40.2 20.5 10.7 6.7 31.1 ERVH48-1 "C21orf105, NDUFV3-AS1, SUPYN" ENSG00000233056 "Endogenous retrovirus group 48 member 1" M5A8F1 21 42916803-42925646 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 65 "placenta: 152.2" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 130.7;Extravillous trophoblasts: 258.3;Syncytiotrophoblasts: 88.8" "Cancer enriched" "Detected in some" 18 "testis cancer: 74.5" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 6 "neutrophil: 7.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.7" "Cell line enriched" "Detected in some" 7 "BEWO: 296.4" "Secreted in female reproductive system" NA NA 57000 "Cluster 1: Neutrophils - Mixed function" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (5.28e-2)" "unprognostic (5.92e-2)" "unprognostic (5.66e-2)" "unprognostic (9.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.92e-2)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (7.74e-2)" "unprognostic (3.12e-3)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" 0.1 0.4 0.5 0.2 0.8 0.7 0.1 2.3 1.3 0.0 0.7 0.1 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.6 0.0 0.1 0.1 0.4 0.4 0.6 0.0 0.2 0.7 0.0 152.2 0.7 0.7 0.0 1.5 0.4 0.0 0.4 0.8 0.5 0.0 0.0 0.4 0.3 1.4 0.4 1.3 0.4 0.0 0.0 0.0 0.5 0.0 0.3 0.7 0.1 0.0 0.0 296.4 0.1 0.0 0.0 0.0 11.9 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 2.8 1.4 0.4 0.1 1.2 0.2 0.0 0.0 0.2 0.0 0.1 11.1 1.0 0.7 0.6 0.0 0.2 8.2 5.0 0.9 0.0 0.3 6.4 0.3 0.1 0.0 0.2 0.4 0.3 0.1 0.0 0.0 44.6 0.3 0.2 0.3 0.2 0.6 0.4 0.1 0.9 2.9 0.5 0.4 3.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.5 0.8 2.3 1.3 0.6 0.0 0.6 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 130.7 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 258.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 19.2 3.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.0 88.8 0.0 0.0 0.0 0.0 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92826831-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 164.2" "Cell type enhanced" "Detected in all" "Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: AB_2683907" "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favorable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 8.7 14.4 5.9 8.2 7.5 12.9 8.0 7.7 8.6 6.5 8.0 9.6 8.1 6.1 5.7 4.2 5.8 10.1 7.1 8.2 6.0 6.4 10.1 10.7 9.5 3.4 2.4 3.9 10.0 6.3 6.1 37.4 3.7 8.6 10.2 164.2 5.6 4.3 31.8 5.0 9.5 7.7 3.3 9.1 7.0 9.9 6.1 8.5 28.4 19.7 8.2 10.1 3.5 7.1 19.8 24.3 25.7 16.8 1.3 1.6 9.1 9.0 24.9 8.1 9.7 9.1 16.5 22.5 19.0 4.3 6.6 12.3 20.8 5.7 10.1 20.1 20.9 35.1 8.3 11.7 9.6 36.4 30.6 2.2 3.0 7.2 4.8 14.6 113.8 14.6 29.2 14.5 4.0 10.7 15.3 23.2 3.5 40.2 7.0 22.5 11.2 11.6 17.4 13.2 8.5 11.9 9.2 9.2 11.8 6.4 18.2 18.8 22.4 0.6 8.2 7.5 14.7 10.8 12.4 18.1 2.8 41.6 9.3 6.2 4.9 15.2 3.0 3.9 3.0 6.7 3.4 2.8 5.1 6.6 2.7 3.2 30.6 2.8 3.9 11.1 3.3 2.4 5.9 7.5 7.7 8.6 8.2 6.0 3.4 2.4 3.7 3.3 6.1 7.1 28.3 16.0 16.7 33.6 27.6 3.3 10.7 8.6 3.4 40.2 9.8 6.5 12.0 20.0 15.0 16.5 39.6 22.9 24.1 14.3 5.9 28.3 5.4 8.8 3.0 53.1 25.6 39.2 181.7 15.4 7.8 7.8 13.7 16.5 10.8 24.3 77.1 14.2 21.4 23.5 100.3 16.6 14.2 18.2 12.5 12.6 4.4 18.9 5.4 146.1 22.8 27.1 19.6 157.3 84.7 14.1 10.3 14.7 13.8 14.1 10.8 8.4 10.0 177.8 13.1 13.6 9.0 25.0 25.5 4.9 4.8 20.5 18.4 29.8 11.9 15.8 EZH1 "KIAA0388, KMT6B" ENSG00000108799 "Enhancer of zeste 1 polycomb repressive complex 2 subunit" Q92800 17 42700275-42745049 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 133.4" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 258.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005478, HPA077684" Supported Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA005478: AB_1848340, HPA077684: AB_2732356" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (2.19e-2)" "unprognostic (8.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.84e-3)" "unprognostic (1.76e-2)" "unprognostic (1.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-3)" "unprognostic (5.22e-3)" "unprognostic (4.11e-3)" "unprognostic (1.48e-2)" "unprognostic (4.60e-2)" "unprognostic (3.29e-1)" "unprognostic (5.39e-2)" "unprognostic (4.74e-2)" 39.6 18.1 35.0 14.4 37.4 15.2 34.1 42.4 41.5 41.5 29.4 31.6 13.0 31.1 26.5 21.6 35.6 12.8 31.8 33.9 33.9 28.6 13.4 25.7 20.5 37.7 36.5 47.8 18.3 25.5 26.3 12.5 40.2 26.0 15.4 133.4 20.2 23.8 43.8 26.1 30.6 20.4 32.3 37.8 20.7 12.0 35.8 22.9 28.4 33.2 20.4 29.2 31.4 41.5 8.9 9.3 12.4 8.5 48.4 29.1 10.4 14.0 12.7 11.4 11.6 4.4 10.8 13.4 8.6 15.0 11.2 19.8 8.1 9.2 16.3 15.0 14.5 4.7 19.7 5.4 16.6 10.2 10.8 16.7 16.6 8.6 20.8 20.0 9.4 13.4 12.5 18.5 10.2 3.7 16.6 12.9 3.4 8.2 4.7 10.7 12.4 14.5 11.7 9.3 8.4 6.8 7.8 3.8 9.5 17.5 13.2 6.5 9.8 12.2 5.0 14.4 8.9 19.3 10.4 8.0 8.8 10.4 6.4 14.2 5.2 7.8 6.0 5.4 8.2 5.8 5.3 6.1 2.0 6.3 7.7 5.8 19.7 5.8 3.6 6.3 6.4 2.6 35.0 37.4 42.4 41.5 33.9 33.9 37.7 36.5 40.2 32.3 35.8 41.5 34.2 9.6 20.8 41.1 23.6 5.2 14.2 6.6 8.6 71.7 8.7 13.1 39.3 20.0 14.1 12.9 66.7 7.9 24.6 9.3 9.8 11.2 0.7 21.8 23.2 20.7 13.1 36.4 36.8 7.5 3.2 25.3 8.6 25.5 20.3 19.4 15.4 7.8 9.0 47.1 34.0 4.9 12.2 17.1 7.2 2.8 31.1 14.7 1.8 15.0 24.1 30.8 33.0 20.6 58.9 12.1 7.7 34.3 15.9 9.1 12.9 10.7 28.0 258.1 52.6 32.7 24.1 10.7 10.6 6.6 6.1 10.8 21.8 26.2 7.4 9.6 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322138 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 173 "intestine: 550.0" "Cell type enriched" "Detected in some" 10 "Proximal enterocytes: 5965.8" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basophil: 1.6;neutrophil: 4.2" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.2" "Cell line enhanced" "Detected in some" "NB-4: 1.2;RPMI-8226: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 61000 "Cluster 1: Neutrophils - Mixed function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.2 0.1 0.1 3.1 0.1 0.9 0.0 0.6 0.2 0.0 0.4 28.2 291.0 0.3 0.1 0.1 0.2 0.1 0.6 0.2 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.2 0.3 0.0 0.0 0.1 0.4 550.0 1.9 0.0 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.3 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 1.6 0.4 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.2 4.2 0.4 0.1 0.3 0.3 0.0 0.1 0.1 0.6 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.8 0.0 0.0 0.0 242.0 0.0 0.0 0.0 1.4 0.1 0.1 1.2 0.0 0.0 0.2 0.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 570.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 383.1 0.0 0.0 0.0 5965.8 17.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 222.5 0.0 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 170000 "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 24: Non-specific - Transcription regulation" Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 45.3 43.2 36.8 30.0 50.1 49.6 38.2 45.3 46.5 44.2 36.9 81.5 57.2 29.4 29.6 49.7 26.8 37.7 78.1 39.0 51.3 61.3 77.0 68.6 20.2 52.4 50.6 28.2 49.4 30.6 47.4 27.3 49.1 63.1 71.5 31.3 43.4 36.1 48.3 41.3 54.6 42.3 45.0 23.6 42.5 86.2 47.0 21.6 48.0 32.8 23.2 46.7 37.7 57.0 63.4 51.2 38.0 31.3 64.6 64.6 46.7 101.3 55.8 52.4 57.1 52.2 82.6 25.1 68.1 98.9 71.1 65.8 47.1 58.5 66.7 73.5 28.8 19.5 63.8 179.5 79.4 30.7 44.9 58.5 75.3 63.5 49.5 76.7 60.6 46.7 47.7 79.8 102.5 91.5 38.0 28.1 30.9 100.9 65.2 21.9 52.7 35.9 95.2 68.7 52.1 45.9 119.3 94.2 81.3 75.2 87.2 23.9 71.3 67.5 59.2 76.6 53.2 59.3 79.8 31.2 42.3 20.5 68.0 79.9 43.9 79.2 31.0 36.7 36.5 45.0 40.3 35.7 34.8 35.8 31.7 31.4 167.5 32.6 31.9 50.8 60.0 30.4 36.8 50.1 45.3 46.5 39.0 51.3 52.4 50.6 49.1 45.0 47.0 57.0 126.7 240.4 176.3 6.5 87.4 160.7 199.4 200.4 83.6 35.8 119.0 118.4 147.8 67.2 168.1 104.8 27.1 71.0 322.2 329.3 119.3 121.9 637.1 235.5 86.6 116.4 133.8 36.0 10.7 249.6 118.0 80.5 107.0 426.4 82.3 43.1 82.5 235.6 75.5 23.5 13.4 189.5 144.5 61.1 130.9 505.9 54.0 85.4 149.4 8.4 125.1 45.3 48.4 9.0 28.4 364.6 220.1 53.0 133.3 211.4 273.7 347.2 177.8 45.5 46.0 65.2 106.2 189.3 106.8 93.1 171.5 123.3 215.7 30.4 224.2 229.5 FAM20A DKFZp434F2322 ENSG00000108950 "FAM20A golgi associated secretory pathway pseudokinase" Q96MK3 17 68535113-68601367 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 82.4;Early spermatids: 69.0;Hepatocytes: 66.8;Hofbauer cells: 94.0;Late spermatids: 189.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;BJ hTERT+: 27.3;HSkMC: 21.8;U-2197: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048964 Approved "Secreted in other tissues" NA NA 13000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "HPA048964: AB_2680575" "unprognostic (3.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.35e-2)" "unprognostic (4.49e-3)" "unprognostic (6.56e-2)" "unprognostic (5.29e-2)" "unprognostic (3.90e-3)" "unprognostic (2.39e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (9.16e-10)" "unprognostic (1.25e-3)" "unprognostic (1.06e-1)" "unprognostic (4.55e-2)" "unprognostic (2.39e-2)" 7.5 1.6 0.4 2.7 0.3 0.6 5.4 0.3 0.6 17.5 2.6 1.6 0.6 12.5 0.1 3.1 6.0 1.3 3.1 0.1 1.1 12.9 50.2 12.6 1.6 0.8 1.7 8.1 1.0 0.3 6.3 2.2 0.7 2.5 0.4 0.1 11.6 0.6 1.6 2.5 2.0 2.3 0.1 4.5 7.8 6.5 3.6 0.4 6.8 0.1 0.5 2.2 5.7 0.7 0.0 0.2 0.0 0.2 1.1 10.1 0.0 0.5 27.3 0.0 0.0 0.0 0.1 0.0 2.0 2.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.1 0.0 21.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.3 0.3 0.6 0.1 1.1 0.8 1.7 0.7 0.1 3.6 0.7 1.4 16.0 82.4 0.7 1.1 2.3 0.1 5.2 0.0 3.2 5.3 0.9 5.2 7.2 21.3 44.1 0.0 0.6 0.4 0.0 0.0 1.2 69.0 6.1 44.4 3.6 0.0 2.7 3.8 0.5 2.2 18.1 42.3 9.7 1.3 2.9 7.5 66.8 94.0 42.1 8.2 0.0 2.0 27.4 3.5 189.3 11.1 26.8 1.8 16.9 1.3 0.2 0.0 4.0 2.1 0.8 0.0 14.7 0.2 0.0 0.0 15.3 0.8 2.8 6.6 3.4 3.0 1.2 0.6 1.2 1.8 2.7 1.0 13.6 0.0 0.1 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "FAM3 metabolism regulating signaling molecule B" P58499 21 41304212-41357727 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 142.6;pancreas: 212.3;salivary gland: 119.4;stomach 1: 114.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 304.6;Exocrine glandular cells: 399.9;Proximal enterocytes: 831.6" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 1.4;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "CACO-2: 19.5;CAPAN-2: 11.7;Hep G2: 32.1;OE19: 27.3;RPMI-8226: 80.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777, CAB034131" Enhanced Approved Vesicles "Secreted to blood" NA NA 2080000 250000 "Cluster 1: Neutrophils - Mixed function" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 45: Enterocytes - Digestion" Vesicles "CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194" "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 1.5 0.1 0.0 2.5 0.1 0.8 17.7 0.1 0.3 4.9 1.3 5.9 142.6 0.3 22.1 56.2 17.2 16.2 0.6 0.1 0.1 17.9 2.6 9.3 1.5 0.1 0.1 0.2 212.3 0.5 5.4 15.2 0.1 37.9 0.1 0.0 119.4 8.7 0.1 2.3 135.0 0.5 0.1 0.6 114.9 6.9 0.1 3.1 8.0 0.0 16.8 34.4 16.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.5 11.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.9 27.3 0.0 0.2 0.0 80.6 0.0 5.8 0.4 0.4 0.0 0.7 0.4 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.3 1.4 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.3 0.7 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 22.4 25.7 0.0 0.8 1.3 17.0 2.9 1.2 0.0 101.3 123.1 0.2 102.9 36.5 66.2 0.0 304.6 1.4 2.7 25.4 172.1 25.2 0.2 0.1 2.5 0.0 0.0 0.1 399.9 11.1 3.4 147.3 0.7 1.3 0.6 0.4 0.3 27.0 0.0 0.1 120.9 42.7 5.0 15.8 11.5 0.6 3.9 5.4 1.9 2.1 0.0 0.0 0.0 0.1 144.6 169.0 0.4 0.2 64.9 831.6 0.7 22.4 0.0 0.0 0.4 1.8 28.0 8.1 29.1 1.3 161.3 0.9 0.0 125.2 130.5 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9295682 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 3.1;testis: 5.9" "Group enriched" "Detected in some" 16 "Spermatocytes: 114.8;Spermatogonia: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "U-266/70: 27.8;U-266/84: 32.1" HPA035135 Uncertain Uncertain Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.0 0.1 0.3 0.0 0.2 0.3 0.0 0.3 0.3 0.1 0.2 0.2 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 3.1 0.1 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.8 0.0 0.4 0.2 5.9 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 27.8 32.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.4 0.5 0.1 0.0 1.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 4.9 0.2 1.7 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 6.6 0.6 0.2 114.8 96.5 0.0 0.3 0.0 0.2 0.0 0.0 0.2 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 61.6" "Group enriched" "Detected in some" 59 "Early spermatids: 565.0;Late spermatids: 852.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.8" "Immune cell enriched" "Detected in some" 5 "neutrophil: 5.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;MCF7: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.3 0.0 0.1 1.0 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 61.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.5 0.4 0.3 0.2 0.4 0.3 0.3 0.4 0.2 0.1 0.8 0.3 0.3 5.4 0.2 1.0 0.3 0.1 0.1 0.3 0.1 1.8 0.4 0.2 0.1 0.3 0.2 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 565.0 0.4 0.0 0.3 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 852.8 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.0 4.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBXL13 "CFAP169, DRC6, Fbl13, MGC21636" ENSG00000161040 "F-box and leucine rich repeat protein 13" Q8NEE6 7 102813230-103074843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 20.7" "Cell type enhanced" "Detected in many" "Early spermatids: 179.3;Late spermatids: 431.8;Oligodendrocyte precursor cells: 107.5;Oligodendrocytes: 88.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "eosinophil: 10.8;neutrophil: 38.4" "Lineage enriched" "Detected in single" 55 "granulocytes: 38.4" "Cell line enhanced" "Detected in some" "HEL: 7.6;HUVEC TERT2: 13.9;U-266/84: 18.1;U-87 MG: 9.5;U-937: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA057232 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "HPA057232: AB_2683375" "unprognostic (1.46e-2)" "unprognostic (1.91e-1)" "unprognostic (6.73e-4)" "unprognostic (1.97e-2)" "unprognostic (1.69e-3)" "unprognostic (4.41e-2)" "unprognostic (2.31e-2)" "unprognostic (6.64e-2)" "unprognostic (7.81e-2)" "unprognostic (1.49e-1)" "unprognostic (7.72e-2)" "unprognostic (2.62e-1)" "unprognostic (1.33e-3)" "unprognostic (4.54e-2)" "unprognostic (1.25e-1)" "unprognostic (1.93e-2)" "unprognostic (1.47e-1)" 0.2 0.8 0.4 0.3 0.7 0.3 0.2 0.2 0.8 0.4 4.4 0.1 0.2 0.6 0.7 0.2 5.0 0.3 0.1 0.2 1.1 0.4 0.1 0.5 0.2 2.2 2.2 0.8 0.4 0.5 0.6 0.2 1.1 0.4 0.3 2.4 0.2 0.3 0.0 0.4 0.2 0.3 1.4 0.2 5.0 20.7 0.9 0.6 0.6 0.0 0.1 0.2 0.1 1.5 0.6 0.1 0.2 1.2 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.5 0.5 1.0 0.5 0.3 0.8 0.4 0.0 0.0 0.5 0.5 0.2 7.6 1.2 0.2 2.4 7.0 0.3 0.0 0.1 3.9 0.1 1.2 13.9 0.8 2.3 0.3 1.0 0.5 0.5 6.4 1.0 0.1 0.4 0.3 0.1 0.5 1.7 0.4 0.5 0.5 0.3 0.0 0.1 0.3 0.1 0.2 0.4 2.0 3.9 1.6 0.2 0.9 18.1 1.8 9.5 12.3 5.9 0.0 0.0 10.8 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.2 38.4 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.8 0.2 1.1 2.2 2.2 1.1 1.4 0.9 1.5 1.7 0.0 1.1 49.0 0.4 1.8 1.0 0.9 1.2 1.0 0.8 1.8 0.7 1.5 1.7 0.0 12.5 0.2 0.2 0.5 3.9 1.3 179.3 12.2 1.5 1.4 1.8 0.4 61.8 1.1 0.1 1.1 13.3 1.3 0.0 2.1 1.1 0.0 0.1 0.0 53.9 0.1 0.0 0.0 0.9 431.8 0.6 0.5 0.0 48.7 0.1 2.5 1.0 107.5 88.0 1.6 0.1 3.4 0.1 0.8 0.0 1.5 25.8 9.6 13.1 1.6 21.9 23.3 6.5 0.2 0.9 0.1 0.4 1.1 0.3 0.8 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1627.1;Skeletal myocytes: 2234.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 45.6" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4;HMC-1: 13.3;hTCEpi: 8.1;Karpas-707: 6.8;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: AB_2682562" "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 394.7 121.6 2.1 118.4 5.5 433.8 91.7 35.7 45.6 150.3 4.8 37.6 24.8 46.6 3.9 187.7 404.1 347.1 48.9 11.1 7.8 34.7 85.5 113.5 67.7 1.5 1.6 274.4 126.3 46.2 27.3 57.8 1.5 118.5 78.4 10.7 76.8 29.6 3.3 267.8 63.1 353.7 0.8 21.8 104.4 8.8 1.2 152.2 316.0 81.3 1.6 213.9 11.0 3.8 0.4 0.6 0.1 0.3 1.2 0.3 1.8 2.3 1.0 0.7 0.7 0.5 1.0 2.0 0.4 1.5 11.4 0.8 0.5 1.6 0.5 0.3 0.7 0.6 0.8 0.4 0.8 1.1 13.3 0.5 8.1 1.7 1.9 0.4 0.9 2.3 0.8 6.8 0.2 0.2 0.2 1.2 0.4 1.0 0.4 0.5 0.1 1.4 0.6 1.3 3.1 0.4 1.4 9.6 1.2 1.9 0.5 0.8 0.1 0.5 0.6 1.1 0.7 5.1 0.8 0.5 1.1 0.8 1.3 0.9 1.2 1.0 0.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.1 2.1 5.5 35.7 45.6 11.1 7.8 1.5 1.6 1.5 0.8 1.2 3.8 1048.7 685.9 761.3 2.6 445.7 380.5 533.4 162.4 865.6 50.6 1627.1 1523.2 177.8 370.3 174.4 11.0 135.5 237.5 359.6 551.1 1.9 145.5 10.1 667.9 1204.4 442.6 877.0 68.6 1.3 74.2 301.9 788.2 911.3 1541.3 830.4 239.3 393.7 77.9 210.3 8.4 0.3 898.4 42.7 345.2 353.4 11.3 240.2 797.3 172.5 1.0 16.3 186.1 1.0 0.0 0.3 111.6 457.3 59.5 503.4 307.3 417.8 2.7 111.5 217.6 302.4 2234.0 608.8 3.3 4.5 476.3 380.9 396.9 481.8 174.2 616.5 208.5 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105252-39274528 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 53.0;lymphoid tissue: 112.8" "Cell type enhanced" "Detected in many" "dendritic cells: 142.9;Extravillous trophoblasts: 88.7;Hofbauer cells: 157.0;Macrophages: 104.2;T-cells: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1670.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HEL: 61.5;JURKAT: 211.9;MOLT-4: 212.9;REH: 61.3;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6200000 "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 10.2 5.8 5.7 82.5 5.5 53.0 5.1 6.3 9.3 6.6 7.4 10.0 9.1 3.8 10.5 5.7 3.6 16.8 2.4 5.4 7.9 5.0 13.6 17.6 85.8 16.7 19.1 2.7 1.8 2.1 1.5 17.9 15.8 4.2 11.0 0.5 7.4 3.0 1.2 2.0 15.0 11.6 9.3 73.0 12.2 3.3 13.3 112.8 2.6 2.7 63.0 17.1 1.8 13.9 0.2 4.2 0.0 0.0 0.5 0.0 21.1 0.1 1.2 0.3 0.4 0.4 0.3 0.3 0.0 0.0 8.0 16.4 0.0 0.3 0.1 0.3 0.0 61.5 0.0 0.1 0.0 23.3 18.6 0.3 0.4 0.0 0.4 0.1 0.0 211.9 0.0 0.0 0.0 0.0 212.9 13.5 0.2 0.1 0.1 61.3 0.0 0.3 1.0 3.5 0.1 0.0 0.1 0.5 6.5 1.4 0.0 5.2 0.0 0.0 0.2 0.2 0.2 0.4 0.0 4.5 0.0 81.4 0.2 151.3 359.0 354.6 76.3 406.5 52.9 1.8 216.7 134.5 127.6 1.3 271.7 169.8 1670.8 89.9 483.9 30.8 231.5 400.1 5.7 5.5 6.3 9.3 5.4 7.9 16.7 19.1 15.8 9.3 13.3 13.9 4.4 16.0 24.7 0.0 6.2 0.0 0.0 0.0 0.0 0.0 3.2 7.6 0.0 0.0 5.6 14.7 0.0 28.8 142.9 0.0 9.8 0.4 0.0 0.7 1.1 4.3 0.0 0.0 0.0 0.0 88.7 3.8 0.0 1.0 15.2 0.1 0.0 0.0 157.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 35.9 3.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 40.2 119.3 0.1 0.0 0.0 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215293-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.0;neutrophil: 20.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 18.5 8.2 69.5 12.9 80.7 39.9 11.6 56.2 65.3 14.8 31.2 9.4 14.4 19.8 3.1 8.9 13.6 9.3 14.5 54.5 68.4 6.7 4.4 20.0 7.0 79.4 70.9 20.0 6.8 6.8 8.8 15.5 74.0 7.0 11.0 3.5 7.1 7.1 6.4 13.3 10.7 17.3 68.0 13.1 8.2 5.7 72.0 21.3 6.6 6.8 5.8 10.6 10.9 97.9 3.7 3.1 8.8 1.0 12.7 5.4 39.1 5.7 6.8 4.0 3.3 23.8 1.9 1.1 24.8 7.9 1.0 5.9 21.2 0.5 5.2 36.3 2.2 14.6 5.9 4.2 6.3 5.6 2.8 6.1 1.9 15.6 2.4 11.8 23.4 4.2 38.8 1.2 6.7 1.5 2.8 13.8 2.8 8.4 4.4 27.4 8.5 0.5 7.3 13.4 7.6 62.1 1.4 2.9 14.4 12.7 13.2 15.5 19.4 1.8 4.5 15.2 1.4 9.8 1.5 0.6 1.5 8.6 16.8 13.0 3.1 0.9 0.0 1.7 0.0 0.7 0.0 0.0 1.0 0.4 0.0 0.0 20.1 0.0 4.9 2.2 0.2 1.0 69.5 80.7 56.2 65.3 54.5 68.4 79.4 70.9 74.0 68.0 72.0 97.9 6.6 3.2 20.7 57.5 8.7 2.0 0.7 0.5 0.6 4.3 3.6 2.7 10.9 1.5 1.1 0.0 0.0 5.0 4.0 9.2 0.0 2.5 7.0 5.5 9.1 7.6 10.7 4.2 80.7 6.4 16.6 6.9 6.6 10.6 5.7 50.4 5.3 0.8 12.1 16.8 147.9 4.0 4.1 29.5 17.5 5.1 8.1 22.8 7.2 204.2 17.5 0.5 1.0 142.7 480.3 8.2 3.3 10.9 4.2 4.3 10.5 0.8 2.6 2.1 13.1 8.3 5.4 3.7 1.7 1.8 2.8 22.2 3.5 3.5 8.9 2.2 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 371.8;urinary bladder: 175.4" "Cell type enhanced" "Detected in many" "Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;monocytes: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 960000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 34.8 11.7 1.3 1.5 1.4 0.4 24.9 1.0 2.3 18.9 40.9 29.2 4.5 13.6 2.2 4.8 5.5 19.9 4.5 4.3 1.3 371.8 88.6 46.9 0.6 2.0 1.7 4.7 112.3 25.9 12.3 86.9 1.5 105.3 24.4 1.2 12.5 4.6 5.5 6.4 12.3 1.9 1.2 11.4 75.5 1.6 2.5 0.3 11.2 0.5 1.7 175.4 19.2 1.6 1.8 95.6 9.4 3.5 22.3 18.5 416.5 33.1 17.9 1.2 18.8 4.2 29.6 0.4 58.8 3.0 97.0 0.7 0.0 12.2 4.7 0.2 2.2 0.9 9.2 225.5 564.9 0.1 35.7 48.8 140.1 90.7 58.6 0.7 99.5 0.0 152.4 0.7 22.9 23.5 0.1 0.8 5.4 34.4 52.5 0.2 3.7 0.2 69.9 94.6 0.9 1.0 0.4 5.5 127.9 35.1 2.6 0.4 213.1 0.0 7.4 1.8 1.5 1.5 4.0 0.4 51.9 0.1 27.8 0.0 0.7 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.1 1.3 1.4 1.0 2.3 4.3 1.3 2.0 1.7 1.5 1.2 2.5 1.6 6.6 35.3 62.4 0.0 1.8 1.3 350.6 366.1 0.0 0.1 54.2 15.5 0.7 47.1 1160.8 259.3 0.0 60.6 0.4 176.0 33.2 316.9 0.0 166.8 35.4 31.9 84.8 0.0 0.1 381.9 263.4 52.9 224.8 261.8 29.2 0.2 2.5 7.0 33.8 0.0 0.1 357.6 453.7 1.6 3.7 0.0 0.9 14.1 3.6 0.0 9.9 0.5 1.0 0.0 0.0 440.4 146.6 1.5 1.3 780.2 22.9 85.7 681.4 0.6 0.0 9.5 46.7 0.7 0.5 1.3 1.7 4304.7 5.5 3.4 291.0 3294.2 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605341-35608935 "Predicted membrane proteins, Transporters" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Paneth cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.7" "Cell line enhanced" "Detected in single" "RH-30: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038266 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 22: Epithelial cell types - Mixed function" "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.2 0.1 0.5 0.2 1.4 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.7 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 GK3P "GKP3, GKTB" ENSG00000229894 "Glycerol kinase 3 pseudogene" Q14409 4 165277812-165279679 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 13.4" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Distal tubular cells: 1.9;Excitatory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060687 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 11: Alveolar cells - Smell perception" "HPA060687: AB_2684343" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.17e-2)" "unprognostic (2.11e-2)" "unprognostic (3.94e-1)" "unprognostic (1.61e-1)" "unprognostic (2.04e-1)" "unprognostic (6.19e-2)" "unprognostic (6.99e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (4.56e-1)" "unprognostic (3.34e-4)" 0.0 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 1.2 1.8 0.0 0.2 0.0 0.1 0.0 0.6 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847288 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favorable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 34.4 35.0 26.9 43.4 27.9 43.4 27.7 21.2 27.7 31.7 35.9 46.0 43.3 30.1 24.6 37.7 45.4 30.4 41.7 29.3 26.5 46.9 38.3 32.8 41.7 24.2 26.1 24.9 35.8 60.4 31.5 33.7 22.8 40.2 43.9 41.9 43.5 37.5 44.1 33.6 40.4 37.2 22.5 39.2 44.7 20.3 26.6 45.7 40.2 37.8 43.2 36.5 26.9 22.4 43.2 47.5 76.4 47.9 66.1 52.5 73.4 80.0 59.0 59.6 50.7 66.7 75.5 69.8 74.0 74.2 49.0 47.3 96.4 67.0 53.4 114.0 59.4 72.4 57.7 47.7 37.3 117.6 129.6 50.2 52.3 56.3 41.5 57.6 77.2 65.0 122.8 58.8 65.6 69.8 96.6 64.8 91.0 65.0 35.2 123.5 59.9 86.5 73.4 64.0 93.1 47.1 86.4 80.7 37.1 83.1 90.3 123.9 86.1 41.1 46.0 186.2 50.3 49.0 73.1 145.5 29.3 57.9 85.5 10.3 14.1 7.8 9.0 12.7 8.0 6.2 6.0 8.9 9.7 9.6 6.2 5.6 28.1 7.0 20.8 10.8 6.5 8.2 26.9 27.9 21.2 27.7 29.3 26.5 24.2 26.1 22.8 22.5 26.6 22.4 28.6 38.5 47.3 35.6 29.9 19.1 18.7 17.1 19.4 36.8 30.3 23.6 42.3 28.6 37.3 31.3 29.2 28.0 31.1 54.9 66.5 24.4 11.3 58.2 36.7 28.1 46.3 45.6 43.6 19.4 31.6 23.0 26.0 43.0 31.6 27.4 26.7 53.0 32.0 45.4 37.0 41.2 18.3 39.3 23.9 10.3 24.2 35.9 21.4 32.8 54.5 25.0 28.8 28.6 35.8 29.2 38.8 16.1 26.5 29.0 38.9 54.7 73.3 42.6 19.7 24.6 36.1 21.9 24.5 23.4 24.2 35.7 26.1 28.1 38.8 21.3 GNA11 "FBH, FBH2, FHH2, HHC2" ENSG00000088256 "G protein subunit alpha 11" P29992 19 3094362-3123999 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 330.6;Proximal enterocytes: 323.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048886 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 45: Enterocytes - Digestion" "HPA048886: AB_2680544" "unprognostic (4.64e-3)" "unprognostic (2.21e-1)" "unprognostic (3.12e-1)" "unprognostic (2.23e-2)" "unprognostic (1.30e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.56e-2)" "unprognostic (1.40e-1)" "unprognostic (6.26e-2)" "unprognostic (7.85e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.48e-11)" "unprognostic (1.05e-2)" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (3.02e-1)" 33.5 32.5 36.4 16.2 31.2 8.3 32.6 53.8 35.3 31.7 18.9 66.7 117.5 42.4 12.7 28.7 44.5 20.0 51.7 33.5 27.3 40.4 26.2 34.7 7.5 30.3 29.6 32.5 33.9 26.3 29.8 22.3 28.6 40.4 38.7 11.0 33.3 47.1 54.2 34.4 139.3 28.7 26.6 21.4 34.9 50.6 31.3 8.5 32.9 39.2 7.0 38.8 27.0 31.1 56.1 31.2 27.9 48.5 41.7 28.4 30.9 53.8 53.7 71.8 57.8 41.7 27.3 12.0 29.2 76.4 43.6 39.0 37.8 42.7 44.3 30.1 21.9 3.3 35.7 23.6 42.2 3.8 11.8 36.9 36.8 48.4 29.2 36.9 57.8 3.4 27.8 1.9 49.1 25.8 3.0 14.4 20.5 38.4 29.4 23.2 26.4 11.9 33.8 40.8 66.0 40.7 38.3 45.2 27.2 18.9 33.3 7.9 50.0 45.7 33.3 85.4 73.5 1.3 3.9 7.9 33.0 2.9 52.3 2.5 1.4 0.3 0.7 0.7 0.8 0.9 0.5 0.6 0.2 1.1 1.2 0.9 5.1 0.5 1.5 2.3 0.1 0.3 36.4 31.2 53.8 35.3 33.5 27.3 30.3 29.6 28.6 26.6 31.3 31.1 62.3 32.1 24.1 5.2 3.5 32.6 9.5 15.4 13.6 22.7 43.2 47.9 17.8 35.8 12.6 27.6 37.5 13.2 2.4 330.6 7.9 21.4 45.2 26.9 23.0 33.9 54.6 5.2 8.8 25.4 13.5 25.3 29.6 26.1 4.5 24.1 58.2 28.5 9.0 45.4 11.3 84.1 26.4 9.1 16.4 20.0 50.1 5.1 23.2 11.2 1.1 29.0 0.0 7.1 14.1 36.1 96.0 80.5 1.2 16.0 323.0 18.9 35.4 15.8 19.7 28.5 30.5 23.7 8.9 20.6 41.2 20.4 2.0 22.1 94.9 13.4 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 19.9 25.2 11.0 7.1 12.7 14.1 24.1 15.0 12.9 21.9 26.5 18.8 12.2 17.4 32.1 15.1 15.8 13.3 18.5 13.2 10.5 18.6 17.9 15.3 8.4 8.5 9.9 21.9 27.1 20.7 25.0 13.4 9.0 25.8 17.1 31.0 25.2 19.9 14.2 20.2 19.0 10.0 9.6 16.6 19.7 14.6 9.3 11.3 21.0 11.1 9.8 16.3 15.7 11.5 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 11.0 12.7 15.0 12.9 13.2 10.5 8.5 9.9 9.0 9.6 9.3 11.5 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 203.8" "Cell type enhanced" "Detected in all" "Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 20.6 32.6 54.4 16.4 50.9 13.7 19.6 49.4 63.8 24.5 42.5 22.6 12.2 23.6 12.6 28.9 22.3 15.0 29.1 52.8 44.3 34.0 33.9 19.4 14.9 55.3 50.5 18.7 16.2 23.2 26.5 15.6 56.2 29.1 7.5 11.8 23.7 14.8 16.8 22.5 19.5 10.4 45.9 24.5 27.4 203.8 56.2 10.6 30.8 15.9 12.8 26.7 21.4 48.2 22.0 50.2 18.6 49.5 34.9 19.9 69.6 25.5 24.3 31.0 18.4 38.0 31.6 22.7 42.4 24.1 51.9 44.3 28.8 17.1 9.7 73.0 27.9 22.7 53.7 22.5 21.6 15.0 40.9 24.8 25.0 27.5 19.0 20.8 16.3 28.4 20.6 56.2 19.1 56.9 16.8 40.5 22.5 20.4 49.9 31.0 18.0 37.5 20.0 30.3 27.2 32.6 30.0 44.6 30.6 21.4 46.0 6.3 23.1 69.1 46.8 53.3 18.7 41.9 84.9 20.5 50.0 12.3 44.9 1.9 2.8 5.1 2.3 2.5 2.9 2.7 2.0 1.7 3.0 3.8 2.1 1.8 14.0 1.9 2.1 3.0 1.6 1.4 54.4 50.9 49.4 63.8 52.8 44.3 55.3 50.5 56.2 45.9 56.2 48.2 13.0 3.2 11.2 12.7 15.0 14.4 18.5 21.8 19.4 14.1 16.2 13.3 5.3 20.0 13.7 12.9 12.5 49.6 9.5 26.2 15.6 39.0 193.1 14.4 14.8 15.8 16.2 14.7 9.3 26.6 69.7 13.4 15.3 10.0 2.5 10.3 11.4 10.8 23.2 20.2 9.0 16.8 14.2 15.4 14.5 573.0 19.3 11.5 14.2 6.5 16.4 38.9 11.3 4.5 11.2 30.8 14.6 16.1 13.4 26.7 31.5 19.6 18.6 9.1 26.3 8.7 14.1 175.0 55.9 16.9 15.2 119.6 10.8 16.6 15.1 23.3 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129102 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.6" "Cell type enhanced" "Detected in many" "Langerhans cells: 268.1;monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 31.8;SK-BR-3: 62.7;U-266/70: 30.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.3 4.8 0.7 4.4 0.8 1.3 3.3 1.1 1.2 7.9 10.7 3.1 4.0 2.9 1.3 30.2 2.9 2.0 12.9 1.4 0.6 2.3 9.0 6.7 3.1 1.7 0.9 4.3 4.1 15.1 1.4 8.7 1.2 3.5 2.2 0.9 8.9 2.3 59.6 22.6 2.8 1.7 0.7 3.9 3.7 2.0 1.1 2.5 3.3 23.9 7.5 6.7 13.7 1.0 9.0 5.0 1.5 4.1 1.4 1.3 8.0 2.8 1.8 2.3 3.1 4.1 3.4 1.1 3.4 3.0 2.9 18.9 4.6 1.8 3.4 25.2 7.6 0.1 16.0 6.2 4.9 0.1 2.0 1.2 3.9 3.9 2.4 2.3 1.8 3.7 1.4 31.8 0.9 6.5 3.8 1.9 1.7 4.4 6.3 0.6 1.3 4.3 1.4 6.0 2.3 6.1 10.8 62.7 5.2 3.0 8.9 1.1 13.3 7.8 2.0 20.5 1.3 30.6 5.2 0.1 5.8 12.6 3.3 0.7 0.4 0.1 0.6 0.3 0.5 0.4 0.4 0.6 0.2 0.6 0.4 0.5 1.2 0.2 0.1 0.2 0.2 0.2 0.7 0.8 1.1 1.2 1.4 0.6 1.7 0.9 1.2 0.7 1.1 1.0 3.1 6.4 8.9 0.0 5.3 13.6 10.2 17.8 12.5 0.7 14.7 8.4 13.4 2.8 12.3 5.5 2.1 34.8 2.9 6.8 0.0 3.5 0.1 13.7 6.9 4.0 0.0 0.0 1.4 3.9 10.0 4.8 5.1 26.5 0.0 3.2 2.5 14.8 4.0 1.7 1.2 4.8 10.2 0.8 268.1 0.2 1.8 13.1 7.2 0.0 107.4 1.0 0.0 0.0 0.2 13.9 4.3 5.3 4.7 6.8 7.5 1.6 7.4 1.4 0.0 5.5 4.2 0.6 2.3 43.6 24.3 48.2 3.5 5.0 5.5 16.1 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "retina: 11.3" "Cell type enriched" "Detected in some" 73 "Cone photoreceptor cells: 329.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 79: Retina - Phototransduction" "Cluster 9: Photoreceptor cells - Phototransduction" Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 3.9 0.1 0.4 0.2 0.0 0.6 1.0 0.1 0.1 0.2 0.0 0.0 0.0 329.4 0.0 0.2 0.0 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 2.4 0.0 0.1 0.0 1.9 0.1 1.1 0.0 4.5 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.3 0.1 0.0 GRTP1 "FLJ22474, TBC1D6" ENSG00000139835 "Growth hormone regulated TBC protein 1" Q5TC63 13 113324163-113364148 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3;Proximal enterocytes: 70.2;Rod photoreceptor cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 60.4;T-47d: 54.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046201 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA046201: AB_2679584" "unprognostic (5.31e-2)" "unprognostic (2.27e-3)" "unprognostic (1.94e-1)" "unprognostic (1.89e-1)" "unprognostic (4.42e-2)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (6.05e-2)" "unprognostic (1.30e-2)" "unprognostic (3.07e-3)" "prognostic favorable (1.50e-5)" "unprognostic (4.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.56e-2)" "unprognostic (4.50e-3)" 4.4 14.2 2.6 3.2 2.6 2.9 7.9 3.5 5.3 14.3 5.8 24.8 46.0 8.6 3.5 21.6 10.5 6.1 2.6 2.7 2.0 19.3 83.9 4.5 1.6 2.8 2.8 12.8 9.8 8.3 2.8 2.9 2.5 18.3 13.3 20.9 14.5 4.9 10.0 25.9 38.8 3.0 2.8 7.8 13.2 9.5 2.7 1.6 4.0 1.3 2.5 10.6 17.0 3.2 10.1 3.8 7.5 12.9 1.2 1.9 23.6 1.9 0.0 0.5 0.2 21.9 23.2 0.6 1.5 0.6 4.7 15.5 6.6 1.9 0.0 0.5 8.7 13.5 11.2 21.9 2.1 1.1 4.8 0.6 2.9 1.6 0.2 1.0 0.0 1.3 8.2 0.7 0.0 20.5 0.2 1.9 21.2 60.4 2.9 1.1 0.3 0.4 1.7 12.3 0.6 6.6 0.4 11.3 2.7 8.9 54.6 1.3 1.0 0.4 2.8 1.8 0.7 3.8 4.3 1.5 8.1 3.0 4.4 0.6 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.1 0.3 0.5 0.2 2.2 0.3 0.5 0.3 0.1 0.7 2.6 2.6 3.5 5.3 2.7 2.0 2.8 2.8 2.5 2.8 2.7 3.2 1.1 0.0 6.0 11.1 0.8 21.7 24.0 23.4 14.2 5.8 12.7 8.6 1.2 30.0 15.9 3.7 81.3 28.8 0.7 51.8 23.5 10.0 0.4 6.2 4.8 3.0 3.6 3.8 0.5 9.2 9.2 4.0 14.3 8.8 0.0 18.3 5.7 30.1 1.7 3.3 0.5 28.2 16.2 0.8 1.9 0.8 8.1 2.3 1.8 1.0 2.6 13.7 0.0 1.0 1.0 9.6 43.3 8.6 0.1 11.0 70.2 45.8 9.6 69.6 0.0 5.9 5.3 0.2 8.8 18.2 23.7 25.3 1.2 2.7 40.1 23.8 GSTCD FLJ13273 ENSG00000138780 "Glutathione S-transferase C-terminal domain containing" Q8NEC7 4 105708778-105847725 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.2;Late spermatids: 52.4;Oligodendrocyte precursor cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046160, HPA061782" Approved Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA046160: AB_10961048, HPA061782: AB_2797265" "unprognostic (4.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.06e-3)" "unprognostic (4.44e-3)" "unprognostic (6.44e-2)" "unprognostic (6.43e-2)" "unprognostic (1.84e-3)" "unprognostic (4.30e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-2)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (8.59e-2)" "unprognostic (2.68e-1)" "unprognostic (1.32e-2)" "unprognostic (7.02e-2)" 2.6 2.4 1.7 3.8 2.1 5.3 5.5 3.8 2.1 3.6 5.7 3.7 2.6 3.6 2.7 5.0 4.3 3.6 2.3 1.6 2.0 4.4 2.5 2.6 4.6 2.0 2.3 2.9 3.2 3.5 2.3 3.7 2.0 3.9 4.0 7.3 2.2 3.5 2.1 3.3 3.0 4.1 1.7 2.8 3.3 10.8 1.9 4.7 5.3 2.7 5.2 2.4 2.2 3.2 11.2 10.0 22.2 19.5 5.8 7.4 16.6 15.5 7.9 18.6 16.6 9.2 21.0 13.2 7.7 6.5 10.8 8.9 25.8 16.0 26.3 19.9 7.2 10.7 9.5 12.6 2.5 20.7 7.4 4.0 8.0 17.2 13.1 7.0 11.6 13.2 22.0 11.7 16.0 9.1 21.9 7.7 12.2 16.4 11.5 14.9 13.1 7.4 20.4 8.0 18.0 8.1 11.9 17.2 6.6 19.5 15.3 8.3 8.8 13.8 14.4 8.6 12.2 4.4 10.1 7.4 8.6 10.4 19.4 0.7 0.8 0.4 0.9 1.1 1.0 1.0 0.8 0.3 1.0 1.1 0.9 1.5 5.5 1.4 1.4 1.3 0.1 0.7 1.7 2.1 3.8 2.1 1.6 2.0 2.0 2.3 2.0 1.7 1.9 3.2 5.8 6.4 3.9 32.7 5.2 2.5 3.6 2.4 2.2 22.3 10.4 4.8 3.3 8.6 1.9 9.2 27.1 6.1 2.6 5.6 3.9 5.8 120.2 7.7 8.1 4.6 4.2 12.8 32.0 5.0 8.1 5.0 6.6 9.9 2.5 9.3 3.6 8.0 7.7 21.9 32.2 4.4 2.0 5.1 3.1 52.4 8.4 4.2 5.4 9.4 4.2 7.3 3.1 53.8 35.4 6.8 1.3 4.5 7.1 3.8 1.7 5.0 2.4 21.4 0.0 5.4 4.9 11.2 7.5 6.4 4.3 3.3 2.9 6.3 6.1 2.0 H1-6 "H1FT, H1t, HIST1H1T" ENSG00000187475 "H1.6 linker histone, cluster member" P22492 6 26107412-26108135 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 2.2;choroid plexus: 1.6;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065718, HPA068266" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "HPA065718: AB_2685543, HPA068266: AB_2685967" "unprognostic (1.06e-2)" "unprognostic (1.80e-2)" "unprognostic (9.52e-2)" "unprognostic (9.94e-2)" "unprognostic (5.12e-1)" "unprognostic (1.57e-1)" "unprognostic (7.48e-3)" "unprognostic (6.51e-2)" "unprognostic (6.86e-3)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (6.28e-3)" 0.0 0.0 0.3 0.1 1.0 0.0 0.1 0.3 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.3 1.0 0.3 0.8 0.5 0.4 1.1 0.5 0.6 0.3 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 H2AC20 "H2A, H2A/q, H2AFQ, HIST2H2AC" ENSG00000184260 "H2A clustered histone 20" Q16777 1 149886918-149887411 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.3;brain: 27.2;choroid plexus: 20.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 60.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 3.8 3.6 15.5 0.8 20.6 25.3 3.5 24.0 14.0 5.4 20.0 3.1 0.2 2.0 0.0 2.2 2.7 0.4 2.6 10.0 27.2 2.3 2.6 4.7 0.5 19.8 13.1 4.3 2.4 0.1 3.0 0.5 16.7 3.2 0.1 0.5 1.4 0.1 0.7 4.5 3.3 0.4 19.9 5.2 2.5 1.2 18.2 1.6 1.8 0.0 0.1 2.5 4.1 18.2 3.9 4.2 5.0 15.7 0.0 0.7 7.8 1.2 0.9 2.4 3.3 2.5 1.1 8.0 0.2 0.2 0.5 2.0 0.3 1.6 0.0 0.7 5.7 1.9 1.6 12.2 0.0 4.7 4.6 0.9 0.2 0.2 0.5 0.1 1.6 2.0 1.7 10.0 0.5 60.6 5.7 5.4 6.7 4.5 10.0 1.8 2.2 1.4 1.0 2.4 1.8 7.5 3.2 1.2 3.8 0.4 0.6 4.4 1.5 1.1 10.9 1.9 2.9 5.5 4.0 4.2 2.9 6.3 2.3 47.2 33.8 19.0 22.9 22.6 20.2 13.1 20.1 18.5 17.7 33.1 14.0 14.8 98.4 19.1 25.6 24.9 16.3 22.6 15.5 20.6 24.0 14.0 10.0 27.2 19.8 13.1 16.7 19.9 18.2 18.2 2.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.7 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 18.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 1.5 0.0 0.0 0.0 H2BC15 "H2B/d, H2BFD, HIST1H2BN" ENSG00000233822 "H2B clustered histone 15" Q99877 6 27837760-27855709 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 0.2 1.5 0.3 0.5 0.5 1.0 0.6 2.1 0.5 0.7 0.6 0.4 0.4 0.6 0.8 0.3 0.7 0.3 1.5 0.4 0.3 0.6 0.9 0.5 0.6 0.3 0.2 1.0 1.4 0.6 1.0 0.3 0.4 0.8 0.3 1.7 0.5 0.1 0.9 0.3 0.5 0.2 0.5 0.6 0.4 1.5 0.2 0.6 1.2 0.1 0.2 0.3 0.4 1.7 0.7 0.1 1.1 0.8 0.9 0.2 0.6 0.5 0.3 0.2 0.2 0.2 0.6 0.5 1.8 0.2 0.5 1.1 1.0 0.3 0.2 0.9 2.1 0.6 2.4 0.6 1.0 0.7 1.8 0.9 0.2 0.1 0.4 0.8 0.1 1.0 5.5 3.8 0.6 0.5 1.6 1.9 0.6 0.5 0.5 0.9 0.7 4.1 0.3 0.2 6.4 1.0 2.2 1.0 0.8 0.5 1.7 0.6 1.2 1.3 1.4 0.7 0.3 3.4 7.1 1.5 0.5 0.4 0.5 0.5 1.4 1.0 1.9 1.2 1.1 4.8 1.3 1.3 2.9 3.3 0.9 0.8 8.8 0.8 0.8 4.0 1.8 0.7 0.3 0.5 2.1 0.5 0.4 0.3 0.3 0.2 0.4 0.5 0.2 1.7 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 11.7 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.1 1.2 0.0 0.0 0.0 H2BC18 HIST2H2BF ENSG00000203814 "H2B clustered histone 18" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 30.8" "Lineage enriched" "Detected in many" 14 "granulocytes: 30.8" "Cell line enriched" "Detected in many" 7 "U-266/70: 49.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 10.2 6.7 4.2 1.3 5.0 3.0 5.3 10.0 3.7 36.5 13.1 6.5 0.6 1.1 2.5 9.6 9.7 1.0 7.4 3.4 7.0 8.9 7.2 28.0 0.9 6.0 7.4 35.3 4.7 0.3 5.6 2.2 6.7 30.2 0.9 2.9 6.9 0.9 0.7 17.8 3.3 0.6 5.4 15.8 12.9 3.7 5.5 2.8 6.1 0.5 0.7 6.1 34.7 7.9 0.7 1.0 0.5 1.0 0.6 0.1 0.5 1.0 0.2 0.8 1.0 0.5 1.3 0.7 0.4 0.2 0.8 2.1 0.2 0.0 0.1 2.1 0.7 0.7 3.0 0.1 0.4 0.4 2.7 1.2 0.0 0.4 0.5 0.4 0.1 0.5 1.8 3.8 0.0 1.5 5.2 3.1 0.7 3.6 1.5 0.5 1.7 1.2 0.2 0.2 2.7 0.9 6.6 0.3 0.5 1.0 2.0 0.4 0.0 0.7 0.0 1.1 0.6 49.7 1.7 2.0 1.0 0.5 0.2 0.0 1.4 0.3 0.8 0.5 0.8 0.7 1.1 0.4 0.9 2.1 0.5 0.4 30.8 0.7 0.6 0.8 0.2 0.2 4.2 5.0 10.0 3.7 3.4 7.0 6.0 7.4 6.7 5.4 5.5 7.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 H3-5 "H3.5, H3F3C" ENSG00000188375 "H3.5 histone" Q6NXT2 12 31791185-31792298 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 21.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 83.8;Endothelial cells: 16.8;Fibroblasts: 23.8;Smooth muscle cells: 31.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 73.0" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.3" HPA042570 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA042570: AB_2678056" "unprognostic (2.82e-1)" "unprognostic (2.80e-4)" "unprognostic (2.60e-2)" "unprognostic (9.21e-2)" "unprognostic (3.77e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "unprognostic (1.45e-1)" "unprognostic (7.56e-2)" "unprognostic (2.39e-1)" "unprognostic (4.06e-2)" "unprognostic (3.53e-2)" "unprognostic (2.73e-3)" "unprognostic (4.02e-2)" "unprognostic (2.99e-2)" "unprognostic (2.80e-2)" "unprognostic (3.86e-2)" 0.5 0.3 0.1 1.0 0.1 3.1 0.5 0.1 0.5 0.6 0.1 0.3 0.5 0.5 0.2 0.6 0.6 0.1 0.3 0.1 0.1 0.3 0.3 0.5 0.4 0.2 0.1 1.0 0.5 0.1 0.3 0.4 0.2 0.3 0.0 0.7 0.5 0.0 0.4 1.0 0.9 0.0 0.1 1.4 0.6 21.8 0.1 0.0 0.4 0.0 0.7 0.4 0.5 0.2 1.6 0.3 0.7 0.3 0.1 0.0 0.5 0.2 0.1 0.4 0.1 0.5 0.6 0.2 0.6 0.0 0.3 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 1.2 1.6 0.3 0.1 0.0 0.8 0.3 1.0 0.1 0.2 1.2 2.3 0.0 0.9 2.0 0.2 0.5 1.5 0.1 0.8 1.5 0.5 2.0 1.1 0.4 0.6 0.7 0.7 0.7 36.7 14.5 41.6 10.2 15.5 9.1 16.0 10.3 10.1 13.2 13.2 10.9 10.4 73.0 15.0 14.0 12.7 14.0 40.9 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 2.7 23.8 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 H3C6 "H3.1, H3/d, H3FD, HIST1H3E" ENSG00000274750 "H3 clustered histone 6" P68431 6 26224199-26227473 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 10.5;hTERT-RPE1: 7.5;SCLC-21H: 11.9;T-47d: 7.3" "Low region specificity" "Detected in all" HPA042570 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "HPA042570: AB_2678056" "unprognostic (2.42e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (9.07e-2)" "unprognostic (1.34e-1)" "unprognostic (3.65e-1)" "unprognostic (1.23e-1)" "unprognostic (3.90e-1)" "unprognostic (1.83e-1)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (1.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (7.66e-2)" 0.6 3.5 1.0 1.0 1.5 0.4 1.8 3.9 3.2 1.2 2.7 2.9 4.7 0.8 4.9 2.8 1.5 1.0 6.0 1.1 1.5 1.6 2.9 0.5 1.3 2.0 1.7 1.0 0.7 1.5 0.6 0.9 2.4 3.4 1.9 0.2 1.9 0.7 5.1 1.2 4.7 0.4 1.9 2.2 2.6 1.4 1.4 1.2 2.6 3.7 0.9 1.2 1.2 3.4 1.9 2.0 2.8 1.3 3.3 1.6 0.2 1.3 1.5 0.7 0.5 0.6 1.1 0.0 10.5 0.5 1.0 2.3 0.0 0.3 0.6 2.9 2.5 0.4 1.0 0.6 1.0 0.1 1.7 2.3 2.4 0.3 0.7 7.5 1.1 0.2 0.3 2.2 1.9 1.8 0.4 0.1 0.2 1.4 1.9 1.4 0.6 0.3 5.7 1.1 11.9 1.4 1.9 3.0 3.4 0.4 7.3 1.2 0.6 1.3 0.4 0.4 0.3 0.8 0.3 0.2 0.6 0.1 0.7 0.2 0.7 0.0 0.5 0.6 0.7 0.5 0.7 0.7 0.5 0.9 0.6 0.7 2.7 0.2 0.6 1.7 1.3 0.5 1.0 1.5 3.9 3.2 1.1 1.5 2.0 1.7 2.4 1.9 1.4 3.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 H4-16 "HIST4H4, MGC24116" ENSG00000197837 "H4 histone 16" P62805 12 14767999-14771131 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.7;Cytotrophoblasts: 1.0;dendritic cells: 2.6;Hofbauer cells: 1.6;Syncytiotrophoblasts: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 4.7;HeLa: 3.7" "Low region specificity" "Detected in all" "CAB011503, CAB037279, HPA042201" Supported Supported Nucleoplasm NA NA 25000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-2)" "unprognostic (3.67e-2)" "unprognostic (9.69e-3)" "unprognostic (4.54e-2)" "unprognostic (3.25e-2)" "unprognostic (5.35e-2)" "unprognostic (6.62e-3)" "unprognostic (4.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.28e-3)" 0.4 1.0 4.5 1.2 12.0 0.6 0.9 3.8 6.0 2.0 2.9 0.7 1.2 0.8 1.8 2.2 1.5 1.4 0.8 1.9 12.1 0.7 0.4 0.8 1.5 6.4 5.9 1.2 1.2 0.2 0.5 1.7 4.2 4.3 1.2 1.2 1.4 0.9 0.5 1.7 1.0 0.6 5.4 1.9 2.7 1.7 15.9 1.4 1.7 0.0 1.2 0.8 1.1 4.9 1.3 0.5 0.0 1.5 1.6 0.0 0.9 0.8 0.0 0.6 0.5 0.8 4.7 1.2 0.3 0.4 0.0 0.8 0.0 0.6 0.3 1.5 0.6 0.0 3.7 1.2 0.4 0.3 1.1 1.1 0.3 0.1 0.6 0.0 0.0 0.4 0.0 1.5 0.0 0.6 0.3 0.4 1.6 0.4 0.2 1.3 0.0 2.3 0.0 3.4 0.5 0.8 3.1 0.8 0.2 0.3 0.5 0.6 1.0 0.2 2.4 0.6 1.0 1.6 1.1 3.6 1.1 0.0 0.8 0.0 2.5 0.3 2.3 2.4 4.1 5.3 2.7 2.6 2.7 5.7 2.4 2.8 24.1 3.0 1.0 4.6 4.0 1.6 4.5 12.0 3.8 6.0 1.9 12.1 6.4 5.9 4.2 5.4 15.9 4.9 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 H4C1 "H4FA, HIST1H4A" ENSG00000278637 "H4 clustered histone 1" P62805 6 26021649-26022050 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 22.1" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 8 "cerebellum: 22.1" "Group enriched" "Detected in some" 6 "eosinophil: 2.9;neutrophil: 10.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 10.5" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;NB-4: 8.4;REH: 9.1" "Not detected" "Not detected" "CAB021887, HPA042201" Supported NA NA 25000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 14: REH - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "CAB021887: AB_2279758, HPA042201: AB_2677898" "unprognostic (5.71e-2)" "unprognostic (3.41e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.75e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (9.76e-2)" "unprognostic (5.99e-2)" "unprognostic (6.42e-2)" 0.1 0.0 0.9 1.0 0.3 1.7 0.1 22.1 2.8 0.2 0.0 0.1 1.1 0.1 0.3 0.5 0.0 0.3 0.1 0.5 0.3 0.1 0.1 0.3 0.7 0.1 2.0 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.9 3.4 0.5 0.0 0.9 0.2 0.0 0.6 2.9 1.1 2.2 0.0 0.4 0.0 0.0 0.2 0.7 0.9 1.4 0.0 4.0 2.0 0.7 0.0 0.1 3.4 1.5 0.0 0.3 0.3 1.1 1.8 1.0 0.0 0.0 0.4 4.1 0.0 0.0 0.3 0.0 0.0 0.9 2.3 0.9 3.0 0.0 0.9 10.1 8.4 1.7 0.6 0.0 9.1 1.5 1.6 0.0 0.2 3.0 1.3 1.1 4.3 0.1 0.0 2.3 2.1 0.0 2.2 5.6 2.1 2.4 1.2 2.0 0.0 1.0 3.3 4.3 0.0 0.8 2.9 0.9 0.7 0.2 0.3 0.9 0.3 0.7 0.5 0.3 0.2 10.5 1.1 0.1 0.4 1.1 0.1 0.9 0.3 22.1 2.8 0.5 0.3 0.1 2.0 2.2 0.4 0.9 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 H4C2 "H4/I, H4FI, HIST1H4B" ENSG00000278705 "H4 clustered histone 2" P62805 6 26026815-26027252 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 87.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 6 "cerebellum: 87.0" "Immune cell enriched" "Detected in many" 6 "neutrophil: 43.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 43.0" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042201 Supported NA NA 25000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "HPA042201: AB_2677898" "unprognostic (1.16e-1)" "unprognostic (2.18e-2)" "unprognostic (2.12e-1)" "unprognostic (6.31e-3)" "unprognostic (2.32e-1)" "unprognostic (1.52e-1)" "unprognostic (6.07e-2)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "unprognostic (7.87e-2)" "unprognostic (2.56e-1)" "unprognostic (6.30e-2)" "unprognostic (1.69e-3)" "unprognostic (4.39e-2)" "unprognostic (3.17e-1)" "unprognostic (4.50e-2)" "unprognostic (1.58e-2)" 0.3 0.0 5.5 0.0 4.2 1.9 0.2 87.0 12.2 0.5 9.6 0.2 0.1 0.1 0.0 0.1 0.4 0.0 0.1 2.5 8.2 0.2 0.4 0.2 0.6 5.2 9.1 0.2 0.1 0.0 0.1 0.1 13.8 0.2 0.0 0.2 0.4 0.0 0.2 0.1 0.1 0.0 7.0 0.2 0.2 0.2 15.2 2.0 0.4 0.0 0.1 0.1 0.2 6.2 0.9 0.0 0.1 1.8 0.0 0.0 0.0 1.4 0.1 0.8 0.5 0.3 0.2 0.7 0.2 0.3 0.5 0.2 0.4 0.0 0.5 0.3 1.9 2.4 1.2 1.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.6 0.2 1.4 2.4 1.9 0.4 0.4 0.3 1.7 0.8 1.5 0.0 0.6 0.5 0.3 0.2 1.0 0.0 0.0 0.2 1.2 0.0 0.5 1.2 1.0 1.8 1.4 1.5 1.2 0.7 0.7 0.9 0.0 0.9 1.3 1.7 1.2 1.5 2.7 1.8 1.3 0.7 6.7 1.4 0.8 43.0 0.3 2.4 2.3 1.3 0.5 5.5 4.2 87.0 12.2 2.5 8.2 5.2 9.1 13.8 7.0 15.2 6.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 H4C6 "H4, H4/c, H4FC, HIST1H4F" ENSG00000274618 "H4 clustered histone 6" P62805 6 26240393-26240793 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 7.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in many" 4 "cerebral cortex: 5.1;white matter: 7.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "MOLT-4: 4.5;REH: 1.9" HPA042201 Supported NA NA 25000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA042201: AB_2677898" "unprognostic (1.47e-1)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" 0.0 0.0 0.4 0.0 0.5 0.9 0.0 0.5 5.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.3 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 4.5 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.5 3.0 2.4 2.3 5.5 3.9 4.0 3.8 6.9 3.2 2.3 10.7 2.1 2.0 6.4 1.1 1.5 0.4 0.5 0.5 5.1 0.9 0.7 1.3 0.7 0.7 1.5 0.6 7.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HBA1 HBA-T3 ENSG00000206172 "Hemoglobin subunit alpha 1" P69905 16 176680-177522 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 24344.4" "Cell type enriched" "Detected in many" 51 "Erythroid cells: 224916.4" "Group enriched" "Detected in many" 4 "endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 142.6;plasmacytoid DC: 101.1" "Group enriched" "Detected in all" 5 "dendritic cells: 101.1;granulocytes: 142.6" "Group enriched" "Detected in some" 36 "HEL: 3355.8;K-562: 2416.8" "CAB032534, HPA043780" Enhanced NA NA 14000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB032534: AB_2294993, HPA043780: AB_2678667" "unprognostic (1.16e-1)" "unprognostic (1.45e-2)" "unprognostic (8.87e-2)" "unprognostic (9.78e-3)" "unprognostic (3.02e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-1)" "unprognostic (6.21e-3)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-2)" "unprognostic (3.59e-2)" "unprognostic (3.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.67e-2)" "unprognostic (9.56e-2)" 893.7 183.0 112.1 82.0 216.3 24344.4 316.6 159.4 246.9 237.7 340.5 141.4 10.6 41.4 2.4 244.9 350.9 60.1 1766.9 56.9 92.1 1405.5 1100.4 2201.7 5.0 141.5 169.4 159.7 100.5 5.1 465.7 1992.7 183.4 170.1 11.5 3.1 138.1 43.7 234.0 194.6 85.0 7.0 211.1 5527.7 135.9 104.8 125.3 20.7 609.2 1123.2 3.6 167.2 351.2 113.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 58.1 0.0 5.7 2.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.2 3355.8 0.0 37.1 0.0 1.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 1.7 2416.8 0.0 0.0 14.7 0.5 0.3 0.4 1.0 0.0 0.1 1.4 79.1 0.0 1.0 7.4 5.3 2.8 0.0 0.0 0.0 1.1 0.0 8.3 0.0 0.0 0.9 0.0 0.0 0.4 0.8 0.0 0.2 0.0 8.5 7.4 48.2 26.3 0.2 0.7 7.5 3.1 8.7 10.0 4.5 8.3 25.7 142.6 13.4 0.8 101.1 0.3 2806.3 112.1 216.3 159.4 246.9 56.9 92.1 141.5 169.4 183.4 211.1 125.3 113.5 72.7 0.0 0.0 0.0 56.8 10.6 0.1 0.0 0.0 0.4 11.3 12.3 1.8 55.8 0.1 0.0 0.0 0.0 93.2 3.2 7.9 0.0 6.0 0.5 0.5 20.4 1.2 224916.4 0.0 0.0 0.0 57.9 0.0 0.4 0.0 0.1 151.0 78.8 0.0 0.0 0.0 5.7 0.0 436.7 64.1 22.4 0.0 234.0 4338.2 0.0 12.7 1.3 1166.9 0.0 0.0 0.1 2.8 0.4 0.5 0.2 0.2 11.1 0.0 16.5 0.0 8.7 58.7 1.5 7.6 0.0 13.2 0.0 155.7 0.0 3.2 0.0 HBA2 HBA-T2 ENSG00000188536 "Hemoglobin subunit alpha 2" P69905 16 172876-173710 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 38218.6" "Cell type enriched" "Detected in many" 22 "Erythroid cells: 198314.0" "Cancer enhanced" "Detected in all" "glioma: 59.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7" "Group enriched" "Detected in all" 7 "dendritic cells: 486.7;granulocytes: 955.3" "Group enriched" "Detected in some" 18 "HEL: 1196.2;K-562: 328.3" "CAB038417, HPA043780" Enhanced NA NA 14000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "CAB038417: , HPA043780: AB_2678667" "unprognostic (1.57e-1)" "unprognostic (7.02e-2)" "unprognostic (2.59e-2)" "unprognostic (2.13e-1)" "unprognostic (3.59e-1)" "unprognostic (3.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (4.99e-2)" "unprognostic (4.43e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.72e-3)" "unprognostic (1.36e-1)" "unprognostic (2.11e-1)" "unprognostic (4.73e-2)" "unprognostic (8.92e-2)" 1592.0 322.5 162.6 186.3 292.4 38218.6 545.3 268.0 377.0 573.3 570.7 254.0 21.6 85.9 5.9 432.5 570.5 147.6 2590.3 86.6 156.5 2302.8 1853.6 4204.3 9.7 210.6 249.2 288.5 141.3 11.4 807.8 3618.9 260.6 302.7 26.7 4.0 305.4 131.9 568.3 188.5 154.3 12.9 316.4 8125.4 264.0 185.0 185.4 34.6 1192.5 1744.6 10.1 325.2 632.8 179.9 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.4 0.1 0.0 0.0 3.2 0.0 1.9 4.9 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.6 1196.2 0.5 0.0 0.0 0.2 1.7 0.4 0.1 0.4 0.0 0.0 0.0 0.1 328.3 0.0 0.1 0.6 0.0 0.3 0.1 0.5 0.0 0.0 0.0 43.4 0.0 0.9 11.9 9.7 1.1 0.0 0.0 0.1 1.4 0.2 5.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.2 119.6 28.1 315.1 99.6 1.7 3.7 39.2 8.5 7.1 42.5 19.1 22.8 73.9 955.3 49.5 3.3 486.7 1.0 15003.3 162.6 292.4 268.0 377.0 86.6 156.5 210.6 249.2 260.6 316.4 185.4 179.9 184.7 3.2 1.5 0.0 97.6 44.4 0.4 0.1 0.6 1.7 20.2 22.2 6.8 70.1 0.7 0.0 0.0 0.0 162.2 6.9 54.8 0.0 3.4 0.6 0.8 50.9 3.0 198314.0 0.0 0.0 0.0 241.0 4.1 0.9 1.3 0.3 142.8 131.2 0.0 0.0 0.0 7.5 4.1 770.6 149.6 16.9 0.0 402.9 8790.3 0.0 37.5 2.3 954.7 0.0 0.0 0.0 3.6 0.0 0.3 0.2 0.1 29.6 2.5 58.6 0.0 25.2 171.5 1.0 9.9 1.1 44.6 0.0 306.3 0.1 5.0 0.1 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 133301.6" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 672352.3" "Group enriched" "Detected in all" 4 "cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1" "Region enriched" "Detected in all" 11 "cerebral cortex: 3368.5" "Group enriched" "Detected in all" 5 "neutrophil: 658.1;plasmacytoid DC: 379.7" "Group enriched" "Detected in all" 11 "dendritic cells: 379.7;granulocytes: 658.1" "Cell line enhanced" "Detected in some" "HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2" "CAB009526, HPA043234" Enhanced NA NA 10000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 1641.5 481.4 155.7 217.3 219.2 133301.6 637.4 235.7 3368.5 546.2 384.6 278.2 28.8 78.8 45.6 505.7 829.6 792.7 2658.8 108.9 154.4 2333.1 1907.3 4039.6 26.8 209.6 243.5 289.0 158.5 50.5 808.2 6345.0 303.0 312.0 148.9 31.0 548.1 290.6 578.8 135.3 169.8 66.3 316.2 9225.9 269.1 170.6 171.4 196.8 1152.0 12902.5 40.3 320.1 633.5 180.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.1 4.2 0.0 0.0 0.0 0.0 99.5 25.3 73.7 37.8 1.3 4.0 21.5 6.8 1.1 35.2 13.8 13.7 39.9 658.1 47.9 5.0 379.7 1.4 22388.9 155.7 219.2 235.7 3368.5 108.9 154.4 209.6 243.5 303.0 316.2 171.4 180.7 441.7 3.2 8.4 0.0 280.5 157.0 2.3 5.1 0.0 4.0 54.7 72.0 3.4 217.3 4.5 7.3 4.2 2.2 369.9 5.2 50.9 0.0 0.0 6.8 6.6 151.7 3.6 672352.3 0.0 0.0 11.3 276.1 0.0 5.1 0.0 4.6 443.4 420.5 7.3 3.3 0.0 7.2 6.1 1452.1 702.6 0.0 0.0 1091.0 27383.1 0.0 72.7 9.7 38.1 0.0 0.0 0.1 3.5 0.0 1.9 0.0 0.1 272.4 84.9 117.8 0.0 126.0 396.8 0.0 0.0 0.0 252.5 2.2 769.8 0.3 3.0 0.1 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 6.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 52.5 41.8 7.7 28.5 8.1 23.6 45.3 3.2 9.7 46.2 24.6 44.2 8.9 51.4 13.6 23.5 50.3 16.8 31.6 4.1 4.8 29.3 6.0 55.0 27.3 17.2 7.1 44.9 14.5 20.1 20.6 19.5 10.2 34.4 4.8 2.8 30.6 17.1 16.2 40.1 28.6 16.9 3.4 38.4 27.2 7.9 10.7 80.0 39.2 9.4 15.2 44.3 38.5 7.6 41.6 28.1 28.6 46.9 21.9 60.2 25.3 39.4 30.7 28.3 18.8 37.4 38.4 80.5 126.8 37.1 13.9 37.8 6.7 31.4 10.5 38.8 13.6 27.6 29.9 8.6 23.6 9.1 1.2 39.4 10.8 28.6 15.4 51.6 58.6 45.9 29.9 33.4 18.6 18.0 83.2 21.8 39.4 9.1 29.1 64.2 14.7 29.6 12.1 26.9 8.1 18.8 30.6 14.1 14.4 18.4 13.4 12.0 66.6 56.9 61.0 47.6 28.9 70.8 58.8 67.4 23.8 41.9 19.1 0.0 1.4 0.0 0.8 0.5 0.9 0.8 0.7 0.7 0.4 0.5 0.8 0.6 6.5 0.9 0.5 0.3 0.3 1.5 7.7 8.1 3.2 9.7 4.1 4.8 17.2 7.1 10.2 3.4 10.7 7.6 80.6 41.7 32.1 34.9 32.7 13.8 26.8 28.7 8.6 20.3 22.5 17.4 13.4 28.6 28.6 36.8 0.0 4.8 18.6 5.3 1.9 31.6 15.5 26.2 39.4 79.3 7.3 40.4 19.9 23.0 3.5 37.8 25.5 58.4 8.8 20.2 101.7 2.0 15.6 28.6 17.5 9.6 24.4 32.7 14.1 6.9 55.0 13.3 14.2 46.9 20.5 11.7 28.8 10.6 13.6 66.8 7.3 33.1 42.9 69.1 0.6 3.8 31.8 4.0 26.3 18.3 26.9 1.1 3.7 10.3 21.6 2.9 28.2 9.3 8.1 46.8 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720895 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 117.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 727.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.2 0.0 0.1 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.4 0.1 0.4 0.0 0.0 6.8 0.2 0.1 0.0 0.9 0.1 117.8 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.1 0.0 0.1 4.9 0.0 0.0 0.1 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.1 6.5 0.0 11.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 5.4 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 3.4 0.0 0.3 0.0 0.1 88.3 0.5 0.1 0.5 0.0 0.0 2.7 0.0 2.1 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.8 0.0 2.0 0.0 0.0 1.3 0.9 35.1 5.3 0.8 0.0 1.0 1.5 0.0 0.0 1.0 0.1 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.5 0.0 32.9 0.0 0.4 727.7 163.5 0.0 9.2 2.2 0.0 0.3 0.2 0.1 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102686 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 23.3;Breast myoepithelial cells: 3.8;Enteroendocrine cells: 4.8;Hepatic stellate cells: 6.4;Squamous epithelial cells: 6.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 16 "medulla oblongata: 4.5;pons: 3.3;spinal cord: 4.7;white matter: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 14.5;HaCaT: 6.2;RPTEC TERT1: 4.9" "Region enriched" "Detected in single" 36 "pons and medulla: 5.8" "Group enriched" "Detected in some" 17 "medulla oblongata: 4.2;pons: 1.1;spinal cord: 3.0" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 1.9 1.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 1.6 0.0 3.3 0.9 2.0 5.1 2.3 4.1 1.0 0.2 0.0 0.0 4.4 0.2 1.7 0.2 4.5 0.2 0.6 0.3 5.7 0.0 0.0 3.3 1.7 1.8 0.0 0.0 2.1 0.7 1.6 2.6 0.9 4.7 1.2 2.2 0.1 0.1 1.8 0.8 3.0 0.6 2.0 0.9 4.3 1.1 0.6 4.0 14.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.6 3.4 0.1 1.5 0.1 1.8 6.2 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.2 1.8 0.1 0.3 0.8 0.0 3.1 3.1 0.0 2.5 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.9 1.0 0.7 0.0 4.9 0.5 0.9 0.0 0.2 0.0 0.9 0.2 0.0 0.0 2.5 0.0 0.2 1.1 0.5 0.0 0.0 0.1 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 3.3 4.7 0.1 4.3 1.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 23.3 0.0 1.2 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 1.3 2.5 4.8 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 1.1 0.5 0.0 0.0 0.0 1.0 1.9 0.0 0.0 6.3 0.3 0.0 0.1 0.0 1.7 0.7 IGHV3-74 ENSG00000224650 "Immunoglobulin heavy variable 3-74" A0A0B4J1X5 14 106810442-106811131 "Immunoglobulin genes, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 103.9;lymphoid tissue: 327.0;salivary gland: 102.6" "Cell type enriched" "Detected in some" 454 "Plasma cells: 19404.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 861 "Daudi: 2948.0" "Immunoglobulin genes" NA NA 27000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "prognostic favorable (2.47e-4)" "unprognostic (9.70e-2)" "prognostic favorable (8.33e-4)" "unprognostic (6.96e-3)" "unprognostic (1.42e-1)" "prognostic favorable (7.79e-4)" "unprognostic (1.06e-1)" "unprognostic (7.06e-2)" "unprognostic (3.94e-1)" "unprognostic (3.07e-2)" "unprognostic (2.42e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (4.70e-6)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-1)" 11.3 1.2 0.1 0.0 0.2 0.0 12.6 0.0 1.5 9.3 0.0 103.9 0.0 2.1 1.9 87.3 2.6 1.3 0.7 0.0 0.3 4.7 6.6 22.2 0.0 0.6 0.0 2.5 1.9 0.6 0.8 0.1 0.2 6.5 0.0 0.0 102.6 0.0 0.5 3.2 74.1 0.0 0.3 327.0 27.5 0.2 0.1 0.0 7.7 0.0 0.0 46.4 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 2948.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 0.1 1.2 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.7 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.3 0.6 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 42.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.4 27.5 0.2 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19404.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.3 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613563-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 15.9;liver: 24.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 5.7;Early spermatids: 7.9;Hepatocytes: 11.9;Late spermatids: 9.9;Proximal enterocytes: 40.8" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 10.5;Hep G2: 5.4;SiHa: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA051811 Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.2 14.7 0.1 0.7 0.0 0.0 0.1 0.5 0.1 0.1 0.4 24.5 0.2 0.0 0.4 0.4 0.0 3.7 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 15.9 0.0 0.1 0.0 0.1 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.3 0.0 0.0 0.5 0.3 0.5 0.0 0.4 10.5 0.3 0.0 0.7 0.3 0.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.7 1.6 0.0 0.0 0.2 0.0 1.9 0.3 0.4 0.4 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.4 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.9 0.3 0.0 0.1 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.7 11.9 0.0 0.0 0.4 1.2 0.0 0.3 0.0 9.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 1.2 0.0 0.0 0.0 40.8 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.0 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639550-21652608 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Group enriched" "Detected in many" 13 "Hofbauer cells: 216.2;Kupffer cells: 246.9;Langerhans cells: 132.6;Macrophages: 327.1;monocytes: 179.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 1213.7" "Lineage enhanced" "Detected in all" "granulocytes: 1213.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 4: Macrophages - Innate immune response" "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favorable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 2.6 2.3 0.5 13.4 0.6 1.7 1.2 0.8 1.0 1.0 0.7 5.1 1.7 0.4 0.2 0.6 1.1 0.3 0.7 0.6 0.5 0.8 5.5 7.4 3.9 1.0 0.7 0.4 0.9 0.7 0.5 3.3 0.9 0.9 1.5 0.2 2.0 1.6 0.2 0.5 2.7 0.5 0.5 29.8 1.3 0.2 0.6 2.2 0.6 0.9 1.2 2.3 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.5 303.9 46.2 0.7 357.2 0.8 3.8 0.5 0.9 233.9 0.5 0.9 1.2 1213.7 2.7 263.5 55.5 1.0 210.7 0.5 0.6 0.8 1.0 0.6 0.5 1.0 0.7 0.9 0.5 0.6 1.4 1.7 3.2 12.2 0.7 7.1 3.2 0.7 0.0 0.0 1.3 1.4 3.7 4.0 2.8 5.0 1.8 10.4 0.7 15.2 0.0 0.0 0.2 0.4 1.0 1.2 4.0 0.0 6.5 1.1 0.0 1.4 3.2 0.0 2.5 10.1 0.4 2.9 1.8 216.2 0.0 0.8 0.3 0.0 246.9 132.6 0.1 0.9 327.1 8.8 16.9 179.9 0.7 3.1 1.0 0.4 0.0 1.2 0.0 1.3 0.6 0.1 0.4 4.4 2.1 0.0 0.9 1.1 0.1 0.2 0.6 2.0 1.4 5.4 0.2 0.0 0.5 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 225.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 23.8;neutrophil: 95.0" "Lineage enriched" "Detected in many" 15 "granulocytes: 95.0" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 350000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 2: Hepatocytes - Metabolism" "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 6.2 2.9 4.0 11.4 1.1 20.3 4.3 0.0 8.7 4.4 0.5 2.2 1.8 4.0 2.6 13.1 5.4 12.1 3.9 4.6 3.1 3.3 225.8 8.2 2.7 2.4 3.7 3.0 3.9 1.5 1.2 37.0 3.3 3.9 2.2 2.4 5.2 3.4 1.3 11.9 2.2 6.4 1.5 5.4 4.5 1.3 5.5 4.6 4.0 2.1 4.8 9.4 5.5 3.3 13.3 3.0 5.5 0.8 9.5 7.7 10.0 5.8 11.9 13.4 13.2 5.8 29.3 2.2 59.2 16.4 31.1 34.1 3.0 57.6 18.7 2.5 3.6 2.9 5.3 14.5 19.6 20.2 9.5 10.3 23.1 19.7 59.2 27.8 6.0 5.9 0.4 0.2 6.4 6.5 1.7 9.4 8.5 6.0 6.0 9.5 8.2 4.8 5.3 14.8 1.0 0.0 26.3 15.0 247.1 5.2 9.6 14.6 7.9 10.3 10.4 32.1 26.6 5.0 0.2 0.5 17.2 18.0 60.9 11.7 3.8 23.8 1.8 4.3 3.3 2.1 2.1 2.3 3.8 2.1 2.0 1.3 95.0 0.3 6.3 0.6 2.1 1.4 4.0 1.1 0.0 8.7 4.6 3.1 2.4 3.7 3.3 1.5 5.5 3.3 3.5 0.0 14.7 6.5 6.8 44.7 16.5 45.8 68.9 6.5 2.5 4.7 5.5 40.0 22.8 3.7 8.4 8.5 3.6 1.8 0.0 7.7 4.4 8.6 3.8 8.0 5.4 4.4 44.3 7.5 109.2 7.3 7.1 12.3 7.6 0.7 7.5 295.8 7.8 0.0 63.3 1.4 4.1 33.7 17.7 0.6 4.4 28.8 8.8 53.4 5.0 1.0 6.2 298.6 1.5 19.7 0.8 2.6 5.3 11.5 0.7 1.1 8.7 0.6 0.0 18.0 5.1 0.1 0.6 30.9 37.2 24.2 5.2 1.4 1.1 14.3 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 409.3" "Cell type enriched" "Detected in some" 19 "Theca cells: 24080.8" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.5 1.6 1.2 4.8 1.3 1.8 0.5 2.3 1.5 0.1 1.3 0.5 1.5 0.3 0.8 0.6 0.8 0.4 0.2 1.4 1.5 0.5 0.4 0.9 2.9 1.2 1.3 29.6 0.2 0.0 0.2 0.3 1.4 0.6 0.0 0.1 0.6 0.0 0.2 0.3 1.7 0.0 1.2 5.2 0.8 409.3 1.5 0.5 0.3 0.4 1.2 0.4 0.3 1.3 0.2 0.6 0.1 0.5 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 1.1 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.5 0.0 0.2 0.0 0.0 1.2 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 1.0 0.2 1.1 0.0 1.1 2.6 0.9 0.0 0.1 0.1 0.3 5.2 4.7 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 2.1 0.1 0.1 1.3 0.0 0.4 0.2 0.0 0.7 0.4 0.7 0.0 0.9 0.9 0.1 1.1 0.7 1.0 2.2 0.5 0.1 0.1 0.8 0.5 1.2 1.3 2.3 1.5 1.4 1.5 1.2 1.3 1.4 1.2 1.5 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.1 6.8 0.0 0.1 3.4 0.0 0.0 0.3 0.0 0.4 42.3 0.0 0.0 0.0 0.9 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 257.1 1240.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 2.9 5.7 0.0 0.0 0.5 0.8 24080.8 0.0 0.0 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363241-34540748 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 139.7;Oligodendrocytes: 260.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles No No "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607" "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 19.5 16.2 13.7 18.1 27.1 27.3 20.0 19.6 17.7 24.5 17.7 21.6 20.2 19.4 16.6 42.8 15.7 17.0 20.2 14.7 15.9 23.3 55.6 18.7 21.4 19.8 20.0 18.8 16.5 23.1 7.8 25.6 21.0 19.6 23.5 25.6 18.7 19.9 17.2 14.0 20.9 21.5 15.9 20.4 20.9 38.5 20.2 23.2 26.3 21.7 25.7 30.6 14.8 45.7 55.5 34.6 35.2 25.9 38.3 57.4 42.7 43.5 52.0 56.2 54.0 101.5 83.8 26.7 42.1 55.6 73.9 66.2 54.9 92.3 66.2 20.8 17.9 78.3 28.2 59.3 43.9 32.6 34.4 31.7 46.2 44.4 72.2 49.8 41.7 40.6 45.5 45.7 46.2 26.5 49.2 18.8 16.9 35.6 44.2 40.9 76.3 63.6 34.7 91.2 21.4 16.4 82.0 32.7 51.0 33.9 38.3 31.1 39.5 61.5 36.0 42.8 33.3 36.2 40.5 40.0 41.0 21.6 38.0 4.6 6.7 7.0 12.0 7.0 12.5 9.2 4.2 6.1 4.9 7.8 3.7 5.7 20.2 7.6 4.9 14.3 5.8 4.3 13.7 27.1 19.6 17.7 14.7 15.9 19.8 20.0 21.0 15.9 20.2 45.7 26.1 12.8 21.8 56.5 33.1 15.0 23.9 11.7 25.6 19.5 15.1 8.5 25.0 12.8 25.6 31.3 25.0 17.5 46.1 28.8 5.9 12.8 59.0 26.5 34.6 20.7 12.0 26.5 85.0 16.3 21.2 24.2 33.1 36.1 19.0 17.9 18.2 53.0 15.8 15.2 72.3 16.9 10.2 24.3 26.7 139.7 22.4 31.4 26.6 68.4 30.0 38.2 43.3 79.4 260.0 22.6 23.7 15.4 50.3 25.8 21.1 26.8 23.5 26.0 13.1 21.4 22.0 40.6 25.5 30.4 16.2 46.9 30.8 12.3 11.9 40.6 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360536 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 10: Non-specific - Unknown function" "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 23.1 21.4 11.0 35.8 11.1 73.6 15.3 6.6 12.3 22.1 17.5 19.5 17.6 19.5 12.9 36.7 15.4 19.0 20.0 10.3 10.3 21.2 27.4 27.0 53.3 12.1 12.5 16.4 67.0 18.7 16.2 24.7 11.8 17.8 20.1 16.0 18.4 15.0 23.3 26.5 22.4 18.0 9.4 43.3 24.7 15.2 15.3 30.0 50.7 18.9 50.9 22.2 24.5 15.7 41.2 19.7 4.8 14.2 13.6 18.1 43.5 24.5 22.8 11.1 13.2 19.2 21.4 63.6 21.2 20.4 32.7 18.2 21.9 15.5 18.3 50.8 21.0 86.1 12.6 21.4 22.9 44.7 47.6 14.2 17.7 19.4 33.7 21.1 35.3 23.7 25.0 46.7 17.6 16.9 18.4 21.7 8.9 24.9 19.1 22.8 55.7 19.0 19.6 76.0 3.3 9.9 19.4 20.6 29.5 19.2 14.1 23.7 49.1 23.6 20.6 19.6 22.9 50.6 60.4 65.0 18.8 40.4 21.0 69.6 30.4 56.2 31.1 37.0 32.8 68.7 26.8 27.7 28.7 73.1 27.4 24.6 112.8 26.5 59.3 18.9 31.2 20.3 11.0 11.1 6.6 12.3 10.3 10.3 12.1 12.5 11.8 9.4 15.3 15.7 62.6 96.1 103.3 64.6 143.2 51.7 82.0 21.7 41.5 23.7 21.9 20.2 70.5 22.8 48.5 29.5 20.9 26.1 88.6 42.5 17.6 53.0 4.3 42.8 21.5 62.8 24.5 33.2 114.7 75.5 35.3 40.7 53.0 62.1 103.9 30.4 39.3 27.8 42.4 13.5 98.2 28.6 26.4 93.1 111.1 7.6 30.1 102.2 24.9 132.1 107.1 16.0 105.0 104.0 140.5 88.3 48.4 18.0 85.2 74.9 40.1 27.0 35.3 33.2 13.1 54.2 40.3 95.6 58.8 36.4 58.1 24.2 94.9 28.3 24.6 116.6 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246069-15522042 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.8" "Cell type enhanced" "Detected in all" "Langerhans cells: 195.0" "Cancer enhanced" "Detected in all" "testis cancer: 34.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 73.8;SuSa: 78.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: AB_2685143" "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 7.3 4.7 6.7 9.2 7.1 57.8 6.0 23.6 8.7 5.3 3.7 5.0 5.7 5.0 6.7 13.7 3.9 4.4 6.4 7.5 6.2 4.1 3.6 7.2 9.0 7.1 6.8 5.7 3.5 3.6 4.4 7.1 7.8 4.5 4.6 20.0 6.4 3.3 11.8 13.4 6.8 4.1 5.2 10.6 7.0 16.0 8.0 20.0 3.8 4.3 9.8 5.8 6.8 8.2 12.4 8.5 34.0 19.6 4.1 4.0 33.5 3.5 8.3 4.5 5.5 8.8 9.4 6.5 12.3 7.1 6.8 6.3 8.0 20.1 4.1 13.0 12.4 23.3 10.6 11.6 4.6 23.9 26.3 5.7 12.3 6.6 26.2 13.4 4.7 73.8 30.5 10.8 2.7 12.6 47.6 44.6 36.4 6.1 3.8 20.9 10.4 18.6 4.2 13.0 26.2 15.0 7.3 24.9 32.1 78.1 8.7 25.0 8.5 20.6 11.4 11.5 12.3 6.9 17.8 11.7 7.0 21.9 26.6 10.1 3.8 3.2 3.4 2.4 2.9 2.5 1.6 2.1 3.1 3.4 2.1 2.9 13.2 4.9 2.7 4.4 1.4 2.1 6.7 7.1 23.6 8.7 7.5 6.2 7.1 6.8 7.8 5.2 8.0 8.2 30.1 6.4 12.8 175.3 40.7 80.4 10.7 23.0 31.9 74.2 28.3 23.1 10.5 15.7 17.1 5.5 87.6 27.0 62.9 10.0 1.9 8.2 89.2 30.7 18.0 27.1 26.8 50.9 125.9 4.4 25.0 17.6 19.9 77.5 25.3 14.8 15.7 13.8 24.0 154.8 124.4 16.4 16.2 61.3 195.0 40.8 8.7 89.5 26.6 97.4 49.1 134.0 54.6 136.7 136.6 15.6 9.3 8.6 34.9 6.8 16.6 3.8 8.7 89.7 6.6 18.1 23.6 9.4 71.1 43.4 151.6 25.2 43.2 17.4 14.7 15.4 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 590.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 49.7" "Immune cell enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA056175: AB_2683057, HPA066195: AB_2685634" "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 16.3 12.5 3.7 18.9 5.4 40.2 22.3 49.7 6.6 19.9 6.4 11.3 16.9 24.0 11.3 12.8 12.5 24.6 12.1 4.0 4.5 15.6 22.3 16.0 22.1 5.0 5.0 24.7 13.1 21.9 6.8 14.4 6.2 14.1 12.3 41.4 13.1 11.5 11.0 11.1 18.9 15.6 3.1 20.9 14.5 15.7 4.8 20.4 20.8 13.8 21.3 16.0 9.4 7.7 23.2 11.5 26.5 20.4 13.8 25.2 9.3 15.8 32.5 13.9 19.0 19.8 24.2 31.3 9.4 14.9 12.6 18.6 7.6 15.2 24.7 8.5 9.6 11.9 11.9 14.4 16.8 25.8 4.3 25.3 15.3 24.7 71.3 31.5 25.4 22.0 21.4 23.0 33.1 6.2 19.8 13.8 28.3 5.2 40.0 34.0 57.5 15.0 14.1 16.5 14.4 23.5 23.8 14.7 22.8 19.3 14.6 46.0 30.6 12.9 18.1 11.3 20.0 20.4 17.4 29.1 15.7 15.1 11.7 0.6 2.7 3.2 1.8 1.8 2.7 4.4 1.9 1.9 2.3 4.2 2.7 2.3 14.1 1.7 1.6 4.0 1.8 1.1 3.7 5.4 49.7 6.6 4.0 4.5 5.0 5.0 6.2 3.1 4.8 7.7 256.1 112.2 93.3 214.5 184.4 151.9 369.2 46.6 93.9 88.7 106.7 92.7 69.4 55.8 96.9 55.2 152.2 34.7 117.4 80.7 13.7 63.3 38.3 155.8 179.7 176.7 86.0 75.3 590.1 47.0 27.7 141.1 119.8 210.1 93.1 79.1 118.2 37.2 57.9 117.8 416.5 66.8 38.7 89.8 185.0 42.3 103.8 206.8 76.5 355.1 96.6 61.2 58.7 419.2 378.8 76.7 88.4 89.5 124.8 161.0 90.6 32.4 104.1 170.9 72.3 214.4 112.6 158.6 146.5 56.4 134.0 33.2 145.6 76.0 52.3 286.7 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971844 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 10.6;NB-4: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 3.8 0.9 2.8 1.5 2.8 2.7 1.8 5.5 2.7 2.7 0.1 2.0 0.8 3.6 1.4 1.1 5.4 2.4 2.3 2.9 3.0 1.7 1.4 2.6 1.3 3.6 2.9 2.7 1.1 0.4 2.3 1.0 3.9 2.3 0.8 6.1 0.9 2.1 0.5 1.3 2.2 2.5 3.3 3.3 1.8 1.5 3.2 0.7 1.8 0.4 1.4 2.3 2.3 3.8 0.3 1.6 0.7 3.9 5.1 4.1 1.3 0.8 3.3 2.3 1.5 1.1 0.5 1.3 2.8 2.6 0.6 0.5 0.6 0.3 2.2 2.3 2.7 1.2 1.8 0.1 1.9 0.3 2.5 10.6 1.4 4.2 0.4 3.7 0.8 1.9 0.9 3.0 1.7 3.1 0.4 9.2 2.1 0.2 0.6 1.1 0.7 1.3 2.6 1.3 0.4 1.8 0.7 0.0 1.8 7.9 1.7 1.3 2.0 0.5 2.1 0.5 0.2 2.5 3.5 3.2 1.4 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.8 2.8 5.5 2.7 2.9 3.0 3.6 2.9 3.9 3.3 3.2 3.8 0.9 0.0 1.1 1.0 0.4 0.8 0.0 0.4 0.0 0.2 0.3 0.3 0.8 0.0 0.2 1.8 0.0 0.1 0.4 0.3 1.9 0.2 0.1 0.2 1.0 0.6 3.5 0.0 0.7 0.0 0.1 1.2 0.5 0.5 0.0 1.7 1.1 0.0 0.1 0.0 1.1 0.3 0.0 0.6 0.0 0.2 1.8 0.4 0.0 1.0 0.1 0.4 0.0 2.0 0.1 0.1 0.0 3.8 0.1 0.2 0.2 0.1 0.3 3.0 0.0 0.1 0.6 0.6 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.2 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium inwardly rectifying channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 279.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.3 0.4 10.0 0.4 14.0 0.6 3.8 22.7 11.6 0.1 2.3 0.6 0.7 0.5 15.9 0.3 5.1 18.8 0.6 6.8 39.5 196.1 1.3 0.9 0.8 39.7 37.6 0.2 44.2 269.2 1.0 0.9 25.7 0.2 0.2 1.2 11.8 21.7 0.3 0.8 2.5 0.0 29.9 1.5 23.4 1.7 27.3 0.2 139.4 0.0 0.1 0.0 0.0 20.8 0.1 0.4 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.5 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.8 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.3 0.6 0.1 0.0 12.7 0.0 0.0 279.8 0.2 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.1 0.1 0.0 0.2 0.8 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.3 0.3 0.1 0.0 0.3 0.2 0.2 1.6 0.3 0.0 0.1 0.3 0.1 10.0 14.0 22.7 11.6 6.8 39.5 39.7 37.6 25.7 29.9 27.3 20.8 0.1 0.0 0.0 12.1 0.0 0.0 0.0 2.7 0.0 0.0 2.3 1.1 0.4 54.3 2.6 244.6 0.0 0.0 0.0 0.0 41.1 12.4 0.0 2.8 0.1 0.0 0.0 0.0 1.0 1.4 0.0 0.3 3.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 54.8 0.1 6.0 0.0 0.0 0.0 0.0 1.0 95.2 9.8 0.0 0.0 0.2 0.3 0.2 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578147-6640711 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Excitatory neurons: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA023057, HPA023494" Enhanced Approved Centrosome,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 4.9 5.7 6.8 4.6 6.8 3.5 7.3 3.8 7.3 8.4 10.5 7.1 3.5 8.5 11.0 7.1 10.1 5.2 4.1 7.2 6.6 8.7 3.7 5.3 5.0 4.3 4.9 10.1 5.6 14.0 8.8 5.3 3.6 7.7 6.9 10.8 5.7 8.3 2.1 5.7 5.4 8.4 3.4 7.6 6.5 16.6 6.0 8.5 9.0 2.7 5.1 6.4 6.4 5.5 19.9 16.1 19.4 13.2 7.2 11.9 7.7 10.5 10.0 15.1 14.0 11.1 4.8 7.9 7.1 10.4 9.9 18.4 17.8 10.1 23.9 8.1 15.1 4.3 14.8 8.7 12.0 6.9 9.3 7.1 12.9 13.7 13.0 15.5 11.8 9.1 9.9 1.0 12.3 5.9 7.7 6.2 11.8 9.7 8.1 11.1 6.8 2.5 13.9 12.9 7.3 12.7 13.2 3.9 8.9 12.5 6.5 4.5 11.1 13.1 6.7 7.6 16.8 1.8 2.6 2.8 9.8 4.5 10.6 0.0 0.7 0.6 0.5 0.7 0.6 0.8 0.5 0.5 0.4 0.4 0.3 0.3 1.9 0.4 0.4 0.6 0.4 0.2 6.8 6.8 3.8 7.3 7.2 6.6 4.3 4.9 3.6 3.4 6.0 5.5 5.4 6.4 12.3 25.8 3.4 3.2 2.9 2.6 4.6 3.8 5.9 5.2 3.6 7.2 8.3 0.0 16.7 2.4 2.9 5.2 0.0 4.1 90.9 13.2 9.5 5.7 7.2 3.0 46.6 3.8 1.1 6.3 9.7 5.8 1.3 12.9 3.9 2.1 2.5 10.1 29.2 3.9 4.1 3.1 0.6 15.4 4.4 3.2 0.0 25.3 2.8 2.1 2.1 27.2 14.7 3.9 4.9 3.4 5.6 3.6 2.2 2.9 29.3 12.1 0.0 5.9 5.4 15.1 7.8 5.0 2.4 1.2 3.1 9.3 4.4 2.7 KIAA0825 "C5orf36, DKFZp686F0372, MGC34713" ENSG00000185261 KIAA0825 Q8IV33 5 94152966-94618597 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 53.2;Cone photoreceptor cells: 50.1;Excitatory neurons: 171.0;Inhibitory neurons: 168.5;Microglial cells: 56.2;Oligodendrocyte precursor cells: 63.3;Oligodendrocytes: 62.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "neutrophil: 12.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 12.4" "Cell line enhanced" "Detected in many" "HeLa: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038030, HPA038031" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA038030: AB_10672735, HPA038031: AB_2675794" "unprognostic (1.26e-1)" "unprognostic (7.73e-2)" "unprognostic (1.93e-4)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (7.63e-3)" "unprognostic (4.44e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-1)" "unprognostic (4.95e-3)" "unprognostic (2.14e-1)" "unprognostic (1.07e-1)" "unprognostic (9.02e-5)" "unprognostic (3.00e-2)" "unprognostic (8.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.09e-2)" 0.9 1.0 1.8 0.6 1.9 1.0 1.1 1.9 1.8 1.0 1.0 0.6 0.4 1.4 1.3 1.1 2.6 1.2 0.9 1.6 1.6 1.5 0.9 1.0 0.7 2.3 2.4 1.6 0.9 1.4 1.0 0.9 1.7 1.0 0.7 3.4 0.6 0.8 0.4 0.6 0.6 0.9 1.2 0.8 0.6 3.0 1.8 0.7 1.9 0.6 0.5 1.0 0.5 1.3 0.5 0.2 0.6 1.6 2.1 2.7 0.2 1.6 1.4 1.0 1.5 0.0 1.1 0.2 1.7 0.6 1.1 0.8 0.3 1.1 1.3 0.0 0.3 0.2 9.9 0.2 1.5 0.3 0.1 1.6 1.1 1.3 0.3 1.3 1.0 0.9 0.2 0.0 1.9 1.1 0.7 0.7 0.9 0.3 0.2 0.8 0.1 0.1 2.0 0.5 1.0 1.3 1.6 0.1 0.3 1.0 0.8 1.2 1.0 0.9 0.2 1.3 0.6 0.4 0.4 0.0 2.0 0.5 0.8 0.0 0.6 0.0 0.4 0.2 0.2 0.8 0.4 0.6 0.6 0.4 0.2 0.3 12.4 0.6 0.4 0.6 0.2 0.2 1.8 1.9 1.9 1.8 1.6 1.6 2.3 2.4 1.7 1.2 1.8 1.3 3.0 6.4 4.1 53.2 1.5 1.3 1.4 1.4 1.2 9.8 2.8 1.7 2.3 2.8 2.1 1.8 50.1 1.0 2.7 0.8 0.0 1.1 10.4 20.3 6.5 1.6 0.0 1.3 171.0 0.6 0.6 4.6 1.5 2.3 1.3 3.7 1.4 1.8 1.0 15.2 168.5 0.6 2.0 1.0 1.6 6.0 1.2 1.7 0.0 56.2 0.7 4.6 0.0 63.3 62.7 0.8 0.2 1.5 1.7 0.6 1.0 3.3 13.1 20.5 0.0 4.4 3.0 8.7 3.9 1.2 1.1 0.3 4.3 5.8 0.6 0.7 KIF27 DKFZp434D0917 ENSG00000165115 "Kinesin family member 27" Q86VH2 9 83834099-83921465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 23.8;testis: 26.2" "Cell type enhanced" "Detected in all" "Early spermatids: 181.2;Endometrial ciliated cells: 72.2;Late spermatids: 125.4;Spermatocytes: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 9 "granulocytes: 16.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (9.75e-2)" "unprognostic (3.86e-2)" "unprognostic (1.46e-1)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (2.83e-3)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" "unprognostic (3.86e-3)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (2.55e-1)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (1.85e-1)" "unprognostic (2.01e-1)" 2.7 2.5 4.7 2.0 4.8 2.4 3.6 4.7 5.2 4.0 23.8 2.3 2.1 5.0 4.0 2.4 7.5 2.9 2.4 4.4 5.6 2.8 2.2 3.3 2.6 9.0 9.9 4.8 3.1 4.7 3.4 3.2 7.0 3.2 2.1 9.9 3.0 3.0 2.4 4.3 2.5 2.1 7.0 3.1 2.9 26.2 6.5 3.1 8.1 1.7 2.0 2.0 2.5 7.8 4.6 4.8 3.5 5.4 2.5 2.3 6.7 2.2 2.4 1.4 1.1 1.2 2.4 0.5 1.9 1.0 4.2 4.0 1.5 1.6 1.6 4.7 1.2 1.3 1.8 1.9 3.9 3.5 1.3 1.4 3.9 1.9 5.1 5.3 2.1 5.2 1.4 1.7 0.6 3.4 4.5 3.3 1.9 3.3 2.5 4.4 3.3 1.1 2.7 1.5 3.8 3.1 3.2 0.8 2.8 4.7 1.6 2.7 1.1 2.5 2.7 2.6 2.2 2.9 2.2 0.6 1.5 1.3 2.5 1.4 0.7 2.4 0.6 0.7 0.6 1.7 0.7 0.6 0.8 1.1 1.0 0.6 16.1 1.2 0.3 1.3 0.2 0.3 4.7 4.8 4.7 5.2 4.4 5.6 9.0 9.9 7.0 7.0 6.5 7.8 8.9 6.4 9.8 28.1 4.6 3.4 4.6 2.2 1.2 5.8 5.8 6.5 8.7 1.5 14.0 3.7 16.7 3.1 6.7 2.1 1.9 4.5 181.2 72.2 7.3 6.3 1.8 1.7 21.7 3.8 1.9 5.5 6.1 11.8 3.8 8.3 3.9 2.4 1.4 11.8 27.2 2.4 2.0 2.8 2.4 125.4 9.9 3.7 3.6 24.4 2.1 9.6 2.1 20.1 27.6 2.3 2.1 6.8 4.1 3.5 3.0 2.4 50.2 15.5 6.6 16.9 5.0 67.4 22.6 2.2 2.4 2.6 3.9 4.3 2.9 2.1 KIF9 MGC104186 ENSG00000088727 "Kinesin family member 9" Q9HAQ2 3 47228395-47283451 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022031, HPA022033, HPA030429" Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921" "unprognostic (1.93e-2)" "unprognostic (6.37e-2)" "prognostic favorable (2.26e-4)" "unprognostic (1.17e-3)" "unprognostic (8.86e-2)" "unprognostic (1.13e-1)" "unprognostic (2.80e-3)" "unprognostic (1.70e-1)" "unprognostic (2.94e-2)" "unprognostic (4.59e-2)" "unprognostic (7.47e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.95e-6)" "unprognostic (4.21e-2)" "unprognostic (2.03e-1)" "unprognostic (9.17e-2)" "unprognostic (1.23e-1)" 6.5 7.4 9.3 3.1 10.1 11.8 10.6 8.8 14.4 7.6 23.1 9.1 6.1 7.9 20.5 5.8 26.3 6.4 14.1 10.1 9.8 26.8 6.0 8.6 2.6 12.0 12.9 5.0 12.7 10.1 16.4 3.7 11.4 7.7 8.1 18.7 8.9 4.8 9.4 8.4 5.6 4.5 11.0 5.7 9.3 64.4 10.0 2.3 21.0 5.7 3.1 6.8 5.4 9.5 19.4 21.7 7.6 19.1 3.6 8.7 6.2 5.9 6.1 8.8 7.8 8.4 23.0 12.8 7.3 7.6 11.8 12.0 22.6 15.3 8.7 6.6 14.6 11.9 16.5 26.9 3.4 25.3 3.8 4.5 15.3 12.8 9.6 7.4 19.0 13.5 26.5 5.1 6.6 15.5 13.7 37.6 21.7 44.4 30.5 8.6 5.3 18.3 36.7 10.9 10.8 19.9 6.8 13.0 21.8 3.9 8.4 17.6 9.0 5.1 11.0 8.3 13.6 4.4 19.7 16.1 18.9 25.1 11.3 2.5 3.6 2.1 1.5 2.6 3.0 3.5 1.4 2.3 5.7 0.6 1.7 1.9 6.3 3.5 2.3 3.3 1.0 1.3 9.3 10.1 8.8 14.4 10.1 9.8 12.0 12.9 11.4 11.0 10.0 9.5 34.5 19.2 18.4 4.2 6.7 20.1 53.7 44.3 20.5 7.2 61.4 74.5 28.2 38.6 51.9 64.4 35.5 10.7 7.5 23.8 109.5 45.5 690.3 398.0 17.8 29.3 58.9 20.0 16.6 32.7 11.1 12.1 34.1 38.5 29.1 11.3 17.9 20.7 9.2 5.0 10.3 40.1 52.9 7.2 7.1 160.6 14.0 8.0 16.0 2.8 3.8 17.2 3.1 2.5 3.2 26.0 15.7 13.2 5.7 37.6 15.1 198.1 359.0 44.0 13.1 42.2 16.7 328.8 37.3 17.2 20.2 8.2 7.8 21.8 37.8 37.4 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 436.6" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 2075.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Supported Nucleoplasm,Nucleoli,Vesicles,Cytosol No No "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: AB_2686157" "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favorable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 211.3 46.9 19.0 122.1 18.0 436.6 129.7 19.2 22.4 95.4 21.9 92.1 55.4 98.1 17.7 165.5 77.2 181.9 49.7 18.0 19.2 64.1 141.8 117.0 65.4 29.4 20.1 47.3 118.3 31.8 12.0 98.2 25.2 32.8 99.6 18.4 73.8 33.7 84.9 197.1 106.0 208.2 22.7 64.3 73.2 14.6 23.0 56.8 193.9 41.3 45.0 136.3 92.7 25.0 55.0 14.7 27.2 9.0 155.1 154.3 17.1 91.7 46.5 95.9 64.8 38.0 71.4 15.6 20.8 100.0 74.5 32.7 17.0 84.9 79.5 76.6 10.2 2.2 17.5 35.8 66.4 10.3 51.5 51.4 158.2 68.6 129.3 34.2 99.3 10.1 17.5 117.9 123.6 4.0 19.4 15.9 10.2 29.2 26.0 12.6 28.2 55.5 94.1 53.4 12.0 11.5 22.5 64.0 142.8 73.5 32.0 8.6 130.9 128.7 17.8 76.9 43.0 22.6 78.1 28.6 34.7 13.7 40.8 318.8 85.2 234.1 129.8 74.2 115.9 81.1 147.4 131.5 67.6 70.9 44.9 69.0 391.6 72.5 104.6 152.8 120.6 148.7 19.0 18.0 19.2 22.4 18.0 19.2 29.4 20.1 25.2 22.7 23.0 25.0 511.0 1246.8 489.4 14.0 716.9 585.5 1298.4 625.8 1227.0 39.6 985.9 630.0 63.6 544.7 451.9 138.0 33.3 163.1 518.3 1507.0 21.5 808.6 58.0 1065.6 618.9 469.9 397.3 77.9 18.5 553.0 473.8 545.5 1120.3 1905.9 626.7 195.9 248.4 309.9 583.6 37.0 10.0 746.7 429.3 968.7 885.1 53.2 130.5 992.1 483.8 58.1 609.8 42.9 150.4 7.5 4.3 857.9 949.9 133.9 1172.5 600.2 1009.9 97.4 342.0 90.1 138.1 194.8 441.8 9.0 19.4 2075.6 628.2 195.9 920.5 67.1 542.0 572.5 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207561-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 125.4;Oligodendrocytes: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 7.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 65: Brain - Ion transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 11.8 11.8 35.3 12.1 50.9 21.4 13.0 26.7 55.8 5.9 14.3 7.2 5.3 7.7 13.5 19.7 9.9 10.7 5.5 78.4 34.7 15.4 27.1 14.2 11.2 33.2 35.7 4.1 7.8 9.5 16.3 7.7 30.8 8.2 6.7 8.8 20.0 10.0 4.7 6.4 6.5 10.7 33.3 14.6 8.3 6.1 35.5 6.3 12.3 6.8 9.5 15.2 8.8 45.2 16.1 14.7 9.8 10.1 14.1 12.9 10.2 21.3 16.7 10.7 11.7 8.9 11.5 16.3 5.1 10.9 19.2 10.5 16.1 10.4 13.9 27.2 6.0 14.1 12.8 12.9 12.9 14.2 19.3 10.7 30.5 9.8 37.1 18.5 25.9 6.1 6.4 33.0 16.1 6.0 0.4 4.0 6.0 8.9 6.5 5.6 7.0 5.1 18.1 14.9 49.1 8.1 13.5 4.5 13.0 18.1 3.3 15.1 37.0 8.4 17.6 9.6 14.0 21.5 16.3 13.2 10.1 9.7 16.9 1.8 0.9 1.3 0.5 1.0 0.3 0.3 0.3 0.3 0.8 0.8 0.9 1.0 7.2 0.3 1.2 0.4 0.5 0.4 35.3 50.9 26.7 55.8 78.4 34.7 33.2 35.7 30.8 33.3 35.5 45.2 19.0 6.4 17.9 33.3 10.7 6.0 13.1 8.0 4.6 8.9 13.2 10.9 4.7 8.6 9.7 22.0 14.6 4.3 8.3 7.5 27.4 8.7 1.9 8.3 6.6 14.6 15.5 2.1 125.4 12.9 9.4 5.2 8.2 13.5 9.5 4.0 25.7 35.6 8.3 32.0 33.0 6.2 8.2 42.5 13.9 1.7 4.1 22.7 5.4 39.4 13.5 5.8 1.0 43.2 144.5 9.6 7.4 4.5 6.3 11.9 5.4 19.0 10.9 7.3 0.0 11.9 7.2 3.3 7.4 7.7 7.5 3.7 9.2 3.9 3.9 20.1 KLHL21 KIAA0469 ENSG00000162413 "Kelch like family member 21" Q9UJP4 1 6590724-6614607 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 169.9" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 104.8;Suprabasal keratinocytes: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 21.4;neutrophil: 63.0" "Lineage enriched" "Detected in all" 8 "granulocytes: 63.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051364, HPA059307" Uncertain Supported Centrosome NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 61: Squamous epithelial cells - Keratinization" Centrosome "HPA051364: AB_2681455, HPA059307: " "unprognostic (6.13e-3)" "unprognostic (5.26e-2)" "unprognostic (2.30e-2)" "unprognostic (9.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.39e-2)" "unprognostic (5.77e-3)" "unprognostic (2.28e-1)" "unprognostic (8.52e-2)" "unprognostic (4.85e-2)" "unprognostic (4.02e-1)" "unprognostic (6.33e-3)" "prognostic favorable (1.71e-4)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (9.74e-2)" "unprognostic (4.19e-2)" 30.5 29.5 31.3 12.6 37.3 25.5 24.6 33.6 35.9 27.2 73.1 44.7 6.9 35.3 8.7 36.4 24.2 14.4 53.3 32.1 31.5 28.2 22.2 16.4 9.2 41.0 44.0 28.6 33.3 21.5 30.1 6.9 37.4 31.7 5.0 7.6 33.3 28.3 169.9 37.0 15.9 16.4 30.7 17.2 30.0 15.2 35.5 9.7 18.7 101.3 7.6 46.5 25.0 44.3 25.8 15.1 7.5 24.3 41.5 25.8 19.5 35.5 28.1 23.0 13.7 44.1 16.1 0.9 30.8 21.9 20.7 41.7 16.6 39.2 12.8 54.8 26.8 29.7 27.8 40.3 34.4 17.8 17.5 28.9 13.0 52.3 17.6 21.6 9.9 14.8 33.3 23.1 19.0 8.9 18.4 15.7 13.8 13.1 55.5 28.0 31.3 32.3 13.5 7.8 30.2 7.5 27.8 22.0 62.8 6.5 14.5 21.0 33.3 74.4 9.1 68.9 86.1 26.2 35.2 18.0 72.2 33.1 28.4 8.4 6.2 21.4 7.1 2.6 6.2 4.5 6.6 7.0 3.8 2.6 5.3 5.3 63.0 2.9 2.3 3.4 8.2 6.1 31.3 37.3 33.6 35.9 32.1 31.5 41.0 44.0 37.4 30.7 35.5 44.3 11.6 3.2 5.1 19.6 8.9 71.2 46.9 22.3 63.2 4.1 47.1 44.4 68.3 7.2 10.7 9.2 4.2 5.1 15.6 10.1 7.9 12.0 2.7 19.6 14.9 15.6 3.0 2.1 8.2 12.9 7.0 24.7 31.1 35.3 0.0 6.4 7.1 23.6 5.6 5.0 8.9 5.6 14.2 10.4 30.1 7.6 10.8 17.1 26.6 8.4 7.6 12.2 4.1 6.6 14.1 20.0 7.3 15.1 12.6 43.1 5.3 7.6 14.0 5.9 13.1 32.2 25.2 2.0 10.9 104.8 72.0 6.4 15.3 9.2 5.5 31.3 KLHL24 "DRE1, FLJ20059" ENSG00000114796 "Kelch like family member 24" Q6TFL4 3 183635610-183684519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056337 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA056337: AB_2683103" "unprognostic (3.68e-1)" "unprognostic (1.37e-3)" "unprognostic (1.62e-1)" "unprognostic (1.53e-3)" "unprognostic (8.56e-3)" "unprognostic (3.85e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-2)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "unprognostic (3.31e-1)" "unprognostic (1.39e-3)" "unprognostic (1.08e-1)" "unprognostic (7.85e-2)" "unprognostic (8.40e-2)" "unprognostic (1.02e-2)" 16.5 13.1 8.4 10.5 22.4 41.0 16.1 71.6 33.2 13.7 0.0 14.9 16.0 15.3 10.3 11.5 10.3 13.4 41.3 8.4 9.0 18.5 20.3 18.8 15.8 18.4 17.6 20.0 15.3 41.7 10.4 13.9 21.0 13.9 14.0 16.1 17.8 11.5 48.5 11.2 14.6 11.3 5.1 16.2 15.1 9.0 21.2 17.8 23.3 46.4 14.7 14.0 11.9 28.3 4.4 4.3 9.9 10.5 22.1 12.0 20.6 2.2 16.9 2.7 4.8 2.8 8.0 8.9 30.1 6.1 25.2 6.2 5.7 2.6 4.8 10.1 7.9 5.4 6.9 2.9 18.9 4.7 7.1 24.7 14.0 2.9 9.2 16.7 14.4 13.8 3.5 28.5 3.7 2.1 7.9 6.0 6.4 6.7 6.5 10.0 7.5 28.7 7.8 13.6 17.5 24.5 10.3 32.1 23.5 14.4 11.8 10.4 12.5 3.4 4.4 5.4 2.9 54.1 38.4 37.7 6.0 7.5 2.2 43.1 20.3 25.0 17.3 22.7 14.7 25.7 14.3 15.8 13.8 27.7 20.7 14.8 40.9 16.3 22.5 10.7 20.5 15.3 8.4 22.4 71.6 33.2 8.4 9.0 18.4 17.6 21.0 5.1 21.2 28.3 44.5 112.2 72.3 88.8 73.4 43.6 30.7 21.8 77.4 39.8 33.2 24.8 137.8 27.1 33.4 31.3 70.9 12.1 63.2 32.0 13.7 28.1 16.1 35.5 42.0 39.5 42.3 26.1 99.5 18.9 18.0 44.5 29.6 49.3 26.0 110.1 33.2 47.7 27.1 60.6 104.3 28.5 46.8 51.9 31.4 7.0 30.7 46.5 35.6 68.4 31.3 24.4 41.2 92.0 185.2 18.1 29.3 24.5 48.5 51.9 52.3 27.7 35.8 45.8 32.9 59.7 48.8 27.9 12.4 46.1 43.9 43.8 49.5 45.1 26.0 44.8 KMT2C "HALR, KIAA1506, MLL3" ENSG00000055609 "Lysine methyltransferase 2C" Q8NEZ4 7 152134922-152436641 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 363.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074736 Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA074736: AB_2686709" "unprognostic (7.75e-2)" "unprognostic (3.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.31e-1)" "unprognostic (5.23e-3)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.01e-6)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (3.04e-2)" "unprognostic (2.64e-1)" 12.7 11.2 16.7 7.3 25.7 16.4 12.9 16.7 15.7 15.3 5.5 13.1 5.7 14.3 13.7 14.1 11.9 7.7 10.2 13.0 18.9 8.9 10.4 12.7 8.1 25.3 19.4 16.8 18.5 12.4 12.1 10.3 20.6 9.3 7.6 21.7 14.2 9.0 25.9 17.6 12.8 7.5 12.2 12.2 15.2 13.4 19.1 16.1 14.6 16.9 9.5 11.3 12.7 28.6 13.4 6.1 11.6 11.7 19.0 13.9 10.2 4.7 6.4 5.0 5.5 10.9 4.7 22.4 8.9 11.3 9.2 5.2 14.3 7.5 9.2 12.7 6.5 14.0 7.3 4.5 8.9 22.9 12.8 6.6 9.1 7.1 8.2 7.2 8.4 9.7 22.5 15.0 11.7 12.7 14.8 11.1 6.8 8.5 7.9 9.5 12.3 8.4 5.8 10.9 19.6 12.8 13.4 15.8 6.3 10.6 4.6 15.7 12.8 8.0 4.4 9.0 8.9 15.3 7.7 22.4 10.7 14.7 8.4 6.1 3.0 4.4 1.9 2.7 1.6 6.9 2.0 1.5 1.4 3.9 1.9 1.4 15.2 2.2 2.6 3.7 1.3 0.8 16.7 25.7 16.7 15.7 13.0 18.9 25.3 19.4 20.6 12.2 19.1 28.6 62.4 76.9 71.9 292.8 75.0 89.1 38.3 31.5 62.0 89.0 59.6 35.2 65.8 44.3 72.4 46.0 173.0 38.0 61.9 61.7 5.9 37.6 32.1 94.4 92.1 58.9 67.9 55.5 180.7 33.1 51.7 58.3 89.2 200.5 65.2 52.8 56.7 46.0 33.7 80.8 172.2 53.5 42.7 54.7 79.6 17.3 67.4 90.5 42.7 202.4 77.1 57.7 59.8 299.6 363.2 37.6 49.0 60.2 90.3 53.6 36.3 14.7 46.9 73.0 26.3 83.0 55.5 42.3 33.9 80.9 96.3 127.2 76.8 54.8 39.1 61.4 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421902-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 20.2 18.4 10.0 19.8 10.6 11.4 11.9 10.6 15.0 14.1 6.7 15.5 13.0 13.6 15.1 21.8 12.9 12.1 20.3 11.6 10.7 16.1 32.0 13.0 15.7 11.2 10.2 10.6 18.8 19.2 9.0 15.9 11.2 15.1 15.4 28.6 12.4 16.3 74.4 13.5 13.6 23.0 11.6 12.3 14.5 20.6 10.7 15.5 17.9 41.0 20.6 22.1 11.4 12.6 75.1 43.4 73.2 37.2 46.6 51.2 23.2 56.5 47.5 60.4 54.4 52.6 35.6 54.1 50.6 62.4 47.8 38.3 58.2 48.2 88.9 14.8 22.1 66.6 37.1 29.5 27.3 59.8 29.5 35.7 61.0 43.7 60.9 29.5 67.3 28.8 47.6 30.5 55.8 34.6 43.7 14.1 31.8 52.5 46.2 44.1 60.8 34.8 26.2 51.8 50.4 30.3 60.5 32.6 50.1 56.9 43.2 34.8 57.9 37.7 41.2 18.7 44.1 29.1 31.8 99.9 52.7 40.9 39.1 27.1 19.3 18.8 17.4 19.5 18.6 15.8 15.2 19.3 25.4 12.7 15.4 15.8 41.5 21.2 29.3 7.9 17.6 18.2 10.0 10.6 10.6 15.0 11.6 10.7 11.2 10.2 11.2 11.6 10.7 12.6 27.9 16.0 31.8 53.5 31.9 41.4 22.2 15.8 28.5 30.1 24.2 12.3 31.1 22.8 32.9 14.7 31.3 21.2 31.5 18.6 13.7 23.2 120.1 35.0 26.1 27.6 16.3 49.2 107.2 33.4 25.9 26.1 19.4 29.5 38.7 18.6 22.5 50.2 23.3 20.2 81.7 19.7 18.3 27.9 47.4 221.8 22.4 30.0 17.8 61.8 31.5 22.2 26.8 59.8 91.7 35.1 19.8 24.8 36.6 34.5 18.6 23.1 44.8 47.4 13.1 25.4 32.1 42.1 18.0 27.1 45.5 24.9 31.3 19.6 14.0 27.5 KRTAP12-3 KRTAP12.3 ENSG00000205439 "Keratin associated protein 12-3" P60328 21 44657932-44658341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 62 "skin 1: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 61: Skin - Cornification" "Cluster 63: NK-cells & T-cells - Immune response" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 LAMB3 "BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa" ENSG00000196878 "Laminin subunit beta 3" Q13751 1 209614870-209652425 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Amelogenesis imperfecta, Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 73.2;urinary bladder: 73.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 370.0;Basal respiratory cells: 447.6;Pancreatic endocrine cells: 853.8;Urothelial cells: 392.7" "Cancer enhanced" "Detected in all" "head and neck cancer: 223.9" "Region enriched" "Detected in many" 7 "cerebral cortex: 21.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 353.8;HaCaT: 538.2;HBEC3-KT: 1315.0;hTCEpi: 412.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA007584, HPA008069, CAB078183" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 20000 "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228" "prognostic favorable (8.43e-4)" "unprognostic (3.08e-2)" "unprognostic (1.46e-2)" "unprognostic (2.88e-2)" "unprognostic (8.00e-2)" "unprognostic (1.60e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.55e-4)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.02e-1)" "unprognostic (2.38e-1)" "unprognostic (6.01e-2)" "unprognostic (4.92e-3)" 10.9 16.0 2.6 13.1 2.9 10.7 20.7 0.9 21.3 13.2 0.5 26.2 31.5 18.0 2.6 47.2 16.4 11.9 6.8 2.9 2.1 16.3 9.3 28.4 1.2 1.5 1.5 1.1 4.2 0.1 1.7 5.8 1.6 25.9 16.6 0.2 41.5 24.1 6.8 42.1 43.7 2.3 1.7 1.0 73.2 1.0 1.9 5.8 1.2 0.3 13.2 73.1 32.6 2.8 178.4 25.8 0.0 0.4 18.1 11.7 1.0 5.1 15.4 6.0 9.1 68.9 353.8 0.1 15.1 3.7 8.9 538.2 0.1 1315.0 9.1 13.1 1.4 1.1 86.9 1.1 2.4 1.0 1.3 2.6 412.8 19.1 253.4 11.7 6.4 0.1 2.5 6.7 1.9 0.3 0.2 1.2 0.6 81.0 74.0 0.2 17.1 165.4 70.9 109.0 0.5 0.5 73.9 8.5 15.4 1.0 2.0 9.7 138.3 29.1 61.3 1.0 104.6 1.7 3.4 0.4 42.2 0.8 2.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.6 2.9 0.9 21.3 2.9 2.1 1.5 1.5 1.6 1.7 1.9 2.8 0.4 221.2 67.7 1.6 1.2 109.7 370.0 447.6 159.9 0.3 11.5 64.4 8.4 4.3 168.5 47.8 0.0 1.1 0.4 247.5 0.0 180.5 6.0 50.8 10.0 3.5 7.8 0.4 2.5 153.0 1.4 7.5 195.7 135.0 18.4 0.2 0.4 3.9 2.0 3.3 2.3 71.7 18.3 0.3 30.0 10.9 1.8 9.9 8.8 0.0 2.1 0.4 0.0 1.0 1.7 853.8 229.1 0.7 2.1 185.0 111.9 2.3 52.2 0.3 0.0 5.3 10.4 0.3 0.6 51.7 26.0 0.5 4.0 0.0 63.1 392.7 LCOR "C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2" ENSG00000196233 "Ligand dependent nuclear receptor corepressor" Q96JN0 10 96832254-96995956 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 264.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031429, HPA057621, HPA077000" Approved Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824" "unprognostic (5.61e-2)" "unprognostic (1.59e-1)" "unprognostic (2.11e-1)" "unprognostic (2.23e-1)" "unprognostic (1.49e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (2.19e-1)" "unprognostic (2.40e-1)" "unprognostic (1.54e-1)" "unprognostic (4.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (4.40e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.16e-4)" 3.7 3.1 7.1 6.2 6.4 25.5 5.0 21.8 6.6 4.3 3.3 8.7 11.2 4.2 4.6 7.0 3.9 3.9 3.7 4.8 15.6 5.3 5.9 4.8 6.3 6.9 5.6 6.4 8.2 4.3 5.3 4.9 6.7 4.7 8.5 15.8 5.6 3.5 9.2 4.1 10.7 3.4 4.8 5.5 8.3 4.6 7.5 6.0 5.4 5.1 6.0 6.8 4.7 15.8 14.7 9.3 16.5 8.9 4.4 6.2 7.9 6.2 6.0 7.5 8.5 12.0 10.0 15.4 7.3 6.4 7.0 12.2 16.5 8.6 13.3 7.4 8.0 17.7 6.0 15.2 8.4 22.1 8.8 4.9 7.5 11.5 20.4 7.7 8.1 7.8 12.7 7.2 11.9 6.7 9.2 8.4 6.3 7.9 4.0 11.2 12.7 4.3 8.6 30.7 7.5 6.6 7.0 4.4 8.8 7.1 8.3 6.9 12.5 5.8 13.0 5.2 11.6 9.4 6.7 17.9 6.1 13.9 3.1 1.7 5.0 8.0 5.8 4.1 4.7 4.6 4.4 5.3 3.7 8.6 4.7 3.7 16.7 5.0 2.0 5.4 3.6 2.5 7.1 6.4 21.8 6.6 4.8 15.6 6.9 5.6 6.7 4.8 7.5 15.8 26.4 19.2 26.8 72.1 36.1 15.4 16.7 31.3 25.6 45.2 37.0 20.3 17.8 37.1 38.2 31.3 77.2 18.8 46.5 85.3 11.7 27.0 0.8 34.6 26.8 23.1 46.9 17.7 138.3 33.9 8.2 17.1 28.1 35.9 26.6 67.1 20.3 22.2 14.1 40.4 151.6 31.2 52.9 30.5 29.7 2.3 10.2 40.0 21.4 103.0 28.1 11.7 24.7 143.2 264.9 41.5 62.0 13.9 36.8 26.9 67.1 25.4 54.1 58.9 19.7 21.6 26.8 21.7 26.3 29.2 12.9 38.6 34.0 22.0 33.6 34.4 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 566.5;Late spermatids: 1737.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 97.0;EFO-21: 115.2;U-698: 200.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 2700000 "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 29.3 10.8 6.7 28.4 8.9 9.9 18.8 9.1 9.7 27.5 27.3 73.3 13.8 61.9 11.8 49.4 32.2 21.3 16.7 6.1 11.2 11.5 12.1 19.1 17.2 15.6 7.9 14.7 8.8 9.9 2.9 11.5 12.6 39.0 31.7 2.4 12.0 53.1 12.4 12.0 23.0 81.3 6.6 10.8 32.7 18.6 13.8 8.0 8.8 9.1 21.4 57.0 22.1 7.8 25.6 23.3 16.7 11.3 35.3 36.0 17.9 16.0 20.9 11.8 7.8 42.2 12.1 97.0 115.2 37.3 14.7 10.7 5.2 11.0 29.5 10.7 5.7 4.6 18.4 11.1 15.0 2.0 5.5 25.7 15.3 26.4 22.5 16.9 20.1 5.2 0.2 2.0 21.0 8.1 5.1 2.1 6.6 16.3 7.6 6.2 12.3 0.5 13.1 26.8 1.1 0.3 35.3 11.4 19.2 27.3 9.0 8.8 43.7 27.1 20.8 19.6 41.1 0.2 4.0 200.0 13.6 4.3 24.9 0.8 4.9 2.2 5.1 4.5 3.3 3.3 4.5 3.8 2.6 5.6 2.4 2.9 18.9 4.8 4.6 5.3 1.8 1.9 6.7 8.9 9.1 9.7 6.1 11.2 15.6 7.9 12.6 6.6 13.8 7.8 104.7 89.8 69.8 357.5 48.5 78.0 84.9 65.0 70.0 9.5 141.8 111.5 143.0 100.1 86.2 69.9 14.6 44.7 65.7 207.1 29.4 139.7 566.5 49.3 134.4 91.8 77.5 12.0 132.8 90.9 24.1 124.9 97.9 93.6 18.3 136.6 126.4 94.8 42.5 5.0 191.2 91.7 44.7 65.1 121.0 1737.1 225.3 75.8 80.0 308.2 55.8 24.8 54.6 395.6 214.9 120.2 158.1 476.9 24.6 172.5 127.5 80.2 60.9 7.1 335.2 159.2 368.2 9.8 8.0 64.2 68.2 18.6 55.3 46.8 151.3 149.3 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lung: 52.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 502.2;Excitatory neurons: 92.0;monocytes: 133.1;Oligodendrocyte precursor cells: 256.9" "Cancer enhanced" "Detected in many" "renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 8 "neutrophil: 58.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 58.2" "Cell line enhanced" "Detected in some" "A549: 4.6;ASC TERT1: 5.6;BJ hTERT+: 3.2;RPTEC TERT1: 7.8;T-47d: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Supported Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 11: Alveolar cells - Smell perception" Vesicles "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 4.8 3.1 1.1 10.1 1.9 9.0 2.6 0.9 2.1 5.1 1.2 4.3 0.6 4.8 1.9 7.0 4.1 6.2 3.9 1.3 1.1 10.9 5.6 52.4 6.8 1.7 1.1 5.4 3.6 8.4 2.1 1.2 1.4 2.6 1.8 1.5 3.5 2.0 5.5 2.1 3.6 4.0 1.1 10.8 2.1 0.8 1.2 2.5 2.9 7.9 5.4 4.5 5.5 1.9 0.0 4.6 0.0 0.0 2.3 5.6 0.0 1.3 3.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.4 0.0 2.1 0.4 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.3 0.0 0.5 2.7 0.1 3.1 1.5 1.0 0.4 0.5 0.6 0.4 0.0 0.0 0.0 1.3 0.0 1.7 0.0 7.2 2.2 0.0 5.2 0.0 1.8 0.0 0.0 2.1 1.7 0.0 0.0 58.2 0.0 6.9 0.3 0.0 1.3 1.1 1.9 0.9 2.1 1.3 1.1 1.7 1.1 1.4 1.1 1.2 1.9 7.4 32.1 502.2 17.3 29.9 2.4 1.8 0.4 2.8 8.6 1.3 1.4 7.8 5.7 17.3 27.6 0.0 0.0 1.9 0.0 1.9 1.3 0.5 0.4 2.6 7.0 0.0 2.1 92.0 2.7 0.1 16.1 0.5 0.4 13.9 2.7 13.2 8.2 4.6 47.1 28.0 0.0 0.0 55.8 8.7 1.2 19.0 52.2 12.4 73.1 133.1 8.6 3.1 256.9 3.1 0.8 1.1 12.0 2.8 0.6 0.0 22.5 3.4 1.0 0.0 22.5 4.8 0.3 1.0 12.6 3.1 0.4 3.4 11.2 0.0 0.7 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.5;testis: 36.0" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4" "Cancer enhanced" "Detected in many" "cervical cancer: 11.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.8" "Cell line enhanced" "Detected in many" "A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017770, CAB075742, CAB075743, CAB079929" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 5.4 0.2 0.6 0.2 0.6 0.3 4.4 0.9 1.7 3.3 0.0 0.5 0.3 0.5 0.2 12.5 1.2 0.4 1.5 0.8 1.0 3.0 0.2 0.8 0.2 1.7 0.8 0.7 0.3 0.0 0.4 2.4 2.0 1.1 0.0 2.4 1.7 0.8 5.4 6.8 0.3 0.1 1.1 0.2 1.1 36.0 0.7 0.6 1.0 1.3 0.6 1.0 5.1 1.1 125.2 2.0 0.0 6.3 2.4 7.9 1.5 131.9 15.3 39.9 24.0 0.2 0.5 0.0 10.9 15.0 14.3 10.8 0.0 7.5 33.5 1.2 0.2 0.1 142.4 0.3 1.9 0.0 0.0 11.7 21.1 29.7 38.0 0.1 3.7 0.0 0.0 0.6 76.2 1.0 0.2 0.3 4.2 4.1 2.0 0.3 0.5 0.2 6.7 1.7 3.7 0.5 206.3 2.7 41.3 6.6 0.5 0.2 5.4 1.9 11.8 273.2 0.2 0.2 0.1 0.3 0.6 0.1 13.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.9 1.7 0.8 1.0 1.7 0.8 2.0 1.1 0.7 1.1 25.6 3.2 0.5 0.0 0.4 38.9 54.2 4.3 21.6 0.6 15.1 49.8 0.2 5.7 9.8 25.8 0.0 13.5 0.3 0.0 0.0 0.8 7.7 3.1 8.5 9.2 0.0 0.0 0.0 0.0 186.7 8.0 0.0 9.0 0.0 0.0 3.3 0.1 6.0 0.0 0.0 0.0 6.1 0.3 28.7 14.8 4.1 4.6 12.4 0.0 0.0 0.5 0.0 0.0 0.1 6.7 1.1 3.0 0.0 105.2 0.0 0.2 3.6 0.6 0.0 17.8 13.1 404.4 105.8 32.2 44.9 25.3 0.7 0.1 0.0 131.4 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 85.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 55.9;HHSteC: 53.7;HSkMC: 51.8;hTERT-RPE1: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 12.6 7.6 12.9 5.4 15.2 3.2 10.3 25.9 19.6 23.5 4.3 13.3 3.2 22.9 4.8 4.0 18.5 14.0 8.6 15.6 11.3 8.5 1.7 11.2 4.4 11.9 11.1 21.6 3.6 7.3 22.7 6.4 13.2 9.6 3.8 13.6 4.9 10.9 2.7 5.7 8.9 14.4 8.0 9.0 7.3 9.0 13.0 6.0 8.6 6.3 2.7 14.0 12.2 13.7 0.5 15.1 8.6 14.2 55.9 28.9 1.2 10.1 18.9 10.8 11.0 0.3 1.8 3.5 5.4 10.8 8.7 0.1 4.3 6.8 4.3 4.9 5.4 3.5 8.3 0.0 53.7 0.1 3.6 51.8 5.2 14.6 7.8 69.1 16.9 7.8 0.1 15.7 10.0 6.7 3.8 0.9 3.2 0.0 5.5 5.4 6.3 1.0 5.4 0.1 9.3 12.4 5.6 6.8 14.9 1.8 4.6 10.3 12.9 10.2 10.8 4.5 2.5 6.1 8.0 0.0 16.8 6.9 10.4 0.0 0.5 0.0 0.4 0.4 0.8 0.1 0.5 0.6 0.2 0.0 0.2 0.3 1.0 0.2 0.1 0.0 0.1 0.1 12.9 15.2 25.9 19.6 15.6 11.3 11.9 11.1 13.2 8.0 13.0 13.7 11.4 6.4 14.6 21.5 8.1 0.8 2.4 0.5 4.6 28.9 5.6 5.2 0.8 7.2 6.4 1.8 37.5 1.9 12.2 4.8 9.8 6.7 1.5 11.5 27.6 10.4 3.5 1.3 21.1 1.8 2.2 11.0 2.0 15.8 12.7 7.0 15.0 7.8 4.1 30.3 19.1 2.8 2.0 10.3 2.2 1.8 8.1 8.6 0.0 8.4 8.5 19.9 5.2 10.6 11.0 4.4 2.1 8.2 6.7 5.3 7.1 14.8 5.5 85.0 6.6 23.5 10.2 2.5 2.1 2.5 1.0 2.2 11.6 12.5 4.1 3.9 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 130.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1501.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 45: Intestine - Brush border" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Microtubules "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.7 8.4 36.6 4.9 81.2 4.8 13.1 53.0 49.8 6.1 0.6 24.6 29.0 2.4 19.5 15.8 10.0 8.2 1.4 40.2 59.8 32.6 17.2 7.0 1.5 78.0 67.2 1.5 25.1 24.9 12.0 6.8 75.8 20.0 23.2 57.3 20.3 6.4 0.8 17.1 26.6 2.4 43.3 1.8 18.7 27.4 63.0 5.1 16.1 0.2 5.1 12.0 9.6 130.4 25.6 39.2 0.3 0.1 0.2 0.2 40.4 0.7 1.2 0.4 0.7 59.8 26.3 0.1 5.3 0.8 6.7 38.2 11.1 34.6 0.7 0.2 24.6 26.6 69.2 0.5 0.3 26.1 3.0 0.1 31.5 0.2 2.4 1.0 0.2 2.0 18.4 0.6 0.1 88.5 0.2 2.6 5.2 55.3 5.7 0.1 1.0 4.8 23.6 68.4 24.4 5.2 27.4 51.7 0.6 9.1 20.5 2.6 0.5 0.1 1.9 0.4 1.7 4.6 6.4 0.2 0.5 10.1 0.7 2.8 2.3 0.0 0.0 1.6 0.3 1.4 0.5 0.0 5.7 1.6 0.1 0.0 12.2 0.7 3.1 0.0 0.2 0.7 36.6 81.2 53.0 49.8 40.2 59.8 78.0 67.2 75.8 43.3 63.0 130.4 4.0 57.7 51.4 117.2 1.9 28.2 48.7 21.7 33.6 367.0 29.5 18.4 3.0 28.6 42.9 18.4 146.0 33.1 0.7 67.9 31.3 35.8 293.9 30.4 5.9 4.9 117.7 35.1 217.1 49.0 23.1 4.4 42.8 60.8 0.0 1.2 0.7 37.0 16.3 304.5 258.6 81.5 22.4 3.2 8.5 53.1 6.8 6.2 17.8 15.0 3.2 50.9 0.0 26.2 1501.2 37.2 51.9 3.4 4.4 56.6 60.7 81.8 56.0 104.7 19.7 2.0 5.2 37.5 23.4 49.0 30.4 76.2 3.4 2.8 64.2 62.8 MAPKAP1 "MGC2745, MIP1, SIN1" ENSG00000119487 "MAPK associated protein 1" Q9BPZ7 9 125437393-125707234 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029091, HPA029092" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA029091: AB_10599732, HPA029092: AB_10601568" "unprognostic (6.65e-2)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (5.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.68e-1)" "unprognostic (8.94e-2)" "unprognostic (2.59e-1)" "unprognostic (8.08e-2)" "prognostic favorable (7.23e-6)" "unprognostic (1.66e-1)" "unprognostic (2.04e-1)" "unprognostic (2.98e-1)" "unprognostic (4.27e-2)" 42.9 47.1 43.4 36.7 48.6 34.7 32.8 39.2 45.6 36.4 44.9 47.3 30.4 29.1 35.9 44.0 29.2 28.0 69.7 44.3 41.6 48.0 46.0 30.1 34.8 47.8 46.2 26.1 36.9 53.3 19.2 30.2 41.9 30.3 38.5 42.9 42.1 36.1 103.7 26.2 32.6 46.2 43.2 28.8 36.2 42.0 51.6 36.6 47.4 76.4 37.9 39.4 31.6 40.9 87.4 97.1 64.3 68.3 86.7 82.2 107.9 108.6 110.0 82.0 57.2 97.9 94.9 89.1 65.9 151.6 89.7 119.1 99.5 126.9 110.8 101.8 41.1 64.3 111.9 95.1 97.3 116.0 72.1 80.9 114.6 117.0 121.7 91.2 123.0 85.8 103.6 67.7 176.4 180.3 87.5 46.8 102.4 204.3 122.0 72.4 152.0 119.3 90.2 62.3 77.9 76.7 109.7 100.9 70.0 86.6 115.8 67.1 79.7 115.3 76.1 140.5 182.5 86.1 225.2 89.9 165.5 52.5 127.6 4.4 6.1 5.7 4.3 6.0 5.9 8.2 4.7 4.8 4.9 7.4 4.1 7.1 19.1 5.8 5.6 7.2 5.8 2.5 43.4 48.6 39.2 45.6 44.3 41.6 47.8 46.2 41.9 43.2 51.6 40.9 22.3 12.8 17.0 64.6 33.5 15.8 30.2 15.3 25.6 25.6 30.6 24.1 68.3 22.8 27.5 14.7 41.7 35.4 31.7 28.9 54.8 48.3 80.2 26.2 42.6 27.1 9.6 22.3 82.6 65.6 50.9 27.0 32.1 29.3 17.7 31.2 19.6 34.5 50.7 32.0 80.1 20.8 22.4 29.5 23.4 116.9 19.0 37.3 23.2 59.0 55.1 30.1 35.0 97.0 96.4 59.2 20.1 17.7 32.3 45.2 27.2 84.6 14.6 26.2 6.6 29.1 33.0 75.4 71.4 29.1 19.5 50.9 29.5 38.4 27.6 37.8 MBD6 KIAA1887 ENSG00000166987 "Methyl-CpG binding domain protein 6" Q96DN6 12 57520710-57530148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 13.6" "Cell line enhanced" "Detected in all" "RH-30: 116.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038948, HPA038949" Uncertain Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA038948: AB_2676285, HPA038949: AB_10671868" "unprognostic (2.56e-1)" "unprognostic (4.15e-2)" "unprognostic (1.64e-2)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (2.84e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.19e-1)" "unprognostic (1.83e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-1)" "unprognostic (1.01e-2)" 32.8 40.0 18.7 34.5 22.1 57.1 36.5 19.5 21.3 43.3 21.9 38.8 41.6 46.9 17.9 35.8 40.7 19.1 25.8 17.7 22.8 38.8 44.2 34.4 26.1 24.1 20.8 43.8 44.5 23.0 105.0 25.6 20.0 38.6 20.7 38.5 46.9 27.1 34.1 37.8 44.9 19.8 17.2 64.9 42.6 57.5 25.0 27.9 110.2 18.8 18.8 34.3 35.0 26.8 22.7 31.7 24.2 26.0 16.6 11.9 33.9 25.7 15.8 16.6 12.3 33.0 35.3 22.8 19.3 14.0 16.2 31.3 22.3 19.4 11.6 45.2 22.5 40.2 33.4 22.8 20.3 24.2 99.7 20.8 33.7 17.8 24.8 25.1 22.3 19.3 26.1 58.7 13.5 23.3 25.3 23.9 23.3 16.7 23.2 24.6 116.7 17.7 14.3 44.4 33.3 20.2 20.5 40.6 25.0 14.2 45.7 38.7 21.9 17.8 29.0 18.2 17.4 60.5 22.4 15.7 23.2 15.1 30.6 0.0 1.0 0.4 1.3 0.9 0.5 1.3 0.2 0.4 0.5 0.8 0.5 0.5 13.6 0.7 0.4 0.3 0.2 0.6 18.7 22.1 19.5 21.3 17.7 22.8 24.1 20.8 20.0 17.2 25.0 26.8 24.7 6.4 17.8 12.4 14.1 11.0 13.4 11.9 22.2 55.5 27.5 22.4 6.2 25.8 13.0 9.2 27.1 12.4 12.6 20.6 5.9 9.4 13.3 18.9 19.7 16.7 15.6 18.7 5.4 12.0 8.8 12.2 29.0 32.8 19.0 21.7 14.6 24.3 14.0 25.2 6.6 20.5 8.2 23.8 11.0 9.4 14.6 23.1 12.4 15.0 9.1 30.4 11.3 6.6 8.1 9.2 20.7 12.8 14.8 12.3 20.8 4.4 16.3 69.4 19.7 14.9 17.3 51.7 30.8 23.7 12.4 22.6 16.8 16.9 16.8 15.8 MDM2 "HDM2, MGC5370" ENSG00000135679 "MDM2 proto-oncogene" Q00987 12 68808177-68850686 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 504.6;U-698: 517.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000086, CAB016303, CAB079977" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: " "unprognostic (1.16e-1)" "prognostic favorable (3.23e-4)" "unprognostic (6.16e-2)" "prognostic favorable (4.51e-7)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.77e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (3.23e-1)" "unprognostic (1.80e-3)" "unprognostic (2.36e-1)" "unprognostic (4.22e-2)" "unprognostic (4.59e-2)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (8.95e-2)" 14.0 11.6 5.4 10.4 10.0 28.6 11.9 7.4 7.6 13.9 28.0 20.7 6.4 9.5 7.1 13.0 14.1 12.0 6.8 3.8 7.4 9.5 26.9 14.3 13.8 9.9 8.5 10.8 14.3 10.9 5.0 16.4 9.2 11.3 21.9 14.2 9.6 11.5 18.6 10.9 7.5 12.4 6.0 11.4 10.0 6.6 9.2 15.6 15.4 12.9 17.0 15.1 10.8 12.8 18.7 42.1 43.5 22.6 55.9 51.5 223.4 49.7 50.3 26.2 41.5 26.8 8.4 188.6 13.5 34.7 7.3 11.0 31.4 504.6 42.1 51.0 22.0 35.3 36.0 115.0 55.7 32.6 31.0 77.8 46.5 101.5 69.4 26.9 73.7 32.1 37.1 45.4 50.8 28.0 43.1 10.7 36.9 10.1 8.2 149.4 31.7 16.2 16.0 146.0 34.3 20.2 32.0 25.0 11.3 88.8 58.3 21.4 82.3 20.2 38.0 16.8 18.5 68.2 47.7 517.6 31.3 12.8 81.2 6.1 5.4 5.2 4.1 4.1 3.7 4.7 3.5 4.1 3.0 5.4 3.6 3.5 19.2 3.7 7.2 3.9 4.1 3.6 5.4 10.0 7.4 7.6 3.8 7.4 9.9 8.5 9.2 6.0 9.2 12.8 23.1 32.1 56.3 26.1 36.4 15.6 30.5 42.6 22.8 26.8 21.4 17.1 20.9 24.3 75.8 25.8 33.3 47.5 32.1 19.3 13.7 19.5 2.5 257.4 34.5 22.0 25.1 29.9 28.8 24.2 28.0 31.9 28.5 74.8 32.9 33.2 15.7 45.0 18.3 30.3 32.9 23.4 32.6 49.0 25.0 2.9 19.3 44.9 12.4 37.5 35.4 27.8 10.3 25.6 71.8 22.4 20.1 15.1 117.7 39.8 15.8 21.3 141.7 35.3 19.7 30.0 32.4 17.3 20.0 59.5 22.0 94.3 31.8 49.4 20.9 82.0 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13L" Q71F56 12 115957905-116277693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 303.9;Excitatory neurons: 311.5;Inhibitory neurons: 321.0;Microglial cells: 427.2;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 305.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "T-47d: 124.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 18.4 7.9 5.5 15.8 7.3 52.7 20.8 27.0 6.3 15.8 5.3 12.9 10.3 20.5 6.5 13.8 12.5 13.2 11.5 6.4 5.9 12.4 7.9 14.4 14.6 9.2 7.3 24.3 17.5 15.3 5.5 16.3 6.9 12.7 13.5 12.6 14.8 12.8 18.6 19.0 13.4 15.9 6.3 16.6 12.2 13.8 7.7 39.1 18.0 25.8 16.2 13.1 12.7 10.7 16.9 33.2 19.6 16.9 23.6 42.0 16.5 15.8 21.3 23.7 16.3 25.2 5.9 13.3 13.6 29.0 14.5 9.9 20.4 14.2 29.6 24.3 14.0 26.9 10.0 7.2 26.2 24.8 28.6 30.6 21.8 26.8 40.7 17.4 15.9 28.2 28.9 11.4 18.7 21.8 42.1 22.2 10.5 7.1 8.2 28.7 25.0 24.8 11.1 18.4 17.7 12.4 14.2 7.8 15.0 34.9 124.8 39.9 20.7 26.0 16.8 17.2 19.5 17.9 9.7 21.6 12.0 22.3 12.8 1.5 0.6 1.5 0.2 0.3 0.2 0.3 0.5 0.2 0.7 0.7 0.3 0.4 3.5 0.3 0.4 1.1 0.0 0.1 5.5 7.3 27.0 6.3 6.4 5.9 9.2 7.3 6.9 6.3 7.7 10.7 84.4 64.1 54.9 303.9 47.5 99.2 38.4 21.7 70.6 52.4 51.4 42.4 35.6 21.5 35.5 25.8 54.2 9.4 38.5 30.5 3.9 13.5 84.0 42.5 115.2 56.9 31.3 49.6 311.5 26.0 19.6 56.0 29.0 96.7 14.0 93.4 53.6 30.6 21.1 57.2 321.0 31.8 14.2 48.7 60.6 47.2 92.2 60.5 32.0 427.2 56.4 22.8 17.5 352.8 305.4 26.8 21.0 67.0 65.6 49.4 22.7 12.3 27.2 44.6 46.0 61.9 57.0 20.3 23.3 48.0 101.6 14.2 30.5 23.7 25.9 51.0 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145567-19192131 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 39.3" "Cell type enriched" "Detected in some" 4 "Plasma cells: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "Daudi: 223.4;U-266/70: 217.6;U-698: 299.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 3.0 1.8 4.4 13.9 5.4 2.3 2.6 4.4 6.1 4.0 4.4 3.1 1.8 2.3 0.7 2.2 3.5 1.4 2.2 4.5 4.7 2.7 3.8 2.6 39.3 5.2 4.9 3.9 1.5 0.4 2.6 1.0 4.8 4.5 1.1 0.9 2.6 1.3 1.0 2.8 4.9 1.3 4.3 8.8 2.6 3.2 5.2 1.8 3.4 0.7 31.5 2.3 3.3 6.1 2.3 0.5 1.5 2.1 1.3 2.5 2.2 1.3 0.9 1.8 2.2 0.0 3.2 223.4 1.0 0.9 0.5 2.0 0.3 0.8 0.3 1.0 5.1 1.4 0.6 1.1 2.8 1.2 2.0 1.0 1.8 1.1 1.6 1.0 0.1 4.2 0.9 3.9 0.8 3.9 1.6 1.8 0.2 0.2 12.8 4.6 0.9 5.2 0.5 0.3 0.3 1.8 2.5 0.3 1.7 0.0 0.0 2.5 0.7 1.1 4.0 6.9 1.8 217.6 24.0 299.5 2.6 3.9 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 4.4 5.4 4.4 6.1 4.5 4.7 5.2 4.9 4.8 4.3 5.2 6.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.3 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.4 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 METTL22 "C16orf68, FLJ12433,MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 119.9;Late spermatids: 357.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported "Nucleoplasm,Nucleoli rim" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli rim" Nucleoplasm "HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672" "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 4.4 5.8 9.0 5.7 10.2 7.7 4.5 16.4 13.2 6.7 9.5 5.9 4.9 5.9 6.1 5.3 5.4 4.4 9.3 8.8 9.1 5.1 6.6 4.7 6.1 12.7 10.7 6.4 6.1 3.1 5.1 5.0 13.3 7.2 4.0 10.4 4.7 5.2 20.2 8.4 4.1 4.7 9.1 4.7 5.1 13.7 12.6 4.0 5.2 5.9 5.0 5.5 5.8 12.9 4.3 8.7 9.7 9.3 3.6 9.1 8.4 7.2 3.8 8.4 9.5 8.5 9.8 6.7 6.3 6.4 3.1 7.9 6.1 11.5 5.5 9.8 8.4 6.9 17.3 24.6 10.8 7.2 5.1 9.2 8.2 9.2 10.1 5.1 6.8 9.2 9.4 6.6 6.5 15.2 7.4 17.0 5.2 1.9 8.5 11.1 7.3 13.9 4.1 4.5 11.9 7.9 6.3 7.3 4.7 5.2 8.0 5.9 5.4 10.0 8.7 8.2 3.3 8.9 5.3 10.4 3.6 9.3 4.7 1.6 2.5 2.0 0.9 1.9 0.9 0.9 0.9 1.0 2.3 0.8 1.1 0.5 9.7 1.6 2.2 1.3 1.2 1.0 9.0 10.2 16.4 13.2 8.8 9.1 12.7 10.7 13.3 9.1 12.6 12.9 5.1 9.6 5.6 8.5 7.6 3.3 6.9 7.5 8.6 13.8 5.8 6.1 18.3 4.3 6.0 0.0 4.2 12.8 2.7 4.9 11.7 9.3 119.9 3.5 6.5 7.2 7.2 18.5 13.4 9.8 9.8 7.4 9.2 3.5 8.2 11.3 5.7 7.4 29.5 1.7 14.3 7.0 2.0 31.8 9.6 357.8 10.8 27.5 1.8 12.2 17.6 4.9 11.3 12.5 13.3 8.4 6.8 13.9 7.7 11.0 8.3 8.9 3.4 11.8 0.0 9.0 8.5 39.6 15.7 7.5 2.7 13.3 6.6 7.8 6.5 8.1 MGRN1 "KIAA0544, RNF156" ENSG00000102858 "Mahogunin ring finger 1" O60291 16 4616493-4690974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 16.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007653, HPA008033" Approved Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "Endoplasmic reticulum" "HPA007653: AB_1846304, HPA008033: " "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (4.24e-1)" "unprognostic (1.26e-2)" "unprognostic (9.96e-2)" "unprognostic (1.70e-1)" "unprognostic (4.03e-2)" "unprognostic (9.47e-2)" "unprognostic (6.41e-2)" "unprognostic (2.32e-1)" "unprognostic (9.06e-2)" "unprognostic (1.79e-1)" "unprognostic (5.04e-2)" 23.3 34.3 18.6 25.0 20.6 32.6 22.8 11.9 25.4 28.3 4.9 30.6 28.9 36.9 6.8 20.4 32.1 19.7 26.9 26.4 11.4 24.0 53.5 30.3 18.1 14.1 10.4 30.5 34.6 18.5 33.2 18.5 8.8 30.1 10.9 9.0 25.6 20.5 52.1 23.0 29.9 17.5 8.1 37.7 35.3 18.0 12.0 11.7 28.8 16.7 10.9 28.2 20.6 24.3 13.6 63.9 32.4 33.2 19.0 18.4 44.0 28.7 20.0 23.6 20.0 42.5 31.4 40.0 36.2 35.0 17.6 21.4 26.0 23.6 7.0 56.0 28.8 22.0 45.2 59.6 34.7 32.1 52.3 34.2 15.0 33.0 14.1 17.0 23.0 26.0 32.7 28.6 16.4 59.7 33.3 42.9 48.0 19.2 27.4 60.7 17.0 54.3 20.8 39.3 51.8 42.8 47.6 50.6 28.2 14.8 30.7 31.4 40.8 43.7 24.1 124.3 25.0 44.6 37.8 27.2 18.6 31.8 32.0 5.4 3.5 3.8 2.5 3.9 2.3 1.3 1.4 2.3 2.4 1.5 3.2 1.9 16.2 1.4 2.6 4.1 1.7 3.7 18.6 20.6 11.9 25.4 26.4 11.4 14.1 10.4 8.8 8.1 12.0 24.3 14.7 25.6 34.0 24.2 22.2 9.2 29.5 10.0 6.2 27.3 15.8 11.0 11.4 22.8 9.6 18.4 43.8 23.5 28.2 27.7 5.9 18.6 16.2 20.1 24.2 16.9 37.0 13.7 26.6 22.7 17.7 19.0 44.9 24.5 14.0 30.4 15.0 34.8 30.4 25.2 25.0 23.5 4.1 30.1 21.4 27.2 26.8 27.0 21.4 8.4 36.5 20.8 23.7 18.6 29.8 32.0 15.8 24.8 29.0 23.7 31.7 13.9 11.1 35.2 0.0 20.4 17.6 9.3 12.5 11.9 16.3 34.2 24.0 29.8 23.1 27.8 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 455.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 11.8" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA042018: AB_2677800, HPA049432: AB_2680765" "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 71.4 61.9 25.6 25.2 25.0 82.6 42.7 24.9 32.3 48.0 16.1 53.9 22.3 34.2 6.3 99.2 64.6 31.4 72.9 21.1 32.1 46.9 50.5 67.0 19.1 44.8 30.1 61.4 37.4 8.2 81.9 15.5 29.8 39.2 12.0 12.4 46.6 11.5 141.6 79.1 52.6 12.4 29.8 50.3 56.1 19.6 32.4 19.0 35.0 17.4 15.1 42.2 55.7 23.1 14.7 31.8 53.5 25.0 11.2 19.0 39.2 25.0 14.9 12.6 8.9 41.8 16.1 23.3 26.6 18.9 6.8 29.6 16.3 26.5 4.9 32.9 30.0 32.8 21.8 33.3 22.7 33.3 46.9 29.4 24.4 15.1 14.3 19.5 20.8 27.3 42.7 24.0 13.5 58.9 44.6 13.6 117.6 28.6 21.1 68.8 15.2 10.7 23.8 17.2 42.7 55.9 52.9 50.1 33.7 27.7 20.2 37.7 26.2 22.9 25.4 106.2 27.3 22.4 13.2 32.2 43.9 14.6 79.5 1.6 1.0 1.1 1.0 1.0 0.7 0.2 0.3 0.7 0.4 0.3 0.2 0.5 11.8 1.3 1.1 0.4 0.1 0.7 25.6 25.0 24.9 32.3 21.1 32.1 44.8 30.1 29.8 29.8 32.4 23.1 330.7 38.5 60.5 17.3 101.1 98.9 128.3 114.4 175.8 53.9 290.6 224.2 84.3 117.2 86.2 134.3 31.3 15.8 184.8 455.8 19.6 125.5 34.7 220.6 84.5 186.1 164.5 19.4 8.0 155.5 47.3 84.0 132.0 294.7 61.5 60.6 197.4 80.9 77.9 21.9 5.6 219.5 59.0 100.0 134.9 33.3 49.7 150.9 42.7 24.4 49.7 77.8 96.8 32.2 10.3 259.0 306.8 33.1 69.9 190.9 242.1 35.8 109.6 35.7 39.5 219.8 142.4 3.3 12.0 227.3 148.0 81.3 122.9 33.2 167.8 190.7 MISP3 ENSG00000141854 "MISP family member 3" Q96FF7 19 14072536-14075062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 17.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 19.3;Breast myoepithelial cells: 20.8;Collecting duct cells: 14.7;Distal tubular cells: 35.2;Endometrial ciliated cells: 12.4;Exocrine glandular cells: 11.5;Proximal tubular cells: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.3;OE19: 11.3;RPMI-8226: 6.3;U-266/84: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042225 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 35: Glandular cells - Unknown function" "HPA042225: AB_10795396" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.01e-2)" "unprognostic (3.66e-2)" "unprognostic (1.76e-3)" "unprognostic (9.77e-2)" "unprognostic (1.31e-2)" "unprognostic (8.81e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.52e-4)" "prognostic favorable (3.11e-5)" "unprognostic (2.97e-1)" "unprognostic (1.01e-1)" "unprognostic (9.78e-2)" 1.4 2.1 7.2 0.3 7.3 0.5 2.0 7.6 10.3 2.0 6.3 7.6 3.9 1.0 0.4 3.0 3.0 0.3 6.3 7.6 8.1 17.7 5.6 2.9 0.0 7.4 7.4 0.5 12.1 2.8 2.6 0.5 7.6 3.6 1.4 1.1 7.8 1.0 2.5 7.9 5.2 0.1 7.7 1.3 11.1 0.9 7.5 0.2 3.0 1.0 0.1 1.7 2.8 7.8 1.7 0.9 0.3 0.7 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 1.1 0.1 0.0 0.6 0.8 0.0 0.0 2.1 1.5 0.2 0.3 0.8 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.7 0.2 1.0 0.2 5.3 0.0 3.0 0.3 0.7 0.0 11.3 0.7 0.5 0.1 6.3 1.1 0.0 1.5 0.4 0.0 0.5 0.6 0.0 0.9 0.0 0.1 0.0 0.4 0.5 0.0 3.6 4.3 0.4 0.8 1.3 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 7.2 7.3 7.6 10.3 7.6 8.1 7.4 7.4 7.6 7.7 7.5 7.8 3.2 9.6 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 19.3 20.8 0.0 0.0 1.8 14.7 0.0 0.2 3.7 0.0 35.2 2.5 0.0 12.4 0.8 0.7 0.0 0.0 0.0 11.5 0.1 1.0 0.0 5.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.3 0.0 0.0 22.8 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 1.5 0.3 0.0 0.0 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 9.8" "Cell type enhanced" "Detected in many" "Adipocytes: 25.4;Breast myoepithelial cells: 33.9;Early spermatids: 33.9;Late spermatids: 31.4;Spermatocytes: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.5" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 0.8 0.6 2.0 0.3 2.3 1.4 0.8 3.1 3.1 0.7 2.8 1.0 0.2 1.0 4.0 0.5 1.0 0.6 1.3 2.2 2.3 0.8 1.4 0.4 0.5 1.9 2.0 0.9 0.8 0.4 2.6 0.4 2.1 1.0 0.5 3.9 1.1 0.9 2.5 1.8 0.6 0.9 1.7 0.8 0.5 9.8 2.3 0.7 0.7 2.5 0.9 0.6 0.5 2.4 0.6 0.0 0.9 0.3 1.3 0.6 0.6 0.3 0.2 0.3 0.3 1.3 0.7 1.0 0.2 0.0 0.7 0.6 0.5 0.0 0.5 0.0 0.0 0.7 1.3 0.3 0.4 0.2 0.6 0.3 0.1 0.3 0.0 0.8 0.9 0.7 0.6 0.6 0.0 0.0 0.5 1.6 0.3 0.0 0.3 0.7 0.0 0.2 0.5 0.7 0.5 0.5 0.5 0.0 0.4 0.7 0.0 0.1 1.7 1.0 0.3 0.2 0.1 0.9 0.2 1.0 0.9 0.1 0.9 1.3 0.9 0.5 0.3 0.7 0.2 0.7 0.3 0.4 0.3 0.6 0.2 0.2 4.5 0.1 0.6 1.1 0.2 0.3 2.0 2.3 3.1 3.1 2.2 2.3 1.9 2.0 2.1 1.7 2.3 2.4 25.4 3.2 0.6 17.3 2.0 0.6 1.1 0.5 1.8 6.2 6.6 33.9 3.0 7.2 0.2 0.0 8.4 3.7 0.7 1.6 0.0 0.3 33.9 2.2 6.5 4.0 1.2 3.2 15.0 0.2 1.1 5.3 6.1 2.6 0.0 11.9 1.8 3.9 2.7 0.0 17.5 1.2 0.0 1.6 1.1 31.4 1.5 3.2 1.8 3.7 1.0 5.8 1.0 7.1 8.5 0.1 1.4 3.0 3.5 0.6 4.0 2.6 1.5 4.9 0.0 1.1 11.7 23.6 5.9 1.5 0.4 1.4 1.5 3.4 1.3 0.4 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "MSL complex subunit 1" Q68DK7 17 40121971-40136917 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 358.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 60.2 52.0 34.3 48.0 33.6 56.7 56.7 26.1 39.6 76.6 16.1 62.7 51.7 75.1 55.9 48.1 77.5 38.6 46.8 32.1 26.5 57.1 43.9 61.5 50.8 24.1 25.7 58.3 59.3 47.8 78.8 48.5 22.2 59.8 46.8 41.1 56.5 51.9 63.6 60.8 61.6 53.7 21.8 88.2 57.1 66.2 27.9 62.3 79.8 51.6 51.6 53.3 62.0 27.7 35.9 42.2 88.3 57.9 78.5 67.6 45.0 61.6 65.3 76.1 68.4 42.4 37.8 78.8 45.6 65.0 48.4 65.2 74.7 40.5 78.2 68.0 59.6 43.6 60.5 50.6 40.9 59.7 81.6 56.9 63.6 56.1 46.5 77.4 71.0 47.2 69.3 62.8 61.4 22.8 95.0 64.8 37.6 39.4 27.2 77.1 48.7 72.1 55.4 38.9 80.9 48.0 57.5 358.8 46.5 80.1 83.5 81.0 58.7 51.0 56.4 37.8 52.3 98.5 58.5 77.7 52.0 43.7 60.7 0.0 1.0 0.8 1.7 0.6 0.8 1.1 0.9 1.3 0.7 0.9 0.9 0.8 8.7 0.7 0.8 1.4 0.6 0.5 34.3 33.6 26.1 39.6 32.1 26.5 24.1 25.7 22.2 21.8 27.9 27.7 44.1 28.9 40.7 42.7 22.7 50.0 37.8 21.7 69.4 55.2 41.6 32.3 29.5 25.8 25.8 11.0 12.5 15.4 43.8 36.4 3.9 17.2 16.1 35.8 53.9 43.3 31.2 22.3 39.8 20.7 15.4 37.4 20.4 48.1 3.8 24.8 36.4 35.9 25.2 52.2 33.4 29.1 8.2 36.4 42.8 28.5 58.4 34.2 32.0 33.7 30.6 31.3 30.9 25.1 32.4 24.7 32.1 39.9 26.8 72.7 35.4 9.0 32.7 28.4 39.5 29.2 40.7 71.8 49.2 57.5 65.8 17.0 29.9 27.5 31.4 58.7 MTRNR2L1 ENSG00000256618 "MT-RNR2 like 1" P0CJ68 17 22523415-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20164.8;choroid plexus: 8845.1" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 16283.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 4804.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 4804.8" "Cell line enhanced" "Detected in all" "HeLa: 3045.1;Hep G2: 1708.1" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favorable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 713.0 996.4 8845.7 173.6 8845.9 274.4 262.3 8845.0 20164.8 111.8 8845.1 625.8 358.0 130.9 204.8 373.7 139.4 196.7 2311.0 9146.7 8845.4 1188.8 941.5 142.9 125.6 9179.3 8845.3 138.8 404.2 616.0 0.0 184.5 9002.4 233.2 536.5 633.2 441.1 281.0 3639.3 418.2 401.8 204.0 8865.7 216.5 445.2 369.7 8847.1 119.8 100.4 3327.7 193.1 177.0 0.0 8862.4 268.9 621.7 231.5 771.3 365.2 150.1 292.9 243.5 59.4 57.5 66.0 386.2 417.6 362.9 260.2 130.7 40.4 685.1 18.1 90.8 71.0 214.7 441.0 331.6 3045.1 1708.1 118.5 77.8 376.1 338.0 191.1 63.1 152.7 407.1 62.9 232.2 276.6 211.5 172.8 222.1 121.7 528.1 65.0 208.0 138.3 196.3 145.4 186.7 321.5 380.3 121.8 215.0 119.2 217.6 376.5 222.6 205.9 551.4 118.8 302.6 251.1 364.1 156.7 196.5 68.6 174.1 169.9 483.3 67.0 2097.9 721.0 1313.4 204.5 325.1 248.2 597.3 255.0 225.8 245.8 585.3 331.9 301.3 4804.8 301.1 339.6 428.7 248.4 677.0 8845.7 8845.9 8845.0 20164.8 9146.7 8845.4 9179.3 8845.3 9002.4 8865.7 8847.1 8862.4 16.2 131.4 117.3 0.0 16.2 84.4 1432.1 2.8 0.0 0.0 54.3 88.4 16283.9 5.7 145.5 77.3 0.0 0.8 3.0 4.0 111.6 0.6 6.6 23.4 4.5 460.8 1.8 0.0 0.0 0.7 0.7 591.3 0.0 56.4 166.5 128.9 4.2 11.9 0.8 0.0 0.0 6.5 0.0 7.2 56.2 17.8 15.5 71.6 62.2 0.0 1.3 0.0 0.0 0.0 0.1 0.3 2.7 4.1 0.5 261.1 1.0 1169.4 101.8 0.0 0.0 346.1 450.7 10.2 18.2 0.0 171.3 1.0 79.5 34.6 2.2 749.7 MTRNR2L10 ENSG00000256045 "MT-RNR2 like 10" P0CJ77 X 55181392-55182442 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "brain: 1196.7" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 9177.9" "Cancer enhanced" "Detected in single" "stomach cancer: 0.6" "Region enriched" "Detected in all" 37 "cerebral cortex: 1196.7" "Group enriched" "Detected in all" 5 "basophil: 171.3;eosinophil: 137.1;neutrophil: 395.3" "Lineage enriched" "Detected in all" 8 "granulocytes: 395.3" "Cell line enhanced" "Detected in many" "A549: 178.6;HeLa: 834.8;Hep G2: 578.6" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (4.42e-1)" "unprognostic (3.04e-2)" "unprognostic (1.15e-1)" "unprognostic (5.10e-4)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-2)" "unprognostic (8.42e-2)" "unprognostic (1.58e-2)" "unprognostic (9.01e-2)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (6.28e-2)" "unprognostic (2.97e-2)" "unprognostic (4.99e-2)" "unprognostic (3.97e-4)" 38.3 32.2 18.5 5.8 18.6 8.3 3.7 18.5 1196.7 0.7 18.5 38.9 11.3 12.0 38.4 23.1 17.0 10.6 161.2 32.3 18.5 121.9 79.5 3.4 2.6 28.7 18.6 14.9 23.8 5.1 0.0 6.6 22.3 8.3 66.1 2.4 27.7 3.5 127.9 12.7 10.5 24.6 20.3 8.4 10.7 22.5 18.6 1.0 5.7 15.0 21.2 4.4 0.0 18.9 10.5 178.6 2.4 49.1 4.5 2.2 12.8 16.1 0.8 0.9 0.5 12.1 25.7 24.2 3.4 1.1 2.1 36.6 0.1 1.2 0.5 7.0 36.4 12.3 834.8 578.6 1.1 4.1 6.5 6.2 2.7 0.3 2.0 42.0 0.7 18.4 21.8 13.7 1.9 67.9 3.8 28.8 1.1 0.9 14.0 9.2 9.9 11.3 4.0 111.5 2.5 10.2 4.7 4.3 18.1 23.2 14.4 21.1 25.7 18.0 3.8 6.2 1.6 4.4 3.1 2.0 11.2 5.3 4.0 171.3 50.3 137.1 9.5 25.1 11.4 38.2 14.8 12.7 21.7 36.5 19.1 22.3 395.3 22.8 24.5 26.2 16.2 63.8 18.5 18.6 18.5 1196.7 32.3 18.5 28.7 18.6 22.3 20.3 18.6 18.9 3.8 0.0 0.0 0.0 4.9 8.2 411.9 1.0 0.0 0.0 15.8 6.6 9177.9 2.8 0.6 42.3 0.0 0.3 1.3 0.0 84.1 0.0 0.3 11.5 6.5 296.2 0.0 0.0 0.0 0.0 0.3 289.5 0.0 16.0 0.0 4.0 1.8 6.2 0.6 0.0 0.0 0.0 2.0 5.5 23.2 1.1 0.6 75.9 16.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 222.0 0.0 611.6 0.6 0.0 0.0 995.2 385.1 0.6 0.9 0.0 9.1 0.3 70.1 4.3 0.0 449.2 MTRNR2L11 ENSG00000270188 "MT-RNR2 like 11" S4R3Y5 1 237943724-237945275 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 13 "brain: 4100.7" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 1131.8;Proximal tubular cells: 286.7" "Not detected" "Not detected" "Region enriched" "Detected in all" 11 "cerebral cortex: 4100.7" "Group enriched" "Detected in all" 4 "basophil: 95.3;eosinophil: 74.4;neutrophil: 274.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 274.5" "Cell line enhanced" "Detected in many" "HeLa: 302.4;Hep G2: 155.2" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (1.07e-1)" "unprognostic (9.70e-2)" "unprognostic (4.49e-2)" "unprognostic (5.26e-2)" 76.7 74.6 270.2 11.8 270.2 16.9 12.1 270.2 4100.7 4.2 270.3 48.8 23.6 12.8 7.2 6.7 5.4 3.8 88.5 355.4 270.2 73.9 52.3 7.6 5.5 358.1 270.2 8.6 26.1 25.0 0.0 9.0 302.0 16.1 23.8 40.6 30.9 11.3 324.5 12.5 27.3 9.3 280.2 16.7 33.1 19.9 270.4 4.7 2.4 121.4 8.1 5.8 0.0 271.2 26.2 59.8 27.3 77.1 23.1 5.8 21.8 42.4 3.5 2.4 3.4 25.5 36.7 44.3 26.5 8.4 4.4 77.4 0.9 5.6 2.3 19.5 41.2 44.6 302.4 155.2 7.6 12.6 34.4 23.3 8.1 2.8 10.3 53.2 3.5 28.5 31.8 25.7 7.2 22.3 12.6 42.3 7.4 32.1 10.8 23.6 22.2 18.1 16.4 35.4 10.4 18.2 16.6 19.3 33.0 26.7 23.5 39.1 68.7 30.7 21.6 25.0 12.4 19.4 6.9 17.4 17.0 42.6 7.6 95.3 33.0 74.4 6.0 13.8 6.9 23.9 9.0 8.1 11.9 23.4 12.4 13.3 274.5 12.8 14.4 15.0 8.9 42.9 270.2 270.2 270.2 4100.7 355.4 270.2 358.1 270.2 302.0 280.2 270.4 271.2 0.2 0.0 0.0 0.0 1.2 4.0 26.3 0.3 0.0 0.0 0.8 0.1 1131.8 0.0 0.0 12.9 0.0 0.1 0.1 0.0 46.9 0.0 0.1 0.2 0.1 22.9 0.0 0.0 0.0 0.0 0.1 33.1 0.0 0.2 0.0 0.0 1.1 1.6 0.1 0.0 0.0 0.0 0.0 0.8 9.0 0.1 0.0 3.0 8.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 286.7 0.0 0.0 0.0 6.5 25.6 0.3 0.3 0.0 4.0 0.0 1.8 0.1 0.0 17.7 MTRNR2L12 ENSG00000269028 "MT-RNR2 like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 125442.5;choroid plexus: 60537.0" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 34487.4" "Cancer enhanced" "Detected in all" "stomach cancer: 14.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 23357.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 23357.3" "Cell line enhanced" "Detected in all" "HeLa: 19226.4" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 7057.6 9488.3 60539.4 1610.0 60538.6 2401.2 2897.2 60547.3 125442.5 1316.1 60537.0 7130.2 3200.8 1495.8 1887.7 3942.3 1591.4 2141.9 24682.6 62534.7 60541.4 11477.3 10961.9 1405.1 1111.1 63276.7 60541.2 1471.0 3698.8 5500.5 0.9 1862.5 61842.9 2592.6 5672.7 5513.6 4076.4 3320.1 36694.8 4024.2 3630.6 2282.8 60728.7 1990.0 5139.8 3848.1 60548.8 1093.2 1305.3 22600.1 1986.4 1741.0 0.7 60592.0 3129.7 3743.3 2766.3 9914.1 4165.4 2220.4 2507.6 3970.8 808.2 749.3 954.5 2070.2 4888.5 6887.0 3132.2 1502.3 436.5 8365.9 196.7 1668.9 1010.6 2008.1 3570.2 7299.3 19226.4 8838.4 1579.3 1469.9 3824.2 4061.3 1945.5 784.9 2127.7 4578.8 844.6 3040.7 5258.3 2276.0 2553.9 1634.8 1252.5 4510.6 808.3 1892.5 1113.4 1992.1 2667.8 2102.8 4420.6 2269.6 1246.8 2408.9 2618.4 2595.6 3524.2 2439.6 2667.3 4152.9 3817.7 3062.1 2505.1 3462.1 1143.3 1197.9 802.7 3365.5 1896.5 8908.3 850.3 10533.0 3473.8 6467.2 1043.1 1696.3 1353.8 2636.4 1309.8 1129.5 1256.2 2611.9 1648.9 1580.6 23357.3 1490.6 1781.5 2078.4 1275.7 2740.2 60539.4 60538.6 60547.3 125442.5 62534.7 60541.4 63276.7 60541.2 61842.9 60728.7 60548.8 60592.0 1081.2 2705.1 2934.5 0.0 291.8 112.5 420.7 10.3 3.4 0.0 702.7 1431.3 34487.4 147.3 1441.4 84.6 0.0 8.4 394.0 24.5 62.6 1.1 19.7 1096.7 707.4 1236.7 4.9 182.7 0.0 1.8 8.6 1698.5 29.6 1465.4 1715.6 334.8 100.3 171.7 12.3 0.0 0.0 7.1 4.1 126.9 333.5 49.0 42.9 633.1 193.9 0.0 29.8 0.0 28.8 0.0 0.0 1.4 8.4 23.0 213.1 337.3 6.6 521.0 1431.8 0.0 46.0 2907.6 1520.5 36.3 39.6 3.3 80.7 10.5 625.8 220.9 5.2 397.1 MTRNR2L13 ENSG00000270394 "MT-RNR2 like 13" S4R3P1 4 116298876-116300320 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;choroid plexus: 1.7;skeletal muscle: 1.5" "Cell type enriched" "Detected in some" 20 "Cardiomyocytes: 176.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Group enriched" "Detected in some" 6 "HeLa: 4.3;Hep G2: 1.8" "Secreted - unknown location" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" 0.2 0.6 1.8 0.0 1.8 0.1 0.0 1.8 3.0 0.0 1.7 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.9 1.9 1.8 0.6 0.3 0.1 0.0 1.8 1.8 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 1.5 0.1 0.2 0.0 1.8 0.0 0.1 0.1 1.8 0.0 0.0 1.0 0.0 0.0 0.0 1.8 0.1 0.4 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.3 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 1.8 1.8 1.8 3.0 1.9 1.8 1.8 1.8 1.8 1.8 1.8 1.8 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.0 176.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.8 0.0 0.0 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.7 MTRNR2L4 ENSG00000232196 "MT-RNR2 like 4" P0CJ71 16 3370979-3372668 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 293.5" "Cell type enriched" "Detected in some" 14 "Cardiomyocytes: 154.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 168.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 168.2" "Cell line enhanced" "Detected in many" "AN3-CA: 48.8;HaCaT: 51.3;HeLa: 88.0" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (8.53e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-1)" "unprognostic (1.05e-1)" "unprognostic (3.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (6.81e-3)" "unprognostic (1.65e-1)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (9.27e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" 18.0 52.7 25.5 10.8 25.5 9.4 2.4 27.1 54.2 1.1 25.6 14.7 20.7 4.7 2.2 10.8 2.3 3.4 66.0 28.2 25.6 31.8 17.1 5.7 3.8 27.7 25.5 4.8 13.8 1.7 0.3 6.4 26.8 7.3 9.1 7.3 17.0 2.8 293.5 9.7 21.7 3.4 25.7 9.1 19.1 12.2 25.7 0.2 1.8 3.2 3.3 1.4 0.1 26.9 13.8 8.8 2.6 48.8 1.1 1.6 15.0 7.3 0.4 0.9 0.7 4.2 28.7 10.2 14.5 0.4 0.3 51.3 0.1 0.5 0.4 7.8 5.0 9.0 88.0 36.6 0.2 3.0 23.5 1.0 0.7 0.2 0.5 1.1 0.1 1.1 6.9 13.6 1.5 3.0 6.4 23.8 4.0 0.5 1.7 11.6 6.9 9.2 2.1 10.2 5.7 13.0 4.6 11.6 19.1 0.8 16.1 22.7 6.6 15.4 13.5 18.0 5.3 7.1 2.5 9.7 10.6 22.8 3.7 62.3 25.6 72.1 4.9 12.9 5.5 14.3 6.2 6.4 11.1 16.5 6.9 8.7 168.2 8.6 13.4 13.4 7.7 23.3 25.5 25.5 27.1 54.2 28.2 25.6 27.7 25.5 26.8 25.7 25.7 26.9 0.2 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 0.2 0.1 154.2 2.8 0.0 1.8 0.0 0.1 0.1 0.0 3.9 0.0 0.0 0.1 0.2 3.1 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.8 0.0 10.4 0.0 0.0 0.0 2.5 3.3 1.0 0.3 0.0 0.3 0.1 0.4 0.1 0.0 1.4 MTRNR2L6 ENSG00000270672 "MT-RNR2 like 6" P0CJ73 7 142666272-142667718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 1192.8;choroid plexus: 472.8;skeletal muscle: 369.4" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 1037.7;Proximal tubular cells: 454.5" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 169.7;eosinophil: 127.3;neutrophil: 431.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 431.2" "Cell line enhanced" "Detected in many" "HeLa: 194.4;Hep G2: 136.7" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (5.34e-2)" "unprognostic (1.34e-3)" "unprognostic (3.80e-1)" "unprognostic (4.45e-3)" "unprognostic (1.33e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-2)" "unprognostic (3.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-2)" "unprognostic (6.02e-2)" "unprognostic (1.04e-1)" "unprognostic (3.69e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-3)" 43.9 72.8 472.9 13.7 473.0 11.8 8.8 473.0 1192.8 2.9 472.8 41.4 18.7 11.2 7.1 22.3 7.1 9.5 163.2 527.9 472.9 70.3 52.9 6.5 5.5 508.2 472.9 7.0 27.6 20.7 0.0 11.2 498.0 13.8 27.2 35.9 27.9 8.7 369.4 21.9 30.8 8.7 477.5 14.8 27.2 23.9 473.0 5.5 3.6 76.0 11.6 6.2 0.0 474.1 17.9 29.5 9.8 67.9 11.2 5.7 16.5 18.3 1.7 1.8 3.1 9.7 31.5 15.2 23.0 3.5 1.4 60.6 0.3 3.6 1.6 9.7 11.2 21.3 194.4 136.7 3.7 4.4 21.7 9.8 4.3 1.5 4.8 37.9 1.7 18.1 18.6 22.2 5.4 9.9 8.8 48.3 3.8 9.6 3.5 14.0 8.4 11.6 11.6 25.5 6.5 24.1 4.9 11.4 39.0 14.1 15.9 29.8 21.3 19.3 19.3 23.2 6.4 8.8 4.2 10.4 11.5 26.9 4.8 169.7 49.8 127.3 12.4 26.8 12.2 45.0 15.0 15.0 23.0 36.7 16.4 21.2 431.2 24.8 25.3 22.9 17.2 62.4 472.9 473.0 473.0 1192.8 527.9 472.9 508.2 472.9 498.0 477.5 473.0 474.1 0.8 38.5 47.7 0.0 1.9 6.4 8.5 1.5 0.0 0.0 1.8 1.9 1037.7 0.0 70.7 33.1 0.0 0.5 0.3 0.1 45.0 0.0 0.3 1.8 0.9 32.4 0.0 2.7 0.0 0.0 0.6 67.0 0.0 2.2 55.5 1.1 1.1 2.7 0.7 0.0 0.0 0.1 2.0 1.6 15.9 2.0 2.5 14.8 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 0.0 454.5 41.3 0.0 0.0 6.6 54.7 1.0 2.3 0.0 4.4 0.3 8.8 4.3 0.0 5.1 MTRNR2L8 ENSG00000255823 "MT-RNR2 like 8" P0CJ75 11 10507894-10509186 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20406.5;choroid plexus: 8122.9;skeletal muscle: 7550.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 32407.2" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 9219.1" "Cell line enhanced" "Detected in all" "HeLa: 3532.5;Hep G2: 1873.3" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 1000.1 1776.9 8126.4 330.8 8126.2 480.5 249.4 8126.3 20406.5 105.8 8122.9 906.3 612.7 222.9 263.8 642.6 200.9 300.7 3864.2 8509.5 8134.6 1780.1 1280.5 190.2 198.6 8655.4 8131.2 239.2 613.2 509.7 1.3 236.5 8396.6 342.3 741.4 864.6 742.7 271.9 7550.7 621.6 723.9 285.9 8194.3 375.6 681.5 599.0 8130.7 96.8 149.4 1897.1 267.0 201.6 0.6 8143.9 527.3 715.6 334.3 1521.1 294.0 151.4 438.7 562.6 61.4 61.1 75.9 427.1 742.2 698.2 544.0 91.4 54.0 1407.6 10.0 103.2 66.3 307.0 613.3 685.6 3532.5 1873.3 109.4 143.3 625.4 277.5 137.1 58.0 141.0 578.3 54.0 412.8 543.6 353.2 180.7 260.8 202.2 910.4 124.0 222.2 194.5 333.0 287.7 352.4 328.7 447.0 186.5 418.8 248.4 399.0 703.2 282.9 418.6 836.4 416.2 433.8 414.5 508.2 189.6 213.6 116.4 414.1 313.4 1053.0 125.3 3689.6 1275.5 2784.3 319.4 577.0 409.2 944.6 407.8 353.4 445.8 957.8 509.9 480.1 9219.1 466.8 613.2 688.5 439.4 1155.3 8126.4 8126.2 8126.3 20406.5 8509.5 8134.6 8655.4 8131.2 8396.6 8194.3 8130.7 8143.9 649.6 830.1 866.0 0.0 131.5 471.7 1069.8 27.1 1.2 0.0 599.2 1010.1 32407.2 124.4 492.7 57.0 0.0 6.9 118.0 2.1 72.4 0.0 23.1 785.5 473.5 1034.0 0.0 139.8 0.0 0.0 6.9 1450.7 3.1 916.4 543.7 140.3 119.2 384.5 12.8 0.0 0.0 0.5 4.1 129.6 1091.1 52.7 65.6 420.6 723.9 0.0 14.5 0.0 8.2 0.0 0.3 0.1 0.3 44.8 92.0 618.5 0.3 770.4 481.4 0.0 65.7 2750.1 1533.4 30.9 38.2 0.8 488.9 11.2 370.6 42.0 0.5 1232.9 MUSTN1 Mustang ENSG00000272573 "Musculoskeletal, embryonic nuclear protein 1" Q8IVN3 3 52833114-52835019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1689.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.79e-2)" "unprognostic (3.73e-2)" "unprognostic (4.11e-1)" "unprognostic (2.60e-2)" "unprognostic (2.34e-2)" "unprognostic (6.21e-3)" "unprognostic (2.78e-1)" "unprognostic (1.13e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-3)" "unprognostic (6.00e-2)" "unprognostic (1.79e-1)" "unprognostic (8.11e-2)" "unprognostic (1.88e-2)" 86.1 10.1 107.0 9.3 118.7 6.5 46.4 106.9 177.9 89.1 105.7 27.2 8.4 44.6 49.0 44.9 52.1 42.5 142.5 104.2 105.8 17.5 12.5 31.0 5.4 107.2 107.4 37.6 6.6 1.6 12.1 4.5 110.3 43.8 21.2 0.8 26.3 59.3 1689.2 28.7 26.7 30.6 99.9 10.9 22.1 4.3 118.5 5.7 31.1 305.6 3.9 54.5 65.7 105.1 0.0 0.0 4.7 0.0 0.5 2.1 1.9 0.0 0.5 0.2 0.5 0.0 0.5 0.0 0.0 1.4 0.2 0.4 0.6 1.3 0.4 0.1 0.5 0.0 1.4 8.0 0.3 1.0 0.4 4.8 1.0 0.6 0.7 0.9 1.2 0.9 0.0 0.0 0.3 0.1 0.4 1.6 0.1 0.6 1.0 0.3 4.4 0.0 0.9 0.0 0.2 0.3 0.3 0.4 0.4 2.0 0.1 2.6 0.0 0.6 0.2 1.0 0.2 0.0 0.0 0.3 0.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 107.0 118.7 106.9 177.9 104.2 105.8 107.2 107.4 110.3 99.9 118.5 105.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 N4BP1 ENSG00000102921 "NEDD4 binding protein 1" O75113 16 48538726-48620148 "Predicted intracellular proteins" "Immunity, Innate immunity" "Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 134.6;Glandular and luminal cells: 113.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040849, HPA041080" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040849: AB_10794866, HPA041080: AB_10794186" "unprognostic (1.07e-1)" "unprognostic (2.17e-1)" "unprognostic (5.07e-2)" "unprognostic (2.50e-3)" "unprognostic (1.16e-1)" "unprognostic (3.19e-1)" "unprognostic (4.35e-3)" "unprognostic (9.18e-2)" "unprognostic (4.36e-1)" "unprognostic (1.10e-1)" "unprognostic (3.71e-1)" "unprognostic (1.35e-1)" "prognostic favorable (9.03e-8)" "unprognostic (9.00e-2)" "unprognostic (1.49e-1)" "unprognostic (1.96e-1)" "unprognostic (8.36e-2)" 9.3 6.7 8.0 7.3 7.8 10.3 9.0 9.7 8.0 10.2 7.9 8.8 5.9 8.6 8.3 18.9 8.4 6.3 7.9 7.6 11.0 7.4 7.0 14.7 7.5 8.5 7.8 9.7 7.6 11.4 9.1 7.5 8.2 8.8 6.3 6.9 10.7 6.4 10.5 19.9 9.3 6.3 7.1 10.9 9.2 4.7 10.7 10.3 8.3 7.9 9.0 8.1 11.3 8.4 7.1 11.8 8.3 8.5 11.4 9.0 6.9 6.5 9.9 12.4 6.3 9.3 5.8 7.9 5.9 10.0 5.5 14.4 7.5 10.3 6.8 4.9 6.2 4.1 4.7 8.3 11.1 6.2 10.8 13.0 15.5 4.4 6.4 9.1 6.3 8.1 6.4 8.2 7.5 4.0 7.4 11.2 6.6 7.3 6.7 11.1 13.5 12.4 6.2 11.9 9.3 6.6 5.5 10.0 9.2 8.6 4.2 8.5 9.3 6.3 5.6 3.5 3.9 12.2 7.8 12.0 7.3 4.9 5.6 0.9 1.3 1.8 1.0 1.2 1.3 0.9 1.3 1.6 0.8 0.6 1.1 1.1 8.4 0.4 0.9 1.0 1.0 0.6 8.0 7.8 9.7 8.0 7.6 11.0 8.5 7.8 8.2 7.1 10.7 8.4 41.2 134.6 32.7 28.4 15.3 20.0 21.6 32.4 19.4 24.1 21.3 21.2 15.1 22.8 25.8 7.3 16.7 13.4 53.8 35.4 5.9 8.4 6.4 36.8 35.8 25.7 9.6 6.5 47.5 13.2 10.5 20.1 30.5 113.8 12.6 23.1 24.3 13.4 19.5 26.9 50.1 21.2 6.1 25.9 40.3 3.7 16.1 36.5 5.4 58.1 31.9 15.3 21.6 38.7 54.8 26.7 21.6 20.7 30.2 30.6 16.1 9.4 18.4 23.0 0.0 26.3 17.6 12.6 24.4 26.8 22.7 28.5 36.5 23.8 13.4 47.5 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13116862-13141147 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.6 19.5 31.0 14.6 19.2 8.8 10.3 7.1 26.6 9.7 0.0 17.3 13.3 18.4 7.9 27.6 11.9 6.4 20.9 25.7 7.4 14.8 20.5 16.7 12.1 13.4 15.9 7.7 12.2 10.7 14.8 12.4 15.1 14.6 6.6 3.7 15.8 11.2 24.2 17.4 16.0 7.7 8.9 15.9 16.0 17.0 20.6 11.3 14.0 7.9 8.8 15.0 12.6 16.4 98.8 110.0 28.0 59.6 15.0 17.7 74.9 47.4 34.2 42.4 32.4 114.8 40.4 50.9 104.1 39.8 37.3 49.0 34.8 80.7 16.2 89.1 52.5 32.4 87.9 84.7 35.5 52.0 82.3 28.8 28.0 46.1 24.7 36.5 50.2 46.4 72.5 19.8 22.9 206.1 82.9 39.6 123.6 28.9 101.7 47.8 32.9 49.5 28.2 101.1 58.2 37.7 49.6 64.9 39.1 29.8 59.3 46.4 76.7 94.6 58.8 67.2 87.0 53.4 88.1 42.4 99.7 52.8 58.9 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 31.0 19.2 7.1 26.6 25.7 7.4 13.4 15.9 15.1 8.9 20.6 16.4 4.9 0.0 1.7 6.2 5.6 12.1 7.5 11.8 2.8 16.6 11.5 7.5 2.1 12.8 8.5 16.5 2.1 19.0 12.9 22.7 7.9 12.3 2.3 10.9 8.9 8.1 4.9 12.2 7.2 8.8 20.0 5.2 10.7 17.6 10.2 13.3 8.6 18.0 21.1 26.9 5.9 16.2 14.2 9.6 9.6 2.0 4.4 8.8 5.4 3.7 10.5 12.0 10.3 5.5 5.4 21.7 11.1 9.4 5.6 16.5 14.0 15.0 5.9 7.7 6.6 7.5 7.0 11.1 15.6 8.4 13.9 27.1 7.9 15.2 15.4 17.2 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485188-55487568 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 62.6;Horizontal cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 168.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" Mitochondria "HPA047187: AB_2679974" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 5.3 13.1 32.9 4.5 32.2 3.9 7.5 32.2 37.8 23.5 30.2 20.5 2.4 23.8 7.8 5.2 25.2 4.0 11.6 33.8 32.5 25.5 6.5 10.5 3.8 29.8 32.9 20.6 8.4 10.7 47.1 6.9 28.7 14.9 2.1 8.4 5.3 7.8 3.0 5.7 8.5 8.8 27.8 7.1 10.1 11.6 36.2 53.6 20.0 1.2 2.9 11.8 10.8 29.0 8.2 27.6 32.1 59.8 12.9 16.3 19.4 29.6 35.5 32.5 46.3 9.7 26.6 3.1 10.3 19.5 16.4 10.6 20.8 18.8 20.0 32.9 168.2 26.1 41.0 21.9 23.3 19.4 25.8 22.7 6.5 22.7 6.2 65.5 24.3 46.9 32.3 9.1 19.7 10.0 33.1 29.7 44.2 16.4 13.1 32.7 19.9 12.6 78.2 15.3 93.4 64.5 11.9 17.8 28.9 12.2 14.5 20.0 28.5 11.8 31.5 1.7 24.5 18.0 7.4 13.7 26.7 3.3 30.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.4 0.1 0.0 0.4 0.0 0.1 32.9 32.2 32.2 37.8 33.8 32.5 29.8 32.9 28.7 27.8 36.2 29.0 4.0 6.4 3.2 9.1 3.8 2.9 6.7 4.4 4.6 62.6 11.7 13.8 4.1 5.7 2.6 29.5 35.5 13.3 3.8 1.2 15.6 14.5 1.5 41.7 31.7 7.2 12.7 10.3 12.9 1.1 8.3 10.4 3.1 9.7 0.0 11.5 3.9 3.6 2.9 148.0 13.1 2.1 4.1 0.8 2.4 3.1 11.8 1.7 5.4 2.8 2.3 39.6 1.0 7.1 2.8 4.3 0.4 10.5 2.7 4.4 0.7 3.7 18.1 39.9 0.0 13.8 12.1 4.2 3.9 0.7 0.6 6.0 2.6 9.7 1.1 1.9 NBEAL2 KIAA0540 ENSG00000160796 "Neurobeachin like 2" Q6ZNJ1 3 46979666-47009704 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.2" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HEL: 69.1;SK-BR-3: 64.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051969 Approved NA NA 31000 "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA051969: " "unprognostic (3.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-1)" "unprognostic (3.37e-2)" "unprognostic (5.99e-3)" "prognostic favorable (4.60e-4)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (6.27e-2)" "unprognostic (5.29e-2)" "unprognostic (1.06e-3)" "unprognostic (3.75e-1)" "unprognostic (6.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.34e-2)" 16.7 16.0 4.0 23.3 3.6 92.1 19.3 3.3 5.7 34.3 4.4 21.5 12.8 10.5 4.6 103.2 14.7 11.0 15.2 3.3 3.4 36.9 11.2 54.0 20.9 4.2 3.8 7.9 40.7 6.7 11.3 4.8 4.5 21.5 8.4 0.8 35.6 8.4 6.5 86.0 31.0 5.6 3.8 70.0 42.5 6.3 4.6 11.2 14.7 2.9 15.8 16.6 56.8 3.7 20.2 22.1 4.0 11.3 2.3 0.8 12.9 2.8 1.7 3.8 2.5 19.4 14.2 17.4 7.7 2.4 3.7 13.0 8.3 9.0 1.9 15.4 12.4 69.1 27.8 12.2 2.2 11.9 48.5 1.9 14.8 3.9 6.0 4.6 34.2 36.2 14.6 26.3 1.9 31.2 20.5 32.7 10.6 31.9 10.0 21.6 0.5 23.0 9.1 41.1 6.1 9.9 2.4 64.4 5.7 4.9 31.5 19.9 25.3 0.3 11.7 5.1 8.9 20.1 20.7 16.3 5.1 55.0 2.9 0.2 0.6 0.4 0.5 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.1 0.1 4.4 0.4 0.4 0.1 0.2 0.3 4.0 3.6 3.3 5.7 3.3 3.4 4.2 3.8 4.5 3.8 4.6 3.7 15.0 12.8 9.4 7.8 10.0 3.3 5.5 2.4 5.7 1.3 16.3 18.2 4.3 8.6 9.3 33.1 18.8 2.2 30.8 15.1 1.9 22.9 1.4 20.0 4.1 9.8 7.2 10.3 4.0 23.1 1.1 3.0 144.3 23.9 6.3 5.1 11.7 1.2 11.1 0.0 1.5 11.5 4.1 12.9 8.3 1.0 1.2 27.9 0.0 6.5 14.6 1.5 26.8 1.0 1.4 31.4 5.6 0.0 14.2 6.2 3.4 1.3 6.6 1.9 13.1 3.4 3.5 0.5 2.4 33.6 8.0 1.9 26.3 4.5 15.1 21.0 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064711-146229000 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 46.1;Basal keratinocytes: 57.0;Langerhans cells: 100.9;Suprabasal keratinocytes: 105.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 3.7 1.1 3.4 2.8 2.8 7.6 4.3 2.2 6.4 4.9 7.4 2.8 1.1 3.5 3.8 2.8 3.0 2.2 1.3 3.6 2.2 1.9 3.2 3.3 2.5 3.8 3.1 5.4 3.3 3.2 0.3 2.5 2.9 2.7 2.8 4.6 2.0 3.0 1.0 7.4 1.2 3.4 1.7 4.4 1.8 3.3 4.5 2.7 2.3 2.2 2.4 2.2 1.4 4.1 6.4 1.7 3.6 2.4 11.3 13.6 3.0 3.3 4.5 3.3 3.3 1.5 3.0 2.7 0.7 6.4 3.2 3.0 4.0 4.5 6.7 3.4 3.0 6.3 5.0 0.8 4.5 2.7 1.9 12.4 4.1 9.2 8.8 10.6 3.9 1.7 2.0 8.7 7.1 7.3 1.1 2.4 1.5 1.6 4.7 1.4 2.6 3.6 2.3 4.5 0.4 0.4 5.1 4.9 1.8 5.8 4.2 3.6 12.3 3.2 2.9 2.9 4.4 5.8 2.3 3.4 2.9 2.9 2.7 2.2 2.0 2.7 0.3 1.0 0.4 1.5 0.3 0.3 0.8 1.5 0.3 0.2 5.6 0.3 2.3 2.2 0.3 0.1 3.4 2.8 2.2 6.4 3.6 2.2 3.8 3.1 2.9 1.7 4.5 4.1 0.5 76.9 46.1 13.7 12.8 57.0 4.9 15.4 5.2 0.5 3.7 2.0 8.4 2.8 22.0 0.0 0.0 0.7 9.2 1.5 0.0 5.3 15.1 2.8 2.8 3.4 0.0 10.5 0.8 2.7 5.0 18.2 3.1 6.1 20.2 6.4 0.7 1.8 1.4 0.0 1.1 2.7 14.2 5.0 100.9 3.3 6.5 17.7 30.2 4.7 14.2 2.0 9.2 5.0 0.1 5.5 25.3 8.2 5.7 2.1 2.2 0.2 19.6 2.0 0.0 7.6 9.9 9.9 5.4 23.8 105.8 0.5 6.6 1.4 3.4 4.5 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 89.8;Astrocytes: 95.0;Paneth cells: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 128.6" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 31.3 10.3 18.1 26.1 16.8 44.2 26.1 11.0 31.9 21.4 40.8 19.6 9.1 29.4 22.4 24.2 22.5 19.9 9.3 23.5 12.1 13.9 21.2 22.1 22.2 21.2 17.3 45.2 26.9 18.4 3.9 15.7 14.4 19.3 20.1 26.1 16.3 14.7 13.6 51.8 11.3 27.5 10.4 31.9 11.4 23.6 25.1 16.3 16.5 12.2 18.6 16.6 15.7 20.7 80.9 12.9 30.7 21.1 64.1 90.4 14.4 26.5 25.4 16.9 20.2 11.5 21.3 16.0 6.6 32.0 25.1 23.7 20.0 26.4 29.4 29.4 21.3 36.5 47.1 2.3 22.8 30.9 14.9 83.2 23.9 55.7 58.5 97.3 29.2 11.5 13.9 50.8 43.8 44.2 7.8 20.8 13.1 14.8 31.4 11.7 25.4 39.8 17.9 34.0 0.4 0.5 54.4 28.6 15.6 30.2 36.7 26.7 128.6 23.4 23.2 22.9 50.1 41.7 16.2 35.5 39.1 27.0 31.1 11.9 16.2 15.2 2.0 8.3 1.0 11.8 1.5 1.3 4.5 11.3 2.0 1.8 34.9 2.4 15.6 17.7 1.8 1.7 18.1 16.8 11.0 31.9 23.5 12.1 21.2 17.3 14.4 10.4 25.1 20.7 2.9 89.8 83.7 95.0 34.8 2.2 47.3 0.6 10.8 2.0 16.9 9.3 20.2 11.5 15.2 12.9 4.2 1.3 28.1 10.7 0.0 37.4 47.3 11.4 8.5 3.7 3.6 15.5 3.7 16.2 14.0 31.8 6.1 20.0 53.7 21.2 3.3 9.9 13.7 0.0 4.4 7.4 0.0 45.3 3.4 43.8 28.3 49.6 1.8 17.8 61.8 13.3 6.2 28.1 0.7 26.4 174.5 17.0 13.3 22.2 6.9 8.6 9.1 9.8 13.1 14.0 18.1 47.5 13.0 38.2 6.3 1.5 12.4 8.4 21.0 41.3 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070998-161089558 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.9;skin 1: 113.6;vagina: 57.3" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 384.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 170000 "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.4 0.1 0.1 0.5 0.1 0.7 13.7 0.3 0.2 26.5 0.0 1.5 0.7 1.2 6.9 98.9 2.9 3.8 0.1 0.1 0.0 3.1 0.1 3.5 0.1 0.1 0.1 0.0 4.5 0.4 0.6 12.2 0.1 9.4 1.7 0.1 33.6 4.3 0.6 113.6 0.6 0.1 0.0 0.0 8.8 0.6 0.3 0.8 0.2 0.0 14.5 16.8 57.3 0.4 10.9 0.4 0.0 0.1 0.0 0.1 56.5 0.1 0.1 0.1 0.2 0.0 14.6 0.0 0.2 0.0 0.1 37.0 0.0 1.2 0.2 0.0 0.5 0.0 0.8 11.1 0.0 0.1 0.7 0.0 14.6 3.0 3.6 0.1 0.0 0.0 0.0 0.1 0.1 24.0 0.1 0.1 0.1 24.6 0.0 0.0 0.0 0.1 0.0 17.5 0.0 0.2 0.2 47.8 0.0 6.4 31.1 0.0 0.0 0.1 2.4 0.5 0.2 0.2 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.4 0.2 6.4 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.6 17.8 0.0 0.0 8.1 16.5 0.0 39.4 0.4 0.0 0.0 41.7 0.0 28.1 2.9 0.6 0.0 0.0 0.0 30.0 67.1 1.2 0.0 43.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 67.1 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 384.2 0.4 0.1 0.0 0.0 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862905 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 197.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 3.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;U-266/84: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" NA NA 180000 "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 23.9 57.2 0.7 0.4 0.8 0.0 22.4 2.5 1.2 21.2 1.2 25.1 0.7 19.5 0.0 14.9 16.8 1.0 22.5 0.7 0.6 43.7 29.9 28.9 0.3 0.8 0.5 20.3 35.9 0.3 33.0 0.2 0.8 26.5 0.0 1.6 38.6 0.0 21.3 20.1 24.3 0.1 0.3 25.3 29.8 8.2 1.0 0.0 31.8 0.0 0.0 23.2 16.2 1.7 0.3 0.2 0.8 1.4 1.8 0.4 0.7 0.2 0.2 0.3 0.3 1.5 0.6 0.7 0.4 0.1 5.4 0.3 2.2 0.0 0.4 2.5 0.3 0.6 0.9 1.2 1.4 0.9 1.8 1.0 0.2 1.4 0.7 0.2 0.6 0.9 1.1 1.2 0.5 0.3 0.6 0.0 0.6 0.5 0.4 0.9 0.4 0.9 1.0 0.4 0.7 0.4 0.2 0.3 0.7 0.9 0.9 0.5 0.7 1.1 0.8 0.7 0.6 3.7 9.6 0.9 1.7 0.4 0.4 1.3 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.6 0.2 0.3 3.0 0.3 0.2 0.3 0.2 0.1 0.7 0.8 2.5 1.2 0.7 0.6 0.8 0.5 0.8 0.3 1.0 1.7 65.7 25.6 46.3 5.2 57.0 34.3 48.5 45.0 39.9 26.4 87.7 55.8 29.0 51.5 54.8 47.8 25.0 62.8 100.5 83.7 9.8 114.2 0.8 29.3 53.5 42.8 113.5 4.6 6.3 59.6 57.8 73.8 32.6 60.8 67.9 17.4 30.7 34.5 170.9 10.1 7.6 39.9 79.3 63.0 65.9 1.4 27.7 93.0 71.2 9.4 25.8 48.8 9.2 5.0 4.0 34.4 88.1 23.3 81.7 89.0 115.0 59.9 29.2 32.7 26.3 60.8 43.7 5.4 10.0 29.3 41.6 197.0 81.7 40.3 41.1 34.6 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061545 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1357.5;tongue: 858.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 154.3 130.5 109.3 75.0 99.3 31.1 91.1 101.6 98.3 103.5 225.0 107.6 106.0 149.4 88.2 126.0 130.6 97.3 430.8 112.4 146.3 159.6 104.0 83.3 63.8 135.0 131.1 148.8 65.2 115.2 82.5 100.6 131.0 95.7 80.1 67.1 92.1 123.5 1357.5 121.1 113.3 141.0 116.3 113.0 79.0 69.3 126.8 62.3 132.6 858.4 59.2 89.7 86.3 138.2 122.2 265.4 172.0 147.4 349.8 168.2 128.6 193.7 269.2 135.1 149.8 327.6 137.6 139.8 379.2 244.6 175.2 245.5 122.5 154.5 144.7 239.9 104.1 78.8 181.0 111.1 418.6 178.0 122.1 232.6 380.7 246.7 267.2 228.7 214.6 93.5 142.5 377.4 169.4 103.3 115.5 56.0 113.0 110.0 101.4 80.1 241.8 136.4 150.0 181.0 105.8 160.2 132.4 89.0 272.4 222.5 175.7 120.5 291.2 324.2 141.4 112.3 197.4 626.6 460.1 134.1 310.4 73.6 191.3 14.2 11.8 4.0 3.4 6.5 2.0 5.2 3.1 3.5 2.6 4.9 2.4 2.7 26.1 3.0 8.7 12.9 1.2 1.3 109.3 99.3 101.6 98.3 112.4 146.3 135.0 131.1 131.0 116.3 126.8 138.2 60.1 57.7 49.4 25.1 15.8 55.7 19.3 45.0 34.1 68.8 39.2 33.8 303.1 50.1 34.4 77.3 35.5 22.7 14.7 150.7 25.4 41.3 8.1 57.9 92.0 66.3 30.1 11.6 24.5 36.2 21.5 47.9 27.5 58.8 28.4 89.3 80.3 126.7 36.0 72.3 28.0 51.5 38.7 32.8 18.9 10.6 102.2 23.8 21.4 20.6 31.5 25.4 15.5 9.0 14.4 51.8 64.8 83.8 17.4 33.8 100.3 39.1 49.5 34.8 59.2 39.3 53.8 30.0 35.5 25.9 48.4 22.3 14.2 44.6 49.4 24.4 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 213.2;Spermatocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 3.0 2.2 1.6 4.4 1.8 4.2 6.4 3.2 1.9 5.4 1.1 3.7 4.6 5.3 10.9 3.8 5.4 3.3 1.8 1.3 1.6 4.1 3.9 3.0 4.1 1.9 1.9 6.1 4.6 6.6 3.2 3.8 1.9 5.0 4.8 3.7 5.2 4.4 2.7 3.9 3.9 5.0 2.0 3.7 4.8 13.7 2.3 4.3 10.1 2.8 4.6 4.3 3.6 1.8 7.0 4.4 4.8 9.9 8.9 14.6 16.2 4.7 6.7 7.6 9.3 7.4 15.6 5.5 8.8 3.1 14.6 7.1 12.4 9.4 8.9 4.3 4.8 6.0 8.7 13.6 11.5 14.8 11.5 9.6 12.3 5.2 30.7 8.9 6.6 11.5 10.8 6.7 7.8 7.0 11.7 6.9 11.6 9.7 6.7 10.3 9.2 9.3 9.6 13.2 15.1 7.3 3.5 9.8 6.8 9.1 6.8 4.2 5.5 9.8 6.2 4.6 10.6 10.8 7.0 11.2 5.7 8.2 8.8 0.0 0.5 0.6 0.7 0.7 0.9 0.8 1.0 0.8 0.5 0.8 1.1 1.0 1.9 0.4 0.4 0.6 0.7 0.6 1.6 1.8 3.2 1.9 1.3 1.6 1.9 1.9 1.9 2.0 2.3 1.8 6.9 6.4 8.7 15.0 6.3 5.4 4.0 5.2 7.4 19.6 10.0 7.0 213.2 11.5 9.9 7.3 10.4 5.6 10.5 6.2 11.7 9.2 36.9 15.7 16.7 7.8 11.4 6.9 35.6 7.1 11.5 27.3 7.1 18.4 2.5 10.9 7.9 7.5 4.8 8.4 35.0 11.2 12.2 6.5 4.3 20.2 12.8 9.9 1.8 17.8 7.3 11.0 8.2 33.7 30.7 7.4 4.7 10.1 13.8 7.0 6.5 4.2 9.9 16.5 0.0 8.1 9.1 81.1 27.2 9.9 4.3 6.7 6.8 5.5 8.1 5.2 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015781-139045939 "Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 8.2 2.0 2.8 3.2 2.6 36.3 4.5 1.7 7.1 1.4 0.0 1.8 1.2 1.6 0.5 1.9 1.0 5.5 2.9 5.0 2.9 3.6 13.9 2.9 2.1 1.5 3.4 0.6 3.0 1.7 2.2 5.6 2.6 1.0 1.6 3.4 1.6 0.5 6.5 2.2 2.2 3.0 1.4 1.7 1.7 2.2 4.4 1.9 1.5 6.1 2.6 4.9 1.3 2.9 6.5 7.1 2.9 5.7 6.6 2.7 17.2 9.4 6.9 13.7 10.0 10.3 2.8 22.7 7.4 7.3 18.4 4.5 15.8 8.9 13.7 9.5 6.1 10.3 4.4 8.7 6.2 15.3 6.0 3.2 4.4 15.4 10.4 2.7 6.3 4.3 18.6 7.0 6.6 8.0 10.0 7.8 10.1 3.0 8.1 8.5 8.6 7.7 9.4 4.3 11.3 7.3 6.0 6.8 5.6 11.2 5.0 11.2 8.7 7.7 9.4 7.2 11.8 5.9 5.5 14.0 7.0 29.8 9.9 0.8 0.5 0.3 1.0 0.6 0.5 0.4 0.4 0.5 0.2 0.7 0.3 0.6 2.7 0.6 1.6 0.6 0.3 0.1 2.8 2.6 1.7 7.1 5.0 2.9 1.5 3.4 2.6 1.4 4.4 2.9 10.9 9.6 1.1 0.0 2.8 0.0 2.7 0.0 5.7 5.6 2.7 2.5 0.0 1.5 0.6 0.0 14.6 6.1 4.7 0.6 1.9 2.3 0.7 10.4 6.3 2.6 0.0 1.7 0.0 0.2 11.8 2.9 6.1 20.6 2.5 0.8 1.1 2.6 1.5 1.7 0.0 0.4 0.0 1.6 0.0 0.1 0.9 6.9 0.0 0.0 0.1 0.6 4.1 0.0 0.0 2.5 0.0 0.0 5.5 2.5 2.6 4.0 0.7 5.2 0.0 5.4 4.3 1.0 3.9 6.5 0.0 12.0 4.3 0.8 0.2 2.3 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 107.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 52.8;Granulosa cells: 97.9;Proximal tubular cells: 143.4" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 35.3;fHDF/TERT166: 22.8;HeLa: 81.4;HSkMC: 50.0;U-138 MG: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 20: HeLa - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 21.3 3.4 1.4 0.8 1.2 4.5 3.8 0.9 1.7 8.0 5.6 5.3 0.7 4.1 2.0 5.3 4.7 4.3 27.3 1.3 2.0 107.8 4.8 11.1 0.9 1.5 1.4 1.7 1.3 1.3 0.6 9.5 1.3 6.3 1.1 2.6 1.1 8.9 5.8 5.0 1.4 3.0 1.1 9.6 1.0 1.7 1.3 4.9 13.0 9.5 2.0 1.8 4.5 2.0 0.3 4.3 0.2 0.4 2.4 35.3 0.1 10.0 1.9 0.6 0.6 0.0 0.2 0.0 0.2 22.8 0.7 0.0 4.9 0.1 1.2 0.1 0.0 0.4 81.4 0.0 7.1 0.1 0.2 50.0 0.6 2.6 6.9 2.3 0.3 0.1 0.1 0.6 3.3 0.6 0.0 0.5 0.1 0.0 11.9 0.1 0.0 0.0 0.0 0.2 0.2 0.0 3.5 13.3 0.1 0.3 0.2 0.0 0.3 21.5 0.3 1.8 0.3 0.2 0.1 0.0 3.5 0.1 0.3 0.1 0.3 0.2 0.3 0.1 0.2 0.4 0.3 0.2 0.0 0.5 0.4 0.5 3.3 0.4 0.0 0.4 0.1 0.1 1.4 1.2 0.9 1.7 1.3 2.0 1.5 1.4 1.3 1.1 1.3 2.0 3.9 16.0 4.9 1.0 0.8 5.4 0.1 1.6 24.5 11.6 0.2 1.1 27.3 0.0 1.7 9.2 0.0 0.0 0.2 0.1 52.8 0.1 1.4 4.5 8.5 11.9 0.0 13.9 0.4 0.0 0.1 2.6 0.0 16.5 3.8 97.9 15.7 1.6 0.1 3.3 11.4 0.0 0.0 0.3 0.0 3.2 11.1 1.3 0.0 0.0 0.2 1.7 0.0 1.0 0.3 0.0 0.1 12.8 1.4 1.9 0.0 143.4 3.7 1.5 6.6 0.3 6.6 0.1 1.2 23.0 1.3 0.1 1.3 16.5 0.0 0.3 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771311 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 4.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.9" "Cell line enhanced" "Detected in many" "BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.3 0.8 1.8 0.9 1.9 4.4 0.9 2.2 1.9 0.8 4.5 2.2 1.7 0.5 0.5 1.9 0.5 0.4 1.0 1.8 1.5 1.7 2.7 1.5 0.3 2.0 1.5 0.3 2.9 0.8 1.4 2.3 1.5 1.4 1.5 3.1 1.2 0.5 1.4 2.2 2.5 0.4 1.4 0.8 0.4 22.9 3.4 0.1 5.4 0.8 0.7 0.7 1.3 1.6 1.2 3.0 14.7 2.0 0.3 0.2 110.7 0.2 1.1 0.8 1.3 26.5 2.9 5.0 1.0 0.1 3.8 2.8 1.6 1.3 1.7 1.1 4.6 4.1 4.8 25.8 0.1 2.3 7.2 0.1 1.3 1.2 1.6 0.3 0.2 1.2 34.1 0.7 0.6 0.6 0.1 3.2 39.2 1.3 1.1 1.2 1.5 2.2 0.5 2.0 2.2 0.8 0.2 0.7 0.9 21.7 2.6 1.3 0.0 1.4 3.1 0.9 0.7 3.3 25.0 4.3 0.9 2.3 0.8 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 4.9 0.0 0.3 0.1 0.0 0.1 1.8 1.9 2.2 1.9 1.8 1.5 2.0 1.5 1.5 1.4 3.4 1.6 0.8 0.0 7.7 47.0 0.6 37.3 17.4 4.2 13.6 3.8 6.8 3.7 2.0 7.2 5.9 5.5 29.2 36.7 1.6 8.9 1.9 10.1 53.5 4.1 0.9 3.2 4.8 6.1 105.5 3.5 160.0 2.0 2.0 3.7 1.3 16.1 1.4 6.0 8.2 1.7 114.7 6.9 8.2 2.2 30.6 30.3 1.2 3.2 8.8 54.4 5.2 7.0 0.0 112.6 73.0 1.9 6.0 1.9 0.5 19.4 24.5 3.3 8.6 10.7 0.0 1.5 3.5 72.7 111.1 8.6 39.8 30.6 0.3 8.1 11.9 15.5 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244526 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "bone marrow: 40.4;brain: 74.6;retina: 26.7" "Cell type enhanced" "Detected in many" "Astrocytes: 34.9;Bipolar cells: 69.6;Cone photoreceptor cells: 171.0;Rod photoreceptor cells: 108.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "basal ganglia: 74.6" "Immune cell enriched" "Detected in single" 5 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "HL-60: 6.8;HMC-1: 16.2;NB-4: 39.0;U-937: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071290 Approved "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA071290: AB_2686381" "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favorable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 0.6 1.9 18.6 1.1 74.6 40.4 0.2 13.3 25.6 0.8 0.0 0.5 1.2 0.5 0.3 0.3 0.5 0.8 5.5 17.6 6.5 0.7 0.3 2.9 1.4 11.5 5.4 0.2 1.0 4.4 1.7 0.5 14.7 6.2 0.2 26.7 0.8 1.1 0.4 0.4 0.8 0.3 5.0 3.9 0.6 2.1 11.4 0.5 0.4 1.4 0.4 0.8 0.6 11.5 0.0 0.5 0.2 0.6 0.6 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.9 0.0 0.2 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.9 6.8 16.2 0.1 0.0 0.2 0.1 1.4 0.0 1.3 0.0 0.0 0.5 0.2 0.3 39.0 1.4 0.0 0.2 0.4 0.4 0.2 0.0 0.0 4.6 4.2 0.2 0.0 0.1 0.0 0.0 0.6 0.1 0.9 2.8 3.6 0.1 0.1 0.0 0.0 1.3 10.0 1.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 18.6 74.6 13.3 25.6 17.6 6.5 11.5 5.4 14.7 5.0 11.4 11.5 0.8 0.0 0.6 34.9 0.5 0.3 0.6 0.0 0.6 69.6 0.1 1.0 3.0 0.0 0.6 0.0 171.0 0.1 5.0 0.0 0.0 0.3 1.4 0.6 2.4 1.3 0.0 0.4 8.1 0.0 0.0 1.9 0.0 1.1 1.3 0.9 0.7 0.1 0.7 1.7 3.6 0.2 0.0 0.3 0.3 1.3 0.6 1.2 1.8 8.4 0.9 20.3 3.1 11.1 21.5 0.1 0.0 1.2 2.0 2.3 0.0 0.1 0.0 108.3 6.6 2.4 1.8 0.5 0.2 0.2 0.3 0.1 1.2 4.3 0.1 0.3 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 79.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.3 14.9 4.4 22.7 3.6 79.9 12.5 10.3 20.4 12.7 11.7 14.9 16.2 11.5 11.9 17.2 10.9 14.0 13.6 5.1 19.9 13.0 24.0 21.0 19.8 12.1 14.7 12.0 14.7 18.4 11.0 29.6 11.0 12.1 13.0 23.1 15.5 9.8 15.9 12.1 13.2 10.3 2.1 20.7 18.7 14.2 10.8 18.0 13.5 17.6 17.5 16.4 14.2 14.1 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 4.4 3.6 10.3 20.4 5.1 19.9 12.1 14.7 11.0 2.1 10.8 14.1 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073853 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.0;testis: 27.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 537.8" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037947, HPA037948" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.5 0.9 1.1 0.2 0.8 1.1 5.5 0.6 1.5 0.8 0.8 0.2 0.1 0.4 0.4 3.0 1.7 1.0 0.2 1.1 0.3 1.1 0.3 1.7 0.3 0.5 0.3 0.2 0.1 0.3 1.0 3.2 0.3 0.3 0.0 0.7 2.7 0.1 0.2 0.7 0.5 0.2 0.2 9.0 0.3 27.0 0.7 0.1 0.4 0.3 0.0 0.2 0.8 1.2 0.0 0.0 0.1 0.2 0.2 0.7 1.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.4 3.6 4.8 0.5 0.0 0.0 0.4 0.1 0.2 0.1 3.6 0.0 0.3 0.2 0.2 0.0 0.3 0.4 0.7 0.2 0.0 0.0 0.0 0.1 0.1 5.3 0.0 2.6 0.1 0.1 0.2 0.0 1.8 0.1 0.1 3.1 0.7 0.2 1.1 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.6 0.4 0.0 0.5 0.2 0.0 1.1 0.8 0.6 1.5 1.1 0.3 0.5 0.3 0.3 0.2 0.7 1.2 0.7 3.2 0.6 0.3 0.1 0.3 0.5 0.0 0.0 0.1 131.3 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 2.7 537.8 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.7 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.2 0.3 66.1 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 8.2 0.0 0.4 0.0 0.0 0.8 0.7 6.6 0.5 1.0 2.8 1.9 0.0 0.3 11.4 0.9 0.1 0.0 0.1 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 67949349-68433913 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.8" "Group enriched" "Detected in many" 5 "Astrocytes: 383.9;Oligodendrocyte precursor cells: 600.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 18: U-2197 - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 4.1 5.1 20.8 1.8 18.6 3.9 4.5 14.2 19.5 6.0 1.0 3.4 2.5 5.6 3.7 3.8 3.2 2.7 3.1 18.0 14.6 4.3 1.3 4.4 1.9 9.5 11.9 4.5 3.1 3.6 2.7 5.6 5.8 10.1 3.4 11.5 5.4 5.0 6.5 6.4 2.9 4.0 6.1 2.3 3.8 2.6 16.3 1.2 4.7 4.8 1.4 2.3 3.8 11.5 23.6 5.1 3.2 7.3 7.1 6.8 5.0 4.2 5.6 8.3 10.1 3.3 4.5 1.5 13.7 4.9 3.4 5.7 3.1 2.9 12.6 0.9 2.1 5.2 6.9 3.7 2.4 2.1 5.2 4.6 4.8 6.9 6.4 10.6 5.6 1.1 3.2 3.1 4.3 10.1 0.8 1.8 7.5 10.0 4.8 0.9 7.3 1.3 8.5 7.6 1.7 2.8 7.2 9.1 13.7 7.1 6.2 1.6 6.0 5.0 7.3 18.1 4.5 2.9 3.4 1.0 4.0 2.8 3.5 1.0 1.0 0.4 0.5 0.4 0.4 0.5 0.4 0.3 0.4 0.8 0.4 0.5 4.6 0.5 0.6 1.6 0.3 0.2 20.8 18.6 14.2 19.5 18.0 14.6 9.5 11.9 5.8 6.1 16.3 11.5 13.8 16.0 19.3 383.9 0.0 3.2 5.4 2.0 10.2 5.4 6.7 5.0 3.3 2.8 6.4 18.4 6.2 23.0 2.3 3.9 0.0 1.2 2.0 7.2 4.3 8.1 4.2 1.3 84.6 0.8 11.7 18.0 14.8 12.9 8.8 36.3 5.0 0.2 4.6 0.0 78.8 3.0 2.0 2.1 9.5 1.7 21.1 5.9 8.8 54.4 1.2 16.0 3.1 600.2 41.7 1.3 2.4 12.0 0.1 8.5 3.8 1.8 10.9 5.1 0.0 24.1 5.4 0.3 1.9 8.9 5.1 66.9 1.4 4.2 4.1 4.2 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132190147-132295315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 324.2;U-87 MG: 323.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No 13000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum, Vesicles" "CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.12e-4)" 17.4 11.7 11.9 16.1 12.1 2.4 12.3 11.4 28.4 29.5 42.2 28.7 22.6 31.1 76.7 19.6 29.6 19.9 40.6 14.4 17.2 80.0 10.5 31.5 2.5 11.4 14.3 8.6 70.7 10.9 19.9 35.1 19.1 10.8 32.7 7.8 32.5 17.1 13.0 16.7 26.8 52.6 10.0 8.7 20.5 9.7 16.8 11.3 20.7 22.9 8.3 22.9 22.3 12.2 57.0 34.9 11.2 57.2 149.2 173.7 61.1 261.9 223.7 108.9 265.0 78.9 50.3 1.5 71.8 283.3 120.5 70.2 33.2 136.5 172.7 41.5 11.9 0.6 48.1 49.0 324.2 0.0 33.9 104.6 193.1 128.8 117.4 162.7 59.1 0.1 21.2 3.6 134.0 23.2 0.2 0.5 3.0 53.7 27.2 0.9 3.6 9.8 31.1 11.0 5.4 15.8 67.7 22.3 47.9 84.1 28.4 3.7 88.9 171.7 63.5 51.0 57.1 24.4 28.1 11.8 323.4 0.4 48.3 0.0 0.4 0.0 0.8 0.3 0.7 0.0 0.4 0.1 0.2 0.0 0.0 0.1 1.0 0.9 0.0 0.3 0.0 0.2 11.9 12.1 11.4 28.4 14.4 17.2 11.4 14.3 19.1 10.0 16.8 12.2 13.0 35.3 10.3 7.5 1.1 16.8 43.6 115.6 23.9 11.6 9.5 9.5 13.3 8.6 36.9 11.0 22.9 2.6 0.3 43.2 5.9 68.3 1.4 26.7 96.9 12.2 15.0 0.0 7.7 71.8 70.2 61.6 12.8 28.0 5.7 11.1 9.3 7.8 7.6 0.0 7.7 18.6 32.6 1.3 5.5 2.0 8.1 4.4 30.2 2.8 2.6 6.8 0.0 1.5 1.2 81.9 41.0 5.3 3.0 19.6 41.4 44.6 71.9 5.2 26.3 109.4 47.6 23.0 29.1 6.8 9.8 7.5 4.8 10.4 13.8 15.3 PARP14 "ARTD8, KIAA1268, pART8" ENSG00000173193 "Poly(ADP-ribose) polymerase family member 14" Q460N5 3 122680839-122730840 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008846, HPA012063" Supported Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA008846: AB_1854982, HPA012063: AB_1854981" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-1)" "unprognostic (2.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (1.44e-1)" "unprognostic (4.20e-2)" "unprognostic (1.74e-3)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-3)" "unprognostic (1.71e-2)" 14.0 12.6 4.3 24.3 5.1 20.1 11.3 3.6 2.7 11.4 5.5 11.5 15.3 8.2 2.4 9.0 10.7 15.2 11.1 2.8 5.1 14.9 24.5 33.5 24.0 15.1 5.9 9.2 7.8 7.3 7.6 17.8 8.6 13.0 8.7 1.1 11.7 7.2 5.0 5.3 17.5 10.2 10.9 37.4 11.7 2.2 8.9 15.4 14.7 8.3 26.8 13.7 9.4 7.8 15.6 13.0 8.0 8.3 9.1 26.2 0.0 6.1 40.1 74.7 113.1 6.9 28.7 0.0 24.2 13.4 41.8 11.5 11.9 11.6 15.0 24.0 1.5 14.6 5.8 8.7 20.4 6.4 6.8 14.7 4.7 13.0 4.8 16.4 32.2 12.3 7.0 22.7 2.1 7.9 24.8 1.5 1.1 2.1 11.1 34.2 8.3 4.3 9.5 16.2 0.6 0.0 15.3 3.1 14.1 0.8 5.7 9.3 22.0 4.0 9.4 2.3 5.5 8.7 1.6 2.7 12.0 13.8 7.2 13.1 10.8 5.8 8.6 13.7 7.2 12.8 4.5 5.6 5.6 20.3 3.6 4.1 29.5 9.5 14.7 0.7 9.9 4.3 4.3 5.1 3.6 2.7 2.8 5.1 15.1 5.9 8.6 10.9 8.9 7.8 111.5 246.8 98.4 17.3 115.3 16.8 17.0 35.9 13.1 2.1 19.6 15.6 14.6 24.3 65.9 25.8 4.2 14.1 64.9 43.0 3.9 36.0 0.3 118.8 59.8 94.7 10.7 18.5 0.5 41.2 28.4 37.2 24.5 149.8 32.2 69.6 67.1 32.5 36.5 0.0 3.0 18.2 26.4 61.6 39.9 2.1 28.0 83.9 16.0 124.6 132.2 15.1 58.7 47.3 1.1 44.0 20.2 17.3 50.9 31.8 29.5 11.5 73.0 1.0 13.1 32.7 30.3 1.9 1.1 13.7 10.5 4.8 51.4 42.8 16.0 25.9 PCDHB13 PCDH-BETA13 ENSG00000187372 "Protocadherin beta 13" Q9Y5F0 5 141213919-141218979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Exocrine glandular cells: 3.1;Horizontal cells: 3.3;Ionocytes: 4.1;Melanocytes: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 7.3;T-47d: 14.4;U-2197: 11.6" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (9.91e-3)" "unprognostic (3.34e-2)" "unprognostic (8.89e-2)" "unprognostic (2.06e-3)" "unprognostic (2.06e-1)" "unprognostic (1.29e-1)" "unprognostic (9.59e-2)" "unprognostic (3.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.61e-3)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (4.49e-2)" "unprognostic (2.80e-2)" "unprognostic (3.99e-2)" "unprognostic (8.19e-2)" "unprognostic (6.93e-3)" 1.1 1.3 0.2 0.5 0.6 0.2 1.1 0.5 1.2 1.4 0.0 1.0 0.2 1.6 1.2 0.7 1.1 1.6 1.4 0.7 0.0 0.8 0.6 0.9 0.3 0.1 0.2 1.4 1.9 0.7 1.5 1.3 0.0 1.2 0.6 1.2 1.5 1.1 0.5 1.8 0.4 1.3 0.1 0.8 0.8 1.0 0.1 0.1 0.9 0.7 0.2 0.8 0.9 0.5 0.0 0.1 1.8 1.4 4.6 4.9 0.4 0.3 2.4 0.7 1.4 0.0 2.0 0.0 7.3 1.8 2.5 0.5 1.7 0.0 0.4 0.0 0.1 0.0 0.9 0.3 0.1 0.0 0.9 0.4 1.2 0.1 0.1 2.1 0.7 0.2 0.3 1.8 2.3 0.3 0.2 0.1 0.4 0.0 0.2 5.6 0.8 0.0 0.1 0.1 1.7 0.6 2.4 0.2 0.7 0.5 14.4 0.1 2.2 0.5 1.3 11.6 0.0 0.0 0.1 0.0 3.2 0.1 3.6 0.9 0.2 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.2 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.2 0.6 0.5 1.2 0.7 0.0 0.1 0.2 0.0 0.1 0.1 0.5 2.1 0.0 0.0 0.0 0.0 0.8 0.2 1.5 1.8 3.7 0.4 0.4 1.5 2.8 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 1.0 0.5 2.1 1.6 0.0 0.0 0.0 3.1 0.0 1.2 0.0 0.6 0.0 0.5 1.1 0.7 0.1 3.3 0.0 0.2 4.1 0.0 0.0 0.0 0.9 0.1 3.6 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.2 1.2 0.1 0.2 0.0 0.8 0.1 0.3 0.0 2.1 0.8 0.4 0.2 0.9 0.9 0.0 0.0 0.1 0.1 0.6 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.5;brain: 109.1" "Group enriched" "Detected in many" 5 "Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 88.9" "Group enriched" "Detected in all" 5 "B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 18.3 3.1 40.1 39.5 82.5 75.5 20.0 63.3 53.5 7.2 1.6 8.3 4.6 8.3 1.1 4.5 4.2 10.1 21.4 45.7 68.4 5.4 10.9 14.7 23.2 85.9 74.4 2.1 1.6 1.4 3.8 17.2 78.5 23.0 10.5 14.1 21.1 12.1 44.3 8.9 12.2 12.4 66.4 22.6 5.1 3.8 62.9 14.0 7.2 15.0 19.9 32.1 4.6 109.1 0.2 18.5 34.7 61.8 1.6 1.7 0.1 11.5 13.3 10.1 13.4 0.0 0.0 5.3 0.2 20.7 0.4 0.1 0.3 0.0 9.7 15.5 0.1 0.3 5.2 0.0 1.2 13.1 0.0 3.4 0.5 4.5 0.2 1.6 93.2 0.0 0.0 3.3 4.7 0.3 0.0 7.5 56.1 0.0 0.7 2.6 6.2 3.6 8.7 0.0 0.2 26.6 0.0 3.0 58.6 2.9 0.2 4.5 52.6 7.2 1.9 4.6 1.9 1.5 51.6 19.3 8.6 13.4 3.7 10.8 6.8 22.0 10.1 5.8 19.5 36.8 19.4 14.8 6.2 37.4 21.3 15.0 88.9 11.3 5.7 6.4 34.7 9.6 40.1 82.5 63.3 53.5 45.7 68.4 85.9 74.4 78.5 66.4 62.9 109.1 24.7 9.6 12.2 531.8 233.3 20.3 28.4 0.5 27.9 40.9 51.6 34.3 25.4 0.0 6.9 5.5 0.0 7.3 79.8 0.4 0.0 0.8 14.4 1.7 14.9 36.8 4.2 0.0 315.6 0.9 2.0 20.2 9.7 4.2 15.2 0.2 11.7 2.4 13.0 114.4 559.7 1.9 8.2 40.6 187.4 9.4 0.3 176.9 51.6 173.3 67.0 19.3 1.0 1722.6 4039.6 0.1 0.4 2.6 351.9 93.6 0.0 2.1 1.5 4.0 0.0 54.0 10.3 0.7 0.8 4.8 8.1 5.6 143.1 0.4 1.3 9.4 PFAS "FGARAT, GATD8, KIAA0361, PURL" ENSG00000178921 "Phosphoribosylformylglycinamidine synthase" O15067 17 8247618-8270491 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 49.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022140, HPA022886" Enhanced Approved Vesicles NA NA 670000 "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA022140: AB_1855232, HPA022886: AB_1855233" "unprognostic (1.90e-1)" "unprognostic (9.21e-2)" "unprognostic (2.12e-1)" "unprognostic (5.19e-3)" "unprognostic (2.59e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (5.47e-3)" "unprognostic (1.08e-3)" "unprognostic (9.51e-3)" "unprognostic (3.63e-2)" "unprognostic (6.57e-2)" "unprognostic (2.88e-3)" "unprognostic (3.85e-1)" 8.4 9.9 4.7 7.8 5.1 9.8 8.2 6.2 5.8 7.8 2.8 6.7 4.8 9.0 2.6 8.4 8.0 2.8 6.3 5.1 3.3 11.0 10.1 5.8 9.8 3.9 3.9 9.7 10.3 5.6 5.5 5.2 4.6 6.9 5.6 5.8 6.4 4.7 6.4 6.8 7.7 6.8 3.3 11.0 7.8 7.8 3.9 7.5 7.8 3.2 8.2 7.6 6.2 6.0 15.6 67.0 33.8 50.2 12.1 10.0 38.7 19.4 7.4 35.1 26.4 32.9 13.7 69.8 30.8 11.4 12.4 35.1 78.5 25.6 25.8 30.6 64.0 40.0 63.2 41.9 10.4 32.9 28.3 9.5 6.2 40.5 25.5 9.9 29.5 36.6 54.8 10.1 13.7 23.0 58.1 28.4 55.7 8.5 29.9 86.0 35.2 32.6 16.1 25.5 20.4 31.7 24.1 15.3 22.2 17.9 15.3 14.9 20.9 19.2 25.0 35.7 49.0 11.8 23.5 33.7 21.0 45.4 32.9 20.2 5.1 12.7 6.8 4.5 8.7 14.8 8.8 7.9 4.4 16.7 10.9 8.6 49.1 5.2 3.7 12.9 5.0 2.3 4.7 5.1 6.2 5.8 5.1 3.3 3.9 3.9 4.6 3.3 3.9 6.0 2.9 0.0 7.9 3.9 6.0 2.4 1.7 1.9 1.8 8.1 4.5 3.7 4.3 1.5 4.1 3.7 6.2 5.2 3.2 2.1 0.0 3.7 2.1 2.4 5.9 3.6 0.0 9.2 5.8 3.0 4.3 4.0 5.6 3.7 1.3 9.7 2.5 4.2 4.6 1.7 5.4 3.5 2.0 2.5 1.4 1.1 5.3 3.4 3.6 4.7 4.5 1.6 4.1 6.6 3.9 1.9 4.9 1.5 5.3 2.9 0.8 2.7 5.1 7.3 0.0 5.1 3.2 5.6 8.8 3.9 2.0 3.1 3.3 7.7 6.2 1.4 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 269.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 450000 "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 28.9 61.0 3.7 12.6 4.1 0.0 21.0 5.8 3.8 51.7 3.3 269.4 15.4 154.0 40.8 98.6 96.5 19.6 126.1 3.1 4.1 11.5 5.1 14.6 5.8 4.6 4.0 19.8 2.7 5.0 4.3 5.8 4.3 159.0 34.2 8.0 6.7 214.0 37.5 11.1 72.0 132.5 4.7 10.8 65.2 3.0 4.6 2.9 13.1 30.5 2.9 216.7 40.6 4.6 0.2 0.2 0.0 0.0 0.7 0.0 0.3 8.2 6.3 3.8 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 9.2 0.0 9.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.7 0.0 0.0 56.5 0.0 38.8 1.8 1.5 0.0 0.0 0.2 0.1 47.8 2.8 1.2 0.0 0.0 0.1 0.0 5.7 0.3 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 3.7 4.1 5.8 3.8 3.1 4.1 4.6 4.0 4.3 4.7 4.6 4.6 21.6 0.0 1.7 0.7 0.2 2.3 5.6 0.0 0.6 25.3 0.2 1.5 107.2 2.8 1.8 12.9 4.2 0.0 0.1 0.1 1.9 0.1 1.8 3.7 2.8 36.6 0.0 4.0 1.4 0.0 0.2 12.4 0.0 1.1 0.0 18.7 39.3 0.1 0.1 0.0 1.7 2.7 0.0 4.0 2.8 0.5 8.1 2.1 3.6 124.6 1.0 8.3 0.0 1.0 2.3 0.1 0.1 4.9 0.0 2.1 0.8 1.2 0.8 1.9 52.6 1.7 35.9 0.1 0.2 0.4 2.4 0.0 0.6 30.0 1.6 1.5 PHF24 KIAA1045 ENSG00000122733 "PHD finger protein 24" Q9UPV7 9 34957608-34982544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 44.8;testis: 16.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Cone photoreceptor cells: 8.4;Early spermatids: 3.9;Late spermatids: 7.9;Muller glia cells: 14.2;Spermatocytes: 4.9;Spermatogonia: 4.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in single" "WM-115: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020974 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "HPA020974: AB_1852364" "unprognostic (5.54e-3)" "unprognostic (1.21e-1)" "unprognostic (9.00e-2)" "unprognostic (2.44e-1)" "unprognostic (1.00e-2)" "unprognostic (6.30e-2)" "unprognostic (3.66e-2)" "unprognostic (1.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.97e-1)" "unprognostic (4.80e-4)" "unprognostic (1.24e-1)" "unprognostic (4.58e-6)" "unprognostic (1.87e-2)" "unprognostic (1.41e-1)" "unprognostic (9.23e-2)" "unprognostic (2.30e-1)" 0.7 0.2 20.6 0.4 27.8 0.0 0.6 0.0 44.8 0.3 0.0 0.5 0.1 0.5 0.2 0.2 0.4 0.2 0.2 25.5 1.6 0.2 0.1 0.2 1.0 10.5 7.3 0.1 0.0 0.0 0.4 0.0 10.0 0.1 0.2 6.7 0.1 0.0 0.1 0.9 0.5 0.4 0.6 0.2 0.3 16.1 9.4 0.7 0.4 0.0 0.8 0.1 0.3 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 20.6 27.8 0.0 44.8 25.5 1.6 10.5 7.3 10.0 0.6 9.4 21.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.4 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635802-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 19.6 18.2 12.5 16.9 18.9 39.5 21.4 32.2 15.3 20.6 11.7 16.7 16.0 22.8 17.5 12.8 16.7 16.1 13.7 11.0 15.4 19.7 28.0 16.0 21.6 17.4 13.7 32.2 18.4 23.8 12.2 24.3 19.4 18.2 17.6 27.7 15.2 15.9 20.3 16.5 16.1 15.5 14.5 21.3 18.3 14.3 14.7 30.6 26.1 22.9 18.1 15.4 16.8 30.5 35.8 17.5 28.1 17.0 27.3 29.6 28.6 23.0 32.5 16.9 22.3 24.0 16.6 44.0 19.3 20.7 24.4 15.3 27.7 23.9 27.8 35.2 23.3 52.5 21.7 38.2 24.7 45.3 20.7 21.4 21.2 24.0 34.1 29.1 19.8 23.0 58.4 39.9 17.4 21.2 19.5 23.9 16.3 22.9 10.4 33.7 25.6 21.2 20.5 21.0 30.8 22.7 27.7 12.5 20.1 30.7 21.3 41.2 28.2 25.9 30.4 20.0 27.6 33.9 37.6 41.0 11.9 35.6 20.3 15.5 6.2 7.1 7.6 8.0 7.4 7.3 7.1 6.1 5.5 8.9 10.0 7.6 14.4 5.0 11.5 6.7 5.5 4.4 12.5 18.9 32.2 15.3 11.0 15.4 17.4 13.7 19.4 14.5 14.7 30.5 87.9 157.0 133.2 76.0 108.0 54.9 62.1 42.2 71.7 67.9 49.4 56.8 95.2 34.3 88.6 46.0 47.9 47.6 91.2 50.1 15.6 48.4 40.5 68.8 93.7 61.1 43.1 63.1 71.1 37.6 31.5 77.2 60.6 84.3 103.0 85.5 41.7 47.1 28.8 50.5 80.5 46.1 28.5 46.2 33.2 26.5 81.1 65.3 23.2 70.3 69.6 47.4 74.2 76.9 129.8 29.8 40.5 56.8 92.4 64.1 55.5 36.4 72.9 66.8 59.2 103.7 58.5 103.0 69.3 48.4 42.9 31.2 97.1 114.2 49.4 51.0 PHIP "BRWD2, DCAF14, FLJ20705, ndrp, WDR11" ENSG00000146247 "Pleckstrin homology domain interacting protein" Q8WWQ0 6 78934419-79078254 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019140, HPA019838" Approved Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA019140: AB_2670073, HPA019838: AB_2670287" "unprognostic (1.58e-1)" "unprognostic (1.60e-1)" "unprognostic (9.43e-2)" "unprognostic (8.47e-3)" "unprognostic (1.05e-1)" "unprognostic (2.01e-3)" "unprognostic (3.50e-3)" "unprognostic (5.03e-2)" "unprognostic (4.03e-2)" "unprognostic (6.40e-3)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.55e-2)" 8.5 5.7 7.6 8.4 9.9 29.4 12.0 18.8 9.3 11.0 6.0 8.5 5.8 11.1 8.4 6.2 9.8 6.3 6.6 6.6 9.0 6.1 4.8 8.8 11.0 8.8 8.7 11.7 8.4 8.5 9.4 7.9 9.2 8.7 7.7 20.5 8.5 7.0 9.7 8.9 7.9 7.1 8.3 9.9 8.1 6.4 8.5 13.1 7.8 8.4 9.1 8.4 9.2 14.0 13.6 10.8 25.2 24.6 9.6 13.7 14.6 14.3 11.3 12.0 15.1 13.4 8.2 22.3 11.1 9.0 10.1 12.2 19.1 9.1 20.1 32.2 13.9 25.0 20.7 10.0 4.4 28.2 15.4 8.4 7.9 14.4 14.3 10.1 12.9 14.0 25.5 20.8 11.7 9.1 11.0 21.0 15.9 7.0 11.8 18.9 32.3 9.7 12.9 18.0 24.7 15.8 19.0 14.4 9.2 16.0 11.2 37.6 15.2 13.9 9.8 6.8 23.8 14.2 14.9 12.3 5.9 17.9 21.2 10.0 4.2 7.7 4.4 3.0 4.7 6.1 5.3 5.0 2.9 6.6 5.8 4.6 14.4 4.6 5.7 5.3 4.8 2.1 7.6 9.9 18.8 9.3 6.6 9.0 8.8 8.7 9.2 8.3 8.5 14.0 64.4 70.5 109.9 181.8 92.5 63.2 88.9 56.7 48.9 183.4 53.7 52.2 58.6 54.3 95.9 55.2 152.2 85.4 95.3 52.1 1.9 71.6 33.8 94.6 75.1 74.5 72.7 80.4 168.9 47.2 91.0 77.3 59.7 58.4 115.2 76.6 71.0 21.3 51.0 181.7 196.4 58.2 71.2 83.8 75.6 17.2 101.2 83.3 49.8 154.6 134.7 84.4 83.4 154.3 346.1 58.1 49.1 87.6 124.8 81.5 46.7 19.0 148.4 174.1 52.6 97.9 87.4 127.3 53.6 50.1 56.4 102.1 92.9 50.5 62.1 104.5 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 264.6;tongue: 172.3" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Hepatocytes: 46.5" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 4.0 4.1 11.4 0.7 15.0 1.7 2.8 14.8 11.6 1.8 8.8 8.5 1.1 1.3 0.7 5.2 1.9 1.6 18.7 11.8 15.6 1.1 1.6 1.7 0.8 17.6 17.5 1.8 1.2 0.9 2.4 0.3 15.3 2.3 0.7 0.9 5.2 0.5 264.6 3.3 2.5 1.1 16.6 1.5 1.6 1.0 16.9 0.7 2.0 172.3 0.9 4.1 1.2 15.4 1.1 0.8 0.2 0.7 1.1 2.0 0.6 0.1 0.2 0.4 0.3 0.3 0.5 0.3 0.2 0.3 0.5 0.6 0.5 0.1 0.3 0.3 0.9 0.3 1.5 0.3 0.2 0.6 1.2 1.2 0.8 0.5 0.2 0.3 0.0 0.8 0.9 1.5 0.0 0.5 0.9 2.4 0.3 0.3 0.5 0.5 0.0 0.3 0.2 0.8 0.6 0.6 0.1 0.8 0.0 0.1 0.4 0.8 0.3 0.2 0.6 1.7 0.5 0.6 0.3 0.9 0.4 0.6 0.4 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.0 11.4 15.0 14.8 11.6 11.8 15.6 17.6 17.5 15.3 16.6 16.9 15.4 12.6 12.8 4.2 16.0 10.4 1.3 7.7 0.2 0.6 3.9 25.6 6.7 1.7 48.6 3.7 27.6 0.0 7.5 17.7 9.0 1.9 14.6 2.7 20.8 11.3 8.2 16.7 6.6 3.1 12.3 14.5 10.4 2.6 16.4 8.2 4.6 23.6 46.5 12.1 11.8 3.8 12.6 0.0 36.8 1.2 5.9 18.0 8.9 1.8 3.7 10.7 5.0 8.2 3.5 5.2 11.0 10.1 16.1 5.2 11.6 17.8 16.8 2.2 5.4 13.1 34.0 7.2 11.1 9.1 1.2 1.0 7.3 8.2 3.7 24.1 8.4 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174902-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 2267.8;lymphoid tissue: 2103.1;vagina: 1595.8" "Group enriched" "Detected in many" 10 "Basal respiratory cells: 5354.5;Club cells: 2170.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Group enriched" "Detected in some" 22 "cerebral cortex: 12.0;pons: 7.3;thalamus: 19.0" "Immune cell enriched" "Detected in some" 1021 "neutrophil: 1763.3" "Lineage enriched" "Detected in single" 4377 "granulocytes: 1763.3" "Group enriched" "Detected in many" 5 "EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 1400000 "Cluster 1: Neutrophils - Mixed function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 6.1 0.7 0.2 101.9 0.5 1.8 8.8 0.2 12.0 180.1 1.2 124.3 1.9 2.3 1.1 2267.8 4.8 56.6 1.7 0.2 0.4 1.5 3.3 32.5 0.4 0.3 0.3 0.7 1.6 0.2 2.8 1.1 7.3 11.7 43.3 0.0 460.8 3.5 0.6 78.6 42.3 7.5 0.3 20.0 9.0 0.5 19.0 90.6 0.8 1.9 2103.1 44.7 1595.8 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 7.7 0.4 0.0 3.1 2.1 1.4 89.3 0.0 1.1 109.8 0.0 23.2 0.1 1.2 0.0 0.5 6.3 0.9 0.0 0.7 0.0 0.0 21.7 17.8 1.9 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.1 0.1 0.2 103.7 189.9 0.0 1.0 0.0 21.9 0.4 0.0 0.0 15.7 2.1 0.1 0.0 0.0 0.0 0.8 1.0 10.9 0.3 0.9 0.3 1.8 0.4 14.3 0.7 0.1 0.3 0.4 1.7 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1763.3 0.0 0.1 0.1 0.1 0.6 0.2 0.5 0.2 12.0 0.2 0.4 0.3 0.3 7.3 0.3 19.0 0.3 0.1 0.0 8.6 0.0 7.4 0.1 4.7 5354.5 0.0 0.0 39.4 8.4 0.2 8.6 2170.2 18.4 0.0 0.2 0.5 375.4 0.0 46.6 0.1 3.7 0.7 3.0 16.6 0.0 0.0 317.3 0.0 0.8 2.6 6.9 4.5 0.0 0.0 0.0 0.1 0.0 0.0 31.8 197.4 0.0 0.4 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 231.8 219.6 0.0 0.2 29.1 33.9 0.2 152.9 0.0 0.0 0.0 50.5 0.0 0.0 36.2 3.8 0.0 2.5 0.1 154.1 150.4 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Lipid metabolism, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 14.7 7.9 3.1 8.1 3.7 12.4 8.5 9.7 8.3 8.7 0.3 6.7 4.2 8.3 4.8 7.9 5.7 8.4 9.5 3.7 3.6 8.2 7.1 7.9 9.2 5.1 4.2 10.3 4.3 11.5 3.4 11.1 5.1 7.3 5.8 12.4 4.5 7.1 7.1 5.5 5.3 8.9 2.3 8.8 5.8 6.1 3.7 13.7 7.9 13.0 9.2 8.6 5.8 6.4 19.9 6.5 9.6 9.2 22.7 27.7 6.5 10.8 16.5 10.9 16.0 5.1 13.0 16.1 21.7 10.8 14.1 5.9 8.4 9.8 16.5 32.0 6.2 22.4 5.2 4.4 10.7 13.1 12.6 16.8 10.6 12.4 15.0 13.4 15.8 12.9 10.6 17.3 18.9 6.9 10.9 8.5 8.0 8.8 7.8 13.9 10.0 16.7 8.5 10.0 5.2 9.9 13.1 10.8 16.1 9.1 19.0 11.1 21.1 10.4 6.5 18.1 13.3 9.3 13.8 29.0 11.3 9.6 5.4 1.3 1.2 0.4 1.2 1.0 0.8 1.5 0.8 0.6 0.8 1.6 1.0 0.8 2.2 0.7 0.9 0.9 0.8 0.3 3.1 3.7 9.7 8.3 3.7 3.6 5.1 4.2 5.1 2.3 3.7 6.4 31.3 32.1 26.8 60.7 28.3 14.7 17.9 11.2 2.2 27.9 14.4 15.2 18.5 5.7 15.9 7.3 31.3 10.2 17.9 8.7 1.9 10.7 2.0 14.1 21.7 25.6 2.4 9.2 126.7 13.9 6.1 23.5 8.6 21.6 31.6 19.9 33.5 21.9 11.1 38.7 122.0 10.3 14.2 23.5 24.3 3.4 32.6 20.9 14.2 75.9 24.5 17.4 18.6 130.2 84.2 16.9 10.8 39.5 15.1 34.6 9.5 14.8 20.1 27.1 26.3 25.7 28.6 11.8 10.2 9.8 14.9 8.8 19.9 19.6 9.2 32.0 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451263-6556555 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 60.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 20.5;Hepatic stellate cells: 27.8;Inhibitory neurons: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 23 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "HaCaT: 17.7;HeLa: 14.8;hTCEpi: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.3 3.1 23.6 1.1 20.7 0.1 1.4 7.3 23.7 3.1 0.0 7.5 1.3 1.9 3.4 17.8 4.3 1.8 1.3 19.1 1.6 2.8 1.4 3.1 0.2 0.0 0.8 26.6 1.7 0.9 2.0 0.1 0.0 4.5 3.7 7.9 4.7 8.9 0.9 17.0 2.7 4.0 0.5 60.8 6.8 4.2 4.6 0.4 2.7 0.9 1.1 1.7 6.4 13.0 9.0 0.9 0.7 0.3 0.1 0.2 0.7 0.6 0.2 0.8 0.6 0.6 6.3 0.2 3.3 0.2 2.4 17.7 0.3 3.7 0.3 0.3 0.6 0.1 14.8 0.2 0.9 0.4 0.6 0.2 50.4 1.0 2.8 4.1 0.4 0.7 0.1 0.0 0.6 0.8 0.1 0.2 1.0 4.5 2.5 0.3 1.9 0.1 1.2 0.1 0.4 0.5 8.1 3.8 0.2 0.3 1.3 0.0 0.3 0.4 3.2 0.6 2.1 0.5 0.2 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 23.6 20.7 7.3 23.7 19.1 1.6 0.0 0.8 0.0 0.5 4.6 13.0 1.5 3.2 16.5 3.6 0.2 5.1 2.2 9.6 2.2 13.5 1.3 1.8 2.0 4.3 11.4 1.8 4.2 0.1 0.2 11.1 0.0 2.2 4.1 10.1 1.0 7.8 1.2 0.0 20.5 0.5 0.0 1.6 4.6 10.3 5.7 1.6 27.8 1.6 0.1 5.0 24.2 3.7 4.1 4.1 0.4 1.8 0.6 0.3 0.0 2.8 0.1 0.6 0.0 0.5 1.6 10.0 5.7 0.0 0.2 2.4 0.6 0.3 7.8 11.9 0.0 12.0 1.9 3.4 1.7 11.5 5.8 0.1 0.7 7.1 6.5 5.2 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.3 16.5 9.3 17.6 14.2 48.7 24.1 20.7 10.9 16.4 17.0 23.9 30.5 23.6 25.0 24.7 18.1 17.1 14.1 9.5 9.7 16.9 20.5 20.4 18.2 12.3 10.4 31.2 15.5 22.3 10.1 24.7 12.7 20.3 30.0 26.7 16.3 15.4 9.8 20.3 30.8 18.5 10.1 19.0 20.9 10.5 12.6 17.8 26.1 13.4 17.4 21.3 15.4 17.6 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.3 14.2 20.7 10.9 9.5 9.7 12.3 10.4 12.7 10.1 12.6 17.6 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 PNN memA ENSG00000100941 "Pinin, desmosome associated protein" Q9H307 14 39175183-39183220 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001378 Supported Supported "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA001378: AB_1079648" "unprognostic (9.28e-3)" "unprognostic (5.07e-2)" "unprognostic (5.46e-2)" "unprognostic (3.91e-1)" "unprognostic (7.38e-3)" "unprognostic (7.40e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.65e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.51e-3)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.00e-1)" "unprognostic (4.30e-2)" 57.8 60.6 42.7 68.0 46.6 135.9 60.2 50.6 48.1 82.2 77.8 83.1 56.5 81.5 129.5 74.0 77.0 41.8 54.9 42.9 51.4 87.6 124.8 61.4 87.6 47.5 45.1 84.5 78.5 40.8 90.7 53.8 47.2 83.8 63.1 76.0 65.6 48.4 59.9 67.7 90.5 48.0 43.9 103.6 70.7 58.5 47.1 65.6 88.4 27.0 69.5 69.2 73.3 50.9 152.4 72.0 193.2 94.0 45.5 37.4 141.4 116.6 35.4 82.4 81.2 112.3 232.6 229.1 72.7 53.2 69.7 156.4 153.3 85.5 138.5 105.1 109.0 158.6 243.7 246.0 39.1 201.0 107.6 55.8 73.5 80.1 65.1 115.5 57.3 119.0 149.1 128.2 65.8 122.6 145.5 170.3 126.6 76.2 114.3 188.4 137.0 64.2 65.6 219.3 93.8 50.5 126.2 90.5 69.1 133.2 114.4 117.5 92.7 115.9 90.9 52.7 142.2 102.5 87.8 194.0 59.5 167.3 70.6 9.2 13.7 22.0 17.0 11.4 16.1 22.2 12.1 10.9 11.8 25.5 17.2 16.6 27.6 15.4 16.4 22.1 14.2 6.1 42.7 46.6 50.6 48.1 42.9 51.4 47.5 45.1 47.2 43.9 47.1 50.9 105.6 192.3 125.0 40.8 170.5 126.2 244.5 84.4 153.1 203.1 77.5 87.5 63.4 61.5 164.8 60.7 56.3 113.2 230.9 129.3 35.2 89.4 59.0 155.0 178.9 127.9 136.2 121.1 33.1 58.3 100.0 117.1 101.9 289.4 142.5 273.5 69.3 67.8 62.3 153.1 35.6 96.6 71.2 69.3 72.5 53.7 156.3 93.9 49.8 25.3 89.2 138.0 193.6 41.2 54.6 76.7 126.3 151.6 116.7 172.1 82.9 28.9 111.7 172.4 151.2 166.2 161.3 212.8 149.3 145.0 112.0 99.6 170.6 211.8 123.7 245.4 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 356.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 16.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 40.0 11.1 5.1 36.0 12.6 8.3 17.8 8.9 9.9 51.8 15.5 151.0 24.1 222.0 30.5 150.1 52.6 72.5 356.9 5.5 6.5 14.3 8.4 24.8 18.6 17.2 15.3 38.3 7.2 6.2 5.0 34.4 18.0 142.8 64.8 7.6 20.0 198.6 84.1 11.0 30.9 246.4 16.2 30.8 41.5 7.1 9.2 7.7 10.9 80.5 15.1 86.7 23.0 27.3 2.2 4.4 3.3 3.2 4.6 3.3 5.4 1.7 1.7 1.8 1.7 1.9 3.9 2.5 0.8 3.2 4.3 7.0 5.0 2.7 1.9 3.3 3.1 2.5 7.1 1.2 1.1 5.4 2.8 2.6 3.0 2.5 2.6 9.1 1.5 2.8 3.9 2.9 3.1 1.7 4.1 3.4 2.3 2.4 0.9 2.6 8.5 3.7 1.4 8.1 4.0 3.1 3.3 3.9 1.9 4.4 3.4 2.4 1.9 2.5 1.5 1.9 1.5 4.2 4.3 2.7 2.4 4.4 10.2 2.4 1.7 1.5 1.6 1.0 1.4 2.0 1.1 1.0 1.5 2.1 1.3 1.0 16.2 0.7 1.5 1.7 1.7 0.5 5.1 12.6 8.9 9.9 5.5 6.5 17.2 15.3 18.0 16.2 9.2 27.3 12.5 12.8 19.8 181.5 6.0 17.3 49.0 35.6 8.6 59.3 11.1 20.6 836.8 11.5 23.0 12.9 75.0 18.1 8.6 52.9 11.7 10.1 39.2 19.3 16.1 15.2 24.0 5.2 225.7 12.9 8.4 51.4 17.3 7.6 18.9 438.3 16.4 9.6 9.4 26.9 205.0 17.2 63.1 23.5 10.9 13.1 12.2 8.2 8.8 102.1 7.8 10.2 5.2 102.5 647.4 6.3 21.1 51.1 9.6 24.3 12.8 7.1 27.4 30.4 32.9 38.6 162.7 19.3 13.9 7.1 10.9 25.4 10.7 14.2 33.9 28.4 PROSER3 "C19orf55, FLJ30657" ENSG00000167595 "Proline and serine rich 3" Q2NL68 19 35758143-35771028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 89.6;Rod photoreceptor cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058492 Approved Approved "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA058492: AB_2683733" "unprognostic (1.35e-2)" "unprognostic (1.29e-2)" "unprognostic (6.74e-3)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (9.29e-3)" "unprognostic (1.25e-3)" "unprognostic (5.13e-2)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (2.52e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (3.74e-7)" "unprognostic (8.60e-2)" "unprognostic (2.41e-1)" "unprognostic (2.87e-2)" "unprognostic (9.54e-2)" 2.3 2.4 3.4 4.3 3.7 5.2 2.3 2.3 5.2 3.4 6.7 2.9 1.8 3.8 2.8 2.5 4.3 3.3 2.5 2.8 0.6 1.9 1.3 2.7 3.0 3.6 2.7 4.1 5.1 3.1 3.8 2.8 1.6 2.4 1.9 3.6 2.6 3.1 1.7 5.8 2.6 3.3 0.0 2.9 4.0 8.8 2.6 4.6 3.8 1.4 2.6 3.1 2.9 2.5 9.3 26.7 9.4 9.3 3.7 3.8 3.1 6.7 7.6 7.3 7.7 8.2 6.3 5.2 7.3 6.4 3.5 5.5 4.0 11.8 4.9 12.5 6.8 7.5 12.2 3.4 3.2 6.0 15.6 4.6 6.5 10.2 9.0 5.7 3.2 6.7 6.6 9.3 6.4 4.6 10.7 2.5 2.6 5.4 3.9 8.2 2.3 3.9 4.7 9.8 9.2 8.1 7.4 5.4 1.0 3.5 8.7 5.1 8.2 7.7 8.1 8.0 7.2 11.9 8.6 4.2 8.0 3.8 6.1 5.7 1.7 4.0 1.1 1.0 1.9 2.4 1.7 1.0 0.4 2.6 1.4 0.5 10.3 0.8 1.0 1.5 1.6 0.2 3.4 3.7 2.3 5.2 2.8 0.6 3.6 2.7 1.6 0.0 2.6 2.5 2.6 9.6 1.5 1.6 7.4 0.0 12.8 0.0 6.2 10.8 3.1 2.9 1.4 8.6 1.8 11.0 89.6 8.2 9.4 5.3 0.0 5.9 30.0 8.9 6.3 3.4 9.5 9.5 3.7 1.9 5.4 5.6 10.2 3.6 2.5 4.4 7.5 2.6 2.8 6.7 2.1 3.9 0.0 2.8 0.0 21.2 14.3 3.3 0.0 1.0 7.0 6.0 13.4 1.0 2.1 5.3 3.4 4.1 3.4 9.2 5.3 1.8 14.6 39.5 6.6 7.9 5.0 27.2 6.5 4.0 0.0 7.3 6.6 15.4 4.7 5.7 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591004 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 47.2;Proximal enterocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.9;OE19: 18.0;RT4: 11.7;SK-BR-3: 13.3;T-47d: 14.4;U-266/84: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Cluster 1: Neutrophils - Mixed function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 1.2 0.4 0.9 1.2 0.9 0.1 7.0 1.3 2.6 4.9 0.6 8.4 12.0 1.5 12.9 13.5 4.9 4.3 1.2 0.9 1.0 11.8 6.4 3.9 0.9 1.2 0.9 0.3 13.1 28.4 15.6 2.1 1.1 6.2 7.7 0.1 11.3 9.0 0.9 12.9 11.0 1.1 0.9 1.0 9.8 0.9 1.1 2.3 13.4 0.1 3.9 6.7 5.5 1.0 11.1 0.4 0.3 0.9 1.3 0.0 4.6 0.2 0.0 0.4 0.4 2.2 14.9 0.7 1.6 0.1 0.3 8.5 0.3 8.5 0.4 1.1 1.2 0.5 0.8 0.7 0.9 0.4 1.1 0.9 7.4 0.3 0.3 0.7 3.4 0.9 0.2 0.8 0.0 2.4 0.2 0.7 0.6 18.0 1.4 0.2 0.3 8.7 6.5 11.7 2.4 0.3 1.3 13.3 0.1 1.0 14.4 0.2 0.6 0.8 0.7 0.4 0.1 5.1 18.7 0.5 0.2 0.3 0.4 0.0 0.2 0.1 0.4 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.2 0.5 0.0 0.2 1.2 0.2 0.1 0.9 0.9 1.3 2.6 0.9 1.0 1.2 0.9 1.1 0.9 1.1 1.0 6.4 6.4 13.4 0.7 3.4 4.1 11.6 20.2 29.6 2.2 21.5 22.6 0.9 8.6 14.2 12.9 2.1 13.0 4.1 47.2 3.9 31.9 0.7 10.8 4.1 6.4 16.2 1.3 0.5 33.2 6.5 1.6 16.8 16.1 2.5 2.3 1.1 6.8 2.3 5.0 0.4 18.0 8.2 1.9 1.2 0.4 0.3 3.3 1.8 1.9 8.2 0.9 2.1 2.0 0.4 27.4 29.4 0.0 4.4 14.5 46.3 15.5 8.8 4.1 0.0 0.8 3.9 1.9 2.1 23.3 4.7 12.7 4.1 4.6 20.7 14.6 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase receptor type E" P23469 10 127907103-128085855 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.9" "Cell type enhanced" "Detected in many" "dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 634.6;plasmacytoid DC: 475.9" "Group enriched" "Detected in all" 12 "dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 13.6 16.7 13.9 25.3 8.9 46.9 6.7 5.7 13.9 3.9 7.7 9.2 9.5 3.5 2.6 7.9 4.9 10.3 10.6 14.2 11.1 4.3 4.4 16.0 16.4 11.6 9.0 1.6 2.7 2.7 5.0 7.8 10.7 3.4 9.3 1.0 5.8 2.4 1.3 4.7 12.9 7.4 10.8 20.6 7.4 2.6 10.7 8.6 5.5 3.1 9.8 12.7 4.4 14.2 4.3 0.9 0.5 0.0 2.5 0.4 7.5 0.1 0.0 1.6 3.6 1.7 25.1 3.3 2.6 2.1 5.2 2.3 2.1 12.2 0.7 4.0 1.9 0.4 1.4 0.0 4.1 16.2 11.6 0.8 6.9 6.1 12.1 38.6 41.6 10.3 0.0 1.9 2.6 4.0 4.9 32.5 0.2 4.6 1.5 19.1 2.6 6.4 6.8 18.0 0.0 2.5 7.4 1.3 0.3 1.8 0.6 20.1 79.5 1.7 1.8 7.8 8.9 0.9 1.3 4.6 11.3 12.5 0.0 174.3 175.4 147.2 36.6 64.5 22.3 7.7 16.5 25.1 97.9 8.3 11.5 19.6 634.6 31.6 54.9 475.9 26.7 43.3 13.9 8.9 5.7 13.9 14.2 11.1 11.6 9.0 10.7 10.8 10.7 14.2 25.0 83.3 57.2 22.5 26.2 59.5 54.3 42.4 15.9 5.2 14.2 23.6 20.3 8.6 23.7 3.7 0.0 43.2 256.6 15.7 0.0 3.7 2.1 3.6 10.6 78.0 6.7 10.3 112.7 4.4 67.4 17.5 10.7 7.7 31.6 3.7 47.5 2.3 57.5 0.0 191.6 15.8 18.3 166.7 307.9 2.5 0.6 276.3 24.9 165.8 139.5 0.0 150.4 247.3 93.4 49.2 13.3 0.4 38.5 21.3 13.9 2.2 7.8 0.9 0.0 86.0 12.8 0.5 1.9 20.4 64.6 17.0 59.3 9.2 11.7 40.3 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332192 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 420.5;Late spermatids: 1201.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol No No 5900000 "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavorable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 73.8 47.8 26.6 44.4 27.0 82.8 48.5 40.4 37.4 42.8 22.0 47.7 41.9 41.9 68.8 63.6 40.9 34.1 48.7 29.0 29.2 44.4 140.8 39.3 39.4 26.9 27.0 37.8 64.5 50.4 30.5 77.7 26.3 48.2 47.7 42.1 38.4 43.5 153.0 64.7 40.6 55.0 22.5 36.2 41.5 59.4 27.7 58.4 42.6 123.5 49.9 67.5 42.8 30.7 132.9 114.9 158.6 102.9 107.5 166.6 179.9 200.6 162.3 172.8 116.9 190.1 140.5 184.8 79.3 218.6 156.4 181.2 221.0 175.9 172.9 126.4 73.0 96.2 112.0 147.6 140.3 174.2 79.3 141.1 161.3 165.3 248.0 136.0 124.3 79.6 158.3 133.6 159.5 215.0 169.6 88.3 170.5 231.2 133.0 125.3 209.6 87.8 149.8 122.1 144.9 98.2 138.8 193.1 125.8 237.5 197.7 70.5 114.3 129.0 127.0 161.6 152.5 91.9 181.2 98.5 138.0 101.7 138.0 0.9 1.1 1.1 1.9 1.2 2.1 1.8 1.1 1.6 1.0 2.1 1.7 1.5 2.9 2.3 0.8 1.1 2.2 0.6 26.6 27.0 40.4 37.4 29.0 29.2 26.9 27.0 26.3 22.5 27.7 30.7 49.7 44.8 40.4 32.3 54.7 195.5 148.1 40.5 79.1 40.5 65.3 36.6 117.4 68.6 42.2 35.0 27.1 269.7 37.1 82.9 50.9 89.2 420.5 69.8 80.8 68.7 101.0 76.1 54.9 77.4 259.7 79.3 60.6 90.8 36.2 83.0 55.6 209.9 99.5 50.5 47.2 83.8 38.7 65.6 131.1 1201.4 75.5 70.7 74.7 38.4 83.7 40.4 39.1 50.3 54.1 81.0 50.5 87.3 89.3 146.0 51.2 95.9 47.6 43.9 78.9 71.6 88.5 45.3 74.7 126.9 240.9 291.8 50.5 91.1 74.9 141.2 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538114 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "neutrophil: 195.6" "Lineage enriched" "Detected in all" 10 "granulocytes: 195.6" "Cell line enhanced" "Detected in all" "OE19: 239.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: AB_2679738" "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favorable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favorable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 29.7 20.4 42.7 23.4 44.1 30.7 27.8 45.8 82.2 26.8 38.6 34.1 18.7 22.1 23.5 50.3 24.8 20.3 28.5 40.7 45.1 42.7 19.9 22.6 24.0 44.1 48.0 26.3 15.4 47.9 16.8 31.4 44.4 32.6 25.4 13.5 25.0 48.2 38.5 75.9 20.4 21.1 43.6 26.5 25.7 13.0 45.3 29.3 22.9 32.5 25.4 33.8 33.3 45.1 58.9 37.6 34.2 39.0 38.3 60.7 43.3 67.7 38.1 35.6 38.0 42.6 57.5 70.5 47.0 64.8 50.2 32.8 48.1 52.7 44.2 71.4 38.5 38.5 34.6 32.7 31.2 114.8 43.0 42.0 52.2 49.6 48.7 47.7 60.6 64.6 53.7 67.7 56.2 46.3 70.7 50.9 25.4 239.5 31.9 93.6 59.4 54.2 48.4 80.7 44.7 34.8 58.2 52.8 30.9 52.3 32.9 53.8 67.4 105.0 76.9 72.3 81.9 38.7 42.9 77.9 45.6 53.4 40.5 13.0 9.6 15.7 10.3 10.6 8.7 9.9 8.7 8.8 8.7 7.5 7.3 9.4 195.6 14.8 17.8 19.8 6.4 4.5 42.7 44.1 45.8 82.2 40.7 45.1 44.1 48.0 44.4 43.6 45.3 45.1 101.8 57.7 35.7 15.3 48.0 156.4 80.9 59.9 112.7 42.6 96.0 102.2 64.8 88.6 64.6 480.1 29.2 104.2 70.9 122.6 123.3 119.4 16.1 99.1 82.6 86.9 74.2 175.7 25.4 90.7 518.6 71.6 56.1 179.4 40.5 85.8 78.9 88.3 70.1 52.2 26.7 87.7 109.9 92.8 69.7 9.5 72.7 78.4 58.7 20.6 99.6 47.6 83.4 17.1 25.3 166.3 78.2 87.3 63.2 174.4 61.0 115.0 38.6 37.3 65.7 76.8 105.6 66.7 80.0 149.6 242.5 44.6 62.6 128.4 90.1 216.4 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 199.1;skin 1: 237.7;vagina: 113.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 6.3 4.4 38.4 6.8 36.1 4.4 9.1 12.1 58.3 48.7 1.8 53.8 48.3 4.6 9.9 199.1 6.6 8.8 6.8 55.1 12.9 3.8 10.5 8.0 2.2 12.0 11.4 3.7 7.9 1.1 14.2 2.3 10.9 17.7 44.5 6.1 27.4 6.9 12.6 237.7 40.6 4.0 8.3 7.3 31.8 10.2 15.2 3.3 4.5 2.8 20.7 21.9 113.2 30.6 5.3 2.6 13.7 10.2 1.5 3.3 6.6 1.9 1.4 2.7 3.2 6.0 7.6 4.2 1.9 2.7 2.4 92.4 2.7 3.3 3.8 7.7 6.9 2.5 3.6 6.0 1.7 5.2 8.5 3.9 45.8 2.8 1.3 4.0 4.1 13.9 1.9 2.8 2.1 14.6 4.9 6.3 4.3 26.1 2.6 8.8 1.6 2.6 1.7 27.6 26.2 5.3 3.3 31.2 1.3 11.5 80.7 3.9 7.9 3.3 6.8 3.5 3.2 4.6 4.7 3.4 7.8 3.2 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 38.4 36.1 12.1 58.3 55.1 12.9 12.0 11.4 10.9 8.3 15.2 30.6 1.9 0.0 1.1 7.5 1.0 45.5 9.7 14.0 13.1 5.7 2.6 3.7 2.4 11.5 10.9 1.8 6.2 0.2 0.7 87.7 0.0 0.9 2.7 5.9 2.1 2.2 4.9 2.7 47.8 0.8 0.3 1.4 32.6 9.4 5.7 1.7 3.9 4.4 0.5 1.7 32.1 31.9 6.1 1.2 5.2 2.2 3.4 1.9 5.4 1.0 2.4 2.9 1.0 8.0 5.0 1.6 44.6 3.8 0.1 10.9 55.3 0.1 6.5 4.4 0.0 2.1 1.9 12.0 15.0 95.4 97.0 0.7 1.1 1.8 44.1 39.2 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" NA NA 19000 "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavorable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 70.1 55.8 18.4 37.7 17.6 172.0 44.6 33.5 28.0 57.8 22.2 56.0 35.1 54.5 9.2 62.3 61.4 40.8 57.3 16.5 25.0 52.2 47.7 62.2 42.3 24.2 24.0 71.1 41.2 27.3 50.0 40.9 19.4 50.2 16.9 49.5 53.4 22.3 70.3 51.2 46.9 19.2 16.0 56.4 49.7 34.3 16.9 51.1 54.2 33.1 24.1 50.7 62.1 26.5 98.8 87.6 77.0 78.5 48.8 53.8 78.8 131.0 50.6 59.6 60.2 109.3 78.5 137.5 90.6 38.9 67.9 91.2 122.3 67.9 66.5 94.6 96.7 174.6 80.7 101.2 23.4 158.6 99.9 14.4 97.6 68.9 38.4 63.7 57.8 46.4 195.5 117.6 46.3 72.2 194.5 87.9 103.2 87.5 96.8 104.9 136.2 91.7 41.5 56.2 77.9 63.4 91.1 94.7 78.4 109.3 70.6 94.6 91.4 100.8 92.5 90.5 115.8 71.6 164.3 204.0 64.7 123.2 79.2 250.9 120.4 197.5 104.7 111.1 103.6 131.1 91.5 97.6 111.8 140.5 85.7 82.1 427.7 127.2 102.2 160.9 114.7 95.7 18.4 17.6 33.5 28.0 16.5 25.0 24.2 24.0 19.4 16.0 16.9 26.5 302.0 233.9 280.9 144.3 441.7 616.4 521.0 283.0 284.0 258.5 339.1 295.4 189.2 191.6 267.6 200.5 316.9 375.2 624.9 278.1 189.8 203.8 48.1 359.2 496.0 299.7 295.3 214.2 130.1 186.0 389.6 337.9 254.9 540.8 525.8 304.4 215.3 202.1 199.8 220.4 120.9 331.3 215.7 207.7 469.5 41.9 262.5 335.5 270.3 129.3 274.3 208.7 400.6 136.2 160.5 221.3 254.8 214.4 391.0 453.6 271.8 150.6 248.0 386.5 164.3 504.0 410.2 263.5 228.1 215.8 586.9 561.6 490.8 218.2 282.8 532.1 RC3H1 "KIAA2025, RNF198, roquin, RP5-1198E17.5" ENSG00000135870 "Ring finger and CCCH-type domains 1" Q5TC82 1 173931084-174022357 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027428, HPA027434, HPA027448" Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 44: Endometrium - Transcription" Cytosol "Golgi apparatus, Plasma membrane" "HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683" "unprognostic (6.91e-2)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" "unprognostic (2.33e-2)" "unprognostic (7.73e-2)" "unprognostic (1.61e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (5.25e-2)" "unprognostic (2.15e-1)" "unprognostic (3.43e-3)" "unprognostic (6.83e-3)" 4.8 3.8 2.6 4.2 4.7 19.6 5.2 16.0 5.1 4.9 11.4 5.2 3.4 4.5 4.0 6.1 4.8 4.0 4.6 3.1 5.8 3.9 5.8 5.9 4.9 3.5 3.5 5.1 4.8 3.9 4.6 4.3 4.0 4.2 4.2 8.0 4.4 3.5 10.6 7.4 5.5 3.7 2.0 6.7 4.6 5.3 4.1 5.0 5.0 10.3 5.6 4.5 5.1 7.2 6.6 9.1 4.9 7.7 9.2 7.1 6.8 4.4 6.3 5.0 4.4 8.4 7.3 9.4 7.7 7.2 3.9 6.2 7.5 6.3 7.0 6.6 1.8 8.1 6.8 7.0 5.6 10.7 9.1 6.8 4.8 7.3 4.9 4.6 7.9 4.5 9.4 5.6 6.2 5.0 6.5 9.6 8.5 6.1 1.0 7.0 8.8 6.9 8.9 12.7 5.9 5.3 8.4 10.7 4.3 8.2 7.2 10.7 11.4 6.5 6.5 5.6 5.8 6.9 7.5 11.8 4.4 4.8 6.7 3.4 1.9 2.7 1.1 1.9 1.2 1.5 1.1 1.3 1.0 1.8 1.5 1.3 6.4 1.4 2.6 0.8 0.9 0.7 2.6 4.7 16.0 5.1 3.1 5.8 3.5 3.5 4.0 2.0 4.1 7.2 39.8 41.7 34.5 32.0 49.4 34.4 17.3 14.1 60.9 35.6 53.6 28.3 25.7 25.8 20.0 23.9 81.3 10.6 70.2 37.4 9.8 25.4 13.3 77.5 45.9 32.0 34.2 30.7 46.8 18.9 8.2 34.9 68.8 82.9 15.8 20.3 34.2 36.3 11.5 38.7 43.5 28.9 16.2 37.2 48.2 8.1 15.8 38.5 30.2 40.3 33.0 22.7 30.9 42.3 68.2 24.8 22.1 10.5 52.2 38.3 25.1 9.8 30.2 47.3 19.7 39.0 31.5 35.8 14.0 66.8 40.9 11.6 41.4 16.1 25.9 38.5 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 42.1;Collecting duct cells: 46.0;Ductal cells: 43.8;Exocrine glandular cells: 48.3;Pancreatic endocrine cells: 40.4;Proximal tubular cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844, HPA075910" Approved Approved Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544, HPA075910: " "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 34.4 47.6 73.6 26.5 74.1 47.4 34.1 73.2 90.1 42.7 66.1 41.3 31.7 35.1 45.9 38.5 38.4 32.1 24.6 74.9 76.6 51.8 57.2 29.7 34.3 77.4 77.3 51.9 52.4 76.6 43.7 28.3 77.2 36.9 38.5 50.6 39.8 29.7 24.9 45.0 36.7 33.9 76.5 38.2 42.9 104.0 78.8 34.3 44.6 27.7 34.6 37.7 35.9 78.0 34.6 36.2 30.5 46.5 113.2 47.7 32.5 41.4 71.3 49.4 42.7 36.3 58.1 28.1 40.4 78.5 101.4 43.3 37.1 37.1 54.1 39.5 31.0 37.5 51.2 61.1 64.7 41.1 49.6 52.0 95.5 55.5 53.3 84.7 45.2 29.9 26.3 62.8 69.3 50.9 24.8 44.4 22.6 44.0 41.5 31.4 33.8 22.7 41.1 40.3 43.6 44.9 26.7 50.8 98.4 47.4 42.4 44.9 36.0 55.0 29.4 78.6 31.5 63.4 39.3 31.5 57.5 40.3 31.0 12.5 6.3 6.3 9.3 8.3 8.3 8.3 7.4 9.5 4.3 5.7 6.6 8.8 23.5 5.2 8.1 6.6 9.6 3.6 73.6 74.1 73.2 90.1 74.9 76.6 77.4 77.3 77.2 76.5 78.8 78.0 22.4 16.0 13.7 0.0 7.9 0.0 0.0 0.0 0.0 0.0 42.1 32.0 0.0 0.0 6.2 46.0 0.0 31.1 21.1 0.0 21.5 43.8 0.0 21.4 19.3 8.6 0.0 0.0 0.0 48.3 37.2 11.9 0.0 30.5 5.1 29.2 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.4 0.0 0.0 0.0 0.0 40.4 0.0 0.0 5.7 0.0 0.0 42.3 2.2 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 30.1 8.2 24.2 0.0 0.0 REV3L "POLZ, REV3" ENSG00000009413 "REV3 like, DNA directed polymerase zeta catalytic subunit" O60673 6 111299028-111483715 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell type enhanced" "Detected in all" "Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064853, HPA069382" Uncertain Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm "HPA064853: AB_2685369, HPA069382: AB_2686134" "unprognostic (5.54e-2)" "unprognostic (2.06e-1)" "unprognostic (5.09e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (8.59e-3)" "unprognostic (4.42e-2)" "unprognostic (1.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.17e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.34e-2)" "unprognostic (2.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-3)" 6.1 3.6 11.2 6.4 9.2 7.2 3.1 28.8 11.9 16.6 11.3 4.8 4.3 10.3 2.3 4.6 6.2 4.9 4.4 7.2 10.0 4.1 3.5 4.4 5.6 3.6 7.9 7.6 4.2 3.2 0.9 6.8 4.4 4.8 3.5 26.2 3.2 5.0 5.0 4.7 3.6 8.0 1.8 4.6 4.5 7.5 8.4 6.0 6.6 12.2 2.5 4.8 1.0 10.7 9.2 6.3 11.4 13.3 35.2 35.0 11.9 13.6 16.7 6.4 9.6 8.1 5.0 17.0 9.3 15.9 12.0 9.4 17.6 5.7 10.7 13.9 10.0 13.9 13.9 13.3 9.1 13.5 6.9 21.0 3.2 12.0 15.4 10.3 10.2 10.0 18.3 13.9 10.8 7.2 16.7 3.6 3.2 3.8 10.2 11.6 12.7 6.6 2.5 7.9 15.7 11.8 17.5 3.2 12.4 8.5 7.1 14.2 13.7 9.6 9.6 47.0 15.4 14.0 17.1 17.6 9.1 10.5 12.4 0.6 0.6 1.2 1.0 0.5 1.6 1.0 0.8 1.0 0.6 1.6 0.5 1.0 1.9 0.4 0.9 0.9 0.7 0.3 11.2 9.2 28.8 11.9 7.2 10.0 3.6 7.9 4.4 1.8 8.4 10.7 133.4 48.1 82.4 290.6 65.7 30.5 19.5 12.8 45.5 117.5 20.2 17.9 34.5 11.5 29.1 20.2 56.3 27.2 35.3 11.8 3.9 17.3 40.0 151.1 610.1 57.4 59.8 27.5 161.7 11.5 11.9 82.7 41.3 107.5 46.9 61.5 21.8 16.0 11.8 35.3 360.2 18.6 10.2 19.9 87.4 16.3 50.4 57.2 21.4 105.9 23.7 59.6 33.0 594.7 190.3 8.5 12.3 39.1 41.3 21.3 18.4 15.9 43.5 57.6 39.5 122.3 62.3 68.5 70.4 26.1 26.9 33.0 46.4 30.3 21.5 8.2 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941830 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 24.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 74.6;Club cells: 44.8;Distal enterocytes: 52.2;Ionocytes: 46.8;Oligodendrocytes: 53.9;Pancreatic endocrine cells: 53.0;Urothelial cells: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 12.7;CAPAN-2: 41.7;HaCaT: 21.7;RT4: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 2.2 0.4 4.1 1.7 8.8 0.4 2.0 5.6 7.1 4.3 0.3 18.0 1.3 0.6 0.2 24.4 1.1 3.4 7.7 4.0 4.9 0.9 0.4 1.0 0.8 10.0 9.5 0.3 0.6 0.3 1.3 1.1 7.3 1.8 18.0 1.1 7.8 0.5 0.5 16.6 0.8 1.1 4.1 0.4 15.7 7.3 7.4 0.7 0.7 0.0 7.1 9.7 12.8 11.4 12.7 4.3 0.4 0.2 0.2 1.2 1.2 0.7 0.1 0.9 0.1 0.9 41.7 0.3 3.0 6.3 4.2 21.7 0.0 7.1 0.6 0.3 0.2 0.2 2.9 2.5 0.5 0.1 0.5 0.9 1.0 6.0 0.1 4.0 1.0 0.4 0.0 0.4 0.9 0.0 0.1 0.3 0.2 1.3 1.2 0.2 0.2 0.0 0.0 40.4 0.4 0.3 5.0 11.4 0.4 0.6 5.6 0.4 0.9 4.4 0.5 0.3 0.3 0.4 0.5 0.5 4.1 0.8 0.2 1.5 0.6 0.4 0.2 0.4 0.1 0.7 0.2 0.1 0.7 0.3 0.2 0.2 1.7 0.3 0.2 0.7 0.3 0.3 4.1 8.8 5.6 7.1 4.0 4.9 10.0 9.5 7.3 4.1 7.4 11.4 1.3 0.0 0.5 11.1 0.7 17.7 8.0 74.6 5.2 2.7 3.9 2.4 0.4 5.7 44.8 3.7 0.0 0.4 0.2 52.2 0.0 12.4 3.9 4.7 3.4 1.4 2.4 0.0 19.0 15.8 0.3 2.1 27.5 8.4 4.5 1.6 1.8 0.0 0.2 1.7 21.9 17.3 46.8 0.0 2.7 1.0 0.6 0.4 1.8 4.7 0.6 1.3 0.0 10.6 53.9 53.0 22.3 0.0 0.2 13.4 0.2 0.3 33.2 1.8 6.6 1.2 4.0 0.3 0.1 19.0 28.4 0.7 0.5 0.2 30.2 49.9 RICTOR "AVO3, KIAA1999, MGC39830, PIA" ENSG00000164327 "RPTOR independent companion of MTOR complex 2" Q6R327 5 38937920-39074399 "Predicted intracellular proteins" "Host-virus interaction" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 258.9;Oligodendrocytes: 343.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 30.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 30.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037802, HPA037803" Approved Approved Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Mitochondria "HPA037802: AB_10672286, HPA037803: AB_2675676" "unprognostic (2.25e-2)" "unprognostic (8.30e-2)" "unprognostic (4.02e-1)" "unprognostic (7.94e-3)" "unprognostic (5.47e-2)" "unprognostic (2.95e-3)" "unprognostic (2.95e-3)" "unprognostic (1.33e-1)" "unprognostic (3.55e-2)" "unprognostic (4.37e-1)" "unprognostic (2.73e-2)" "unprognostic (8.29e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-2)" 7.7 5.5 7.3 8.8 10.2 24.5 9.4 17.4 9.9 7.7 0.9 7.1 5.4 9.2 6.3 5.5 6.9 6.2 10.0 8.4 7.2 7.0 7.7 9.9 11.3 9.1 7.0 10.0 6.2 6.7 4.9 8.9 10.6 6.6 6.6 26.3 6.4 5.1 11.7 8.4 7.9 6.8 9.2 10.2 7.0 9.3 7.6 12.8 8.6 11.5 9.2 7.1 7.2 16.9 5.9 10.6 7.6 7.6 9.5 10.8 11.1 8.1 18.7 8.7 8.7 6.5 10.5 9.7 3.0 8.0 13.2 9.5 6.7 8.8 10.5 8.6 6.0 11.4 25.4 7.9 6.1 9.7 14.6 9.2 6.4 10.8 11.8 8.6 14.6 7.8 9.4 18.1 5.9 3.1 9.9 16.0 4.9 3.1 8.2 7.9 13.6 8.6 7.2 9.7 6.4 4.4 21.1 7.8 10.9 7.1 5.4 10.5 12.5 17.6 8.5 7.2 6.1 8.0 5.3 9.5 7.5 12.7 6.6 8.7 1.4 8.5 4.9 1.4 4.0 3.8 4.9 4.3 1.5 4.6 5.2 6.0 30.3 3.7 3.4 5.1 3.3 0.8 7.3 10.2 17.4 9.9 8.4 7.2 9.1 7.0 10.6 9.2 7.6 16.9 32.9 64.1 50.2 72.8 62.4 48.8 39.6 38.7 27.3 69.6 28.6 13.5 38.4 28.6 34.7 27.6 204.3 40.5 65.6 28.0 0.0 25.9 2.3 33.0 31.1 43.0 43.6 73.4 153.8 15.9 20.6 37.4 30.1 35.1 33.0 32.9 49.2 33.0 19.3 52.2 153.9 26.0 22.4 40.6 47.6 5.3 47.5 36.3 33.8 108.7 45.2 28.8 74.2 258.9 343.1 28.1 29.9 32.4 48.7 65.8 30.7 15.3 38.0 176.0 13.1 43.6 34.6 36.5 33.2 18.3 45.0 96.5 70.9 21.3 19.6 74.6 RIPK4 "ANKK2, ANKRD3, DIK, PKK, RIP4" ENSG00000183421 "Receptor interacting serine/threonine kinase 4" P57078 21 41739369-41767089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 52.3;Endometrial ciliated cells: 76.5;Gastric mucus-secreting cells: 61.2;Glandular and luminal cells: 174.2;Squamous epithelial cells: 71.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.2;GAMG: 41.2;HaCaT: 47.5;hTCEpi: 31.4;RPTEC TERT1: 28.3;RT4: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA030942 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "HPA030942: AB_2732462" "unprognostic (8.93e-2)" "unprognostic (2.67e-1)" "unprognostic (6.32e-3)" "unprognostic (7.87e-2)" "unprognostic (1.24e-1)" "unprognostic (5.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.22e-5)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.98e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.69e-1)" "unprognostic (2.95e-3)" "unprognostic (2.28e-1)" "unprognostic (2.78e-2)" 1.6 0.0 0.1 0.4 0.0 0.6 4.3 0.0 0.1 11.8 3.7 3.1 9.7 1.1 2.4 72.2 5.8 5.2 1.5 0.1 0.1 11.5 19.1 4.2 0.1 0.3 0.6 0.1 14.3 7.4 10.8 2.3 0.1 10.7 2.0 0.6 14.8 9.8 0.0 21.5 13.6 0.1 0.1 0.0 15.5 2.0 0.1 7.8 7.9 0.0 5.2 6.3 22.3 0.1 14.3 9.0 0.0 0.0 0.0 0.0 13.7 0.1 0.1 0.2 0.2 23.5 32.2 0.0 13.3 2.9 41.2 47.5 0.7 19.2 0.0 0.0 9.4 0.0 6.9 8.8 0.0 0.0 0.0 0.0 31.4 0.2 4.2 0.0 0.0 14.3 0.0 0.0 0.0 10.3 2.0 0.0 0.8 9.3 26.1 0.0 0.0 2.3 28.3 30.8 4.5 0.3 15.5 15.7 15.1 1.3 9.6 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 4.2 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.1 0.1 28.9 9.1 0.0 0.1 15.8 27.4 24.0 52.3 0.0 13.0 12.4 1.1 17.2 28.0 3.7 0.0 8.3 0.3 22.8 9.8 12.4 1.5 76.5 16.9 0.9 22.7 0.0 0.0 10.4 5.1 0.6 61.2 174.2 2.5 0.0 0.0 17.0 1.0 0.0 0.0 14.2 16.2 0.6 1.4 1.6 0.0 0.9 7.2 0.0 0.0 0.4 0.0 0.0 0.0 19.0 11.8 0.0 0.0 24.0 26.5 13.5 22.2 0.9 0.0 0.0 1.3 1.4 2.5 71.2 15.2 2.5 1.5 0.0 11.2 24.1 RNF103-CHMP3 RNF103-VPS24 ENSG00000249884 "RNF103-CHMP3 readthrough" 2 86505668-86721122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 3.9;heart muscle: 4.1" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Excitatory neurons: 17.6;Inhibitory neurons: 12.3;Microglial cells: 6.5;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.4" "HPA015673, HPA073383" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA015673: AB_1858761, HPA073383: AB_2732224" "unprognostic (3.77e-2)" "unprognostic (5.47e-2)" "unprognostic (8.91e-4)" "unprognostic (9.64e-3)" "unprognostic (1.39e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-4)" "unprognostic (3.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.56e-2)" "unprognostic (5.83e-3)" "unprognostic (7.12e-2)" "unprognostic (8.90e-3)" "unprognostic (4.68e-2)" "unprognostic (6.56e-2)" "unprognostic (6.45e-2)" "unprognostic (6.94e-3)" 0.4 0.3 1.1 0.9 1.4 4.3 1.1 3.6 3.9 0.4 0.0 0.5 0.7 0.4 0.0 0.7 0.6 0.4 4.1 1.6 0.4 0.2 0.4 0.2 0.3 2.0 0.7 0.3 0.1 0.3 0.2 0.6 1.0 0.4 0.3 0.4 0.1 0.4 2.2 0.3 0.3 0.3 0.4 0.3 0.9 1.2 0.8 0.6 0.2 0.5 0.5 0.1 0.2 1.9 1.5 0.4 0.9 1.0 1.0 0.0 1.6 1.2 0.6 0.7 1.0 1.3 2.0 2.3 0.8 0.7 11.4 0.6 0.3 0.3 0.2 1.6 0.6 0.8 0.0 1.0 0.2 1.0 1.3 0.8 0.2 0.4 1.1 1.1 0.1 2.5 0.9 1.2 1.3 0.3 2.0 1.0 0.0 0.6 0.2 4.7 2.1 0.1 0.1 1.2 1.7 1.5 1.7 1.8 0.7 0.2 0.2 1.2 0.5 0.6 3.9 0.8 0.9 1.8 0.4 2.1 0.8 1.4 0.2 0.0 0.3 0.2 0.1 0.4 0.5 1.3 0.3 0.4 0.4 1.7 0.1 0.1 2.0 0.7 0.0 1.8 0.2 0.2 1.1 1.4 3.6 3.9 1.6 0.4 2.0 0.7 1.0 0.4 0.8 1.9 0.0 0.0 1.1 5.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.3 17.6 0.4 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.5 0.0 0.0 1.0 10.1 4.2 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 81.6;Inhibitory neurons: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 8.2 7.5 2.0 11.8 3.1 17.3 7.8 8.7 5.3 8.6 1.4 7.2 8.4 9.0 6.7 11.4 8.7 9.3 7.3 3.5 4.7 8.8 10.5 8.4 10.8 1.4 1.7 11.4 9.2 11.9 4.3 11.4 2.1 8.7 7.2 12.5 8.1 8.3 9.5 8.2 8.0 8.3 1.2 11.0 9.0 9.4 3.2 11.5 11.6 11.8 13.3 10.3 7.2 4.3 13.8 31.3 19.6 16.8 16.6 18.5 16.7 17.6 20.6 17.2 22.0 13.9 8.9 16.8 19.4 24.8 14.7 26.3 5.3 13.1 21.3 17.6 11.1 20.9 12.6 10.7 18.0 12.3 22.6 14.7 14.0 18.6 20.4 15.6 19.5 15.4 19.7 16.4 21.5 6.7 16.3 7.9 16.1 4.3 12.0 16.2 27.9 13.8 13.1 24.2 16.0 23.3 15.8 15.5 14.7 22.7 12.2 14.9 22.6 27.4 22.8 14.5 17.1 11.8 17.3 19.9 16.7 19.5 21.1 11.4 15.0 15.7 7.0 11.0 7.1 11.8 7.2 6.5 8.3 10.9 7.9 6.3 41.0 5.6 13.0 7.9 10.0 3.4 2.0 3.1 8.7 5.3 3.5 4.7 1.4 1.7 2.1 1.2 3.2 4.3 11.7 3.2 14.4 34.6 31.9 20.1 12.3 7.3 26.7 12.2 13.0 10.2 19.7 7.2 10.6 12.9 8.4 9.0 12.8 10.0 3.9 12.6 27.6 14.4 15.1 15.3 16.2 11.6 81.6 6.9 10.5 15.0 17.3 15.8 15.8 12.3 17.9 11.2 13.4 10.1 80.4 10.0 12.2 19.8 15.7 7.5 7.8 21.2 12.4 56.2 22.7 8.4 16.5 65.4 66.2 12.9 11.4 14.7 19.5 14.5 11.6 9.9 14.9 13.6 26.3 15.1 13.6 13.8 8.9 27.3 19.9 32.0 21.4 11.8 9.2 21.2 ROCK1 p160ROCK ENSG00000067900 "Rho associated coiled-coil containing protein kinase 1" Q13464 18 20946906-21111813 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 406.2;Late spermatids: 505.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004562, HPA007567, HPA045639" Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401" "unprognostic (7.86e-2)" "unprognostic (2.86e-2)" "unprognostic (1.22e-1)" "unprognostic (6.63e-2)" "unprognostic (9.90e-2)" "unprognostic (1.17e-1)" "unprognostic (6.74e-2)" "unprognostic (1.00e-1)" "unprognostic (1.63e-1)" "unprognostic (8.89e-3)" "prognostic unfavorable (9.93e-4)" "unprognostic (3.85e-2)" "unprognostic (8.93e-3)" "unprognostic (3.04e-2)" "unprognostic (5.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.28e-1)" 8.0 4.2 3.8 5.7 4.8 18.2 6.0 4.4 3.9 5.3 4.6 5.0 3.6 5.9 4.6 4.2 6.3 4.2 5.5 2.8 3.5 4.4 4.8 7.6 5.5 5.4 4.0 5.4 5.1 2.9 2.9 4.4 4.9 4.4 3.2 4.8 4.4 3.4 2.6 3.7 5.2 3.2 4.4 6.2 5.8 2.6 4.5 5.5 4.5 1.9 4.2 6.6 5.4 5.3 6.5 3.9 3.9 3.8 7.2 7.7 6.3 8.9 4.3 3.9 4.2 6.6 2.7 8.0 6.2 10.5 2.1 5.2 3.6 5.2 7.8 11.4 4.1 6.4 7.3 2.9 3.6 17.9 9.6 5.6 4.6 5.8 4.7 3.2 6.0 3.1 3.7 7.9 4.6 4.1 8.5 3.8 3.2 4.3 6.6 11.9 4.5 3.1 3.7 5.9 4.5 3.5 7.1 4.6 3.6 3.4 4.6 6.7 9.9 7.7 6.4 7.1 7.2 10.7 5.3 9.0 5.8 7.5 4.8 3.0 5.0 6.8 5.0 3.2 4.0 3.9 3.6 3.8 4.2 5.0 3.5 3.5 18.0 2.8 4.0 5.5 3.6 2.5 3.8 4.8 4.4 3.9 2.8 3.5 5.4 4.0 4.9 4.4 4.5 5.3 98.2 96.1 88.7 64.6 112.6 46.3 60.4 30.7 43.9 100.4 32.2 35.6 138.6 28.6 61.4 33.1 131.3 57.5 136.9 36.6 15.6 62.5 406.2 64.8 86.9 94.4 99.0 47.9 81.3 38.0 64.9 78.4 62.7 73.8 72.7 68.5 60.0 47.4 60.3 60.6 74.2 45.8 40.7 135.3 126.7 505.0 97.6 166.2 65.8 106.8 137.1 52.3 204.9 87.0 140.0 70.9 62.8 138.8 83.2 63.2 32.3 21.0 44.6 128.6 170.9 81.4 197.6 107.4 80.9 38.7 36.7 43.0 127.4 70.5 38.9 73.3 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327544 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 14.6" "Cell line enhanced" "Detected in many" "HL-60: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: AB_2686603" "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 19.2 5.7 4.7 4.4 4.6 12.2 16.8 5.2 5.5 10.2 15.5 9.1 3.0 11.6 2.5 5.5 15.0 5.5 9.8 4.6 6.3 6.2 3.7 14.8 3.7 7.6 7.0 6.2 7.5 2.6 32.9 3.7 5.8 6.9 3.6 12.1 5.2 2.6 12.1 6.0 9.4 4.5 6.6 5.1 6.8 8.1 5.3 4.7 9.7 3.7 3.2 8.7 8.2 5.4 4.7 6.0 3.4 3.2 3.6 5.2 2.7 5.8 6.5 4.1 4.8 2.7 2.6 7.1 1.8 3.9 3.4 4.4 4.1 1.8 5.6 7.5 7.9 2.5 2.7 5.5 3.3 31.8 5.8 8.0 2.4 8.7 9.2 1.6 18.9 7.5 3.3 0.0 5.7 1.5 9.1 17.7 8.7 2.9 7.5 6.8 11.7 6.4 3.6 3.0 2.7 5.2 6.4 2.6 7.2 5.1 1.7 5.4 22.4 4.5 8.0 10.7 7.2 1.9 3.9 6.0 10.6 6.1 6.2 1.3 2.6 5.9 1.3 2.4 2.9 1.9 1.5 1.8 2.6 1.5 2.2 1.8 14.6 1.7 2.0 1.8 1.9 1.8 4.7 4.6 5.2 5.5 4.6 6.3 7.6 7.0 5.8 6.6 5.3 5.4 75.2 16.0 32.6 21.2 21.8 7.9 13.5 6.6 7.4 29.5 8.8 8.8 8.0 8.6 18.0 1.8 62.6 5.8 14.0 12.6 3.9 15.3 51.4 146.1 30.4 61.3 17.4 5.5 21.8 8.6 9.5 11.8 9.2 21.0 20.3 73.5 121.7 9.7 7.8 35.3 20.0 13.5 10.2 16.2 8.4 9.1 7.8 14.5 5.4 18.7 15.5 9.4 14.4 9.0 17.1 9.9 8.9 4.5 11.0 10.2 5.0 3.1 119.2 85.7 0.0 23.1 12.9 24.9 25.3 4.8 5.8 8.2 17.2 6.6 8.9 11.2 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 943.6;tongue: 422.7" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 134.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049136 Enhanced Approved "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nuclear speckles" "HPA049136: AB_2680648" "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 0.3 0.4 0.9 0.2 0.6 1.7 1.4 1.7 0.8 0.0 1.0 0.2 0.6 0.3 0.4 8.5 0.1 0.5 174.0 0.5 0.4 0.4 0.3 0.2 0.4 0.1 0.0 0.3 11.5 0.0 0.1 0.2 0.1 4.2 0.0 1.2 6.9 0.1 943.6 0.7 0.5 0.0 0.0 0.4 0.2 6.4 0.1 0.1 0.4 422.7 0.1 0.2 0.1 1.0 1.1 1.2 0.3 1.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 4.0 2.1 0.6 0.7 0.0 1.0 1.1 0.1 0.1 0.0 0.5 0.6 0.4 0.9 1.4 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.7 0.0 0.7 0.4 2.8 0.0 0.6 0.8 1.0 0.6 1.2 2.5 0.4 0.3 0.9 0.1 0.4 1.6 0.5 0.5 1.4 0.6 0.7 0.7 0.6 0.6 0.6 1.4 0.8 0.4 1.2 0.6 0.5 0.8 0.2 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.3 0.1 0.4 0.3 0.3 1.2 0.2 0.3 0.4 0.1 0.1 0.9 0.6 1.7 0.8 0.5 0.4 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.2 0.0 0.0 0.1 0.6 134.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.1 1.3 0.0 5.3 0.1 0.0 0.2 2.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 23.7 2.2 0.7 2.4 0.0 0.4 0.0 0.2 0.1 0.1 0.5 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696459-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 349.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 60.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 60.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 7.3 6.4 8.7 11.5 9.1 8.2 12.1 19.0 12.1 10.3 10.2 11.3 9.0 12.5 10.3 10.8 9.5 7.3 5.6 8.5 10.5 9.1 11.3 10.5 16.1 8.2 9.0 14.5 11.2 10.3 6.9 9.9 8.6 10.3 11.7 30.2 9.6 11.4 8.2 7.8 10.4 11.0 9.0 15.0 11.0 26.3 8.6 18.3 16.5 7.6 15.0 9.6 8.2 11.6 15.8 11.9 19.6 34.5 13.4 17.0 9.5 11.5 12.4 16.0 18.2 14.9 27.6 32.4 4.4 12.0 20.2 13.4 26.8 15.0 22.8 17.7 14.4 25.8 18.4 14.7 11.3 32.1 23.3 12.2 10.7 14.7 16.0 12.1 13.5 21.2 35.7 33.0 16.8 18.2 27.7 32.1 14.0 20.3 10.6 28.3 19.6 34.2 10.0 20.5 22.9 24.0 17.5 31.4 12.6 19.9 19.2 16.9 12.9 23.9 21.9 14.5 17.7 14.7 16.7 51.6 11.4 29.2 16.0 21.6 7.4 13.5 9.5 5.8 7.3 11.0 8.4 7.1 4.4 13.5 7.8 8.6 60.6 6.4 6.7 13.9 9.3 2.6 8.7 9.1 19.0 12.1 8.5 10.5 8.2 9.0 8.6 9.0 8.6 11.6 53.6 57.7 60.3 27.1 85.0 78.8 102.1 76.1 88.8 246.8 52.1 57.3 22.1 61.5 84.4 55.2 235.6 52.7 101.5 77.1 39.2 38.1 271.3 55.5 63.3 60.8 77.5 47.7 44.3 50.4 34.1 55.6 51.5 45.6 70.3 51.3 49.2 56.5 43.7 158.2 47.5 104.6 57.0 48.1 69.0 85.2 101.5 46.4 64.0 34.7 59.0 83.2 132.8 53.8 50.1 35.1 62.7 119.6 74.6 56.7 49.6 28.4 72.0 349.9 72.3 44.2 73.0 108.0 156.7 56.2 75.3 38.7 90.2 61.7 79.1 84.0 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.0" "Group enriched" "Detected in many" 6 "Early spermatids: 139.7;Late spermatids: 252.0" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 7.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.7" "Cell line enhanced" "Detected in some" "GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.3 2.0 7.7 0.2 9.4 0.2 0.4 5.9 11.8 1.0 9.4 0.6 0.2 0.8 3.5 0.4 12.4 1.3 0.4 8.3 9.9 7.3 0.4 1.5 0.2 8.6 10.9 3.9 0.9 2.4 3.7 0.1 7.7 0.8 0.2 11.4 0.6 1.7 0.7 1.1 0.3 0.3 7.6 0.5 0.7 25.0 7.2 0.1 1.9 0.1 0.2 0.2 0.4 9.5 0.2 2.5 1.9 2.0 0.0 0.9 0.1 0.0 0.5 0.4 0.4 0.4 0.7 0.5 0.7 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.1 1.0 0.0 0.2 0.4 0.0 1.2 0.0 0.8 0.0 1.0 0.0 0.3 0.3 0.4 0.0 0.6 0.0 0.1 0.0 2.0 4.2 0.0 2.7 0.9 0.0 0.0 0.1 0.1 0.3 0.5 0.0 1.5 0.5 0.1 0.0 4.9 1.9 1.6 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 7.7 0.1 1.8 0.0 0.0 0.6 7.7 9.4 5.9 11.8 8.3 9.9 8.6 10.9 7.7 7.6 7.2 9.5 1.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.5 0.1 1.5 3.7 0.0 4.2 0.0 0.2 0.0 7.9 1.0 139.7 17.8 0.5 0.4 0.0 0.0 3.5 0.2 0.0 0.5 0.0 0.5 0.0 1.2 0.7 0.0 0.1 11.8 2.8 0.1 0.0 0.0 0.0 252.0 2.1 0.3 0.0 0.0 0.0 4.6 0.0 1.0 1.1 0.4 0.0 1.9 0.1 0.2 0.0 17.7 29.2 5.1 0.0 0.8 0.9 29.4 8.3 0.0 0.0 0.0 0.4 2.8 0.1 0.3 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3" 6 158972871-159000202 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 149.3;Respiratory ciliated cells: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039109 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Cytosol "HPA039109: AB_10794423" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 2.9 4.7 0.8 2.2 1.0 1.6 3.7 0.2 4.7 3.9 14.5 4.2 5.9 3.4 4.6 5.7 6.1 3.3 3.8 2.0 1.0 6.3 2.7 4.6 1.4 1.9 2.6 3.4 4.3 13.2 3.5 3.1 1.5 5.2 3.7 6.7 4.4 4.1 1.5 3.8 5.6 3.7 1.6 2.3 4.1 9.9 1.1 1.8 7.6 2.2 2.0 2.9 3.0 1.6 8.5 3.7 2.1 4.9 4.8 6.3 2.2 6.2 7.0 1.9 2.8 1.2 4.6 1.7 4.8 7.2 6.3 6.1 1.4 5.6 2.8 4.4 2.9 2.2 3.9 2.6 4.6 2.4 1.6 7.1 9.5 3.8 6.9 10.0 2.5 2.5 2.8 2.6 4.5 4.3 1.5 2.7 1.2 3.8 2.7 2.2 0.3 1.6 8.6 2.6 2.8 4.0 11.6 3.8 2.2 2.4 4.7 5.3 5.4 2.0 5.5 4.8 3.0 2.9 6.1 1.2 10.1 2.9 3.9 0.9 4.0 0.6 0.6 3.0 1.2 0.9 0.9 1.2 4.0 2.4 0.7 1.1 10.5 1.7 7.0 4.6 1.3 1.5 0.8 1.0 0.2 4.7 2.0 1.0 1.9 2.6 1.5 1.6 1.1 1.6 2.3 25.6 17.9 15.0 4.0 7.4 17.2 19.1 6.2 14.2 12.2 7.6 17.5 17.2 25.1 22.0 35.5 10.3 5.7 25.6 13.7 15.8 149.3 67.0 6.9 6.0 13.1 2.1 32.8 10.2 11.4 7.6 10.2 12.7 2.5 9.2 7.9 8.4 10.1 3.3 18.5 17.6 16.2 9.5 16.5 62.9 14.0 12.6 7.2 4.7 8.3 14.4 4.1 6.0 3.5 13.1 21.1 17.7 5.7 18.4 33.1 19.7 120.4 32.5 6.6 5.9 10.2 57.3 10.9 18.6 8.8 5.9 6.1 12.2 13.1 23.1 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446623 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 524.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 8.6 5.4 2.0 0.8 2.0 2.7 7.8 1.4 2.3 9.4 0.9 9.5 0.8 10.0 0.6 7.1 8.5 1.2 5.7 1.8 2.2 7.6 8.6 11.5 0.8 1.5 1.6 10.9 4.7 0.8 5.9 2.2 1.4 8.7 1.0 2.1 6.7 1.2 4.4 8.3 7.4 1.4 1.4 8.6 7.0 8.1 2.0 1.5 5.8 0.8 1.0 8.8 7.9 2.0 0.9 0.9 1.7 1.6 1.5 1.5 1.1 0.9 2.0 1.7 2.1 1.6 1.2 1.0 0.9 1.5 2.0 0.4 1.9 1.4 2.1 6.0 1.0 4.7 1.2 0.7 1.1 0.9 1.1 2.3 1.7 2.2 3.5 2.2 0.5 1.1 1.4 3.1 1.4 1.4 1.3 0.9 3.1 2.7 1.1 1.4 1.5 0.6 1.3 1.0 1.3 5.2 2.4 2.3 1.2 2.7 0.7 1.1 1.3 2.2 1.6 1.3 0.8 2.5 2.7 0.9 1.1 1.6 2.4 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.8 0.1 0.2 0.2 0.1 0.1 2.0 2.0 1.4 2.3 1.8 2.2 1.5 1.6 1.4 1.4 2.0 2.0 67.4 57.7 27.6 29.4 39.1 107.2 67.8 19.2 46.1 74.7 75.5 51.4 39.2 32.9 28.9 42.3 16.7 26.9 63.1 58.7 33.2 21.1 27.3 67.5 103.7 70.9 81.2 42.7 49.5 24.0 51.7 61.5 13.7 87.5 69.0 27.1 55.0 40.5 16.5 38.7 64.2 50.5 26.4 37.6 77.3 13.4 25.7 71.3 35.6 60.9 31.9 22.4 27.8 42.7 524.1 32.8 49.0 43.6 49.0 65.0 16.8 24.7 32.3 40.8 32.9 74.9 42.1 57.9 37.0 51.7 97.0 186.9 44.3 98.5 34.9 65.1 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 14.0 10.8 17.1 7.2 22.8 17.0 10.4 20.8 18.7 14.8 10.3 7.2 6.1 11.1 7.2 15.6 10.7 9.2 11.3 17.1 17.8 7.3 7.5 10.1 6.9 23.4 24.9 13.6 5.1 9.6 9.2 11.5 22.5 8.1 4.9 22.6 7.7 8.0 27.1 7.1 6.8 10.1 23.6 7.9 5.6 15.2 21.0 6.3 7.8 14.7 6.1 9.5 12.9 29.7 8.7 7.8 12.7 10.0 28.1 25.8 15.1 14.8 29.9 9.1 11.7 12.8 12.4 5.9 9.4 14.3 10.5 15.3 6.8 11.3 15.9 7.2 8.3 2.6 8.0 8.6 15.6 2.7 6.8 24.4 11.2 18.0 24.8 24.6 14.1 6.7 5.6 10.4 21.0 6.1 5.1 4.1 5.7 6.4 23.9 4.4 10.6 2.8 10.3 7.8 1.8 8.7 13.9 17.8 15.1 13.6 7.4 3.1 22.6 10.5 13.7 12.6 10.4 6.9 6.9 6.0 16.4 7.0 6.7 3.1 3.7 2.5 2.9 4.8 1.8 5.5 3.2 3.4 3.4 5.9 2.7 3.1 19.2 4.0 6.6 3.8 3.0 1.3 17.1 22.8 20.8 18.7 17.1 17.8 23.4 24.9 22.5 23.6 21.0 29.7 24.6 9.6 12.5 25.1 25.0 42.3 28.1 34.2 23.9 20.9 21.4 11.3 26.7 10.0 26.5 14.7 14.6 10.4 18.1 10.0 0.0 10.9 47.6 17.3 29.8 24.3 23.4 4.4 50.9 10.2 12.5 29.4 10.2 23.1 12.7 18.5 23.2 10.9 13.2 18.5 37.2 3.3 26.4 16.3 48.4 10.9 25.1 27.8 12.4 35.6 27.8 20.5 12.3 38.2 77.1 16.3 11.4 25.2 22.2 22.3 11.8 7.7 35.4 32.7 32.9 30.9 23.9 54.7 24.3 42.9 42.9 68.0 20.2 12.4 5.2 40.3 SBK2 SGK069 ENSG00000187550 "SH3 domain binding kinase family member 2" P0C263 19 55528611-55537133 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 28 "heart muscle: 87.2;tongue: 28.8" "Group enriched" "Detected in some" 6 "Early spermatids: 1.5;Late spermatids: 2.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;MCF7: 2.5;NTERA-2: 7.7;RH-30: 7.0;SuSa: 3.5;U-2 OS: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030631 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 38: Heart - Muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "HPA030631: AB_10602088" "unprognostic (1.33e-1)" "unprognostic (1.85e-3)" "unprognostic (4.57e-1)" "unprognostic (3.49e-1)" "unprognostic (5.43e-3)" "unprognostic (4.18e-3)" "unprognostic (2.08e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-1)" 0.6 0.0 0.1 0.0 0.2 0.5 0.0 0.9 0.1 0.0 0.8 0.0 0.2 0.3 0.0 0.2 0.0 0.1 87.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 28.8 0.0 0.0 0.0 0.3 0.0 2.5 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.6 1.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.5 2.5 0.0 0.1 7.7 0.0 0.0 0.2 7.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 3.5 0.0 0.2 0.1 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.1 0.2 0.1 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SBNO2 "FLJ00173, KIAA0963, Sno, Stno" ENSG00000064932 "Strawberry notch homolog 2" Q9Y2G9 19 1107637-1174268 "Predicted intracellular proteins" "Differentiation, Osteogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 45.3;HDLM-2: 65.2;U-266/70: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041867 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "HPA041867: AB_2677715" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (6.20e-3)" "unprognostic (4.68e-2)" "unprognostic (8.48e-3)" "unprognostic (1.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (1.58e-3)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (7.98e-8)" "unprognostic (1.34e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.88e-1)" 61.3 42.8 2.8 8.5 2.9 11.4 40.2 1.8 5.0 35.7 4.6 31.8 1.9 28.0 0.2 51.8 33.8 3.0 27.1 0.9 3.2 57.8 41.5 68.4 2.7 12.0 5.4 30.9 21.4 0.2 37.8 2.4 5.4 42.7 0.3 0.1 42.9 0.7 38.6 43.0 30.8 2.1 3.5 60.0 30.0 19.3 8.6 1.5 34.2 0.5 2.5 32.1 35.7 5.5 45.3 5.7 0.8 0.5 0.1 2.8 16.1 13.0 1.4 2.9 1.6 0.3 7.3 9.0 18.2 2.2 2.3 14.6 0.0 2.0 1.0 65.2 9.8 9.9 18.3 0.1 2.4 5.8 28.7 6.8 1.8 4.3 1.7 2.2 2.8 3.9 15.3 12.4 1.1 5.5 5.7 7.4 12.3 0.9 19.1 13.1 7.9 11.0 4.0 2.1 10.3 16.1 7.9 14.2 15.8 1.1 5.0 4.6 15.0 7.9 6.2 23.6 22.1 49.0 24.8 7.8 15.7 5.3 9.0 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.5 0.1 0.1 0.1 0.0 0.1 2.8 2.9 1.8 5.0 0.9 3.2 12.0 5.4 5.4 3.5 8.6 5.5 28.8 9.6 22.8 4.6 8.8 14.9 13.2 10.7 11.4 5.7 39.7 23.9 5.4 5.7 18.8 3.7 2.1 4.7 13.2 22.3 3.9 9.4 2.8 19.3 21.9 25.3 3.0 0.4 4.4 6.8 5.7 13.1 33.6 39.1 3.8 10.4 13.9 10.8 10.3 6.7 3.4 10.2 14.2 15.9 20.7 1.6 9.3 20.2 8.8 5.6 13.0 3.3 5.2 3.5 5.8 17.9 15.1 4.1 16.2 20.8 7.9 1.8 14.5 4.9 6.6 12.0 12.9 7.7 9.0 10.6 18.8 10.9 14.4 9.5 12.3 22.1 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642209-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: AB_2682536" "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 25.4 22.6 24.5 19.0 22.8 17.4 23.7 11.2 31.1 27.2 0.0 30.3 19.3 32.2 6.9 28.1 26.5 18.0 28.3 29.5 13.6 21.1 26.2 21.5 20.4 31.1 21.7 28.9 22.2 17.8 29.4 16.0 22.7 26.7 8.7 11.2 23.2 11.3 47.3 28.3 22.3 15.1 10.7 23.5 23.0 28.2 22.5 17.3 24.7 16.9 13.9 28.7 24.9 21.3 84.1 143.1 38.7 64.0 18.0 17.1 47.2 61.9 20.0 28.4 23.8 78.2 50.6 48.5 41.4 22.9 42.8 63.2 28.0 37.9 8.3 75.4 80.5 54.6 72.9 40.1 30.8 52.1 52.0 28.7 23.5 34.1 24.0 27.4 23.1 19.5 71.6 48.1 22.6 53.4 53.2 28.3 49.6 37.8 86.1 64.7 53.6 50.1 18.7 118.5 57.2 62.7 63.5 66.0 23.4 23.4 46.2 29.0 63.9 102.0 59.1 37.0 91.6 68.5 110.2 46.3 61.6 32.8 59.1 2.0 1.4 1.4 1.9 1.2 1.2 2.8 1.0 1.3 1.1 2.1 1.0 1.1 3.6 1.0 1.1 2.4 0.2 1.8 24.5 22.8 11.2 31.1 29.5 13.6 31.1 21.7 22.7 10.7 22.5 21.3 16.4 6.4 0.0 7.8 17.0 12.1 8.8 12.4 22.2 12.3 15.7 12.7 3.0 12.8 6.0 22.0 4.2 14.6 13.4 32.1 7.9 13.0 31.8 18.6 14.1 10.8 14.4 9.4 7.0 13.1 14.7 12.9 17.3 21.1 5.7 22.1 18.2 14.7 14.5 10.1 8.4 21.1 12.2 9.1 6.9 97.4 22.1 12.3 10.6 8.4 9.5 10.6 10.3 9.0 8.7 19.0 22.7 23.7 18.0 13.4 22.9 13.1 10.6 8.0 13.1 16.5 17.1 24.9 17.8 23.0 11.9 22.0 12.6 17.5 19.8 11.1 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 31.1 21.2 22.3 41.7 29.6 89.6 40.1 38.7 23.7 28.0 36.5 31.6 29.4 34.5 41.2 26.7 26.6 30.9 30.0 19.7 25.2 29.9 42.4 31.0 54.7 30.2 26.5 37.7 23.5 39.8 17.2 31.5 32.5 29.4 34.9 60.8 27.0 24.9 35.2 40.3 31.7 29.2 25.9 43.0 29.6 29.0 26.3 44.4 34.7 38.6 49.8 31.8 23.6 38.3 56.4 49.4 60.6 50.7 41.0 55.7 56.0 64.7 52.6 54.8 39.3 180.3 60.1 116.7 71.0 69.3 32.3 54.0 62.4 52.2 61.9 62.1 42.1 108.8 64.5 47.0 32.3 115.6 70.4 46.4 54.7 47.2 71.1 62.9 57.1 50.0 85.1 62.3 70.3 51.9 87.2 63.4 47.0 0.6 67.4 70.2 81.7 57.9 52.4 70.5 34.2 35.0 71.9 60.8 35.0 47.6 56.4 123.4 71.6 55.9 46.3 42.5 34.9 44.4 36.0 187.9 47.0 245.0 21.8 39.4 19.6 29.5 21.7 19.9 19.9 28.6 20.6 21.3 16.0 28.2 22.2 20.0 51.5 21.3 23.5 30.2 20.8 12.9 22.3 29.6 38.7 23.7 19.7 25.2 30.2 26.5 32.5 25.9 26.3 38.3 180.2 176.3 164.0 91.4 200.4 128.5 127.6 87.4 132.1 134.9 101.8 96.8 187.4 88.6 131.7 79.1 127.2 86.3 229.6 96.1 54.8 117.8 57.7 133.3 148.7 146.2 103.3 118.4 75.3 107.9 72.5 135.3 69.3 152.4 222.7 224.7 114.5 138.9 109.8 107.7 81.7 123.3 67.1 158.0 160.9 39.2 121.8 157.3 67.6 141.5 211.7 105.2 185.3 119.6 122.4 103.4 103.4 103.8 126.4 121.6 97.2 83.5 149.6 198.4 124.9 176.3 129.7 157.6 82.5 116.4 120.5 61.0 170.6 114.2 107.5 145.0 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol NA NA 27000 "Cluster 1: Neutrophils - Mixed function" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Vesicles, Cytosol" "HPA034689: AB_2674282, HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 16.4 16.4 11.8 9.9 14.4 5.2 13.5 14.7 16.0 9.5 7.0 12.9 18.5 11.9 11.4 16.2 10.4 11.2 26.0 10.8 13.6 20.2 22.0 12.2 11.4 14.6 13.4 13.2 14.7 27.7 14.0 13.1 13.6 15.2 13.2 22.8 11.0 12.5 40.5 13.8 14.3 14.0 12.9 11.8 12.4 10.6 14.1 12.4 20.3 35.8 12.1 10.4 8.3 18.5 15.9 9.7 25.8 22.8 18.8 21.1 13.7 24.1 19.0 18.2 22.0 9.6 11.4 3.0 15.6 24.2 14.0 15.5 19.3 21.1 23.9 34.8 17.8 29.7 21.1 7.5 27.8 22.8 15.0 23.5 25.4 34.4 24.5 20.4 21.8 16.7 20.2 11.1 25.0 18.0 18.9 22.2 12.0 35.4 41.0 9.3 25.7 17.5 21.2 16.5 16.0 44.5 16.6 16.2 30.7 26.4 21.8 21.7 15.7 20.9 10.9 25.6 21.0 29.4 32.8 0.5 22.9 11.2 21.8 7.2 5.2 2.2 4.8 3.3 3.4 8.6 5.1 4.6 5.1 11.0 7.8 6.3 20.0 6.9 4.3 8.0 5.6 2.6 11.8 14.4 14.7 16.0 10.8 13.6 14.6 13.4 13.6 12.9 14.1 18.5 7.8 9.6 15.6 18.6 7.0 3.6 12.1 23.7 12.5 12.8 7.9 6.3 22.8 4.3 12.5 9.2 10.4 10.7 3.8 8.4 13.7 9.1 5.1 9.4 8.3 6.0 6.0 11.6 21.0 9.8 6.3 6.9 11.2 5.4 8.8 9.5 8.6 8.7 9.3 18.5 26.3 7.3 20.3 5.8 2.2 4.0 4.7 6.2 3.6 6.5 6.1 22.6 7.2 27.6 25.7 12.2 4.0 6.8 10.3 5.4 9.9 12.5 13.6 15.0 0.0 8.2 7.1 18.9 7.1 20.4 4.8 6.8 5.8 13.0 6.4 9.7 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301252-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.6" "Cell type enhanced" "Detected in many" "Early spermatids: 96.1;Excitatory neurons: 222.4;Inhibitory neurons: 551.0;Late spermatids: 190.0;Microglial cells: 201.4;Oligodendrocyte precursor cells: 112.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.5;BEWO: 10.5;RPTEC TERT1: 8.7;RT4: 11.2;SuSa: 10.3;U-2 OS: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 9500000 "Cluster 1: Neutrophils - Mixed function" "Cluster 25: Pancreas - Digestion" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 3.6 0.4 0.4 4.0 1.0 0.8 2.1 0.0 1.6 9.4 4.8 4.0 1.0 3.2 2.6 1.6 2.6 1.4 1.1 3.4 1.0 1.7 0.1 4.0 1.5 1.6 2.1 2.2 12.6 0.8 2.2 1.7 2.5 1.6 1.3 1.5 0.8 4.1 0.9 1.4 2.4 2.7 0.8 5.3 2.0 3.5 1.6 2.5 0.5 1.6 1.9 5.2 2.2 0.5 2.2 1.8 8.5 0.0 0.0 0.0 10.5 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.4 0.0 3.4 0.2 0.9 0.0 0.2 0.0 5.0 0.0 0.4 0.3 4.1 0.0 0.0 1.7 0.0 0.4 0.5 0.0 0.7 0.1 0.0 0.0 4.2 2.2 0.0 0.0 2.9 0.1 0.0 6.3 5.9 0.0 8.7 11.2 5.3 7.7 0.0 0.0 0.0 10.3 0.0 2.8 0.2 0.0 13.2 0.0 3.8 0.0 0.0 0.0 0.0 1.8 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 1.6 3.4 1.0 1.6 2.1 2.5 0.8 1.6 0.5 1.2 0.0 3.0 31.3 0.1 1.3 0.5 2.3 0.6 22.3 0.6 1.8 20.2 1.5 5.5 5.5 0.0 3.6 1.3 0.0 0.0 1.5 96.1 16.9 57.1 1.9 4.9 0.0 222.4 5.4 0.7 11.6 0.5 9.9 0.0 23.4 1.1 0.0 0.5 1.7 551.0 0.5 0.0 0.3 2.1 190.0 1.8 0.7 5.4 201.4 0.0 0.2 0.0 112.1 14.3 2.2 0.0 5.7 0.0 0.7 0.0 1.5 6.7 1.2 6.6 1.7 7.8 9.8 5.5 0.3 0.4 1.9 0.7 1.4 0.1 0.4 SDR42E2 ENSG00000183921 "Short chain dehydrogenase/reductase family 42E, member 2" A6NKP2 16 22165583-22191754 "Metabolic proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.2;choroid plexus: 1.8;fallopian tube: 2.1;pituitary gland: 1.2;testis: 2.1" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 38.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 4.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.9" "Cell line enriched" "Detected in single" 6 "RPMI-8226: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 45: Enterocytes - Digestion" "unprognostic (8.03e-3)" "unprognostic (2.80e-1)" "unprognostic (2.06e-1)" "unprognostic (1.72e-4)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (8.77e-2)" "unprognostic (3.72e-1)" "unprognostic (4.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.32e-3)" "unprognostic (2.01e-1)" "unprognostic (7.09e-2)" "unprognostic (4.76e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (6.61e-2)" 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.4 1.2 0.4 1.8 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 1.5 3.2 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.2 0.3 0.5 0.3 0.3 0.1 0.8 0.5 0.3 4.9 0.4 0.1 0.3 0.3 0.2 0.6 0.7 0.4 1.2 0.6 0.2 1.5 3.2 1.0 1.2 0.4 0.8 8.9 0.0 2.4 2.6 8.7 0.8 0.7 0.9 0.6 7.7 5.2 11.6 1.9 10.0 0.4 0.0 0.0 0.9 7.4 15.6 0.0 0.9 1.8 3.9 8.4 2.6 2.4 5.7 2.0 0.5 0.3 2.6 12.8 3.2 2.5 1.7 5.0 3.4 2.3 5.0 0.7 15.1 4.1 13.1 3.8 1.4 5.9 5.1 1.8 0.0 6.4 14.7 10.3 0.5 0.4 0.3 3.2 1.5 5.9 1.1 38.2 0.6 3.5 3.7 0.0 0.9 3.0 0.6 0.6 1.4 1.7 1.4 11.1 2.6 8.8 0.3 SECISBP2 SBP2 ENSG00000187742 "SECIS binding protein 2" Q96T21 9 89318500-89359663 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 332.4;Late spermatids: 440.3;Spermatocytes: 338.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044314, HPA054905" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "HPA044314: AB_10964885, HPA054905: " "unprognostic (1.07e-1)" "unprognostic (4.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (4.00e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-2)" "unprognostic (7.18e-2)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "prognostic favorable (8.98e-9)" "unprognostic (5.44e-2)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (4.55e-3)" 22.9 27.2 17.7 22.6 21.0 35.1 28.2 22.2 19.9 29.2 25.1 26.0 23.5 27.4 28.0 19.7 28.1 18.6 18.2 18.5 21.3 31.6 29.2 25.9 31.9 19.4 18.7 40.8 40.8 25.3 28.1 27.1 19.6 25.2 27.5 49.0 27.1 16.3 41.6 29.7 29.3 15.3 17.8 34.8 27.0 68.9 19.9 33.8 35.3 21.3 27.5 24.7 23.6 28.0 29.9 19.9 53.5 31.1 24.7 26.5 38.8 16.9 20.9 19.8 19.4 11.2 24.4 44.4 14.6 15.9 31.5 37.1 36.4 17.0 18.3 29.4 21.6 21.8 16.5 28.7 21.3 44.2 31.5 16.7 31.5 16.8 19.9 21.8 25.0 58.5 28.4 51.1 19.1 27.7 60.9 22.6 55.7 74.5 19.5 29.1 26.2 29.3 22.2 22.7 39.0 38.3 15.3 33.7 45.9 35.4 29.9 37.8 23.2 19.2 22.3 26.0 26.4 61.7 42.3 18.2 33.3 28.3 28.1 17.0 8.2 14.7 10.8 8.9 10.5 14.2 10.9 10.7 7.4 14.8 16.2 13.9 23.0 10.2 11.5 13.0 14.3 6.5 17.7 21.0 22.2 19.9 18.5 21.3 19.4 18.7 19.6 17.8 19.9 28.0 72.5 44.8 58.0 43.8 81.2 19.5 72.0 29.9 38.1 113.8 49.0 59.8 18.3 31.5 40.2 40.5 91.8 70.6 67.7 41.0 43.0 39.4 332.4 44.8 34.6 46.2 37.3 60.4 55.2 31.4 47.2 36.1 42.8 47.7 36.1 51.8 36.0 36.9 26.9 57.2 55.4 56.7 30.5 32.6 19.4 440.3 40.0 69.6 21.4 51.5 47.2 44.8 69.0 46.8 77.5 35.9 49.6 25.6 81.5 64.1 49.2 54.5 41.8 112.9 32.9 63.2 36.3 338.9 223.2 44.2 25.4 91.8 54.3 43.9 50.0 65.4 SH2D4A "FLJ20967, PPP1R38, SH2A" ENSG00000104611 "SH2 domain containing 4A" Q9H788 8 19313693-19396218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001871, HPA001919" Enhanced Enhanced Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA001871: AB_1079949, HPA001919: AB_1079947" "unprognostic (9.08e-2)" "unprognostic (8.40e-3)" "unprognostic (4.04e-3)" "unprognostic (2.72e-3)" "unprognostic (3.51e-2)" "unprognostic (4.07e-3)" "unprognostic (2.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.67e-1)" "unprognostic (2.70e-2)" "unprognostic (8.84e-3)" "unprognostic (2.81e-1)" "prognostic favorable (6.02e-8)" "unprognostic (1.67e-2)" "unprognostic (2.18e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" 5.0 8.8 1.6 4.1 1.4 0.1 6.2 1.2 2.0 13.6 1.9 13.6 12.7 4.0 1.7 20.4 9.1 11.1 3.1 1.6 1.5 12.6 39.1 15.8 1.0 1.6 1.6 36.9 13.1 18.2 1.4 17.7 1.9 7.4 10.8 9.6 24.0 10.1 0.6 7.2 12.6 2.0 1.3 3.3 29.9 2.2 1.5 1.3 16.8 1.6 7.4 18.3 10.5 2.0 60.5 67.3 0.2 0.1 6.5 8.0 44.9 73.9 36.6 70.7 68.3 55.7 53.4 0.0 17.4 181.7 11.2 30.5 2.7 20.0 73.6 0.2 1.0 0.0 40.7 8.6 38.3 1.6 0.3 7.8 24.5 48.4 8.8 42.5 0.3 0.0 0.1 0.1 12.0 27.2 0.1 0.7 15.8 102.5 25.4 0.1 0.0 19.5 19.5 62.6 4.1 0.1 66.0 70.6 0.2 10.4 13.3 5.3 1.2 22.9 0.1 130.8 22.4 0.0 0.7 0.2 23.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.2 0.0 1.8 0.1 0.0 0.0 0.1 0.0 1.6 1.4 1.2 2.0 1.6 1.5 1.6 1.6 1.9 1.3 1.5 2.0 8.5 64.1 33.9 6.5 0.9 1.5 15.0 22.2 5.2 2.2 9.4 5.6 2.0 34.3 26.2 46.0 27.1 87.7 0.3 20.1 43.0 50.3 25.3 30.9 6.0 5.4 3.0 0.0 1.5 67.0 69.4 11.7 67.8 34.4 1.3 43.3 2.5 45.5 37.7 1.7 1.0 24.8 54.9 8.5 1.6 53.5 6.2 6.3 0.0 1.9 0.6 3.5 0.0 11.1 0.3 99.1 8.3 11.3 0.4 14.6 20.5 10.9 46.9 36.2 19.7 3.0 6.5 0.5 2.8 31.9 2.6 30.6 1.0 52.0 26.3 31.2 SH3GL1 "CNSA1, EEN, MGC111371, SH3D2B, SH3P8" ENSG00000141985 "SH3 domain containing GRB2 like 1, endophilin A2" Q99961 19 4360370-4400547 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021485 Approved Enhanced Cytosol NA NA 390000 "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "HPA021485: AB_1856816" "unprognostic (1.32e-1)" "prognostic favorable (1.50e-4)" "unprognostic (6.85e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.84e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.36e-8)" "unprognostic (5.48e-3)" "unprognostic (2.45e-1)" "unprognostic (1.02e-3)" "unprognostic (4.10e-2)" 61.1 64.7 25.0 29.4 28.8 54.4 50.0 32.8 38.1 69.8 24.2 41.3 40.9 45.1 8.2 175.8 43.9 25.4 37.6 34.4 20.5 39.2 57.4 43.8 22.8 24.8 22.5 49.0 41.8 10.8 46.8 38.9 23.8 48.8 9.2 7.0 51.8 24.0 21.2 119.8 43.7 20.8 21.1 46.8 35.9 28.1 24.7 16.8 37.1 10.1 19.8 53.0 91.6 28.0 111.3 49.2 50.0 66.8 57.4 89.0 92.2 94.2 80.3 82.2 81.1 77.4 56.8 24.9 39.0 94.1 39.8 89.5 35.6 103.7 21.9 33.1 59.8 30.0 66.5 102.7 82.6 27.2 32.6 75.0 70.9 69.4 42.4 40.6 97.8 23.7 78.9 55.1 67.1 92.6 26.5 28.4 126.0 40.4 54.3 20.8 69.8 43.6 65.8 96.4 49.1 75.7 83.3 81.9 59.3 23.5 56.5 42.5 149.3 78.6 57.1 166.7 97.2 34.8 23.2 26.7 112.9 70.0 110.4 0.8 2.3 3.1 2.7 1.1 2.6 3.7 4.0 3.9 3.0 2.7 2.2 2.5 5.6 2.3 3.4 3.8 4.1 2.3 25.0 28.8 32.8 38.1 34.4 20.5 24.8 22.5 23.8 21.1 24.7 28.0 31.6 9.6 21.5 11.8 15.2 60.8 41.0 43.2 19.4 17.1 17.1 15.7 3.6 11.5 25.1 9.2 6.2 41.2 14.7 23.6 13.7 32.1 7.2 17.9 33.8 30.7 10.2 30.7 23.4 29.3 153.7 37.5 19.9 29.5 9.5 23.4 32.9 27.3 51.5 10.1 14.0 18.6 20.3 19.4 51.8 6.7 32.6 22.3 23.2 14.0 14.7 20.3 15.5 12.5 10.3 50.4 17.0 24.0 16.4 38.0 61.6 22.9 15.4 8.7 13.1 17.2 29.3 15.7 11.5 36.8 85.8 44.2 15.1 50.1 19.8 67.1 SHOC1 "C9orf84, FLJ32779, MZIP2, Zip2" ENSG00000165181 "Shortage in chiasmata 1" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.1" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.0;Endothelial cells: 1.0" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 4 "U-2 OS: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA032108 Approved Vesicles,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.0 2.4 0.4 0.0 0.4 0.1 0.0 1.8 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.7 2.2 0.0 0.1 0.0 0.9 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.1 1.1 17.1 1.0 0.0 0.0 0.0 0.3 0.1 0.2 1.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 5.0 1.1 0.4 0.0 0.0 0.3 0.1 0.0 21.7 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.8 0.7 0.7 0.7 0.9 0.5 1.1 0.4 1.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHOX2 "OG12, OG12X, SHOT" ENSG00000168779 "Short stature homeobox 2" O60902 3 158095905-158106420 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 7.8;brain: 26.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 90.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Region enhanced" "Detected in many" "thalamus: 26.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;THP-1: 38.7" "Group enriched" "Detected in many" 5 "midbrain: 36.0;thalamus: 54.8" "Group enriched" "Detected in some" 6 "midbrain: 10.6;pons: 16.3;thalamus: 32.1" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.62e-1)" "unprognostic (6.32e-2)" "unprognostic (3.32e-2)" "unprognostic (1.08e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-3)" "unprognostic (2.28e-3)" "unprognostic (7.66e-2)" "unprognostic (7.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.31e-2)" "unprognostic (8.75e-3)" "unprognostic (0.00e+0)" "unprognostic (4.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" 7.8 0.1 8.9 0.0 0.5 0.1 5.4 0.0 1.1 3.9 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 3.4 0.1 6.1 0.0 0.0 0.2 1.7 10.6 13.0 0.2 0.1 0.3 0.2 0.2 7.0 0.1 0.0 0.0 2.2 0.4 1.3 2.2 0.1 0.0 0.5 0.0 0.2 3.4 26.4 0.0 0.5 0.4 0.3 0.4 1.0 0.2 5.5 0.6 0.3 8.1 24.2 15.3 1.5 8.9 3.4 4.8 8.2 1.8 0.7 1.2 0.2 12.8 9.5 0.1 10.1 0.0 1.9 5.1 2.9 13.7 2.7 0.0 0.0 1.2 10.7 6.9 0.3 4.4 0.5 14.8 0.0 0.7 3.8 0.9 2.1 0.3 0.0 0.7 0.0 0.1 0.5 6.2 7.4 1.4 0.0 0.0 2.7 20.5 1.0 0.2 5.2 0.1 0.2 38.7 0.5 15.0 3.1 16.6 14.8 1.1 2.9 0.9 14.5 7.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.1 6.1 10.6 13.0 7.0 0.5 26.4 0.2 3.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.2 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 90.3 0.1 1.7 0.9 0.0 0.0 0.0 0.2 0.7 9.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 1.9 1.2 13.9 2.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.1 1.1 8.5 5.7 2.8 0.0 0.4 0.3 0.1 0.0 0.2 0.0 SLC22A1 OCT1 ENSG00000175003 "Solute carrier family 22 member 1" O15245 6 160121815-160158718 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 381 "liver: 609.6" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 966.3" "Cancer enriched" "Detected in some" 81 "liver cancer: 83.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029846 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 62: Liver - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" "HPA029846: AB_10603026" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "unprognostic (7.80e-2)" "unprognostic (2.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.35e-5)" "unprognostic (2.28e-1)" "unprognostic (8.61e-2)" "unprognostic (3.35e-1)" "unprognostic (9.11e-2)" "unprognostic (9.94e-2)" "unprognostic (1.46e-7)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (4.72e-2)" "unprognostic (8.07e-4)" 0.3 0.3 0.2 0.1 0.1 0.4 0.3 0.0 0.9 0.3 0.3 0.2 0.0 0.3 0.1 0.2 0.3 0.7 0.1 0.5 0.0 0.9 609.6 0.4 0.2 0.1 0.1 0.4 0.4 0.0 0.3 0.0 0.3 0.4 0.1 0.1 0.4 0.1 1.0 0.5 0.3 0.0 0.0 1.6 0.3 0.3 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.2 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.8 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.2 0.6 0.0 0.3 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.6 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.1 0.4 0.3 0.3 0.7 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.9 0.5 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.0 1.3 2.0 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.5 47.1 0.0 0.0 2.1 0.0 0.4 0.1 0.0 0.5 0.3 0.5 0.1 0.9 0.0 13.5 6.1 0.2 0.1 0.2 0.0 0.7 0.0 0.2 11.4 966.3 0.1 0.0 3.7 0.1 0.0 16.3 0.0 0.2 0.3 0.4 0.0 1.0 0.0 0.9 0.0 0.0 0.9 0.1 0.0 0.7 0.1 0.3 0.1 1.8 0.1 0.0 0.0 0.7 0.3 0.0 0.4 0.0 0.3 0.1 1.2 0.3 0.1 0.2 SLC6A8 "CRTR, CT1" ENSG00000130821 "Solute carrier family 6 member 8" P48029 X 153687926-153696588 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 142.0;Distal enterocytes: 382.0;Proximal enterocytes: 235.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 155.8;AN3-CA: 151.3;SK-BR-3: 156.8" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (5.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.39e-2)" "unprognostic (9.98e-2)" "unprognostic (1.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (2.87e-1)" 31.6 66.6 77.2 9.0 99.4 34.5 23.9 77.8 80.0 17.5 39.9 73.5 51.3 32.4 13.0 54.6 17.3 31.3 130.4 76.8 82.1 81.4 4.5 9.2 1.9 89.0 90.5 12.4 20.0 45.6 21.4 36.2 76.9 31.3 30.5 34.7 52.3 35.9 166.6 45.9 75.9 20.7 71.3 13.1 30.8 38.5 87.6 11.9 8.2 75.5 3.0 41.2 36.5 116.6 155.8 6.7 39.5 151.3 14.7 9.9 10.2 22.2 37.7 28.7 35.5 20.1 2.1 0.2 17.0 27.9 33.6 54.3 85.3 78.0 17.0 2.7 83.3 0.6 50.6 59.7 50.0 1.2 10.1 20.9 16.5 27.3 103.3 50.7 14.9 0.9 37.3 2.4 15.7 9.3 0.8 3.6 47.0 30.9 67.0 7.6 5.2 2.1 30.8 29.5 56.0 64.2 33.8 156.8 107.9 9.8 30.9 23.9 14.1 45.2 73.1 58.2 66.5 5.2 3.0 1.8 105.5 4.5 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 77.2 99.4 77.8 80.0 76.8 82.1 89.0 90.5 76.9 71.3 87.6 116.6 5.9 0.0 1.9 14.0 2.7 23.2 14.3 91.1 13.1 142.0 19.6 18.4 106.9 21.5 55.6 5.5 110.5 15.3 2.8 382.0 3.9 4.6 1.5 21.4 38.9 6.5 25.9 23.4 8.2 22.2 37.7 8.8 6.1 16.1 4.5 14.4 3.9 0.9 4.9 119.5 9.9 44.2 38.7 1.9 5.7 3.7 9.0 4.1 24.9 2.8 3.2 19.0 0.0 9.0 23.7 47.5 101.1 8.2 0.8 28.3 235.8 53.3 31.3 49.3 32.9 15.6 19.0 2.9 3.9 16.9 15.6 90.8 2.9 1.5 20.7 18.6 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 117.5" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "neutrophil: 44.2" "Group enriched" "Detected in many" 6 "granulocytes: 44.2;monocytes: 11.5" "Cell line enhanced" "Detected in many" "BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 6.1 4.0 25.7 7.2 25.8 2.0 1.6 0.0 28.0 4.7 0.0 9.6 5.0 19.7 5.6 5.9 5.6 6.5 117.5 30.6 11.0 17.5 3.1 5.8 3.3 1.5 19.8 2.5 1.8 0.7 0.8 11.2 0.7 18.8 4.8 5.9 1.0 27.1 0.3 1.5 5.5 23.4 2.7 7.3 3.5 0.7 19.5 2.0 0.8 0.9 1.5 8.9 2.5 24.1 3.0 2.2 2.1 0.2 3.1 6.4 0.0 28.9 11.1 9.4 6.1 0.0 4.7 0.1 2.2 70.4 10.1 1.1 0.5 4.8 9.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.5 3.7 0.0 10.8 19.8 4.3 0.7 0.0 0.0 0.4 12.1 0.0 0.9 0.1 1.4 0.3 4.0 7.8 14.8 0.0 3.3 0.4 3.2 0.6 0.0 0.0 0.0 9.7 0.1 0.6 9.8 8.8 0.3 0.0 3.1 1.6 0.0 0.0 1.4 1.7 1.4 0.0 8.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 44.2 0.0 11.5 0.3 0.0 1.1 25.7 25.8 0.0 28.0 30.6 11.0 1.5 19.8 0.7 2.7 19.5 24.1 10.3 3.2 2.8 39.5 3.6 1.3 0.0 0.2 1.2 79.1 0.5 5.8 743.1 2.8 0.6 35.0 4.2 0.5 0.3 0.0 0.0 0.0 1.1 2.3 52.8 15.1 0.0 3.0 1267.5 0.0 1.6 26.6 1.5 3.0 0.0 0.2 12.1 0.3 29.3 0.0 631.3 2.5 0.0 78.0 26.7 1.4 0.0 88.8 1.8 574.3 42.7 32.0 1.0 753.0 20.5 0.1 3.8 8.2 0.7 0.2 24.7 0.5 0.0 7.2 13.1 1.4 46.6 0.2 1.2 0.5 3.1 1.1 1.2 0.7 2.5 0.1 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 82.0;choroid plexus: 28.6" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 487.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.0 0.1 48.9 0.1 65.9 0.1 4.0 43.5 80.2 0.0 28.6 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.9 41.3 46.4 1.2 11.5 2.8 0.7 54.0 51.9 0.2 2.4 0.2 0.4 1.2 52.6 0.7 0.0 0.6 15.8 0.0 0.4 0.5 0.1 0.0 45.2 0.5 0.3 1.9 48.3 0.6 0.2 0.0 0.4 0.2 0.0 82.0 2.1 0.6 0.8 0.1 0.0 0.0 3.4 0.0 0.0 0.1 0.0 3.8 1.4 0.1 2.1 0.2 0.0 0.3 0.3 0.2 0.5 0.7 0.9 0.0 0.5 1.5 0.0 0.4 0.3 0.0 1.7 0.2 0.2 1.5 0.1 0.4 4.0 1.2 0.0 2.6 0.4 0.1 16.7 2.0 0.2 0.2 0.2 12.0 0.0 2.2 1.9 2.9 0.0 0.2 0.2 16.1 3.2 0.9 0.0 0.1 1.7 0.8 0.4 23.1 9.8 0.2 0.1 0.3 0.0 0.2 0.1 0.1 0.4 0.1 0.6 0.4 0.6 0.4 0.0 0.2 0.6 0.4 1.3 0.3 0.0 0.2 0.5 0.1 48.9 65.9 43.5 80.2 41.3 46.4 54.0 51.9 52.6 45.2 48.3 82.0 0.0 35.3 3.1 5.9 0.0 0.0 0.0 0.0 0.0 0.2 3.5 2.8 0.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.8 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 102.1 0.0 0.1 0.0 2.5 487.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618669-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 142.1;Spermatogonia: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA040793: AB_10796560, HPA054213: AB_2682419" "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 1.6 1.5 1.7 1.9 1.4 3.4 1.9 4.0 2.1 1.3 0.0 1.9 2.0 1.7 0.9 1.4 2.2 2.0 2.2 1.1 0.6 1.7 1.5 1.4 3.3 0.0 0.4 2.8 2.2 1.3 0.6 1.6 0.1 1.3 2.3 1.8 0.8 1.1 0.9 3.5 2.3 1.5 0.0 2.3 1.2 7.7 0.7 3.5 1.7 1.4 2.5 1.2 0.6 1.7 5.3 6.8 9.4 8.9 3.0 3.5 6.0 7.9 4.0 9.1 12.5 3.6 7.1 8.2 5.3 2.3 11.2 7.0 7.8 6.5 12.0 2.9 6.2 5.3 54.2 3.2 0.9 2.9 5.9 1.8 1.8 8.1 3.5 3.0 3.7 4.9 6.2 5.0 7.8 4.6 8.1 3.7 10.0 3.0 3.6 4.9 10.8 9.1 2.8 3.8 9.4 9.6 9.7 4.1 3.4 7.3 5.5 8.1 2.7 4.3 5.9 6.1 10.7 3.7 8.3 6.7 6.5 8.1 8.8 1.1 1.3 0.8 1.7 1.0 0.9 2.3 2.6 3.3 0.8 3.6 1.2 1.6 7.3 1.1 0.9 1.3 1.7 0.7 1.7 1.4 4.0 2.1 1.1 0.6 0.0 0.4 0.1 0.0 0.7 1.7 16.1 3.2 6.4 0.0 18.2 0.0 4.7 0.0 4.6 25.3 8.9 9.5 0.0 2.8 7.4 5.5 27.1 15.0 17.3 5.3 1.9 8.1 9.1 30.6 10.5 9.5 2.4 28.0 0.0 7.0 14.8 8.3 8.6 5.5 15.2 19.9 11.4 5.6 7.8 20.2 0.0 4.4 0.0 6.0 0.0 7.4 5.6 10.8 0.0 0.0 10.8 8.1 20.6 0.0 0.0 8.9 4.5 6.0 14.0 2.3 31.4 10.3 20.4 37.3 0.0 11.6 7.0 142.1 111.1 7.0 0.0 6.2 34.5 12.3 8.1 3.2 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655726-2805017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 363.7;Plasma cells: 391.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 58.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 58.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 2: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 13.6 6.9 5.4 24.6 6.6 41.1 12.4 11.4 8.3 16.5 6.8 14.4 13.7 14.9 9.2 8.7 14.1 12.4 10.1 5.0 6.6 6.5 8.4 19.0 33.9 7.2 6.1 15.4 16.3 11.9 7.9 16.3 7.4 13.4 14.7 16.3 10.1 11.2 11.0 9.1 20.3 12.8 6.4 28.6 12.4 14.1 6.3 25.6 9.6 11.5 22.4 15.0 14.2 8.7 24.1 10.7 35.8 22.6 15.0 21.8 25.7 23.7 16.8 22.0 27.7 20.3 7.7 51.6 10.2 21.2 24.7 13.0 29.1 13.6 34.4 10.7 15.1 32.3 21.7 19.5 16.8 93.9 24.3 14.4 12.2 27.9 22.8 16.8 18.3 25.5 38.3 31.1 21.3 8.6 39.4 23.9 14.4 13.0 12.4 31.7 29.1 22.9 13.6 36.5 29.2 18.4 32.0 10.6 18.8 19.8 7.9 39.3 17.5 27.1 37.4 37.1 44.0 18.8 30.4 46.5 17.4 17.1 24.0 5.1 2.5 6.6 3.6 1.7 2.6 5.8 4.8 4.3 0.9 7.5 5.9 3.8 58.7 2.3 2.3 2.6 5.4 1.3 5.4 6.6 11.4 8.3 5.0 6.6 7.2 6.1 7.4 6.4 6.3 8.7 96.5 44.8 44.7 71.5 363.7 27.1 35.3 14.5 48.9 112.1 33.3 32.8 53.0 15.7 27.7 18.4 100.1 36.5 232.7 102.7 5.9 23.4 117.2 43.6 83.3 53.0 22.7 69.0 98.4 19.4 22.3 52.8 68.3 75.9 40.4 54.2 30.7 16.4 19.4 99.3 127.2 35.5 10.2 65.4 69.7 38.6 42.0 116.3 30.2 121.8 142.5 32.3 120.5 111.1 130.4 23.6 60.1 38.0 391.1 52.0 46.5 6.1 22.5 88.5 39.5 59.7 69.8 166.7 115.3 41.3 24.9 46.9 257.9 45.9 30.4 57.8 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590198-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavorable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 5.4 3.8 4.8 5.5 5.1 10.4 6.9 8.5 6.7 7.0 4.4 5.4 5.7 6.4 4.6 4.7 5.7 4.0 7.2 4.6 5.0 6.0 7.3 4.5 7.3 5.7 4.9 7.7 5.7 3.7 3.6 5.3 5.9 5.8 5.5 7.3 5.3 4.4 9.7 6.3 6.7 5.4 4.7 6.1 5.4 2.7 5.1 7.1 5.8 7.1 5.9 5.6 5.8 5.9 10.0 7.9 16.2 30.3 8.5 12.5 10.9 11.2 10.4 12.0 13.1 16.9 8.1 23.6 11.8 9.4 11.5 12.6 20.2 12.1 18.2 18.2 19.8 17.0 24.1 32.7 8.9 20.5 10.9 8.8 18.3 13.5 10.2 14.2 10.5 20.8 24.1 3.6 16.8 5.7 33.7 29.6 21.9 17.1 8.8 35.8 13.9 31.6 10.8 8.7 25.0 6.8 21.8 5.6 19.6 29.7 10.9 7.2 11.8 15.8 7.1 9.5 19.6 5.8 34.6 14.5 5.3 16.1 28.9 0.1 0.7 0.4 0.7 0.5 1.2 0.6 0.8 0.9 0.9 1.1 0.7 1.3 2.3 1.1 0.3 1.0 0.7 0.6 4.8 5.1 8.5 6.7 4.6 5.0 5.7 4.9 5.9 4.7 5.1 5.9 18.6 19.2 10.3 8.1 15.7 35.7 20.2 13.6 12.0 18.7 12.6 14.6 32.1 15.7 17.3 9.2 20.9 16.3 22.7 19.2 11.7 18.0 2.5 18.0 14.8 20.5 11.4 17.7 20.4 20.1 15.6 18.0 8.2 19.6 24.1 16.8 20.3 23.4 15.9 5.0 18.8 18.2 0.0 15.1 22.1 2.5 17.7 14.9 8.8 13.1 21.7 15.5 19.6 14.6 23.8 12.1 17.9 16.6 11.5 21.4 27.1 20.1 8.5 17.8 6.6 20.9 23.2 16.1 17.0 11.5 34.0 16.3 18.5 11.2 17.1 20.1 SOX6 ENSG00000110693 "SRY-box transcription factor 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.9" "Cell type enhanced" "Detected in many" "Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.8 1.3 5.4 0.4 5.9 26.9 0.7 2.6 4.7 1.7 5.5 1.2 6.5 0.6 2.0 2.1 4.0 2.6 3.0 4.0 7.2 11.1 4.8 0.8 0.1 7.2 7.8 0.7 6.8 0.1 2.9 2.5 6.0 0.4 1.3 3.2 0.5 0.6 9.3 5.8 11.0 0.5 7.7 0.5 1.0 14.4 4.1 1.6 3.4 5.9 0.2 0.8 0.8 6.8 0.0 0.7 3.9 3.7 0.0 0.0 0.0 0.3 1.3 0.1 0.1 5.7 0.0 0.0 3.6 0.0 0.0 0.1 4.4 1.1 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 1.8 0.0 0.0 0.1 0.4 0.0 4.9 0.5 0.0 0.0 0.0 2.6 2.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 5.9 2.6 4.7 4.0 7.2 7.2 7.8 6.0 7.7 4.1 6.8 2.7 3.2 6.3 308.9 1.0 40.1 5.8 6.8 66.6 26.3 3.7 2.5 21.6 54.3 3.8 36.8 10.4 1.3 0.1 1.4 9.8 19.8 256.8 29.4 5.3 4.8 7.8 126.7 2.8 3.7 0.6 14.5 2.0 27.8 0.0 1.6 2.2 7.5 1.1 0.0 481.0 6.6 0.0 2.9 3.2 70.1 3.4 1.4 35.6 21.5 0.0 48.4 0.0 1687.9 8.9 5.5 20.3 2.2 0.1 3.2 99.8 27.1 8.3 4.3 0.0 26.2 14.6 22.1 4.5 32.7 16.1 0.5 1.1 3.0 11.8 3.7 SP1 ENSG00000185591 "Sp1 transcription factor" P08047 12 53380176-53416446 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000330, HPA001853, HPA012292" Supported Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 52: Non-specific - Ribosome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394" "unprognostic (1.12e-1)" "unprognostic (8.52e-3)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (2.03e-1)" "unprognostic (4.64e-3)" "unprognostic (1.08e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.38e-2)" "unprognostic (5.14e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (4.77e-2)" "unprognostic (2.12e-2)" 23.6 18.6 10.7 23.1 15.1 29.9 26.2 20.3 12.5 23.7 11.6 24.8 30.9 29.8 21.0 38.6 25.5 25.6 13.4 10.6 11.7 20.7 17.0 22.8 24.2 16.4 14.0 29.8 18.6 22.1 10.7 23.7 16.2 20.8 29.8 20.4 27.5 22.0 25.2 40.1 31.2 26.4 13.0 28.0 28.6 19.4 13.5 36.7 19.6 25.8 30.2 24.2 25.3 17.6 34.2 31.3 40.5 31.2 34.7 39.4 32.1 23.1 29.0 27.2 26.9 27.9 70.3 43.9 29.3 27.1 18.3 49.2 43.6 32.9 33.0 31.3 23.8 38.5 48.2 18.3 24.3 39.4 33.1 40.3 36.4 27.0 53.9 55.1 31.0 35.5 37.6 63.8 23.1 50.2 53.9 31.9 22.4 28.0 25.0 37.8 38.5 28.5 25.7 57.8 21.0 30.5 47.7 42.9 26.8 33.5 52.3 42.6 29.5 35.3 30.3 26.4 25.3 21.3 25.4 42.5 26.3 29.9 28.2 3.1 2.6 1.6 1.3 1.7 1.6 1.4 1.3 1.3 1.5 1.5 1.4 1.5 6.9 1.0 1.9 1.8 1.1 1.0 10.7 15.1 20.3 12.5 10.6 11.7 16.4 14.0 16.2 13.0 13.5 17.6 29.7 22.4 15.0 13.1 18.5 23.8 19.9 22.4 33.6 10.6 28.3 19.4 8.2 24.3 26.8 31.3 8.4 16.2 16.6 55.8 5.9 16.1 64.1 21.8 23.4 24.7 12.6 25.2 7.7 13.8 16.3 21.5 23.9 34.7 6.3 17.2 28.2 28.4 18.2 16.8 7.2 29.8 6.1 38.6 16.1 50.3 27.4 24.5 8.8 16.9 42.2 22.7 18.6 12.5 20.4 18.8 21.0 25.9 12.0 35.4 34.8 20.8 23.9 10.8 13.1 31.4 21.0 29.4 22.1 44.2 31.3 21.3 14.8 11.7 26.2 47.7 SPATA1 SP-2 ENSG00000122432 "Spermatogenesis associated 1" Q5VX52 1 84506300-84566194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 2.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Astrocytes: 12.7;Microglial cells: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (6.00e-3)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (2.46e-2)" "unprognostic (4.82e-2)" "unprognostic (8.84e-3)" "unprognostic (7.54e-2)" "unprognostic (2.77e-3)" "unprognostic (5.52e-4)" "unprognostic (2.03e-1)" "unprognostic (5.81e-8)" "unprognostic (1.63e-1)" "unprognostic (5.34e-1)" "unprognostic (7.71e-2)" "unprognostic (3.79e-4)" 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.3 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.3 2.5 6.4 4.8 12.7 1.7 0.0 0.0 0.0 0.0 0.0 3.5 2.7 3.0 0.0 2.5 5.5 0.0 0.0 2.8 2.9 1.9 0.9 0.0 2.6 3.1 1.3 0.0 0.0 5.4 1.4 0.0 0.9 0.0 2.4 0.0 1.7 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 8.4 1.6 0.0 0.0 4.5 5.0 0.3 2.2 0.0 0.3 0.0 0.0 1.8 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.7 1.3 0.0 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9" "Cell type enriched" "Detected in many" 8 "Hofbauer cells: 60702.5" "Group enriched" "Detected in all" 4 "glioma: 1690.9;renal cancer: 1385.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "neutrophil: 24.8" "Lineage enriched" "Detected in single" 249 "granulocytes: 24.8" "Cell line enhanced" "Detected in many" "EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3" "Region enhanced" "Detected in all" "pons and medulla: 316.8" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 73000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 113.1 24.4 276.0 59.5 490.3 1.0 70.2 652.0 736.4 27.5 265.0 44.9 9.5 131.2 9.8 4.8 52.8 2424.4 37.0 301.6 417.1 3587.6 35.6 18.8 9.1 813.2 645.3 9.9 292.0 19.2 20.6 2791.9 781.8 15.7 7.6 745.5 88.7 22.1 16.0 2.7 14.4 38.3 472.6 9.2 11.0 11.7 633.1 8.4 8.3 0.4 5.7 25.0 6.0 855.0 2.2 144.0 19.1 1.1 0.0 0.2 0.3 5.6 4.4 1.4 9.1 0.6 0.2 0.2 4825.8 2.3 371.5 1.4 0.0 0.0 3.1 11.2 0.0 0.0 1.8 2469.7 0.3 6.8 5.1 0.5 0.3 34.9 0.1 118.8 4.2 0.2 0.1 10.8 1.3 0.2 1.2 21.3 227.5 0.3 0.0 2.4 0.5 1189.8 10348.3 1.8 1.1 0.9 0.3 0.8 339.1 441.9 0.5 5.2 0.3 11.5 27.1 0.4 25.8 0.9 7.9 13.9 436.3 1.1 457.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 276.0 490.3 652.0 736.4 301.6 417.1 813.2 645.3 781.8 472.6 633.1 855.0 35.7 3.2 4.7 5.2 34.0 1.5 5.2 0.1 1.2 46.6 1767.7 22.4 17.9 1584.2 0.3 2183.1 27.1 335.6 6.9 0.0 1003.7 7273.8 0.1 61.2 25.2 367.9 0.0 2.7 1.4 71.7 294.5 48.9 0.0 154.2 0.0 1.7 5.7 5.0 60702.5 785.7 9.9 0.0 0.0 57.4 7.7 1.0 0.9 247.7 1.8 99.3 69.2 3862.9 0.0 4.5 532.1 215.4 0.0 0.0 0.1 0.4 0.0 5594.0 1.6 169.7 0.0 0.9 21.6 0.5 0.2 1.1 1.0 667.8 30.0 0.4 0.0 9.9 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837011 "Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 219.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "RPMI-8226: 202.5;SK-BR-3: 178.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB005406: AB_2194226, HPA043343: AB_2678439, HPA043878: AB_2678710" "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favorable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favorable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 42.2 219.2 26.8 7.9 41.5 20.1 46.5 20.4 37.2 51.5 9.4 37.7 28.7 23.4 8.9 68.7 42.7 14.0 27.4 20.0 25.9 24.7 128.5 26.4 9.1 30.1 29.7 41.4 17.0 8.4 37.0 7.8 24.2 37.2 6.7 3.9 89.5 16.7 34.5 47.8 34.0 5.6 23.4 17.2 25.2 35.4 35.8 14.4 27.0 2.9 6.3 32.5 48.8 41.7 54.1 122.5 12.0 85.2 24.9 55.8 23.5 18.5 60.0 16.4 39.2 23.3 104.2 33.5 17.2 14.8 14.5 144.0 16.7 47.2 4.0 21.1 7.2 16.8 86.4 19.1 36.1 2.5 29.6 42.0 19.6 21.8 12.5 12.2 17.6 64.9 36.8 105.8 2.5 118.7 46.9 26.1 17.8 38.3 23.1 32.6 10.8 202.5 9.0 23.1 16.3 70.5 24.4 178.7 48.0 8.9 62.0 32.6 21.5 8.2 40.5 19.5 12.5 32.2 3.1 15.5 48.9 24.6 45.2 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.4 0.6 1.3 0.1 0.1 0.1 0.0 0.2 26.8 41.5 20.4 37.2 20.0 25.9 30.1 29.7 24.2 23.4 35.8 41.7 6.1 6.4 26.0 66.9 11.9 9.3 12.0 29.2 14.8 24.5 58.0 30.6 9.4 18.6 29.7 20.2 29.2 4.5 11.4 44.5 1.9 16.5 2.7 30.9 37.2 10.5 29.9 24.8 12.8 23.5 15.7 24.7 31.1 31.9 14.7 13.2 12.8 72.2 12.1 58.9 11.3 30.8 24.4 14.0 13.3 4.9 29.8 15.1 8.8 15.0 11.0 51.7 1.0 10.6 56.7 16.7 20.8 10.9 8.4 19.0 33.2 6.6 32.1 31.6 13.1 15.6 12.9 11.4 4.9 40.2 18.3 19.8 13.4 27.5 41.1 25.2 SRF MCM1 ENSG00000112658 "Serum response factor" P11831 6 43171269-43181506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001819, CAB005416" Supported Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 21: OE19 - Mitochondria" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Nucleoplasm "CAB005416: AB_2255249, HPA001819: AB_1079928" "unprognostic (1.44e-3)" "unprognostic (1.09e-1)" "unprognostic (5.39e-3)" "unprognostic (2.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (4.60e-2)" "unprognostic (9.84e-2)" "unprognostic (4.28e-2)" "unprognostic (2.21e-2)" "unprognostic (6.72e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.31e-2)" "unprognostic (1.59e-1)" "unprognostic (5.10e-2)" "unprognostic (1.97e-2)" 29.7 16.7 16.0 27.0 15.3 27.3 24.7 12.4 18.7 31.2 12.4 82.6 13.4 69.3 12.4 33.3 49.2 26.5 61.2 17.6 11.6 17.0 20.2 28.6 21.4 14.1 12.7 27.6 21.8 18.5 18.8 17.4 11.8 38.7 14.9 8.8 16.8 45.5 55.4 21.2 29.3 48.2 12.1 22.3 37.0 12.6 13.4 21.4 23.9 32.7 16.5 54.5 25.7 16.7 38.4 15.0 34.2 22.6 19.8 16.2 50.2 34.2 28.0 29.0 17.9 40.4 11.1 48.1 30.5 36.7 36.7 30.4 35.0 30.2 25.5 53.5 34.4 43.6 30.7 40.2 37.7 41.2 50.9 27.8 32.3 44.8 32.7 27.4 24.5 41.0 31.6 36.8 22.2 41.1 51.2 35.9 23.8 85.7 18.3 38.7 34.9 17.3 21.3 24.5 20.0 18.1 28.0 21.1 34.2 26.2 21.7 75.6 29.9 34.2 26.4 33.4 59.5 25.4 22.6 80.6 21.4 29.2 23.5 0.4 0.4 0.8 0.8 0.8 0.6 0.5 0.4 0.6 0.5 0.5 0.3 0.6 1.2 0.3 0.6 1.0 0.6 0.3 16.0 15.3 12.4 18.7 17.6 11.6 14.1 12.7 11.8 12.1 13.4 16.7 17.1 38.5 22.5 3.9 8.8 78.0 64.3 22.6 38.1 5.7 64.0 52.1 89.6 18.6 21.7 11.0 20.9 9.7 9.4 29.8 0.0 13.6 4.7 23.8 24.6 17.5 102.2 20.2 4.9 20.0 22.6 17.0 18.3 29.5 7.6 20.6 17.2 50.6 12.7 10.1 3.5 39.1 8.2 11.3 18.8 1.1 12.5 11.6 24.9 0.0 8.0 12.5 5.2 1.5 2.8 21.5 19.6 29.0 6.5 17.8 11.1 3.8 20.3 7.5 13.1 23.6 21.8 5.2 3.3 28.7 66.9 12.2 10.5 8.9 25.6 30.2 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.0" "Cell type enriched" "Detected in many" 4 "Microglial cells: 497.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 41: Macrophages - Immune response" Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 23.6 19.8 29.8 15.8 32.9 22.3 18.0 114.0 41.8 16.5 21.7 12.4 5.8 13.8 13.4 12.9 14.6 11.7 12.3 36.5 34.5 15.4 8.0 20.9 15.2 48.4 41.0 18.2 7.9 25.3 10.4 20.0 55.9 9.0 6.0 9.9 10.0 9.0 6.8 46.9 10.6 15.3 43.4 24.7 8.7 10.7 42.8 13.8 9.9 18.0 13.7 11.9 16.5 57.4 45.6 30.0 99.7 25.6 46.4 41.6 39.0 38.5 28.7 32.9 35.9 20.7 34.0 17.6 21.6 42.9 43.8 36.1 30.0 25.4 32.7 22.2 24.4 36.5 56.4 31.2 19.3 25.4 39.4 37.6 21.6 42.2 29.3 35.7 57.9 22.6 30.6 55.4 21.2 31.6 20.3 22.4 32.2 8.1 34.1 45.3 40.8 42.6 14.1 8.2 33.2 15.2 32.7 23.9 47.5 37.4 29.7 44.4 57.9 32.1 38.4 39.9 35.8 36.8 35.7 16.5 38.4 34.6 80.0 1.0 12.2 0.7 3.2 11.8 1.3 2.6 2.6 3.3 8.3 5.3 1.0 2.2 17.7 2.1 14.0 16.2 4.0 3.7 29.8 32.9 114.0 41.8 36.5 34.5 48.4 41.0 55.9 43.4 42.8 57.4 45.5 9.6 12.1 9.4 18.0 23.8 6.1 7.5 8.6 39.5 3.6 4.4 4.6 11.5 7.9 11.0 4.2 4.1 17.1 0.3 0.0 7.2 57.7 16.4 18.4 37.2 1.2 13.2 72.2 2.1 18.3 18.6 10.2 9.7 8.2 12.0 28.9 2.9 19.0 1.7 105.0 3.3 0.0 46.2 62.5 51.0 7.8 54.1 16.0 497.5 25.4 6.6 5.2 54.3 58.5 4.8 1.3 2.6 16.0 4.2 1.4 0.8 14.5 5.8 0.0 18.5 17.9 19.0 11.6 12.1 36.4 4.2 11.9 9.7 1.8 5.8 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 108.2" "Group enriched" "Detected in all" 4 "Early spermatids: 1275.7;Late spermatids: 2280.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 219.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 219.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 14.3 16.2 27.2 15.0 29.7 10.7 18.3 20.1 46.8 16.3 0.0 13.3 11.4 18.1 15.8 16.4 14.6 16.0 14.7 31.0 30.0 13.8 14.2 12.8 17.9 27.9 25.5 17.3 14.7 15.1 12.9 17.1 30.4 18.8 14.8 24.2 15.1 14.4 11.3 24.4 11.4 18.3 19.3 17.8 16.3 108.2 26.7 41.4 15.5 11.8 20.6 18.2 11.6 47.1 36.9 24.0 37.3 74.5 39.3 43.8 21.0 35.4 40.8 34.5 39.9 18.9 30.5 23.4 43.7 45.8 38.5 21.6 38.3 37.3 43.7 40.5 33.2 33.1 21.8 16.5 45.1 31.8 47.1 30.6 67.5 29.2 54.6 33.0 59.8 54.4 33.0 92.2 38.5 69.3 118.3 23.9 31.1 20.8 25.9 37.9 41.3 51.1 49.5 56.1 54.8 37.8 40.1 59.0 37.7 49.1 22.1 21.8 39.7 62.9 45.9 60.8 33.4 100.6 106.6 56.5 24.8 32.3 48.1 50.3 30.2 103.3 41.4 21.0 24.8 45.0 31.1 31.6 27.3 44.0 29.3 33.6 219.5 38.7 25.1 23.6 38.6 25.2 27.2 29.7 20.1 46.8 31.0 30.0 27.9 25.5 30.4 19.3 26.7 47.1 35.8 28.9 29.5 128.9 62.9 212.9 60.6 68.1 49.5 76.9 45.2 40.0 23.3 28.6 41.5 23.9 50.1 52.4 87.1 16.6 27.4 52.9 1275.7 54.3 41.9 51.8 28.8 17.2 298.1 46.3 35.6 47.3 40.8 51.6 41.2 48.9 53.6 35.9 47.6 124.5 300.9 35.2 54.9 43.0 42.9 2280.6 76.7 39.2 58.7 168.6 57.0 73.7 103.0 172.4 399.8 36.4 24.4 95.9 54.8 100.7 15.7 25.9 54.2 67.6 46.0 40.3 59.1 198.8 66.0 36.7 103.3 64.4 58.2 61.4 26.1 67.9 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336236-136752403 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 13.7 9.1 7.6 12.3 8.8 15.7 15.6 17.0 8.3 16.9 9.9 13.5 9.6 19.3 10.6 10.8 13.5 10.3 10.5 6.5 8.7 12.0 10.8 11.2 14.7 9.3 7.8 21.9 12.4 13.7 5.0 17.6 9.0 10.8 14.4 13.2 11.6 12.1 15.0 13.7 11.0 16.1 8.8 11.8 10.0 8.9 7.8 22.5 15.8 15.8 15.9 12.0 11.5 11.2 34.6 17.6 29.1 25.1 21.5 36.8 15.7 37.9 48.4 35.0 33.0 30.2 14.9 26.9 23.3 39.7 28.1 23.4 31.6 17.3 47.4 33.2 14.9 28.8 25.1 16.7 16.3 50.6 27.7 23.4 19.3 25.6 28.6 20.3 27.5 28.8 18.7 52.7 22.3 29.5 33.6 16.4 19.0 23.7 13.9 29.6 31.6 35.7 19.1 24.5 14.2 22.8 40.8 16.0 17.5 15.0 22.9 21.2 23.3 40.1 29.0 36.0 33.9 39.1 28.9 59.5 24.6 17.0 26.2 4.0 3.0 4.6 4.4 3.0 4.6 6.4 3.7 4.0 2.8 4.4 4.1 3.3 8.7 5.5 3.5 4.5 4.8 2.1 7.6 8.8 17.0 8.3 6.5 8.7 9.3 7.8 9.0 8.8 7.8 11.2 44.5 25.6 24.2 95.6 42.4 40.0 31.4 18.7 38.7 43.8 24.8 26.7 10.8 22.8 23.5 16.5 39.6 29.3 39.5 42.1 11.7 20.7 2.8 23.7 59.5 34.1 18.7 29.7 161.8 22.2 26.7 33.8 23.9 39.6 22.2 30.3 31.4 21.5 18.6 28.6 166.8 27.9 8.2 16.9 22.0 4.8 49.4 25.1 16.0 231.4 27.2 25.6 42.2 223.2 188.4 27.4 17.5 32.4 53.1 27.2 24.2 13.2 14.5 68.1 26.3 67.1 36.2 54.8 50.5 27.5 36.7 31.7 39.2 16.0 23.4 24.3 STAG2 "SA-2, SA2, SCC3B" ENSG00000101972 "Stromal antigen 2" Q8N3U4 X 123960212-124422664 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002857 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA002857: AB_1079861" "unprognostic (1.62e-1)" "unprognostic (1.01e-2)" "unprognostic (6.75e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.70e-2)" "unprognostic (3.77e-2)" "unprognostic (9.67e-3)" "unprognostic (4.68e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-1)" "unprognostic (3.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.81e-1)" "unprognostic (2.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.97e-1)" 27.9 22.9 20.7 34.2 26.3 72.8 41.5 32.6 24.1 33.3 30.4 28.8 23.8 35.7 28.3 26.8 30.1 25.2 21.5 18.0 22.6 33.7 28.5 28.6 45.0 26.2 21.9 46.0 31.7 51.9 12.0 35.8 27.8 29.8 28.2 45.5 26.5 29.6 23.3 26.1 26.5 25.8 24.2 37.4 28.5 8.0 21.2 81.4 49.3 36.0 44.3 28.4 17.6 39.6 62.6 56.9 84.5 53.0 34.9 52.3 54.4 58.0 61.8 58.5 73.2 53.8 65.1 115.0 79.6 52.3 65.5 55.6 173.6 48.8 82.5 81.9 74.7 106.6 110.8 35.7 35.6 140.7 80.0 42.2 46.4 69.5 111.4 50.2 49.7 114.2 105.4 118.9 43.1 67.8 180.6 62.9 44.5 55.8 84.4 125.9 112.0 96.1 44.9 117.3 75.7 60.6 131.2 47.7 66.9 59.2 28.9 62.2 61.5 0.3 31.1 69.4 66.6 50.9 82.2 141.6 36.8 84.3 60.3 28.2 15.2 28.0 15.0 18.9 17.8 15.0 15.6 14.6 19.1 19.0 21.3 17.5 44.5 18.8 23.1 16.5 13.5 10.0 20.7 26.3 32.6 24.1 18.0 22.6 26.2 21.9 27.8 24.2 21.2 39.6 71.1 64.1 56.6 42.4 80.9 56.2 61.5 31.5 72.3 51.0 58.0 48.4 44.9 37.1 50.6 44.1 60.5 32.2 113.4 42.9 21.5 42.3 1.1 65.1 70.4 62.3 58.1 77.0 41.8 38.2 32.7 64.5 39.8 79.3 58.1 53.6 59.3 42.2 36.0 45.4 51.9 35.0 28.5 71.4 65.0 4.2 65.9 89.9 33.8 70.3 91.4 61.2 97.9 69.4 114.0 54.9 29.3 69.2 73.8 81.4 28.0 35.7 51.4 62.9 65.7 104.0 60.3 14.8 15.4 51.0 56.1 71.4 87.2 49.5 38.9 83.6 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155308 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "testis: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.2 0.0 0.0 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 14.7 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.3 0.4 0.6 0.2 0.4 0.2 0.4 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736959 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 808.1;tongue: 581.5" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 259.3" "Lineage enriched" "Detected in all" 9 "granulocytes: 259.3" "Cell line enhanced" "Detected in many" "HaCaT: 146.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA 210000 "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 26.4 13.4 3.7 22.7 3.9 37.2 22.6 1.3 8.9 45.8 2.5 314.5 14.8 116.2 24.1 92.1 55.5 52.0 165.0 2.2 2.7 15.4 10.4 22.9 12.6 7.0 4.1 83.3 18.5 31.8 8.5 17.9 4.4 70.3 37.1 10.3 40.6 100.0 808.1 26.9 60.1 107.0 4.4 7.6 77.6 11.7 4.9 19.1 35.0 581.5 10.8 173.2 40.3 5.2 71.4 27.9 12.4 5.4 32.1 84.4 22.1 12.6 24.1 4.3 4.7 34.4 63.1 2.4 43.0 4.9 31.9 146.8 8.6 25.6 5.2 1.4 17.6 0.1 33.6 19.9 21.4 8.0 1.5 72.7 24.5 44.2 19.1 71.9 69.6 14.7 0.1 0.4 6.7 19.9 7.7 4.0 7.0 27.8 15.1 15.5 32.1 0.9 40.2 20.1 18.1 14.1 12.3 1.4 34.3 39.8 12.9 7.9 46.3 21.9 23.4 94.4 34.4 0.6 0.8 0.3 64.5 14.0 65.4 43.4 12.1 58.2 11.1 14.0 10.9 0.6 11.2 7.6 7.3 1.0 17.1 10.9 259.3 14.6 29.6 3.0 4.3 3.7 3.7 3.9 1.3 8.9 2.2 2.7 7.0 4.1 4.4 4.4 4.9 5.2 31.3 48.1 30.5 2.3 3.7 70.2 108.0 41.1 204.9 11.7 36.6 67.1 469.6 18.6 53.5 38.6 25.0 29.7 11.3 39.7 7.9 94.1 4.0 26.3 65.8 61.1 23.9 1.7 8.3 42.3 18.5 68.1 7.7 43.6 10.1 35.7 32.2 11.8 10.4 5.0 43.9 31.3 28.5 7.5 45.7 6.8 109.6 25.3 28.4 146.1 16.7 30.6 13.4 28.1 6.6 63.4 40.2 260.7 3.3 131.8 18.4 10.8 42.2 15.0 46.0 90.6 92.9 6.5 11.1 103.8 60.0 24.8 14.6 27.9 39.2 98.3 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981863-158099176 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 116.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 133.4;TIME: 109.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavorable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 4.2 5.8 26.1 6.2 69.9 20.0 8.0 58.6 42.0 4.5 1.9 10.6 7.1 7.6 10.5 7.7 5.5 9.4 10.7 22.5 32.4 8.4 4.9 4.5 5.9 98.1 74.7 3.6 8.1 1.5 4.1 3.5 78.9 6.9 10.4 2.3 16.5 5.8 7.2 4.3 6.8 7.7 57.8 4.2 8.5 9.4 58.2 6.5 5.2 9.5 6.5 11.0 4.6 116.2 16.4 56.6 4.5 7.3 3.4 11.2 24.2 29.8 60.4 35.0 41.1 28.7 13.5 0.5 19.8 57.9 133.4 15.4 10.1 18.5 40.1 22.9 9.3 31.8 29.8 30.9 6.5 10.9 32.6 5.9 9.9 53.3 12.4 47.1 61.7 16.4 24.7 6.5 16.1 7.6 14.0 12.2 5.1 51.4 31.2 6.0 19.1 13.4 11.8 18.8 34.8 2.0 22.7 14.2 5.9 17.2 10.9 7.1 109.7 25.8 26.8 61.4 36.5 2.5 7.8 0.4 49.2 17.5 18.4 3.0 0.6 0.5 0.9 0.3 1.9 1.0 1.3 0.8 0.6 2.0 1.1 0.8 4.3 1.0 0.4 0.5 1.2 0.5 26.1 69.9 58.6 42.0 22.5 32.4 98.1 74.7 78.9 57.8 58.2 116.2 17.2 3.2 3.3 5.2 15.4 21.7 19.9 7.5 14.2 2.4 25.4 18.4 13.9 21.5 8.6 18.4 0.0 7.7 12.8 20.0 3.9 59.0 35.5 48.5 13.7 26.4 17.4 5.5 102.1 35.2 5.0 16.6 34.1 114.2 5.1 37.7 7.9 5.2 2.0 0.0 10.1 14.8 10.2 2.2 17.6 56.5 1.2 12.5 10.6 7.5 6.9 1.6 16.5 8.5 502.1 140.2 7.1 6.4 13.5 50.6 13.1 1.7 14.4 0.6 0.0 7.3 18.9 0.9 1.1 11.5 17.2 15.9 17.1 2.2 15.7 36.2 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 68.3" "Cell type enhanced" "Detected in many" "Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9" "Region enriched" "Detected in many" 5 "hypothalamus: 30.1" "Low region specificity" "Detected in all" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 3300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 6.9 4.1 6.9 2.2 13.2 2.3 6.0 4.5 5.1 21.7 14.1 9.8 2.1 43.1 3.1 3.9 17.8 4.0 3.2 5.2 13.1 5.6 10.5 4.7 0.7 8.4 9.3 68.3 8.3 1.2 18.8 3.6 7.4 12.7 9.7 1.3 6.1 7.2 2.3 2.0 4.9 32.7 6.1 3.3 7.4 6.8 18.0 0.6 8.8 4.9 1.7 6.1 10.2 7.9 0.3 6.0 1.6 0.0 8.5 4.8 0.1 7.7 4.9 8.0 14.3 0.7 7.6 0.0 2.0 5.4 6.9 6.8 29.5 2.3 8.4 0.0 2.6 0.1 10.8 0.4 2.1 0.0 60.0 1.7 0.5 7.3 0.4 3.1 20.5 0.0 3.0 0.0 3.8 2.0 0.1 0.0 1.2 21.2 0.0 0.0 2.4 0.0 7.0 40.8 14.5 0.6 3.1 11.5 1.7 3.0 7.1 0.6 34.9 4.2 8.8 20.9 1.9 0.1 0.0 0.1 5.2 0.0 4.8 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.8 6.9 13.2 4.5 5.1 5.2 13.1 8.4 9.3 7.4 6.1 18.0 7.9 15.6 28.9 1.7 41.8 0.5 0.1 7.7 3.1 1.2 0.2 19.0 6.6 3.8 18.6 8.0 3.7 0.0 0.4 0.7 29.1 3.9 8.9 1.6 4.3 25.8 13.5 0.0 5.0 0.5 2.3 0.4 20.0 26.5 6.2 3.8 58.1 11.4 38.6 1.3 0.0 1.0 26.9 8.2 1.6 1.9 3.8 72.7 7.2 3.6 8.4 0.5 5.4 0.0 10.6 0.2 7.2 27.1 41.8 0.5 11.9 5.8 2.6 8.1 0.6 52.6 38.1 11.8 2.6 4.4 2.6 0.9 0.0 0.9 18.0 9.6 13.8 TAOK1 "FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1" ENSG00000160551 "TAO kinase 1" Q7L7X3 17 29390363-29551903 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007669 Approved Uncertain Vesicles NA NA 1600000 "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Vesicles "HPA007669: AB_1080201" "unprognostic (1.46e-1)" "unprognostic (7.15e-3)" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.81e-2)" "unprognostic (4.85e-2)" "unprognostic (1.28e-2)" "unprognostic (4.31e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (2.85e-2)" "unprognostic (5.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" 13.7 9.1 12.0 9.8 16.0 10.5 10.3 13.8 13.1 11.8 1.2 9.5 5.2 10.8 8.5 10.3 7.9 9.6 13.2 13.3 12.8 10.2 8.6 9.8 9.9 16.4 14.5 10.3 7.8 19.4 8.0 11.7 14.9 9.0 8.5 20.9 7.8 10.0 11.4 10.4 7.3 11.7 13.2 10.4 8.1 11.7 13.9 13.2 14.5 15.2 9.5 12.1 8.7 20.4 19.3 35.0 32.1 13.4 24.1 29.8 11.3 20.0 23.9 20.3 21.1 20.7 7.9 13.8 15.8 35.9 20.7 16.3 30.4 15.7 36.4 20.7 18.2 21.0 21.3 12.2 16.6 26.5 16.7 19.4 19.6 29.0 30.6 21.3 27.3 14.0 20.7 12.0 26.7 14.2 18.5 9.5 12.0 12.9 8.6 15.1 41.2 8.8 19.1 31.5 16.1 18.7 34.6 34.4 21.1 32.6 23.6 21.6 33.6 28.0 19.7 23.7 27.5 9.3 18.6 14.0 20.3 14.8 24.3 0.6 0.5 0.5 0.6 0.6 0.5 0.5 0.6 0.7 0.5 0.6 0.7 0.7 1.7 0.5 0.6 1.4 0.4 0.3 12.0 16.0 13.8 13.1 13.3 12.8 16.4 14.5 14.9 13.2 13.9 20.4 96.9 48.1 45.8 105.8 35.9 44.5 27.4 27.0 52.9 56.6 35.5 23.2 90.2 30.0 37.7 46.0 98.0 18.7 40.5 29.3 15.6 27.3 11.8 45.0 72.0 55.4 37.7 18.7 162.3 24.3 16.0 58.0 31.6 80.1 28.5 44.3 52.1 29.5 30.1 52.2 160.5 23.7 24.4 65.6 60.4 19.8 39.7 67.3 40.9 92.8 55.8 37.1 29.9 142.2 220.8 38.9 24.0 54.2 34.2 40.4 17.6 22.1 31.0 54.7 26.3 66.1 52.1 59.1 33.2 49.5 45.9 37.6 43.1 43.0 21.1 41.6 TAS2R40 GPR60 ENSG00000221937 "Taste 2 receptor member 40" P59535 7 143222037-143223079 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "brain: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" 0.0 0.0 0.6 0.6 4.6 0.0 0.0 2.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 3.1 0.0 0.0 0.1 0.0 7.3 3.6 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.6 4.6 2.8 3.1 0.8 3.1 7.3 3.6 6.1 2.7 4.2 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm NA Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 47: Non-specific - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA062347: AB_2684744, HPA064856: AB_2685371" "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favorable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.59e-5)" 13.9 10.9 25.2 8.5 22.3 6.7 12.0 11.4 29.9 17.1 6.3 15.3 3.1 14.0 2.1 11.3 14.2 8.1 16.4 27.3 19.3 12.9 3.4 12.3 6.0 18.4 19.8 21.4 9.6 10.1 11.6 9.5 18.2 13.4 2.2 10.4 15.9 9.3 35.5 7.4 7.8 7.9 11.6 18.4 10.5 14.2 24.4 3.2 11.7 22.3 3.4 14.9 12.3 18.5 0.5 10.0 18.3 19.4 9.2 9.3 11.9 10.1 10.6 4.9 5.8 62.8 1.5 0.3 9.9 12.6 8.7 1.1 14.4 2.6 2.9 12.3 32.6 26.8 9.8 10.7 21.2 5.1 5.7 18.8 6.5 1.1 1.8 15.2 17.4 7.3 23.5 0.0 2.8 2.8 3.3 25.2 25.5 0.5 7.0 12.0 5.7 10.5 6.1 0.8 15.8 29.5 4.8 1.2 5.2 17.2 11.0 11.4 20.2 15.1 17.8 18.4 1.2 6.8 0.7 12.4 8.8 9.6 3.9 0.0 0.2 0.4 1.0 0.1 0.5 0.0 0.3 0.8 0.2 0.2 0.1 0.3 2.2 0.9 0.0 0.2 0.2 0.1 25.2 22.3 11.4 29.9 27.3 19.3 18.4 19.8 18.2 11.6 24.4 18.5 15.5 0.0 1.1 13.4 2.4 4.0 3.2 0.9 1.8 13.7 2.8 3.4 3.7 1.5 1.1 3.7 2.1 0.1 6.3 0.0 1.9 1.1 6.9 0.7 3.5 9.7 5.3 3.2 6.9 1.8 0.2 3.9 2.6 1.2 0.0 4.2 10.4 1.1 3.2 28.6 12.1 0.5 4.1 2.9 4.0 6.6 8.7 2.2 1.8 5.6 1.1 4.7 5.2 9.5 1.2 0.9 0.0 8.6 2.2 5.5 0.0 5.0 0.8 3.7 0.0 1.5 2.7 3.8 5.3 2.0 3.0 0.3 3.9 1.3 0.1 2.2 TCF25 "KIAA1049, Nulp1" ENSG00000141002 "Transcription factor 25" Q9BQ70 16 89873570-89913627 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041699, HPA041786" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "HPA041699: AB_10960254, HPA041786: AB_10960526" "unprognostic (1.33e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "prognostic favorable (6.95e-4)" "unprognostic (6.67e-2)" "unprognostic (4.96e-2)" "unprognostic (2.72e-1)" "unprognostic (6.02e-2)" "unprognostic (2.50e-1)" "unprognostic (3.49e-1)" "unprognostic (1.05e-2)" "unprognostic (1.27e-1)" "unprognostic (7.64e-3)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (6.10e-3)" "unprognostic (1.08e-1)" 71.9 91.2 48.2 51.1 53.7 98.7 71.0 45.6 58.4 72.2 34.6 77.4 61.4 77.4 42.3 69.3 69.0 55.0 73.4 50.7 52.1 65.8 78.4 68.3 63.8 48.2 44.8 85.3 85.9 65.4 85.7 53.3 52.4 70.6 37.2 22.9 72.8 53.7 83.8 71.8 70.9 46.1 35.2 78.0 84.9 76.9 48.8 45.0 77.7 41.4 44.4 73.3 65.4 48.1 51.1 72.9 80.6 107.8 65.4 70.1 89.7 122.4 91.9 91.9 42.9 46.9 75.4 120.2 95.0 88.2 30.7 50.3 45.7 53.8 36.5 50.6 96.7 61.2 71.0 94.4 109.7 72.1 78.7 84.8 55.3 56.6 61.1 90.4 83.1 46.7 113.6 72.4 95.4 166.8 78.4 138.9 52.1 77.3 40.4 122.4 77.2 68.2 78.1 69.0 71.7 42.7 184.5 70.5 67.9 33.6 66.0 75.1 126.6 75.0 81.6 42.7 51.8 91.0 34.7 68.7 72.0 83.0 98.8 124.5 131.5 107.5 97.8 107.4 72.3 74.9 71.2 76.3 91.5 93.2 60.1 63.0 222.6 78.2 102.9 145.3 67.2 81.0 48.2 53.7 45.6 58.4 50.7 52.1 48.2 44.8 52.4 35.2 48.8 48.1 160.7 160.3 154.7 64.3 170.9 102.3 155.7 145.6 124.7 360.0 135.7 142.0 90.7 107.2 148.7 165.5 277.3 249.1 277.8 194.9 148.7 110.8 271.7 165.3 209.1 143.3 148.2 85.0 65.2 152.3 329.5 149.4 181.5 203.1 172.8 153.1 126.7 157.7 156.4 464.4 69.7 233.2 120.1 154.6 161.0 383.9 173.4 160.2 186.7 45.0 195.6 150.8 307.9 38.7 54.7 117.2 179.7 184.3 236.4 175.1 192.8 179.1 162.7 279.4 157.8 119.1 152.1 192.7 74.6 114.9 104.0 538.8 193.8 185.4 185.6 199.4 TCTEX1D4 ENSG00000188396 "Tctex1 domain containing 4" Q5JR98 1 44805893-44807351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 21.6;fallopian tube: 10.2" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 94.5;Respiratory ciliated cells: 129.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 12 "neutrophil: 7.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.9" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.7;TIME: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062652 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA062652: AB_2684818" "unprognostic (3.12e-1)" "unprognostic (3.13e-1)" "unprognostic (1.81e-1)" "prognostic favorable (1.58e-4)" "unprognostic (5.28e-2)" "unprognostic (3.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.26e-1)" "unprognostic (3.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.26e-2)" "unprognostic (4.92e-2)" "unprognostic (4.70e-3)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.83e-3)" 1.1 2.0 0.7 1.2 1.0 2.4 0.4 1.1 2.1 1.1 21.6 0.4 0.4 1.3 2.2 0.7 10.2 1.8 0.6 0.9 1.4 0.6 0.6 2.8 0.3 5.1 4.0 0.4 0.9 0.4 0.8 0.1 3.0 0.3 0.1 0.0 1.1 0.3 0.4 0.6 0.5 0.1 2.6 0.4 1.0 0.4 3.9 0.0 0.9 0.2 0.0 0.4 0.3 3.0 0.5 0.9 0.3 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.7 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 1.1 0.0 0.1 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 0.5 0.9 0.0 0.0 1.8 0.1 0.7 0.2 0.3 0.7 0.4 0.0 0.2 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.2 0.7 1.0 1.1 2.1 0.9 1.4 5.1 4.0 3.0 2.6 3.9 3.0 0.2 0.0 0.5 0.0 0.3 0.3 0.4 11.4 0.0 0.0 0.6 0.8 0.2 1.5 10.6 1.8 0.0 0.2 0.1 0.9 0.0 1.2 0.0 94.5 0.9 0.4 0.0 0.0 0.0 4.0 0.2 0.4 0.0 1.5 0.0 0.2 0.0 1.2 0.8 0.0 0.0 1.7 10.2 1.2 0.9 0.1 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 2.4 0.0 0.0 0.4 2.3 1.3 129.4 0.0 0.0 0.8 3.8 0.1 0.6 0.0 0.0 0.3 0.3 0.5 0.6 0.5 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 433 "epididymis: 575.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 30: Epididymis - Antimicrobial activity" "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.0 0.0 0.5 0.0 0.2 0.1 0.0 1.3 0.3 0.1 0.1 0.0 0.0 0.0 575.8 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.5 0.2 1.3 0.3 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084094-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 62.8;testis: 71.2" "Group enriched" "Detected in some" 4 "Early spermatids: 523.7;Late spermatids: 306.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 8 "NB-4: 37.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027248, HPA027461" Approved Approved Microtubules NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 2.2 0.1 2.4 1.5 0.9 1.9 2.6 3.5 12.2 0.6 0.1 1.5 0.1 0.2 62.8 0.1 0.1 2.3 3.0 3.1 0.1 6.3 0.1 4.6 6.3 0.5 2.4 0.7 4.3 0.0 3.7 0.7 0.0 0.1 0.4 0.5 0.0 0.2 0.2 0.3 4.4 0.0 0.4 71.2 3.1 1.1 2.7 0.0 0.0 0.1 0.3 3.3 0.0 0.0 4.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 37.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.2 2.4 1.9 2.6 2.3 3.0 4.6 6.3 3.7 4.4 3.1 3.3 0.2 0.0 0.0 0.0 0.2 0.1 0.6 9.4 0.0 0.0 0.8 0.6 0.6 0.0 8.0 1.8 0.0 0.2 0.0 0.0 0.0 0.9 523.7 81.2 0.8 0.4 1.8 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.1 12.2 0.0 0.0 306.1 5.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 3.8 0.0 0.4 0.0 2.5 84.7 0.1 0.0 0.0 2.6 27.6 4.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 TENT4B "PAPD5, TRF4-2, TUT3" ENSG00000121274 "Terminal nucleotidyltransferase 4B" Q8NDF8 16 50152911-50235310 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042968, HPA048225" Uncertain Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Nucleoli, Plasma membrane" "HPA042968: AB_2678244, HPA048225: AB_2680319" "unprognostic (1.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.27e-1)" "unprognostic (2.91e-2)" "unprognostic (4.33e-2)" "unprognostic (2.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (3.30e-2)" "prognostic favorable (1.85e-4)" "unprognostic (4.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (7.00e-2)" 6.1 6.4 2.4 1.7 2.3 7.1 4.6 3.9 2.6 7.3 3.0 6.9 4.6 6.9 2.3 5.4 6.5 2.0 3.7 2.7 3.0 4.2 8.9 5.0 2.3 2.2 2.4 6.8 4.3 3.9 4.8 2.8 2.2 5.3 1.9 1.4 4.7 1.7 5.4 5.5 5.9 2.5 2.2 4.6 5.5 5.7 3.1 1.7 4.7 2.1 1.9 7.2 6.4 2.7 5.5 1.9 0.6 3.3 3.8 2.0 4.3 3.9 2.3 3.5 1.6 3.4 2.3 6.5 5.6 2.7 1.4 3.6 3.9 2.0 3.1 3.8 4.5 3.6 1.6 5.4 3.8 2.4 4.9 1.9 2.6 2.3 3.3 2.3 1.8 2.1 4.2 1.5 4.1 1.5 3.5 4.6 4.2 1.5 4.5 4.9 4.8 6.9 1.7 0.5 4.0 2.2 4.9 2.7 2.3 1.5 1.5 0.9 3.0 2.1 4.1 4.0 1.9 4.9 3.7 6.9 1.7 2.7 2.7 0.0 0.4 0.0 0.4 0.2 0.1 0.3 0.2 0.5 0.2 0.2 0.3 0.5 0.7 0.2 0.2 0.4 0.1 0.1 2.4 2.3 3.9 2.6 2.7 3.0 2.2 2.4 2.2 2.2 3.1 2.7 17.9 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 17.8 16.3 0.0 0.0 0.0 14.7 0.0 18.1 82.8 0.0 3.9 10.9 0.0 44.3 24.4 6.1 0.0 0.0 0.0 14.9 11.5 6.7 0.0 31.5 0.0 13.5 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.2 0.0 0.0 22.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 18.3 14.9 17.3 0.0 0.0 TET2 "FLJ20032, KIAA1546" ENSG00000168769 "Tet methylcytosine dioxygenase 2" Q6N021 4 105145875-105279816 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 55.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 55.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043135 Supported Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA043135: AB_10794177" "unprognostic (6.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.69e-2)" "unprognostic (9.42e-2)" "unprognostic (4.15e-2)" "unprognostic (5.88e-2)" "unprognostic (6.12e-2)" "unprognostic (1.19e-3)" "unprognostic (1.15e-2)" "unprognostic (1.57e-2)" "unprognostic (5.77e-2)" "unprognostic (7.29e-2)" "unprognostic (2.70e-3)" "unprognostic (6.10e-2)" "unprognostic (1.89e-1)" "unprognostic (9.15e-2)" "unprognostic (7.84e-2)" 4.3 3.1 2.9 10.1 4.4 22.4 5.4 2.5 2.7 6.3 5.8 5.2 6.1 7.2 6.0 7.7 4.9 5.0 3.3 2.1 4.6 4.1 4.2 5.4 5.6 5.3 4.4 4.3 3.7 4.6 1.8 10.2 5.3 4.4 5.9 6.6 4.7 3.3 2.8 11.0 6.0 5.7 2.9 7.2 5.3 1.3 4.1 5.4 4.2 5.2 7.0 5.5 4.5 5.6 5.1 3.1 10.9 11.1 2.1 3.7 4.2 3.1 4.8 4.8 4.7 3.1 6.4 0.5 4.0 4.0 2.1 4.9 9.3 6.1 5.3 6.7 2.9 7.0 6.5 1.6 4.9 15.5 11.8 3.8 7.9 4.5 5.6 8.6 6.4 4.1 7.7 13.6 4.4 3.1 2.5 4.7 2.5 6.2 2.2 8.4 4.7 1.0 4.7 9.4 7.5 5.9 4.2 9.1 0.8 5.9 4.5 11.8 9.1 7.8 6.7 2.1 5.3 9.5 6.8 6.8 4.8 3.8 7.2 30.1 13.6 14.7 3.9 10.4 1.6 5.3 2.3 2.2 10.2 6.3 1.9 2.9 55.5 5.9 13.6 8.9 3.1 3.3 2.9 4.4 2.5 2.7 2.1 4.6 5.3 4.4 5.3 2.9 4.1 5.6 24.5 25.6 29.1 58.8 28.3 14.4 11.0 14.2 12.5 22.8 15.6 13.6 27.9 5.7 23.9 9.2 16.7 23.1 34.1 19.0 7.9 7.0 0.4 22.1 38.3 20.3 23.3 10.9 48.4 7.5 5.7 18.0 21.4 33.2 27.8 15.5 13.6 8.5 14.5 35.3 89.7 15.8 32.6 48.8 93.3 0.9 8.1 98.3 5.4 90.9 48.1 5.8 34.0 112.6 128.3 8.2 18.7 7.2 22.5 12.1 16.3 2.8 22.3 24.3 13.1 47.0 21.7 0.2 1.3 28.4 35.9 34.2 18.9 24.7 14.0 27.5 TEX54 ENSG00000283268 "Testis expressed 54" A0A1B0GVG6 11 62832319-62832803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 76.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in all" 6 "neutrophil: 147.9" "Lineage enriched" "Detected in all" 17 "granulocytes: 147.9" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" 0.2 0.3 0.2 0.3 0.2 0.6 0.2 1.0 0.5 0.2 0.6 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.1 0.5 0.4 0.2 0.3 0.3 0.4 0.3 0.5 0.0 1.1 0.2 0.1 0.6 0.0 0.1 2.1 0.0 0.2 0.9 0.4 0.0 0.1 0.4 0.6 76.8 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.8 0.2 0.0 1.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.0 0.4 0.4 0.1 0.0 0.5 0.3 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.5 0.2 0.2 0.6 0.0 0.7 0.2 0.3 0.0 0.0 0.6 25.1 8.9 20.3 5.0 6.2 8.4 6.4 5.2 4.5 2.8 6.7 8.8 6.4 147.9 5.2 2.9 7.5 3.9 0.9 0.2 0.2 1.0 0.5 0.3 0.1 0.3 0.4 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 TG "AITD3, TGN" ENSG00000042832 Thyroglobulin P01266 8 132866958-133134903 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Thyroid hormones biosynthesis" "Hormone, Thyroid hormone" "Cancer-related genes, Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 685 "thyroid gland: 9329.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 5.5;Cardiomyocytes: 3.0;Early spermatids: 2.3;Late spermatids: 2.2;Microglial cells: 1.9;Proximal tubular cells: 4.0" "Cancer enriched" "Detected in some" 1672 "thyroid cancer: 3072.8" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HSkMC: 2.4;Karpas-707: 5.6;PC-3: 2.8;U-266/70: 2.0;U-266/84: 1.8" "Region enriched" "Detected in single" 5 "cerebellum: 1.1" "Low region specificity" "Detected in some" "CAB000077, HPA002740, CAB056155" Enhanced "Secreted in other tissues" NA NA 1600000 "Cluster 1: Neutrophils - Mixed function" "Cluster 1: Thyroid gland - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277" "unprognostic (1.18e-1)" "unprognostic (6.86e-2)" "unprognostic (7.40e-4)" "unprognostic (1.20e-2)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.77e-2)" "unprognostic (7.38e-2)" "unprognostic (4.96e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (5.11e-2)" "unprognostic (3.64e-2)" 1.6 3.2 3.0 0.5 0.4 7.8 1.4 0.2 1.9 1.2 1.5 1.8 0.0 1.8 1.0 2.0 0.4 8.6 13.6 1.7 0.2 2.9 3.6 4.2 12.0 0.4 0.5 1.2 8.0 2.7 1.2 0.2 0.5 3.6 0.1 0.1 3.9 1.8 2.8 6.3 1.7 0.1 0.2 1.9 2.2 2.9 0.5 0.4 9329.0 0.0 0.6 0.6 1.7 0.5 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 1.7 0.6 0.0 0.5 0.0 0.7 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.2 0.1 1.6 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.0 1.8 0.0 0.1 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.1 0.1 3.0 0.4 0.2 1.9 1.7 0.2 0.4 0.5 0.5 0.2 0.5 0.5 0.3 0.0 0.6 0.3 0.2 0.0 5.5 0.1 0.0 0.0 0.1 0.1 3.0 0.0 1.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.3 0.1 0.4 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.2 0.4 0.4 0.3 0.0 0.7 0.3 0.0 0.0 0.0 2.2 0.0 0.1 0.0 1.9 0.7 0.3 0.0 0.5 0.1 0.1 0.0 0.4 0.1 0.5 0.0 4.0 0.0 0.0 0.0 0.3 0.3 0.8 0.3 0.0 0.6 0.0 0.2 1.1 0.0 1.2 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313309-42325064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 67.8;pituitary gland: 18.3;retina: 28.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 64.5;Cone photoreceptor cells: 29.2;Excitatory neurons: 26.5;Horizontal cells: 69.0;Inhibitory neurons: 54.3;Rod photoreceptor cells: 33.0" "Cancer enriched" "Detected in many" 5 "glioma: 8.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 6.8;neutrophil: 14.2" "Lineage enriched" "Detected in many" 11 "granulocytes: 14.2" "Cell line enhanced" "Detected in many" "HMC-1: 13.7;PC-3: 11.6;SCLC-21H: 26.2;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.0 4.3 17.7 0.7 21.0 2.0 0.7 67.8 37.3 0.2 0.1 0.8 1.2 0.6 1.0 0.5 0.6 0.8 0.9 16.5 15.6 0.5 0.7 0.3 1.1 17.8 20.0 0.6 2.5 1.8 18.3 0.2 18.2 0.5 0.6 28.8 0.5 0.5 1.8 2.3 0.6 0.6 10.7 0.9 1.2 4.2 19.2 0.4 0.7 0.8 0.5 0.6 0.2 21.0 0.7 3.2 2.4 7.3 0.2 0.2 1.0 0.3 0.1 1.1 3.0 0.6 0.9 1.9 0.3 1.2 0.7 0.3 1.7 0.6 1.5 8.5 2.0 3.5 3.5 3.1 0.2 2.0 13.7 0.7 0.6 0.4 0.8 0.2 1.4 1.0 1.9 6.6 0.1 0.7 0.5 2.5 1.7 2.4 11.6 0.3 0.8 6.2 0.1 1.3 26.2 12.7 1.2 0.9 1.7 0.2 2.3 2.1 0.5 2.0 2.3 1.6 0.9 1.4 4.2 1.9 0.9 1.4 6.1 6.8 0.9 1.0 0.6 0.8 0.3 1.2 0.6 0.4 0.3 1.2 0.6 0.9 14.2 0.8 0.8 0.8 0.5 1.2 17.7 21.0 67.8 37.3 16.5 15.6 17.8 20.0 18.2 10.7 19.2 21.0 0.5 0.0 0.0 16.3 0.1 0.3 0.4 0.0 0.0 64.5 0.7 0.9 0.5 0.0 0.0 0.0 29.2 0.0 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.8 0.0 0.0 26.5 0.2 0.1 0.1 0.0 0.2 1.3 0.1 1.1 0.0 0.4 69.0 54.3 0.0 0.0 0.6 0.3 0.2 0.0 0.2 5.4 1.0 0.0 10.3 2.1 15.1 5.7 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 33.0 0.0 1.4 0.3 9.5 17.9 0.0 0.1 0.0 0.1 1.4 0.1 0.1 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 21.1" "Cell type enriched" "Detected in some" 11 "Early spermatids: 179.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.3 0.2 0.0 1.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 179.5 0.3 0.2 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 16.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.4 0.2 1.1 1.2 0.5 0.3 0.4 0.5 0.1 0.1 0.1 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.7;pituitary gland: 41.9" "Cell type enhanced" "Detected in some" "Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1" "Cancer enhanced" "Detected in many" "breast cancer: 5.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.2 9.6 9.2 0.6 5.9 0.8 3.3 28.7 10.5 2.6 0.0 4.5 1.2 0.1 4.5 6.4 0.2 0.2 0.9 5.6 24.6 0.5 0.1 0.5 0.3 4.5 8.3 0.1 4.8 1.5 41.9 0.7 16.9 0.2 3.0 2.4 2.7 0.0 0.5 9.7 2.7 0.6 4.2 3.3 1.9 11.3 18.2 0.1 2.2 0.4 0.3 0.0 7.1 4.3 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 18.5 3.4 0.0 3.0 2.5 3.8 1.5 0.0 1.2 1.4 0.3 1.8 0.0 0.0 3.2 0.1 0.0 7.5 0.0 0.2 0.0 0.0 8.7 0.0 24.1 0.0 9.3 2.6 0.1 0.8 0.0 0.0 0.0 1.2 12.7 0.3 0.0 32.5 4.9 0.4 29.1 0.0 0.6 2.8 1.6 0.0 0.0 5.9 0.0 0.0 1.9 0.1 0.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.1 9.2 5.9 28.7 10.5 5.6 24.6 4.5 8.3 16.9 4.2 18.2 4.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 3.3 2.2 0.8 0.7 0.0 1.7 0.0 2.1 0.0 1.5 3.8 1.9 0.0 9.5 0.3 0.4 0.1 19.2 0.0 25.8 0.2 0.1 0.3 0.0 2.4 0.0 0.2 0.0 0.0 2.7 3.3 22.2 3.0 4.1 0.0 0.0 6.2 0.0 0.2 0.0 3.7 0.6 0.3 0.0 16.1 1.1 0.2 7.0 0.4 0.1 0.0 0.5 0.2 0.1 0.6 0.0 0.0 0.3 0.6 0.1 2.4 0.0 0.0 0.2 0.7 0.7 0.1 TMEM88 "FLJ20025, MGC71744" ENSG00000167874 "Transmembrane protein 88" Q6PEY1 17 7855066-7856099 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.5" "Group enriched" "Detected in many" 7 "Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Group enriched" "Detected in many" 6 "AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052991 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA052991: AB_2682006" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (3.44e-2)" "unprognostic (3.03e-1)" "unprognostic (6.49e-2)" "prognostic favorable (4.43e-6)" "unprognostic (1.98e-1)" "unprognostic (2.64e-2)" "unprognostic (2.18e-1)" "unprognostic (5.68e-3)" "unprognostic (9.04e-2)" "unprognostic (1.09e-2)" "unprognostic (2.68e-3)" "unprognostic (1.71e-1)" "unprognostic (7.56e-2)" "unprognostic (2.72e-1)" 63.2 22.3 11.2 7.9 11.0 6.9 29.5 12.4 24.4 20.0 14.3 18.1 5.7 24.1 3.6 6.4 26.4 12.7 98.5 11.3 11.6 37.7 5.9 14.1 3.6 12.6 11.6 8.5 10.8 7.4 21.4 23.7 12.0 19.3 2.7 2.4 9.3 6.3 35.4 3.8 15.4 10.1 11.0 15.9 18.2 4.9 12.9 2.5 39.6 36.8 0.8 19.1 14.0 10.9 0.2 0.8 8.1 65.2 0.0 0.3 3.9 0.4 0.2 0.1 0.2 1.9 0.3 0.4 0.3 0.7 0.4 0.5 0.6 0.4 0.1 0.0 0.1 0.5 1.2 1.1 42.3 0.6 2.6 1.0 1.8 1.2 0.3 0.6 51.4 0.9 1.2 0.1 0.8 5.0 0.5 1.2 26.5 0.3 0.0 0.3 0.2 0.1 0.6 1.6 0.7 3.7 0.5 0.8 2.0 2.2 1.4 0.2 5.2 0.4 1.6 2.2 0.5 0.2 0.1 0.4 0.2 0.4 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 11.2 11.0 12.4 24.4 11.3 11.6 12.6 11.6 12.0 11.0 12.9 10.9 177.3 6.4 2.2 2.0 6.2 4.1 4.0 1.4 2.2 4.7 7.9 5.2 5.9 0.0 2.4 1.8 4.2 3.1 3.1 2.0 0.0 2.2 3.0 3.1 2.0 142.1 6.6 0.0 0.6 2.2 1.0 19.2 4.6 6.7 4.5 1.8 109.9 2.4 2.6 3.3 0.9 2.5 0.0 7.3 9.3 8.6 0.9 9.9 0.0 5.6 0.2 0.6 0.0 0.0 0.1 4.0 5.7 0.0 1.0 6.5 2.4 0.6 1.5 1.4 0.0 11.3 6.5 1.7 1.8 2.7 3.1 5.2 2.5 0.8 1.5 3.2 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103121476-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 277.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 48.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "RT4: 785.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: AB_2673552" "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.10e-4)" "prognostic favorable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favorable (7.17e-5)" 119.9 76.8 9.0 103.6 11.5 106.8 78.4 6.7 12.2 53.8 12.1 39.8 38.0 50.9 6.6 88.3 57.1 102.2 48.3 8.0 9.7 67.7 61.6 142.4 87.4 17.1 10.4 16.9 33.6 66.8 16.6 48.4 16.2 73.6 26.8 1.6 84.0 14.9 35.0 53.3 52.5 24.8 13.6 147.9 37.4 37.1 21.4 39.5 36.8 32.5 80.3 277.5 74.6 16.1 34.7 156.3 1.1 0.6 10.1 45.9 54.5 9.7 43.2 26.4 8.9 1.6 148.7 0.3 120.3 48.5 142.5 104.2 11.6 0.0 11.9 6.1 0.6 15.4 120.0 0.7 19.2 7.7 20.0 17.8 1.6 8.4 0.1 10.5 14.2 7.7 15.5 35.3 3.6 3.4 0.4 11.6 9.7 19.6 13.4 6.8 18.9 24.9 80.8 785.1 1.3 2.3 150.2 52.4 1.9 5.6 83.8 50.4 28.4 5.1 13.5 30.3 31.5 31.4 2.4 0.9 38.1 34.0 16.1 5.9 16.8 9.0 0.1 18.6 0.1 0.1 0.1 0.0 9.4 0.2 0.1 0.1 48.4 0.2 15.0 0.5 0.0 4.5 9.0 11.5 6.7 12.2 8.0 9.7 17.1 10.4 16.2 13.6 21.4 16.1 45.8 0.0 25.1 2.3 8.2 28.3 41.8 295.5 6.8 1.1 24.2 11.4 14.1 51.5 126.1 27.6 0.0 1.2 1.3 1.0 0.0 160.9 36.8 92.4 122.2 47.1 17.3 1.7 2.5 44.7 61.2 123.3 5.6 172.8 33.7 4.5 18.9 8.0 54.1 0.0 5.7 0.3 85.5 151.2 198.7 48.8 8.4 163.3 30.2 25.3 351.9 5.9 5.2 1.0 0.9 122.1 18.3 2.2 11.7 186.0 0.7 14.4 121.5 0.7 19.7 104.9 39.7 2.1 4.6 20.7 33.4 4.8 8.3 1.1 1.9 138.6 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 30.4 18.3 10.8 29.0 8.9 51.8 30.1 16.2 14.2 40.8 2.2 56.3 25.3 57.6 16.4 26.0 43.5 22.4 22.1 10.3 0.5 22.9 19.8 32.0 16.1 6.2 1.7 46.0 29.5 35.0 22.2 30.6 1.6 36.1 22.6 12.2 28.8 34.3 24.0 33.2 29.0 36.4 1.3 25.2 33.8 22.6 5.1 17.2 32.6 11.1 14.6 40.8 31.9 3.2 72.8 63.4 51.5 43.4 42.9 50.6 133.8 50.4 47.3 27.4 29.0 26.3 62.4 49.3 48.3 74.7 60.8 79.7 30.2 60.5 23.0 21.6 19.2 31.4 56.6 43.1 37.1 104.3 111.2 51.2 70.0 54.8 63.2 39.5 31.3 43.6 45.4 27.2 35.3 120.0 24.6 127.2 4.5 47.5 48.0 27.0 25.7 37.3 22.3 91.3 22.3 53.4 38.8 102.5 37.0 23.1 106.9 106.1 78.7 78.3 109.6 47.0 36.7 38.6 44.1 46.2 44.1 72.6 94.1 14.2 3.8 3.6 1.7 1.5 1.2 2.2 1.2 1.0 1.4 2.3 0.9 1.7 20.8 3.2 2.1 5.4 1.9 0.2 10.8 8.9 16.2 14.2 10.3 0.5 6.2 1.7 1.6 1.3 5.1 3.2 25.6 9.6 29.0 59.7 7.4 9.3 3.7 9.8 13.6 51.7 15.8 25.9 7.5 14.3 12.4 14.7 2.1 14.5 20.4 33.6 1.9 5.0 14.4 22.2 29.7 17.3 31.3 9.7 40.9 6.6 3.8 17.8 19.4 36.2 14.0 48.3 29.6 25.4 11.2 50.5 45.6 30.4 8.2 41.8 12.4 18.8 18.3 22.8 5.4 71.2 25.9 31.0 11.3 32.6 20.3 9.0 10.6 19.9 12.1 6.5 7.4 5.4 11.1 4.0 19.7 18.4 21.2 0.4 2.1 12.5 8.8 10.0 12.3 18.6 25.1 3.8 TNRC6B KIAA1093 ENSG00000100354 "Trinucleotide repeat containing adaptor 6B" Q9UPQ9 22 40044817-40335808 "Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 484.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003180 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA003180: AB_1079196" "unprognostic (1.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" "unprognostic (5.88e-2)" "unprognostic (1.92e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-2)" "unprognostic (9.74e-2)" "unprognostic (4.93e-2)" "unprognostic (2.59e-1)" "unprognostic (8.42e-2)" "unprognostic (1.84e-3)" "unprognostic (8.85e-2)" "unprognostic (7.24e-2)" "unprognostic (7.00e-2)" "unprognostic (1.81e-1)" 4.0 3.6 4.5 4.9 6.2 19.5 3.9 22.0 7.6 4.4 13.2 4.2 3.2 4.0 5.8 3.5 3.7 4.4 4.7 3.6 1.1 3.9 5.4 4.9 5.3 3.7 3.5 4.2 3.9 4.7 5.5 3.6 4.2 3.7 3.5 12.7 4.0 2.8 6.4 5.5 5.2 3.7 1.1 5.6 4.3 14.9 3.9 9.2 5.0 5.1 5.9 3.6 4.2 15.7 6.3 9.3 9.4 9.8 6.1 4.3 5.1 4.2 7.7 6.5 7.9 4.2 4.3 11.9 7.4 5.1 7.6 4.3 11.8 8.6 6.8 13.0 9.3 8.8 9.3 5.3 3.0 10.2 12.5 4.8 4.0 10.2 5.1 3.1 9.0 6.7 7.4 10.8 6.1 6.8 6.3 3.2 12.2 4.8 6.7 7.7 9.0 6.0 6.1 10.6 11.4 2.7 10.2 3.6 5.2 8.5 5.1 3.7 10.3 5.7 20.7 5.8 4.0 8.5 8.2 7.8 3.7 5.1 6.8 228.9 32.8 66.2 48.0 19.2 42.4 100.7 50.5 44.5 16.3 134.6 52.8 53.6 484.5 34.7 29.6 104.9 29.5 12.5 4.5 6.2 22.0 7.6 3.6 1.1 3.7 3.5 4.2 1.1 3.9 15.7 114.0 38.5 54.9 260.8 178.8 74.8 70.2 60.8 92.8 248.7 103.4 85.9 153.6 125.8 56.0 69.9 458.7 36.4 171.1 77.8 70.5 59.8 82.5 142.2 91.0 104.4 141.0 203.1 334.1 59.3 20.7 108.4 61.2 85.0 65.9 78.1 120.7 109.7 39.0 341.6 371.8 76.7 65.1 115.9 80.1 72.4 111.9 71.4 65.8 235.2 117.2 127.2 168.9 255.9 304.0 54.4 76.4 127.9 117.8 79.8 93.0 69.0 91.3 356.9 52.6 175.5 95.1 87.7 88.3 56.6 82.1 7.5 149.0 82.6 83.7 59.1 TP53INP2 "C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH" ENSG00000078804 "Tumor protein p53 inducible nuclear protein 2" Q8IXH6 20 34704339-34713439 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 517.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 143.5;Early spermatids: 208.6;Late spermatids: 353.7;Paneth cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.7" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 219.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (3.33e-2)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (3.08e-2)" "unprognostic (2.07e-1)" "unprognostic (1.86e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-1)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (1.52e-2)" "unprognostic (2.57e-2)" "prognostic favorable (1.26e-8)" "unprognostic (8.03e-2)" "unprognostic (1.68e-1)" "unprognostic (1.93e-2)" "unprognostic (6.17e-2)" 19.7 28.0 315.7 11.1 439.0 89.7 13.8 343.9 403.1 19.6 159.7 42.2 19.9 26.4 15.7 64.8 19.3 23.8 85.5 233.8 348.8 31.8 45.6 19.6 5.6 517.3 444.7 15.5 16.6 35.1 22.0 10.5 464.6 36.9 38.4 45.9 27.6 31.2 53.1 12.3 23.5 34.7 418.6 6.6 24.4 39.9 376.8 2.9 31.6 94.0 17.2 33.0 23.8 485.7 2.5 3.0 9.8 12.6 22.1 18.1 4.2 9.8 30.9 12.8 10.6 17.3 1.2 7.7 6.6 19.6 25.1 1.9 20.8 4.7 14.0 2.3 2.6 14.0 8.2 16.9 28.6 2.2 10.9 52.3 7.0 10.1 1.4 16.0 20.2 6.9 5.8 24.8 14.5 3.4 1.6 4.8 1.3 2.1 7.4 7.4 6.4 12.4 16.1 8.8 21.4 24.1 8.7 219.0 15.2 11.6 15.8 10.3 15.3 35.0 12.0 4.6 4.1 9.8 12.5 6.2 22.2 31.2 12.5 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 315.7 439.0 343.9 403.1 233.8 348.8 517.3 444.7 464.6 418.6 376.8 485.7 9.5 3.2 10.6 5.5 8.1 3.7 17.0 11.7 5.7 20.4 17.4 12.3 75.4 15.7 16.7 3.7 52.1 1.7 12.8 143.5 5.9 16.5 208.6 19.6 10.1 10.4 52.4 0.4 4.3 23.9 1.1 9.6 46.9 24.2 7.0 7.5 11.0 28.7 5.3 32.0 6.1 59.5 32.6 10.2 3.6 353.7 7.5 15.5 5.4 2.8 2.6 10.9 0.0 1.0 17.7 24.3 116.1 13.2 7.4 15.3 34.0 8.9 25.1 55.8 19.7 35.9 27.4 4.0 2.7 4.5 3.0 28.5 8.4 9.1 23.9 24.4 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826819-36945057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 45.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 115.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 115.1" "Cell line enhanced" "Detected in many" "Daudi: 67.9;HMC-1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 7.4 4.6 1.7 14.0 2.5 10.0 6.4 5.2 7.5 24.6 0.0 14.8 11.1 18.0 5.2 3.2 45.0 9.6 6.2 1.8 2.3 3.4 9.9 8.8 18.7 1.9 0.5 15.6 2.4 3.2 6.7 5.2 1.8 16.5 13.4 1.4 6.8 6.3 1.1 2.3 16.7 8.8 3.4 13.1 8.2 2.4 3.3 17.5 6.2 2.5 20.8 16.6 10.0 0.7 1.4 1.7 0.4 0.0 4.5 17.9 0.0 1.4 9.1 3.9 8.0 0.0 7.2 67.9 2.8 5.3 13.5 0.5 0.2 1.0 0.7 3.7 0.1 11.6 4.8 0.0 5.5 3.1 26.1 5.7 3.5 3.1 0.2 1.1 5.4 7.6 9.5 9.9 2.4 0.1 8.9 1.3 0.5 0.0 1.9 2.5 0.3 1.4 1.5 3.3 0.6 0.0 7.2 1.9 0.7 0.8 1.2 3.8 3.7 3.4 1.3 0.2 1.2 9.3 2.2 15.8 0.6 2.6 0.4 7.3 2.0 11.5 14.9 2.9 10.7 10.9 12.3 15.3 1.4 17.5 11.0 10.6 115.1 8.5 3.9 0.2 11.6 3.0 1.7 2.5 5.2 7.5 1.8 2.3 1.9 0.5 1.8 3.4 3.3 0.7 5.4 16.0 7.8 18.3 18.8 0.8 1.3 1.7 6.8 4.4 1.6 2.3 3.6 1.5 4.0 3.7 2.1 1.3 16.5 40.9 0.0 3.1 0.4 6.1 15.1 5.5 5.4 12.6 56.5 1.8 1.6 7.1 18.8 8.8 6.3 73.0 5.7 17.7 5.0 0.0 91.8 16.7 0.0 6.6 0.8 0.0 4.4 7.4 5.4 52.5 8.7 1.6 26.8 23.6 13.2 3.2 16.9 6.0 21.9 1.6 16.7 0.9 5.2 0.7 0.0 2.6 5.2 0.3 0.3 2.6 0.9 0.7 21.8 3.7 4.0 1.5 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545684 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 6: Brain - Smell perception" "Cluster 2: Karpas-707 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 0.7 0.7 1.6 0.8 1.7 3.7 1.0 8.1 5.0 0.4 0.3 0.7 1.0 1.2 1.8 0.7 0.5 1.1 0.9 2.3 0.0 0.7 1.4 1.2 1.7 0.6 0.1 1.0 0.7 3.0 0.0 3.9 1.6 0.7 0.5 4.2 1.2 0.7 1.2 2.3 1.0 0.4 0.1 4.7 1.1 1.5 0.7 0.5 1.8 0.2 0.6 0.5 0.0 3.9 0.8 0.4 1.0 1.5 0.3 1.0 1.1 0.5 0.5 0.4 0.5 0.5 0.7 1.3 0.6 0.2 0.8 1.0 0.3 0.6 0.5 0.6 0.6 1.4 1.9 0.6 0.5 0.9 0.6 0.4 0.3 0.2 0.3 1.5 0.8 1.0 0.8 6.6 0.3 1.5 0.9 1.0 0.9 0.3 0.6 0.8 0.7 2.2 0.7 1.3 1.0 0.7 0.8 0.4 0.5 1.2 0.7 0.8 1.0 1.2 0.9 1.2 0.6 1.2 0.8 0.8 0.8 0.9 0.7 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.3 0.1 2.8 1.6 1.7 8.1 5.0 2.3 0.0 0.6 0.1 1.6 0.1 0.7 3.9 1.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 6.1 0.1 1.1 0.0 0.1 0.0 0.0 4.2 0.0 0.4 0.3 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 4.3;testis: 4.5" "Cell type enriched" "Detected in some" 5 "Respiratory ciliated cells: 382.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.5;SK-BR-3: 1.7;U-266/70: 1.6" "Low region specificity" "Detected in many" HPA057066 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.1 0.3 0.7 0.3 0.6 1.1 0.0 2.3 1.1 0.2 1.3 0.2 0.4 0.3 0.9 0.1 0.9 0.3 0.1 0.4 0.6 0.4 0.0 2.7 0.3 1.0 0.3 0.2 0.8 0.1 2.0 0.1 0.9 0.5 0.1 4.3 0.0 0.0 0.9 1.3 0.2 0.0 0.2 0.3 0.1 4.5 0.6 0.0 1.8 0.5 0.2 0.1 0.0 1.2 0.3 0.0 0.6 0.2 0.3 0.5 0.8 0.4 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.5 0.0 0.3 0.3 0.9 0.6 0.7 0.4 0.4 0.4 0.2 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.5 1.1 0.0 1.7 0.4 0.2 0.4 0.0 0.5 1.0 0.3 0.5 0.3 1.6 0.0 0.2 1.3 0.0 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.2 0.2 1.4 0.2 0.1 0.2 0.0 0.0 0.7 0.6 2.3 1.1 0.4 0.6 1.0 0.3 0.9 0.2 0.6 1.2 0.1 3.2 2.0 0.7 0.0 0.1 0.0 18.2 0.0 3.5 0.1 0.1 1.1 0.0 30.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 72.7 0.6 0.0 0.5 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 14.2 0.0 0.3 6.9 0.0 0.1 0.0 1.0 0.0 5.1 0.0 0.0 3.1 0.0 0.0 0.4 0.1 0.6 0.0 0.1 382.1 9.1 6.6 0.4 5.2 7.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TTLL3 "DKFZP434B103, HOTTL" ENSG00000214021 "Tubulin tyrosine ligase like 3" Q9Y4R7 3 9808086-9855138 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.9" "Low region specificity" "Detected in all" HPA051413 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA051413: AB_2681476" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" "unprognostic (7.23e-3)" "unprognostic (2.08e-1)" "unprognostic (4.96e-1)" "unprognostic (4.04e-4)" "unprognostic (3.14e-2)" "unprognostic (4.39e-2)" "unprognostic (7.71e-2)" "unprognostic (6.83e-2)" "unprognostic (5.46e-3)" "unprognostic (1.08e-2)" "prognostic unfavorable (6.45e-6)" "unprognostic (1.77e-2)" "unprognostic (2.09e-1)" "unprognostic (2.82e-1)" "prognostic favorable (9.51e-6)" 32.2 23.7 24.3 12.4 25.6 30.9 27.5 22.1 30.7 54.5 29.3 31.3 11.5 29.0 16.5 15.9 37.3 25.3 25.6 22.8 25.3 25.2 9.9 24.8 23.0 28.7 28.0 63.0 17.5 11.0 37.5 12.7 26.7 39.7 13.1 8.5 20.1 30.4 11.8 41.0 22.8 20.4 25.6 29.4 19.4 40.8 26.5 13.2 27.2 12.6 15.1 30.8 40.0 30.9 2.0 5.1 10.9 2.1 19.2 36.4 63.9 6.7 6.5 3.6 4.9 8.7 7.7 11.7 5.8 12.5 3.6 3.0 6.9 1.3 2.2 13.6 19.7 14.2 17.6 8.9 6.6 12.9 24.1 23.6 9.2 6.9 2.7 20.8 6.2 17.6 14.0 28.0 8.0 7.0 2.3 20.3 1.4 1.3 2.9 6.7 4.4 5.2 5.4 14.9 5.1 4.6 3.4 1.8 5.8 5.3 4.9 8.9 20.2 9.6 12.4 9.2 3.2 17.8 8.6 16.8 8.0 18.9 3.4 5.9 2.1 6.6 2.3 5.9 1.1 2.8 1.6 1.2 2.7 2.7 1.8 1.5 8.5 2.3 3.5 3.0 2.9 0.9 24.3 25.6 22.1 30.7 22.8 25.3 28.7 28.0 26.7 25.6 26.5 30.9 11.7 12.8 9.1 0.0 5.6 5.2 5.1 6.7 9.1 11.1 6.0 6.5 3.3 1.5 8.5 9.2 25.0 5.4 12.0 11.7 0.0 4.3 29.1 16.5 14.2 10.1 12.0 1.7 0.0 6.7 5.4 14.9 27.0 10.5 8.2 13.6 9.3 1.6 5.3 6.7 0.0 11.9 2.0 14.4 5.7 17.8 22.7 9.2 10.6 0.0 7.9 9.4 11.3 0.0 0.0 7.4 8.2 12.4 4.0 6.6 3.0 2.2 28.7 13.8 13.1 11.6 8.8 15.1 6.7 4.1 4.7 5.1 7.5 9.5 8.5 7.3 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31557009-31598833 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "choroid plexus: 142023.1" "Cell type enriched" "Detected in many" 30 "Hepatocytes: 23659.3" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Group enriched" "Detected in all" 7 "cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0" "Group enriched" "Detected in all" 5 "basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4" "Region enhanced" "Detected in all" "medulla oblongata: 1381.8" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 345000000000 99000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 4.2 0.6 148.5 0.5 56.7 9.6 0.4 621.7 83.7 2.0 142023.1 6.0 14.9 1.3 0.9 2.2 0.8 51.2 2.9 1730.9 37.3 18.4 21288.1 0.8 2.4 106.5 86.0 1.1 1785.1 186.8 6.0 2.7 27.1 1.6 4.5 80.1 1.8 0.4 1.1 15.6 6.8 0.3 12.3 3.8 49.8 2.3 688.2 1.1 1.3 0.0 0.1 2.3 0.6 133.9 1.6 0.4 0.6 0.5 0.8 0.1 1.0 0.8 0.3 0.0 0.0 160.1 0.0 2.9 39.6 0.5 0.6 0.4 0.0 0.3 0.0 5.9 0.8 5.2 1.8 249.0 0.4 11.2 1.0 0.1 0.1 0.1 0.0 0.7 0.0 0.3 2.8 0.4 0.0 0.5 0.4 0.7 0.6 4.5 0.3 0.3 7.4 0.2 0.3 1.6 0.9 1.1 5.8 0.0 0.2 1.7 0.6 0.2 1.7 2.4 57.0 0.5 4.3 1.0 2.6 17.6 0.7 4.3 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 148.5 56.7 621.7 83.7 1730.9 37.3 106.5 86.0 27.1 12.3 688.2 133.9 0.0 0.0 0.0 0.0 15.1 0.5 0.0 0.0 0.0 144.8 0.0 0.0 1.8 779.2 0.0 5.5 162.6 0.3 0.0 1.5 5.9 3.1 6.8 0.5 0.5 14.1 356.2 192.5 0.0 2.0 3.6 0.7 13.3 0.0 0.0 0.2 192.4 23659.3 2.4 26.9 0.1 19.6 0.0 313.7 0.0 8.7 0.3 1.2 0.0 0.0 0.0 24.9 0.0 0.0 0.0 130.5 5.2 0.0 0.0 0.2 1.3 26.9 0.0 56.0 0.0 0.0 0.3 3.3 1.1 0.0 0.1 4.0 10.9 0.0 1.7 0.0 TUT7 "FLJ13409, KIAA1711, PAPD6, TENT3B, ZCCHC6" ENSG00000083223 "Terminal uridylyl transferase 7" Q5VYS8 9 86287733-86354454 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 80.3;Endometrial stromal cells: 61.1;Glandular and luminal cells: 206.7;Syncytiotrophoblasts: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 114.6" "Group enriched" "Detected in all" 5 "granulocytes: 114.6;monocytes: 47.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 12.5 9.4 4.8 16.0 6.4 22.6 18.7 5.9 10.0 12.8 10.9 12.1 11.0 9.1 8.9 24.7 8.8 11.3 8.2 5.1 7.9 7.5 38.4 16.5 19.1 9.0 6.3 8.7 13.1 8.7 8.2 14.3 7.8 20.8 11.8 7.7 14.2 7.2 13.6 33.7 12.3 7.8 5.1 20.6 13.6 11.6 9.2 15.1 8.6 9.3 19.2 13.4 16.0 9.0 16.2 17.2 9.8 14.3 22.4 36.0 12.2 21.6 20.5 9.1 10.6 7.8 13.7 22.8 18.9 14.0 9.5 27.3 11.8 12.0 13.5 27.1 6.0 16.5 18.4 13.7 19.3 19.1 21.8 23.5 22.7 14.5 16.2 13.7 15.0 12.3 15.9 24.0 24.6 14.9 16.0 11.0 7.5 25.1 11.1 8.0 17.5 10.1 15.3 31.4 7.2 5.7 13.1 15.5 7.4 11.6 6.4 7.8 24.8 8.7 10.5 15.7 14.8 27.4 23.3 16.5 20.7 10.8 11.8 35.4 19.4 20.5 15.0 24.7 12.5 11.6 8.2 10.7 11.9 12.2 9.5 10.1 114.6 12.8 47.8 5.5 8.8 8.9 4.8 6.4 5.9 10.0 5.1 7.9 9.0 6.3 7.8 5.1 9.2 9.0 28.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 34.2 16.4 0.0 0.0 0.0 9.2 0.0 22.4 36.6 0.0 5.9 29.6 0.0 80.3 61.1 7.2 0.0 0.0 0.0 17.9 17.4 5.6 0.0 206.7 0.0 36.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 12.4 0.0 0.0 0.0 0.0 27.8 0.0 0.0 13.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 92.5 14.8 30.9 0.0 0.0 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674716 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA 73000 "Cluster 1: Neutrophils - Mixed function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555" "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 74.2 80.9 70.3 101.9 73.0 147.7 70.2 74.6 82.4 92.1 75.4 83.7 85.1 87.4 56.7 98.2 82.8 54.0 69.3 70.3 70.8 79.4 80.2 74.2 119.3 76.2 71.5 98.3 75.0 70.1 93.7 63.6 73.0 74.9 54.0 46.0 72.0 65.9 67.3 80.0 92.3 62.1 72.0 115.7 75.4 81.8 72.1 132.5 78.9 45.9 93.7 78.2 80.7 82.4 244.5 394.0 235.9 191.1 108.3 109.8 249.3 191.9 174.1 314.2 305.3 231.3 222.3 284.5 149.5 164.9 160.5 193.0 299.3 268.3 149.1 218.0 501.9 245.2 176.1 221.5 176.7 287.4 263.5 148.8 161.0 239.5 166.8 120.0 190.8 195.9 293.1 181.3 169.9 239.2 388.0 261.1 260.4 217.1 307.2 414.5 149.7 233.0 189.7 290.0 270.6 211.0 208.6 197.1 125.7 134.6 190.5 296.9 161.5 279.7 203.7 130.0 415.9 165.0 239.3 344.5 124.3 279.5 245.2 0.1 1.1 0.8 1.3 1.5 1.0 0.8 1.1 0.9 1.0 1.1 0.8 0.8 2.1 0.6 1.2 1.8 1.1 0.9 70.3 73.0 74.6 82.4 70.3 70.8 76.2 71.5 73.0 72.0 72.1 82.4 31.0 3.2 9.1 10.4 46.0 45.4 41.4 34.8 57.5 41.8 29.7 21.3 2.7 24.3 20.6 27.6 31.3 58.5 34.1 44.0 19.6 33.0 6.4 33.8 36.0 31.4 45.5 32.6 6.8 23.8 63.0 29.4 51.0 40.9 34.3 30.4 27.5 26.8 37.6 35.3 7.6 42.4 30.5 22.0 32.3 8.4 44.4 31.6 19.6 11.2 37.4 25.3 30.9 4.0 12.0 31.8 29.3 34.3 62.4 41.9 31.9 21.3 15.3 52.0 0.0 26.1 46.6 22.5 32.0 53.5 39.2 71.8 42.7 30.8 43.6 44.9 UBALD2 "FAM100B, MGC29814" ENSG00000185262 "UBA like domain containing 2" Q8IYN6 17 76265348-76271298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 229.1" "Cell type enhanced" "Detected in all" "Urothelial cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.8;neutrophil: 29.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 29.2" "Cell line enhanced" "Detected in all" "HDLM-2: 324.7;Karpas-707: 401.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023046 Uncertain NA Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA023046: AB_1848359" "unprognostic (1.33e-1)" "unprognostic (2.04e-3)" "unprognostic (3.14e-1)" "unprognostic (3.06e-1)" "unprognostic (9.21e-2)" "unprognostic (1.74e-1)" "unprognostic (3.22e-3)" "unprognostic (5.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (4.80e-2)" "unprognostic (3.78e-2)" "unprognostic (9.24e-2)" "unprognostic (3.45e-3)" "unprognostic (1.45e-3)" 43.9 19.4 36.1 54.4 38.0 229.1 43.6 36.5 48.8 33.1 32.4 53.6 80.0 24.5 8.0 97.9 29.4 14.8 44.5 32.5 53.6 39.1 35.2 72.0 45.0 68.4 42.9 17.7 43.6 26.6 22.1 21.9 47.0 33.3 17.9 6.9 59.5 10.9 172.4 63.0 81.5 8.9 35.8 75.1 51.5 23.0 45.2 38.8 34.2 25.9 25.5 33.1 49.6 44.1 118.6 26.2 23.7 18.9 29.2 27.5 56.0 42.7 32.8 17.9 20.3 30.8 127.9 31.2 44.0 12.5 19.7 43.3 12.1 24.1 14.1 324.7 30.5 34.5 31.4 29.0 20.1 40.9 162.8 24.9 31.8 19.1 50.3 21.0 57.4 99.6 55.5 401.9 23.3 61.3 193.2 99.4 21.8 71.4 48.1 93.9 49.6 87.3 33.8 66.6 60.3 57.4 30.1 41.2 217.0 25.8 29.8 106.3 42.3 35.8 52.1 60.3 68.9 177.7 149.2 67.8 41.6 34.0 99.8 7.8 1.8 3.3 2.3 1.5 1.9 2.7 3.9 2.4 0.7 2.1 4.6 3.7 29.2 1.4 1.1 3.9 2.8 0.6 36.1 38.0 36.5 48.8 32.5 53.6 68.4 42.9 47.0 35.8 45.2 44.1 81.6 22.4 17.6 5.2 99.8 71.9 84.5 15.5 18.8 12.8 95.5 78.2 18.0 67.2 16.6 23.9 14.6 9.0 115.3 117.2 15.6 31.4 25.5 126.6 43.1 53.1 36.3 59.8 5.1 30.8 18.6 23.5 42.8 181.6 22.2 21.6 29.6 34.3 29.2 11.8 5.8 84.5 10.2 60.5 55.6 8.2 19.9 87.9 49.8 8.4 27.5 31.3 50.4 6.0 8.7 44.7 80.6 20.3 106.6 93.2 119.3 22.4 30.2 18.7 19.7 25.5 28.8 5.1 4.5 38.7 106.3 27.9 100.9 30.6 72.4 205.6 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564029-42693505 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 138.5;Inhibitory neurons: 142.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 38.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 21: OE19 - Mitochondria" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 11.0 10.7 8.5 12.7 10.1 17.9 12.9 14.1 11.1 10.3 11.3 12.7 14.4 10.9 11.2 9.5 9.4 8.6 11.2 9.0 8.8 12.1 17.2 11.9 12.7 9.0 8.7 12.2 15.6 15.0 8.8 11.7 9.3 10.5 13.8 29.7 12.0 10.0 22.8 12.2 13.8 10.6 8.6 15.3 12.2 6.2 9.1 13.5 13.3 22.3 11.5 10.8 10.4 14.2 18.5 9.0 10.4 16.4 20.9 20.0 14.0 13.8 14.9 12.0 12.4 13.2 7.4 12.5 10.7 15.0 13.9 18.1 15.1 11.8 15.2 17.1 10.6 20.0 13.3 17.3 17.0 19.6 13.1 14.1 12.7 12.0 12.9 14.8 13.7 17.9 23.7 15.4 11.7 14.9 15.4 17.1 9.5 36.2 8.7 13.6 15.5 19.0 13.8 15.7 12.4 9.8 14.0 13.3 13.9 15.7 13.0 18.7 19.8 10.8 8.4 13.5 10.1 14.1 13.4 18.9 5.7 14.5 6.8 17.7 7.1 15.2 6.5 7.3 5.4 5.2 4.2 5.1 5.5 5.2 4.3 4.8 38.5 5.9 9.8 4.1 5.3 3.4 8.5 10.1 14.1 11.1 9.0 8.8 9.0 8.7 9.3 8.6 9.1 14.2 33.5 16.0 24.6 82.6 33.9 16.6 18.1 14.9 28.5 43.0 20.4 15.9 39.3 30.0 22.1 20.2 60.5 17.4 46.6 51.6 17.6 18.5 12.4 27.5 30.8 24.8 12.6 75.1 138.5 15.3 13.4 26.5 34.1 32.9 20.3 31.3 21.8 35.0 13.2 63.9 142.7 22.5 14.2 26.7 28.6 3.9 25.4 26.1 19.6 87.1 43.0 23.5 32.0 123.1 131.4 15.0 29.1 24.0 50.6 22.8 37.2 11.7 27.9 53.5 39.5 30.0 27.2 11.2 10.9 28.1 16.2 17.2 44.0 24.0 21.5 22.7 UIMC1 RAP80 ENSG00000087206 "Ubiquitin interaction motif containing 1" Q96RL1 5 176905005-177022633 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 64.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 64.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037503, HPA037504" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA037503: AB_10671373, HPA037504: AB_10671760" "unprognostic (2.96e-1)" "unprognostic (9.57e-2)" "unprognostic (2.48e-3)" "unprognostic (4.40e-2)" "unprognostic (1.69e-1)" "unprognostic (9.88e-3)" "prognostic unfavorable (7.67e-6)" "unprognostic (1.85e-1)" "unprognostic (1.12e-2)" "unprognostic (6.62e-2)" "unprognostic (1.30e-1)" "unprognostic (5.91e-2)" "unprognostic (1.33e-3)" "unprognostic (8.51e-2)" "unprognostic (5.52e-1)" "unprognostic (7.23e-2)" "unprognostic (1.44e-1)" 28.2 24.6 15.8 14.0 15.9 60.2 27.2 22.3 19.1 31.1 19.1 32.5 9.5 29.4 11.2 18.8 26.6 10.8 27.1 15.1 15.4 21.9 18.6 26.4 22.8 14.0 14.4 35.8 27.2 9.1 19.6 12.7 14.4 23.0 12.4 15.0 17.1 13.3 32.6 23.8 23.3 18.9 12.6 31.4 22.5 62.3 14.9 27.6 23.5 12.0 22.0 29.2 23.8 17.6 27.6 26.6 26.9 33.1 25.8 22.7 38.3 28.1 31.4 35.5 37.0 30.6 30.7 79.1 33.8 23.3 37.8 21.1 27.9 62.7 41.8 91.4 25.4 35.4 30.9 25.7 28.5 43.8 22.7 15.9 29.0 27.0 74.0 26.9 41.6 47.1 30.9 26.1 26.6 25.7 43.1 29.4 19.6 22.2 16.2 39.5 38.8 46.1 38.0 17.4 29.1 23.2 62.3 20.1 30.4 28.3 17.5 24.2 31.6 20.1 20.3 17.7 37.6 39.1 49.8 50.8 19.6 43.2 22.1 15.8 11.8 33.0 9.0 7.0 9.4 11.8 10.3 8.9 7.4 13.9 10.0 8.3 64.5 14.5 4.5 9.5 14.7 6.5 15.8 15.9 22.3 19.1 15.1 15.4 14.0 14.4 14.4 12.6 14.9 17.6 24.8 12.8 21.0 36.9 31.3 10.5 18.0 11.8 23.3 19.3 10.9 11.8 20.6 8.6 17.3 9.2 14.6 13.9 22.5 7.8 7.9 13.7 27.4 19.4 23.1 17.0 13.1 47.8 59.5 12.9 12.7 17.1 12.2 22.8 18.3 20.6 13.2 8.8 9.9 16.8 53.3 7.9 8.2 14.8 14.1 13.2 15.5 19.8 1.8 44.0 18.0 8.9 19.6 43.7 51.1 17.0 9.1 12.4 24.2 12.9 8.1 8.9 19.2 33.7 13.1 17.7 18.8 132.1 73.8 13.2 11.9 6.8 23.0 35.4 8.7 13.9 UPF2 "DKFZP434D222, KIAA1408, RENT2, smg-3" ENSG00000151461 "UPF2 regulator of nonsense mediated mRNA decay" Q9HAU5 10 11920022-12043170 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067008 Supported "Cytosol,Cytoplasmic bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 41: Macrophages - Immune response" Cytosol "Cytoplasmic bodies" "HPA067008: AB_2685762" "unprognostic (1.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.61e-2)" "unprognostic (2.48e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (5.68e-2)" "unprognostic (9.27e-2)" "unprognostic (1.68e-2)" "unprognostic (3.01e-2)" "unprognostic (4.65e-3)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-1)" "unprognostic (8.48e-2)" 12.8 8.1 12.4 14.1 13.7 21.0 12.7 15.8 15.1 12.0 12.5 16.2 10.0 14.9 10.7 10.9 11.0 8.9 10.6 12.5 13.6 10.9 16.7 10.4 18.9 11.8 12.2 16.2 13.7 14.8 7.9 14.1 11.6 13.5 12.9 14.8 11.1 12.2 22.0 12.9 11.4 12.1 11.9 14.8 11.3 19.5 12.7 21.5 12.8 21.4 17.7 13.4 11.8 13.2 35.9 22.3 18.8 23.5 14.0 17.9 21.2 27.5 12.7 19.2 23.0 21.2 28.6 51.4 9.1 23.0 15.8 29.4 27.2 24.9 27.4 32.5 15.7 61.6 18.2 19.4 15.8 28.1 39.8 13.5 19.0 24.3 16.4 18.2 23.8 27.1 37.1 25.7 22.2 17.7 34.8 16.4 18.0 27.1 11.8 30.4 22.5 25.3 18.2 14.2 12.1 13.0 21.6 23.1 23.8 18.7 27.9 37.1 25.5 15.0 31.4 31.1 21.1 23.4 19.8 41.4 24.0 26.9 12.1 13.7 4.2 10.2 4.3 4.2 4.2 10.7 4.9 4.5 3.0 10.6 5.4 4.5 29.5 5.4 2.9 11.5 3.8 1.8 12.4 13.7 15.8 15.1 12.5 13.6 11.8 12.2 11.6 11.9 12.7 13.2 74.8 25.6 34.6 32.0 133.3 71.9 35.0 46.9 64.3 66.3 53.8 38.6 69.6 52.9 39.4 49.7 102.2 47.0 79.6 97.7 39.2 47.7 70.1 99.3 86.2 62.6 66.3 108.4 36.1 44.8 51.7 48.2 58.1 88.7 58.9 71.8 64.2 89.5 41.1 52.2 31.6 90.2 48.8 71.4 125.3 116.9 86.3 56.0 53.4 31.9 89.0 45.5 98.9 37.2 45.4 53.7 78.9 59.0 121.2 38.7 70.6 34.1 41.5 97.2 98.6 54.3 60.1 182.9 149.8 47.3 81.8 56.5 73.6 35.9 65.5 36.3 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 176.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 297.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 297.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Nucleoplasm, Nuclear bodies" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 29.0 21.6 4.5 29.4 4.8 176.2 22.9 12.3 6.7 17.6 10.2 18.0 13.8 14.6 9.2 19.7 17.8 13.7 19.8 5.2 5.5 14.9 27.2 31.5 33.3 6.0 5.4 26.7 19.7 14.9 13.9 18.4 5.7 14.3 16.7 45.8 19.7 8.3 35.5 29.9 24.6 12.6 4.6 44.3 18.8 30.2 5.5 26.5 17.1 14.8 24.9 18.1 19.4 8.0 18.3 16.5 14.2 17.7 25.7 25.1 27.0 29.0 21.2 22.3 16.1 19.6 21.6 15.5 16.6 17.8 10.1 18.5 18.4 23.1 27.6 18.5 15.0 25.2 15.1 14.1 18.8 35.6 61.8 15.0 19.2 27.2 20.7 20.7 26.1 16.3 80.8 36.0 20.0 23.5 26.4 19.3 25.4 16.5 24.0 17.2 19.1 32.3 17.9 22.8 17.9 8.9 30.9 21.6 17.3 17.4 34.7 18.8 37.2 21.2 22.2 32.0 18.2 16.4 24.0 21.9 25.7 26.7 23.5 163.4 60.0 64.3 13.5 31.1 14.9 28.5 19.6 14.0 23.7 20.5 23.5 13.8 297.9 14.7 26.8 26.6 58.8 26.1 4.5 4.8 12.3 6.7 5.2 5.5 6.0 5.4 5.7 4.6 5.5 8.0 57.1 38.5 36.4 68.6 130.3 58.8 40.8 26.2 40.5 54.9 32.3 28.1 74.9 21.5 48.9 23.9 110.5 31.7 142.5 50.2 11.7 36.4 172.2 26.3 46.5 45.4 42.0 248.3 124.8 41.5 43.3 52.5 57.6 38.9 88.6 53.5 21.0 45.3 46.2 42.1 104.2 33.2 12.2 101.3 97.6 172.0 61.8 120.6 53.4 135.9 195.8 25.6 90.6 100.0 108.8 55.1 47.6 29.3 94.3 36.0 30.9 25.9 31.9 151.5 39.5 66.1 60.5 83.7 43.3 49.3 77.0 65.8 130.0 27.0 29.5 60.8 USP3 ENSG00000140455 "Ubiquitin specific peptidase 3" Q9Y6I4 15 63504511-63594640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 36.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053275, HPA060513, HPA077975" Supported "Nucleoplasm,Midbody ring" "Intracellular and membrane" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 50: Non-specific - Ribosome" "Cluster 15: RT4 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Midbody ring" "HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365" "unprognostic (4.63e-3)" "unprognostic (2.71e-1)" "unprognostic (7.88e-2)" "unprognostic (3.33e-2)" "unprognostic (2.16e-2)" "unprognostic (6.03e-2)" "unprognostic (6.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.62e-2)" "unprognostic (2.36e-1)" "unprognostic (3.54e-2)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (8.61e-2)" "unprognostic (2.78e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.38e-4)" 12.7 8.2 5.8 5.4 7.0 21.4 11.2 36.4 5.9 11.7 15.4 13.4 6.5 12.9 4.7 10.9 10.9 5.4 6.0 5.3 6.3 10.1 8.2 13.2 6.5 6.9 6.9 16.2 18.9 3.1 6.2 2.7 7.6 10.4 5.6 6.3 12.4 6.0 10.0 14.6 13.9 4.5 5.3 17.6 15.7 5.3 8.6 7.4 9.1 3.6 6.4 12.4 11.9 7.5 10.4 21.0 12.1 8.1 5.5 7.6 8.2 6.7 9.6 7.1 5.8 6.6 13.1 8.7 15.3 9.3 3.6 12.0 11.6 11.1 5.6 12.2 5.8 10.4 8.6 9.8 6.8 6.4 11.4 11.3 7.8 7.7 10.6 8.9 12.4 17.3 9.5 9.0 3.3 5.2 11.0 8.8 16.2 13.7 5.3 22.2 8.4 11.3 4.5 23.8 9.6 9.5 3.3 13.0 6.7 7.8 5.5 9.5 13.4 7.2 16.9 3.3 10.3 9.3 24.4 18.2 7.4 13.8 7.5 120.0 84.7 12.7 24.8 66.0 28.4 34.1 34.3 26.0 59.8 34.8 34.0 25.2 169.1 19.8 65.4 13.1 28.1 45.2 5.8 7.0 36.4 5.9 5.3 6.3 6.9 6.9 7.6 5.3 8.6 7.5 23.6 38.5 69.2 76.7 63.4 52.6 34.3 24.8 23.3 31.4 27.9 20.3 9.2 25.8 41.4 16.5 12.5 19.8 48.4 37.6 41.1 41.0 21.6 37.8 32.8 26.0 43.8 15.8 11.2 37.2 57.3 28.3 39.8 74.6 27.1 64.5 11.4 24.0 24.8 13.5 40.0 35.4 30.5 78.4 109.6 77.4 15.8 74.5 42.7 75.9 101.8 25.9 41.2 80.4 40.6 39.8 35.6 18.4 69.7 40.6 33.2 28.3 33.3 17.9 13.1 25.3 34.5 14.8 40.3 33.9 59.0 34.1 64.6 40.1 40.6 37.6 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 24.2 18.3 10.5 25.5 13.1 52.6 28.8 13.2 17.8 26.8 9.3 42.3 35.1 22.7 19.5 75.4 18.6 23.7 16.2 10.3 14.6 23.8 28.4 23.8 31.2 13.5 15.9 19.3 17.3 27.8 11.5 28.7 14.0 23.4 37.0 7.0 24.7 19.5 11.0 32.3 36.4 21.0 12.6 28.8 32.5 12.1 12.5 31.4 28.5 13.0 39.1 30.2 31.1 15.6 57.1 21.9 22.4 24.5 33.5 47.1 38.9 48.6 45.5 36.4 39.2 15.7 39.4 54.1 31.2 35.7 30.9 119.6 26.8 53.1 47.5 40.6 22.3 27.6 27.8 23.7 48.6 94.5 56.8 43.1 80.3 32.3 56.2 36.5 33.9 31.0 14.3 49.4 52.1 20.2 59.9 29.2 23.2 22.7 32.3 48.8 47.2 52.4 45.6 66.2 38.2 33.6 36.9 35.4 55.3 28.3 34.2 50.5 52.8 55.4 27.3 21.6 32.7 163.6 86.5 69.3 31.9 44.0 42.3 163.6 54.6 125.0 52.2 56.5 49.0 64.8 54.3 54.2 46.2 73.4 48.2 51.1 185.9 68.4 76.5 45.6 66.7 56.6 10.5 13.1 13.2 17.8 10.3 14.6 13.5 15.9 14.0 12.6 12.5 15.6 52.0 115.4 57.4 21.5 62.4 68.8 47.2 66.5 44.9 37.0 54.4 46.0 39.5 47.1 72.4 33.1 22.9 70.0 92.2 142.0 45.0 48.0 113.3 92.2 74.0 44.6 45.5 27.8 27.3 42.1 56.7 51.0 47.4 145.5 59.3 37.7 36.8 55.8 46.4 43.7 29.6 76.8 67.1 58.8 33.0 15.5 49.0 58.0 32.0 18.7 53.4 39.2 76.2 18.6 49.5 91.3 120.7 36.5 42.1 43.1 61.8 57.9 85.1 31.5 59.2 45.6 54.7 30.1 29.4 87.5 83.4 140.4 67.4 56.5 72.6 79.5 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720898 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.2;Inhibitory neurons: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "neutrophil: 18.0" "Lineage enriched" "Detected in single" 26 "granulocytes: 18.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favorable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 12.9 26.9 23.8 16.2 26.3 13.2 10.5 15.8 39.2 13.2 16.5 14.6 13.5 11.0 4.4 33.3 12.0 7.4 15.8 25.4 19.3 23.1 30.4 16.1 9.3 25.4 19.5 10.8 12.6 12.5 31.6 5.4 25.7 15.3 3.8 5.7 15.3 6.1 11.6 12.7 17.2 4.9 15.4 29.1 12.8 18.8 21.3 3.5 17.3 5.5 5.1 11.2 15.9 23.6 6.2 9.3 10.2 10.8 10.2 9.9 8.5 11.3 11.7 9.6 4.7 8.0 13.6 6.3 7.1 12.6 5.4 14.1 0.9 6.4 2.7 5.7 15.0 4.5 8.7 10.0 7.7 2.6 10.5 10.9 5.8 11.6 2.7 15.5 6.7 5.8 11.5 3.8 6.5 28.1 4.8 10.0 3.8 4.9 10.4 11.8 8.5 3.8 7.7 9.8 8.4 8.8 14.5 5.3 11.6 3.1 24.0 11.0 10.5 12.4 15.5 10.2 6.9 17.4 5.9 5.4 18.0 6.8 10.6 2.2 0.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.3 0.4 0.4 0.2 18.0 0.2 0.3 0.0 0.2 0.2 23.8 26.3 15.8 39.2 25.4 19.3 25.4 19.5 25.7 15.4 21.3 23.6 3.5 6.4 5.1 30.0 3.6 2.0 2.0 5.4 5.7 13.3 6.5 5.5 8.8 2.8 6.4 9.2 10.4 3.0 6.1 11.6 7.9 4.9 13.5 5.8 6.8 3.1 10.8 1.7 43.2 7.8 2.3 5.3 8.2 9.3 4.5 8.7 9.7 9.6 4.8 8.4 41.9 3.9 2.0 8.5 8.3 21.7 6.2 12.6 3.6 4.7 3.7 6.6 3.1 16.1 17.5 6.2 5.1 6.0 3.9 1.8 13.5 6.1 4.6 12.8 0.0 5.2 5.8 12.3 4.7 7.5 3.8 3.0 4.5 8.6 7.2 2.8 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061509-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 17.5 16.0 16.1 9.8 16.8 15.6 13.4 16.5 23.9 12.0 13.2 13.2 11.2 18.5 16.0 11.2 11.1 9.3 23.1 16.1 18.1 12.3 16.3 10.4 11.8 16.3 16.6 13.2 8.7 12.4 8.2 11.5 16.4 14.0 9.1 16.5 8.1 14.7 41.0 11.3 11.5 14.8 15.7 9.8 9.3 12.2 16.5 14.7 11.2 29.8 11.6 11.3 11.0 18.6 15.0 9.8 26.7 17.3 17.1 25.9 16.2 33.3 23.4 25.9 19.7 15.5 15.7 21.4 13.0 23.6 31.2 20.6 10.2 16.7 33.0 22.3 14.3 30.2 10.0 16.0 26.3 19.1 18.8 21.3 25.0 18.8 26.5 21.1 22.0 20.3 16.4 9.1 27.5 12.6 27.3 20.6 16.3 23.2 8.0 25.3 16.5 8.4 23.6 14.6 6.1 14.7 10.6 11.3 16.1 21.5 9.4 29.3 19.3 16.0 14.7 22.2 19.5 6.0 7.0 14.7 19.7 13.7 22.2 19.2 13.0 12.4 10.6 12.0 9.7 14.2 13.6 11.5 11.0 12.6 14.4 14.3 27.3 12.5 21.8 18.5 14.4 6.1 16.1 16.8 16.5 23.9 16.1 18.1 16.3 16.6 16.4 15.7 16.5 18.6 42.4 51.3 29.3 21.2 23.9 54.4 60.3 54.8 33.0 46.8 33.5 37.5 110.0 40.0 32.5 25.8 33.3 55.6 23.0 32.3 76.3 52.3 11.9 32.9 58.4 46.9 37.8 111.7 17.0 42.0 61.1 52.2 15.8 44.5 45.7 27.5 38.2 63.1 40.9 45.4 16.6 28.1 18.3 26.7 47.1 9.7 47.8 33.0 32.0 10.3 60.4 63.8 28.8 17.1 33.3 50.3 33.2 52.6 16.8 60.9 33.8 70.6 23.6 49.2 26.3 55.3 66.7 87.5 103.9 29.7 44.9 49.9 22.3 31.9 27.6 40.9 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669597-84966690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.9" "Group enriched" "Detected in many" 5 "Astrocytes: 241.0;Excitatory neurons: 231.0;Inhibitory neurons: 248.7;Microglial cells: 209.9;Oligodendrocyte precursor cells: 262.9;Oligodendrocytes: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Nucleoli, Plasma membrane" "HPA042734: AB_2678135, HPA048572: AB_2680447" "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favorable (3.64e-5)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 8.6 8.6 14.8 7.6 31.7 14.4 8.7 26.8 22.9 8.5 4.7 5.7 3.6 8.2 6.4 7.4 8.2 8.8 5.7 16.3 15.6 20.1 5.6 7.4 2.6 30.6 30.4 13.6 9.0 16.3 6.5 11.8 28.7 8.6 5.6 26.2 7.2 7.4 5.9 10.8 4.7 8.5 21.7 7.8 5.6 8.1 25.6 3.4 11.7 13.2 2.3 8.7 5.7 44.9 11.9 7.8 14.3 7.9 24.8 19.3 9.0 11.2 11.8 11.5 10.3 9.1 9.6 0.0 11.3 18.8 12.3 5.9 15.4 12.3 14.6 7.9 4.9 7.5 9.0 5.5 9.4 5.9 13.7 14.2 10.9 15.0 15.1 13.9 37.1 6.0 7.5 35.3 21.4 8.5 5.7 1.4 7.4 11.4 4.0 8.4 11.4 1.8 19.6 15.6 16.8 7.8 13.8 15.1 7.5 13.5 7.9 14.4 57.0 15.1 14.9 8.5 14.1 0.1 0.0 0.0 10.2 5.0 16.9 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 14.8 31.7 26.8 22.9 16.3 15.6 30.6 30.4 28.7 21.7 25.6 44.9 28.5 19.2 12.9 241.0 1.0 14.7 9.1 12.4 11.4 46.6 13.8 11.3 18.2 20.0 14.7 16.5 35.5 11.8 0.5 6.5 1.9 8.6 6.7 27.1 27.8 20.1 9.1 1.3 231.0 7.3 6.9 19.5 15.3 43.4 0.0 31.0 17.9 8.1 20.5 28.6 248.7 7.8 20.3 43.1 14.1 10.1 18.3 29.9 7.2 209.9 19.7 28.7 0.0 262.9 440.4 10.7 6.5 24.5 0.2 13.6 4.8 18.4 15.5 41.9 26.3 30.0 22.8 11.4 7.3 14.1 16.1 14.5 1.8 15.0 6.7 13.6 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 93.6;Suprabasal keratinocytes: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 58: Brain - Synaptic function" "Cluster 18: U-2197 - ECM organization" "Cluster 28: Keratinocytes - Keratinization" "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favorable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.8 7.1 22.6 5.5 26.6 12.2 6.3 14.1 27.3 8.8 1.5 8.0 3.7 9.3 5.7 14.4 8.5 7.3 8.1 27.7 17.9 7.6 3.5 7.0 5.6 13.4 11.0 7.5 5.9 9.2 5.3 6.5 14.6 7.3 5.3 37.0 5.8 7.0 17.0 22.9 4.5 10.2 10.9 5.7 6.0 22.7 16.7 7.7 6.2 15.3 7.5 7.5 8.9 19.5 15.6 4.7 8.8 10.9 17.0 14.8 4.7 17.4 10.7 11.4 12.7 4.6 2.3 7.0 9.0 16.7 8.4 17.1 12.5 7.6 15.0 13.1 7.0 5.8 9.9 5.3 9.7 9.2 8.3 9.2 12.4 17.9 8.5 13.8 13.7 8.1 3.5 9.5 19.4 9.3 8.9 7.2 3.7 5.0 9.1 12.5 22.3 3.9 19.0 13.3 15.3 14.0 15.2 8.1 12.5 9.4 3.7 9.3 23.5 15.1 7.0 26.7 14.5 6.1 5.4 5.5 17.6 9.0 23.0 18.0 5.4 7.1 3.3 5.7 3.1 2.4 3.1 3.5 5.8 3.4 2.8 2.5 22.0 2.7 5.9 6.3 5.5 2.6 22.6 26.6 14.1 27.3 27.7 17.9 13.4 11.0 14.6 10.9 16.7 19.5 16.5 12.8 6.5 33.3 13.8 93.6 5.1 7.7 62.0 15.3 11.1 12.6 18.9 10.0 8.0 7.3 45.9 2.4 25.1 2.7 5.9 3.5 33.2 20.5 9.3 12.1 3.0 1.7 46.2 0.9 2.1 10.7 8.2 10.4 2.5 5.6 7.1 2.0 4.4 11.8 39.1 1.0 4.1 5.5 28.4 41.4 8.4 13.9 24.9 19.7 6.3 13.2 8.2 15.1 26.5 3.9 0.9 15.1 14.9 2.4 2.4 5.5 18.9 32.3 6.6 13.5 16.5 32.2 28.9 52.1 104.4 4.9 18.9 3.3 2.1 4.1 WDR73 "FLJ14888, HSPC264" ENSG00000177082 "WD repeat domain 73" Q6P4I2 15 84639285-84654343 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039357 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA039357: AB_10673242" "unprognostic (8.49e-2)" "unprognostic (2.16e-1)" "unprognostic (4.77e-2)" "unprognostic (6.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.48e-1)" "unprognostic (1.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.02e-1)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.19e-4)" "unprognostic (9.21e-4)" "unprognostic (4.12e-1)" "unprognostic (3.16e-2)" "unprognostic (8.58e-2)" "unprognostic (4.02e-2)" 2.2 3.6 1.8 2.2 2.1 2.8 3.3 3.0 2.3 3.2 3.1 3.2 2.3 3.4 4.2 2.7 3.3 1.5 2.2 2.3 2.1 3.2 2.3 2.4 2.3 2.0 2.2 3.3 3.1 3.7 3.2 1.6 2.3 3.5 2.7 3.4 2.9 2.4 2.2 3.0 3.1 2.9 1.8 3.3 2.9 1.8 2.1 3.0 3.9 1.8 2.8 2.9 2.8 2.8 2.8 4.6 5.5 2.7 2.7 3.1 2.8 1.4 2.7 2.4 1.8 4.3 4.7 3.2 1.5 4.7 2.5 6.6 6.4 4.3 2.6 1.7 3.4 2.3 5.5 2.5 3.7 3.4 3.2 5.6 4.0 3.9 5.5 4.5 2.2 3.9 3.9 1.8 1.4 4.7 4.0 5.1 4.7 2.9 1.9 4.2 4.1 2.4 3.7 7.0 3.5 5.8 3.6 5.1 5.8 3.0 8.4 6.5 2.4 2.9 3.3 3.1 4.2 3.4 6.0 2.6 5.1 5.7 4.2 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.2 0.4 0.1 0.6 0.3 0.3 0.8 0.4 0.2 0.3 0.1 0.4 1.8 2.1 3.0 2.3 2.3 2.1 2.0 2.2 2.3 1.8 2.1 2.8 17.0 25.6 32.8 21.9 17.5 5.4 18.9 18.6 12.5 48.4 16.9 20.1 1.1 27.1 25.9 29.5 73.0 33.6 14.4 13.9 23.5 27.6 4.8 32.2 26.3 14.9 18.0 14.3 13.6 14.0 16.1 18.2 16.3 21.8 17.1 38.0 18.9 9.5 13.2 40.4 15.2 13.8 22.4 10.7 5.1 2.3 22.7 9.8 5.4 15.0 17.4 36.8 21.6 13.6 12.2 17.3 11.5 16.1 8.4 17.7 10.1 20.7 70.1 98.5 6.6 27.2 17.7 44.9 18.0 8.7 5.3 25.7 17.1 44.5 15.0 13.9 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 8.1" "Cell type enriched" "Detected in some" 10 "Early spermatids: 159.6" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 15 "Karpas-707: 230.8" "HPA003379, HPA035081" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA003379: AB_10602682, HPA035081: AB_2674451" "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.5 0.0 0.0 15.2 230.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.9 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178621 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 22.9 17.2 14.3 16.4 17.3 10.2 22.9 15.6 14.6 27.2 15.2 20.1 19.0 24.9 17.6 16.1 25.3 16.6 13.1 12.9 17.3 24.8 24.2 20.7 24.5 16.8 17.4 34.6 21.6 24.0 25.8 15.6 17.4 22.9 15.6 15.2 18.5 23.6 21.3 31.9 24.0 17.5 15.2 24.2 17.4 12.4 16.0 21.2 26.7 9.8 21.7 22.9 20.3 18.3 14.3 33.8 36.7 22.6 51.0 35.8 124.8 33.6 88.7 29.9 22.3 11.8 14.7 46.6 14.5 37.5 14.7 15.6 23.6 49.3 23.6 21.5 24.7 24.9 35.7 21.7 45.0 16.8 42.2 50.1 56.4 39.7 77.4 34.2 34.5 19.0 31.2 22.5 32.5 27.2 17.9 16.3 23.5 20.4 21.2 19.3 17.9 33.7 36.2 36.9 8.8 29.9 36.1 27.2 23.5 54.6 29.9 13.8 57.1 11.2 32.1 18.4 15.4 54.5 46.4 25.4 26.5 19.4 41.6 41.4 20.2 26.8 23.2 16.6 22.7 27.1 26.7 23.5 17.9 25.0 28.3 20.8 73.1 24.3 23.3 17.4 24.7 16.9 14.3 17.3 15.6 14.6 12.9 17.3 16.8 17.4 17.4 15.2 16.0 18.3 26.0 60.9 63.2 16.6 39.9 13.8 20.4 25.5 59.2 35.6 19.0 25.9 11.8 31.5 47.7 16.5 39.6 42.5 38.9 13.4 35.2 19.3 2.3 32.2 44.8 29.9 16.3 20.8 18.0 19.2 20.3 29.2 15.3 25.5 47.4 25.0 22.9 40.5 18.2 26.9 22.0 13.9 20.3 23.9 14.9 2.7 30.7 19.6 8.8 15.0 40.1 24.9 54.6 17.1 27.5 19.5 15.0 28.2 29.1 18.9 32.7 66.1 55.0 51.0 26.3 43.3 27.7 28.7 54.9 21.4 11.1 32.0 42.3 26.3 18.1 10.5 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644776-152676141 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 0.2 0.2 0.9 2.3 0.6 5.3 1.5 1.6 2.8 0.3 0.0 1.1 1.7 1.1 0.9 1.0 0.5 0.4 1.0 0.6 1.9 0.4 0.4 0.5 2.9 0.6 0.6 1.0 0.0 0.6 0.0 2.1 1.4 0.7 1.7 1.9 0.2 0.4 0.1 1.9 1.5 0.5 1.1 1.0 1.0 3.0 1.0 3.6 0.6 0.0 2.5 0.5 0.1 1.9 16.5 10.4 18.3 15.8 1.1 1.8 15.0 11.8 3.9 8.2 10.3 14.7 12.8 24.8 9.5 3.5 13.7 13.7 12.8 7.1 19.3 8.9 17.3 16.8 15.5 10.0 0.3 27.3 9.3 0.9 1.1 15.6 3.6 2.0 3.8 15.5 34.2 22.8 8.3 12.6 32.4 21.2 21.6 10.8 12.9 22.8 19.3 15.3 3.1 10.3 16.7 18.1 11.7 7.6 5.0 11.3 5.4 8.3 4.2 17.2 6.9 13.3 23.0 8.8 14.5 19.0 11.0 20.9 20.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.6 1.6 2.8 0.6 1.9 0.6 0.6 1.4 1.1 1.0 1.9 0.2 0.0 1.1 1.6 1.9 1.3 1.0 1.0 0.0 4.9 0.8 0.4 2.9 0.0 1.4 1.8 0.0 11.2 0.4 0.9 0.0 1.1 11.7 0.9 1.9 1.1 0.0 14.1 2.3 0.2 21.2 2.5 3.1 1.4 0.0 20.2 1.1 0.2 2.4 0.0 2.0 1.7 2.0 0.6 0.8 4.9 0.9 0.8 0.0 0.0 0.6 1.1 3.1 4.5 2.0 0.5 0.1 1.2 6.1 0.6 0.3 0.3 0.1 2.3 0.0 1.9 1.8 31.3 19.1 2.7 1.4 12.6 2.2 1.2 2.3 1.0 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350090 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favorable (7.29e-5)" 43.0 27.0 22.4 19.5 26.5 116.6 43.8 31.9 25.0 52.6 18.6 40.0 15.6 43.6 22.7 48.0 42.3 15.3 34.1 20.9 26.0 38.2 33.1 40.6 28.4 23.6 23.6 68.6 44.5 20.3 41.2 23.8 24.8 37.9 19.6 38.5 42.1 17.6 47.2 51.3 40.5 17.2 23.2 41.9 36.3 31.3 23.1 30.3 42.1 16.7 26.7 37.3 50.5 32.7 31.8 18.4 37.1 22.2 21.7 18.8 30.4 33.8 21.3 20.6 21.5 22.9 27.9 50.8 27.0 17.2 16.7 23.3 35.1 29.4 33.1 38.2 21.3 38.8 27.3 25.6 22.1 41.5 29.0 17.8 31.3 18.5 44.0 26.6 22.6 24.7 37.5 29.0 30.7 23.9 48.9 37.1 27.6 30.4 18.0 42.4 41.6 22.8 32.6 35.6 31.9 24.8 29.5 31.5 25.9 34.3 24.6 28.8 24.1 23.5 24.9 16.4 22.5 30.1 21.8 53.7 15.9 26.6 22.0 69.3 20.3 40.4 24.1 12.7 19.0 36.1 19.6 19.8 12.2 44.8 26.9 22.9 105.4 20.8 27.0 39.3 20.3 9.7 22.4 26.5 31.9 25.0 20.9 26.0 23.6 23.6 24.8 23.2 23.1 32.7 104.6 112.2 129.5 54.9 104.7 119.9 103.6 76.2 88.8 105.8 112.8 107.2 92.6 85.8 125.1 73.5 70.9 73.6 136.8 58.1 52.8 70.2 98.5 131.9 135.3 92.2 85.8 74.7 43.8 57.2 124.8 81.3 54.0 254.8 94.7 86.2 63.5 85.6 43.2 90.9 49.4 77.9 63.1 61.0 75.9 22.0 74.6 84.5 64.0 56.2 67.0 99.2 96.8 59.3 110.1 81.6 56.0 67.7 103.2 121.6 42.0 44.0 113.2 138.4 52.6 122.0 98.8 139.2 95.9 127.1 134.5 119.0 122.0 59.5 66.9 119.8 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 12.7" "Cell type enhanced" "Detected in many" "Early spermatids: 60.2;Late spermatids: 67.0;Rod photoreceptor cells: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 3.0 1.6 4.6 2.6 7.5 5.7 2.6 6.3 4.6 2.8 2.1 1.9 1.8 2.1 2.3 1.4 2.1 1.6 2.0 4.4 4.6 2.2 2.1 2.7 3.8 8.6 6.3 3.3 2.0 1.8 2.6 2.1 9.2 2.3 1.6 10.8 2.0 1.4 1.8 3.2 2.3 1.8 4.4 3.8 2.3 9.3 6.4 3.2 2.7 2.2 3.0 2.0 2.3 12.7 1.7 2.5 3.8 1.6 2.3 1.8 4.2 1.5 1.1 2.7 1.9 3.2 2.1 4.6 3.1 2.4 1.4 2.1 3.2 1.7 2.2 2.6 2.0 6.4 3.0 1.6 1.3 3.8 3.9 1.7 1.1 4.0 2.6 1.6 1.4 3.2 5.7 3.0 2.8 1.2 2.6 0.9 3.6 1.3 0.6 1.7 3.3 1.5 1.5 4.2 2.8 3.5 2.1 2.9 2.8 4.0 4.2 3.9 2.5 3.5 3.7 1.7 2.4 5.3 4.2 7.3 2.3 2.1 2.1 0.1 0.4 1.4 1.1 0.4 0.4 0.2 0.5 0.7 0.2 0.6 0.2 0.6 2.3 0.9 0.4 0.9 0.4 0.3 4.6 7.5 6.3 4.6 4.4 4.6 8.6 6.3 9.2 4.4 6.4 12.7 8.5 6.4 6.3 2.0 9.7 2.9 3.7 3.6 4.0 27.2 5.7 2.8 9.2 12.8 4.2 11.0 33.3 8.3 11.9 4.6 7.9 3.6 60.2 9.1 8.8 6.8 3.5 5.7 1.6 3.8 3.9 7.4 5.1 7.6 2.5 16.9 11.0 4.7 5.0 18.5 2.1 3.9 0.0 15.4 5.5 67.0 8.7 10.0 10.6 2.8 10.6 10.3 18.6 3.5 5.3 2.8 2.7 13.2 5.7 4.3 4.7 5.4 10.6 60.1 6.6 9.5 10.8 23.2 13.2 3.2 5.8 9.2 9.3 11.6 3.6 3.4 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314917 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA052589: AB_2681874" "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 13.0 11.2 14.0 10.5 16.4 12.8 15.6 21.3 13.8 12.6 9.1 11.3 8.8 12.0 17.5 11.5 14.6 8.7 11.3 13.2 12.2 25.4 14.1 11.5 15.7 10.4 13.6 15.8 11.4 16.0 8.2 12.6 10.8 10.6 9.8 16.7 14.2 11.6 36.9 14.6 10.9 9.4 11.1 14.3 10.4 36.9 15.0 25.3 13.4 31.4 16.4 12.3 12.0 16.5 14.0 9.1 13.6 12.4 18.9 18.4 14.9 8.3 14.7 7.5 9.4 15.7 42.5 44.0 42.8 14.0 18.4 14.0 19.1 18.0 12.7 37.8 11.6 65.3 10.2 9.7 11.2 34.2 47.2 12.3 19.2 12.8 27.8 15.9 11.5 26.3 18.6 63.8 8.5 11.1 33.4 24.2 12.0 21.1 13.6 21.8 12.1 15.0 21.4 14.2 28.4 12.1 24.4 16.3 6.5 12.9 29.8 26.9 12.8 15.3 13.5 6.9 9.5 12.2 19.4 40.0 4.0 42.4 14.1 0.7 0.7 0.9 2.0 0.8 1.3 1.1 1.2 1.2 0.8 1.3 1.0 1.2 2.0 1.5 0.6 1.6 1.6 0.4 14.0 16.4 21.3 13.8 13.2 12.2 10.4 13.6 10.8 11.1 15.0 16.5 32.6 25.6 39.4 33.0 42.9 72.1 33.9 33.8 46.7 44.4 56.6 41.4 49.3 40.0 28.6 77.3 58.4 34.0 61.6 18.3 19.6 26.6 56.5 47.9 38.7 33.8 19.3 55.2 50.5 20.4 18.6 40.2 16.3 85.3 10.2 56.6 38.6 43.4 14.9 20.2 48.5 26.8 24.4 42.5 29.9 58.3 73.7 30.0 23.2 39.4 33.6 23.2 104.0 64.3 125.7 21.4 16.9 79.0 27.1 51.7 27.7 69.7 30.5 37.6 39.5 64.4 26.5 103.4 61.6 39.8 82.1 26.8 40.2 42.3 33.1 40.9 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523025-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 143.8;Late spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 34: Spermatids - Unknown function" "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 10.7 5.5 6.2 5.8 6.6 26.5 9.1 9.3 8.2 6.7 6.0 7.1 6.7 6.3 5.9 5.5 7.8 8.6 8.5 5.5 6.9 5.5 23.3 10.2 7.0 7.2 6.8 8.0 6.2 5.8 8.0 8.1 6.7 7.3 5.4 10.0 37.2 5.3 12.2 11.6 7.5 5.8 5.3 9.0 6.4 12.0 6.6 7.6 7.3 7.3 6.3 7.9 6.5 11.5 8.0 6.8 5.8 11.5 17.1 7.3 10.9 4.5 6.7 10.5 10.4 3.7 4.8 22.4 5.8 7.4 8.6 13.2 18.6 9.9 4.3 15.5 8.8 5.9 15.6 25.2 5.9 11.4 8.3 7.2 12.6 6.7 12.3 7.6 19.9 9.9 6.4 7.3 3.5 6.5 7.5 4.8 3.7 5.8 6.7 9.7 6.1 0.1 7.3 8.0 7.2 4.5 7.5 16.8 6.6 10.2 5.9 8.9 8.6 10.3 7.0 4.1 6.5 2.8 5.8 9.4 7.6 4.7 3.9 0.0 0.3 0.8 0.5 0.5 0.4 0.1 0.3 0.4 0.1 0.4 0.6 0.4 1.5 0.2 0.1 0.3 0.4 0.1 6.2 6.6 9.3 8.2 5.5 6.9 7.2 6.8 6.7 5.3 6.6 11.5 23.1 25.6 18.8 28.1 10.8 26.6 16.9 7.5 10.8 33.1 15.2 13.2 18.8 20.0 12.4 16.5 54.2 7.4 33.6 10.2 3.9 6.8 143.8 24.1 12.3 28.8 12.6 8.2 48.5 6.2 10.9 9.7 10.2 27.5 2.5 4.4 17.5 35.4 14.1 43.7 33.9 15.5 2.0 44.4 22.0 158.6 8.1 30.6 7.2 29.0 11.9 7.7 9.2 37.2 51.7 5.1 9.1 7.9 10.7 16.5 8.4 5.3 10.8 19.5 6.6 15.6 15.0 16.3 15.2 15.3 18.5 6.8 22.6 5.6 11.5 12.2 ZFP36L1 "Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B" ENSG00000185650 "ZFP36 ring finger protein like 1" Q07352 14 68787660-68796253 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA transport, Transport" "Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1973.2;Squamous epithelial cells: 2019.8;Suprabasal keratinocytes: 3223.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 2901.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 2901.2" "Cell line enhanced" "Detected in all" "hTERT-HME1: 462.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001301 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA001301: AB_1080644" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (7.00e-2)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (3.81e-3)" "unprognostic (1.13e-3)" "unprognostic (1.30e-1)" "unprognostic (1.11e-2)" "unprognostic (6.45e-3)" "unprognostic (5.77e-2)" "unprognostic (2.97e-1)" "unprognostic (5.68e-2)" 342.7 107.9 108.1 218.2 108.3 84.0 305.6 118.0 96.1 466.4 91.7 335.1 127.5 423.1 107.7 293.0 303.3 174.9 178.8 98.7 184.1 157.8 260.1 242.7 199.5 207.8 187.5 453.5 225.4 161.7 67.3 315.8 145.0 222.3 104.2 57.5 319.3 201.7 93.1 511.3 151.5 316.0 162.7 178.5 196.9 49.3 142.6 130.1 190.6 89.6 150.4 335.8 467.0 166.8 235.6 211.8 94.7 139.0 234.4 187.2 203.9 96.4 169.6 59.1 72.9 93.9 159.5 58.4 59.5 177.4 85.5 108.4 8.8 313.8 70.0 27.9 13.2 21.5 115.0 68.2 133.8 3.3 24.3 157.6 396.4 69.1 462.1 195.2 119.2 17.1 61.5 113.7 314.4 54.1 9.3 11.1 78.7 105.1 31.7 150.5 127.1 17.8 213.4 155.3 1.0 2.5 113.7 163.4 87.8 131.9 148.3 3.0 254.4 167.3 122.8 139.0 101.0 62.9 32.9 39.9 213.5 1.4 66.9 230.8 240.9 3.9 211.1 244.7 197.2 266.0 168.8 150.3 123.8 461.4 179.3 162.2 2901.2 154.3 176.1 16.2 174.5 257.5 108.1 108.3 118.0 96.1 98.7 184.1 207.8 187.5 145.0 162.7 142.6 166.8 830.2 477.5 415.6 172.7 513.8 1333.5 761.2 830.2 1973.2 4.6 750.7 504.4 84.2 420.4 523.9 364.1 0.0 442.1 276.5 164.4 84.1 575.8 97.0 434.6 479.6 571.0 20.4 87.7 1.5 573.1 476.6 894.3 218.6 656.2 200.8 21.1 292.7 595.6 548.3 0.0 0.7 225.3 215.7 613.9 1272.8 72.2 502.0 670.0 528.3 142.4 499.0 211.9 131.8 63.8 0.9 544.8 138.3 397.2 191.7 657.7 138.4 143.7 314.5 9.2 269.5 562.0 714.4 12.2 13.3 2019.8 3223.6 898.7 405.2 157.1 191.1 817.8 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491141 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 392.5;tongue: 465.5" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1836.4" "Cancer enhanced" "Detected in all" "melanoma: 29.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 161.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 32.4 11.2 20.8 14.3 29.8 24.4 17.9 19.0 28.1 18.0 109.2 19.7 10.0 15.9 17.3 18.5 12.7 17.2 175.6 23.3 22.6 16.5 8.7 20.9 17.5 23.6 29.1 15.9 10.3 17.8 10.3 12.9 22.5 20.9 13.9 22.0 12.9 14.7 392.5 11.7 13.3 23.0 20.8 17.1 12.8 14.3 27.4 15.6 13.2 465.5 18.6 14.6 9.1 27.7 27.2 15.1 29.0 33.5 86.8 68.5 16.1 21.7 22.2 19.6 20.5 33.9 7.8 17.8 19.0 27.7 22.8 31.8 28.3 23.4 29.5 29.0 13.1 34.7 37.9 13.6 23.2 43.1 20.2 55.4 17.8 28.0 32.6 19.5 32.3 23.2 43.0 2.7 36.9 11.9 16.2 13.3 11.0 26.1 15.1 15.2 54.3 10.8 12.1 31.5 16.5 10.2 45.0 22.8 28.7 23.4 20.0 30.0 42.2 20.8 32.5 26.1 32.3 14.8 32.2 76.5 18.4 33.6 37.6 86.8 63.8 27.1 15.6 52.3 13.5 21.8 13.0 13.3 35.6 26.8 11.3 10.6 161.0 12.5 66.8 36.0 13.0 18.0 20.8 29.8 19.0 28.1 23.3 22.6 23.6 29.1 22.5 20.8 27.4 27.7 58.0 134.6 107.7 46.0 49.6 38.5 57.9 41.9 44.3 58.5 50.9 46.0 1836.4 62.9 57.0 29.5 95.9 37.9 67.2 31.7 41.1 43.2 197.2 75.2 67.1 69.9 40.2 50.5 73.3 42.4 39.3 141.7 31.1 37.5 44.9 49.5 62.8 40.1 53.5 35.3 62.9 32.6 32.6 132.7 43.4 105.2 37.6 89.8 65.8 47.8 124.3 53.6 66.9 31.2 34.2 65.7 26.9 92.6 50.7 74.8 39.7 41.5 161.1 79.9 46.0 151.2 70.0 62.3 38.1 49.8 29.8 30.6 46.0 85.9 36.6 68.2 ZNF107 "smap-7, ZFD25, ZNF588" ENSG00000196247 "Zinc finger protein 107" Q9UII5 7 64666083-64711582 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2" "Cell type enhanced" "Detected in many" "B-cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 47.0;REH: 49.5;U-698: 51.2" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.50e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-2)" "unprognostic (4.13e-3)" "unprognostic (1.62e-2)" "unprognostic (2.34e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (5.49e-2)" "unprognostic (7.15e-3)" 2.3 5.9 1.5 8.8 2.5 8.6 8.3 2.9 1.9 6.8 0.7 2.7 2.7 2.9 2.3 2.7 2.7 2.5 1.3 1.8 2.0 2.1 1.6 2.3 16.2 2.8 2.1 4.4 1.6 2.1 1.8 3.1 2.7 3.3 3.5 3.3 4.8 2.6 0.8 7.5 7.7 2.1 2.1 8.5 3.7 2.8 2.1 13.4 5.0 1.8 14.2 3.2 3.6 3.7 6.8 4.1 11.3 19.8 2.6 2.7 8.3 5.0 3.3 7.4 9.8 6.3 6.3 39.6 8.9 3.3 10.0 5.2 12.6 5.1 11.1 9.7 8.5 7.8 6.6 3.5 1.1 14.9 13.3 4.6 3.5 6.4 3.7 3.7 3.7 36.1 13.8 20.2 6.6 5.7 47.0 15.9 22.0 4.2 4.5 49.5 9.1 8.8 3.7 13.3 12.6 10.1 7.8 8.0 5.1 15.6 12.6 9.7 3.2 12.3 5.0 4.7 7.4 9.4 9.1 51.2 2.8 10.0 8.1 12.0 0.7 1.5 3.4 1.7 3.6 9.0 4.6 4.8 1.1 10.1 6.0 5.8 13.7 2.6 1.3 2.8 4.3 1.8 1.5 2.5 2.9 1.9 1.8 2.0 2.8 2.1 2.7 2.1 2.1 3.7 7.9 12.8 4.2 10.4 45.2 2.2 3.2 3.2 8.6 6.2 13.9 5.8 3.8 5.7 5.4 7.3 2.1 2.7 9.0 1.3 1.9 2.6 8.2 5.1 5.7 6.9 6.6 5.9 6.2 3.1 2.4 6.7 5.1 5.9 0.0 15.0 4.2 0.6 1.9 3.3 9.7 2.9 2.0 3.8 1.5 7.8 4.4 4.8 0.0 10.3 1.7 4.1 10.3 22.6 22.1 3.9 2.4 3.4 22.8 3.5 2.0 1.9 3.3 5.7 6.6 4.0 3.9 4.3 4.7 5.5 4.1 2.5 17.9 17.5 3.6 3.8 ZNF552 FLJ21603 ENSG00000178935 "Zinc finger protein 552" Q9H707 19 57803841-57814913 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "breast cancer: 23.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "neutrophil: 25.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 25.3" "Cell line enhanced" "Detected in all" "BEWO: 30.3;RT4: 42.5;T-47d: 69.6" "Low region specificity" "Detected in all" "HPA043800, HPA053762, HPA072145" Uncertain Uncertain Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "HPA043800: AB_2678675, HPA053762: AB_2682252, HPA072145: " "prognostic favorable (4.57e-4)" "unprognostic (2.09e-1)" "prognostic favorable (2.66e-4)" "unprognostic (9.03e-2)" "unprognostic (9.89e-2)" "prognostic favorable (9.96e-4)" "unprognostic (3.03e-2)" "unprognostic (1.29e-3)" "unprognostic (3.36e-3)" "unprognostic (6.72e-2)" "unprognostic (1.93e-1)" "unprognostic (1.18e-1)" "unprognostic (2.24e-3)" "unprognostic (2.41e-2)" "unprognostic (9.01e-2)" "unprognostic (3.09e-1)" "unprognostic (2.04e-3)" 3.0 2.3 3.0 4.7 3.1 8.1 26.0 14.9 6.5 9.8 9.3 9.4 7.1 5.0 5.4 5.5 5.6 8.7 2.9 3.4 3.0 7.1 4.7 6.0 5.3 2.8 2.0 4.2 4.2 6.0 2.5 6.5 2.3 12.4 12.1 4.0 17.5 6.9 4.9 9.7 7.3 3.0 0.5 6.0 13.9 3.0 3.5 5.0 4.1 2.7 5.5 14.7 5.8 3.4 5.6 3.2 3.7 5.9 3.0 1.5 30.3 2.0 2.4 4.5 2.5 9.6 8.8 7.6 3.8 3.6 1.0 4.8 7.6 5.0 5.4 3.4 15.1 2.6 8.4 7.1 7.1 8.5 3.4 3.3 10.9 3.1 3.2 2.8 6.0 8.0 5.5 2.5 3.0 5.0 3.7 2.5 5.2 6.9 7.3 7.6 4.7 8.0 13.4 42.5 4.9 3.5 10.2 22.6 5.1 10.4 69.6 3.5 4.5 3.8 4.2 2.5 3.5 11.0 8.1 6.1 3.1 6.4 2.2 2.1 3.3 7.4 2.7 3.3 2.5 3.7 3.4 4.3 1.7 3.7 4.5 3.8 25.3 2.4 1.4 2.3 3.0 2.4 3.0 3.1 14.9 6.5 3.4 3.0 2.8 2.0 2.3 0.5 3.5 3.4 2.9 12.8 3.1 4.2 7.8 2.5 14.8 9.7 8.0 6.2 19.4 9.8 3.1 18.6 15.0 20.2 2.1 22.1 5.3 9.4 25.4 6.9 5.7 20.2 4.9 3.7 8.4 6.1 7.7 1.8 5.2 3.8 19.4 15.0 8.8 14.2 7.1 4.2 5.2 3.3 8.1 14.5 14.2 2.4 3.1 1.5 2.8 3.6 1.8 1.9 3.1 2.3 2.1 4.5 5.1 3.1 13.4 2.2 4.8 8.3 15.6 4.8 20.5 12.7 6.6 2.9 3.5 3.8 4.6 7.0 2.7 21.3 7.1 5.4 9.3 14.2 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 11 "neutrophil: 28.0" "Lineage enriched" "Detected in many" 11 "granulocytes: 28.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm No No "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA047730: AB_2680136, HPA048668: AB_2680487" "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 2.6 2.7 2.4 2.0 2.8 2.0 5.4 4.7 3.0 3.6 2.9 2.5 2.1 3.6 2.7 3.5 4.0 1.8 4.4 2.7 2.8 3.7 2.4 3.0 2.7 1.4 1.8 6.3 3.3 5.0 2.4 1.8 1.4 4.0 2.6 5.4 4.1 3.4 5.0 8.1 1.8 2.8 0.9 3.5 2.7 3.5 3.2 2.8 4.5 4.4 3.1 2.5 2.0 2.3 2.3 3.9 3.7 7.0 3.7 4.4 2.8 1.8 3.3 2.4 2.7 0.3 1.7 5.3 1.9 1.7 2.6 6.1 3.0 3.5 2.6 0.2 1.9 0.8 3.5 0.8 4.1 3.3 1.8 3.5 7.8 2.4 3.4 5.0 4.8 3.4 1.1 1.0 3.1 1.3 2.7 1.7 3.1 1.6 6.6 0.2 5.9 1.9 2.6 5.9 5.4 3.2 2.8 1.5 2.7 3.9 2.2 8.4 1.1 3.1 4.0 2.8 2.2 0.6 3.2 1.3 1.4 1.2 3.3 0.8 0.7 2.3 0.9 0.6 0.1 0.8 1.3 1.1 0.3 1.6 1.8 1.0 28.0 2.4 0.6 0.6 0.7 0.2 2.4 2.8 4.7 3.0 2.7 2.8 1.4 1.8 1.4 0.9 3.2 2.3 3.9 3.2 3.2 3.3 2.7 0.9 1.3 1.9 9.6 7.3 2.6 3.8 3.5 2.8 2.4 0.0 0.0 2.7 0.3 0.8 15.6 1.4 0.8 2.3 2.8 2.7 0.0 0.4 6.5 0.7 1.1 2.2 1.5 1.3 1.3 5.8 1.4 2.3 1.8 10.1 7.8 1.8 2.0 2.4 0.3 1.2 3.1 0.8 0.0 1.9 0.2 5.1 0.0 4.0 4.5 0.8 0.3 5.3 2.0 0.9 1.3 4.6 7.5 4.3 0.0 3.9 2.0 3.2 2.9 5.4 2.0 1.0 1.3 3.5 1.4 1.8 ZNF746 "FLJ31413, PARIS" ENSG00000181220 "Zinc finger protein 746" Q6NUN9 7 149472696-149497817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020272 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 2: Immune cells - Immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Cytosol" "HPA020272: AB_2670398" "unprognostic (2.66e-1)" "unprognostic (4.94e-2)" "unprognostic (4.27e-3)" "unprognostic (1.80e-2)" "unprognostic (2.10e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.32e-5)" "unprognostic (2.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.33e-1)" "prognostic favorable (4.22e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (7.47e-6)" "unprognostic (2.21e-2)" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" 7.9 8.1 8.2 6.4 7.8 21.5 7.4 8.2 9.6 8.9 4.6 8.2 4.1 8.9 3.6 7.0 8.5 4.1 6.5 10.0 7.7 7.0 9.5 8.5 7.1 9.7 6.8 7.9 7.9 6.0 10.6 5.7 9.3 8.5 3.0 4.8 6.8 3.9 6.4 8.4 7.8 4.3 5.8 15.8 7.4 16.2 7.9 7.4 7.5 4.1 4.5 8.6 7.4 6.9 9.4 14.7 7.6 21.0 8.5 7.3 11.6 9.4 7.6 7.3 6.3 9.4 6.9 13.4 13.3 8.2 10.7 10.1 10.0 10.6 4.4 17.0 14.0 6.5 7.7 13.2 10.3 12.7 16.7 8.1 12.7 6.0 6.6 6.6 7.7 10.8 20.2 10.0 9.4 14.3 29.1 17.2 18.9 5.8 10.1 19.1 7.1 11.8 7.1 11.1 10.8 14.9 12.4 13.5 8.9 4.5 6.3 15.6 10.9 9.2 3.3 16.0 13.9 18.5 9.4 10.7 12.1 10.1 16.6 2.0 0.7 0.8 0.4 0.4 0.4 0.2 0.6 1.0 0.4 0.3 0.7 0.5 6.9 0.4 0.4 0.6 1.1 0.3 8.2 7.8 8.2 9.6 10.0 7.7 9.7 6.8 9.3 5.8 7.9 6.9 6.4 0.0 7.2 8.8 7.6 3.6 5.2 2.6 4.6 15.4 5.4 4.2 7.1 4.3 4.1 11.0 4.2 7.0 11.0 4.3 0.0 3.5 10.9 4.3 8.8 5.7 6.0 17.2 13.8 2.4 6.9 6.6 9.7 4.4 6.3 6.2 5.0 7.4 8.3 26.9 12.8 4.3 4.1 14.2 4.0 16.0 6.2 7.7 3.6 7.5 9.1 7.6 8.2 6.0 8.2 4.1 3.1 6.8 4.9 6.6 2.3 4.2 4.3 11.1 0.0 8.0 5.5 18.3 9.7 6.0 3.4 8.8 8.4 10.1 3.9 5.3 ZNF775 MGC33584 ENSG00000196456 "Zinc finger protein 775" Q96BV0 7 150368790-150398630 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 21.2;Granulosa cells: 26.5;Horizontal cells: 30.3;Muller glia cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 18.9;RPMI-8226: 23.0" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (9.67e-3)" "unprognostic (6.96e-2)" "unprognostic (1.06e-2)" "unprognostic (8.47e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (5.65e-2)" "prognostic favorable (1.35e-5)" "unprognostic (1.49e-1)" "prognostic favorable (2.84e-4)" "unprognostic (1.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.84e-2)" "unprognostic (1.28e-2)" 3.3 3.7 9.1 2.6 12.2 1.7 3.1 10.1 10.1 6.9 5.1 9.8 3.0 7.4 1.8 2.3 6.2 1.1 4.5 7.9 7.6 3.6 1.7 3.3 3.0 11.2 10.1 8.8 3.8 2.1 7.1 1.4 9.5 6.3 1.9 2.4 3.0 2.4 5.4 3.0 4.1 1.4 9.1 4.2 4.0 6.3 10.8 3.4 3.6 1.0 2.0 6.4 4.0 13.7 1.4 4.4 4.7 4.5 1.6 1.6 1.2 1.9 2.5 2.4 3.1 1.4 3.7 6.3 4.8 1.2 4.3 1.7 1.5 1.7 0.2 10.1 6.5 4.4 1.0 2.6 3.6 1.1 1.8 1.8 2.2 2.9 0.5 2.6 4.2 7.8 9.9 4.7 1.4 1.2 18.9 4.9 14.4 2.6 6.9 8.9 7.4 23.0 0.4 1.5 13.8 18.3 1.7 0.5 6.9 3.7 1.0 3.8 3.8 5.1 2.9 3.9 3.7 9.5 3.6 4.5 5.0 4.3 5.7 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.1 9.1 12.2 10.1 10.1 7.9 7.6 11.2 10.1 9.5 9.1 10.8 13.7 3.9 0.0 0.0 9.4 8.9 2.7 0.8 2.8 0.6 21.2 2.2 4.7 8.1 0.0 1.4 0.0 10.4 1.3 2.4 7.1 0.0 0.9 2.5 2.9 3.8 4.3 15.6 0.4 1.4 0.6 1.0 3.2 1.5 2.0 4.5 26.5 1.4 1.2 3.1 30.3 2.1 7.1 2.0 1.2 6.2 1.3 4.1 1.7 5.4 3.7 1.6 29.0 3.1 5.0 11.5 1.0 2.5 4.9 1.2 1.3 1.6 1.1 2.5 13.7 0.0 4.4 6.4 1.4 2.1 0.2 3.8 0.4 2.5 12.8 7.7 0.1